Improving continuous crystallisation using process analytical technologies: design of a novel periodic flow process by Keddon A. Powell (1515973)
  
Improving Continuous Crystallisation 
Using Process Analytical Technologies: 
Design of a Novel Periodic Flow Process 
Keddon Andre Powell 
Supervisors: Prof. Chris D. Rielly and Prof. Zoltan K. Nagy 
A thesis submitted for the degree of Doctor of Philosophy at the Department of Chemical 
Engineering, Loughborough University, United Kingdom. 
Submitted: October 19th, 2015. 
Dedication 
 
 
 
 
 
This work is Dedicated to the late Jennifer ‘Claire’ Gowie 
My friend, my angel and wonderful mother. 
iii 
 
Declaration 
 
 
 
 
 
I declare that the work as presented in this thesis is my own except as acknowledged 
in the text and has not been submitted either in whole or in part, for a degree at this 
or any other institution. 
 
 
  
iv 
 
Acknowledgements 
Late evenings, long nights, weekends and holidays, what a life it is to be a PhD student, or was 
it just me? I can’t say I would do anything any differently, the sweat, the tears, the highs and 
lows, the YES! moments have all led to this final piece. Need I say it, the Doctoral Thesis! I can 
safely say it was all worth it! I would like to express my deepest gratitude to all those who 
contributed invaluably to the work presented herein and to those who helping me get though the 
phases, the good, the bad and the in-between times. To my academic supervisors Prof. Chris 
Rielly and Prof. Zoltan Nagy, thank you immeasurably for granting me the opportunity to embark 
on this challenging, but fulfilling experience with you. I want to thank you for your invaluable 
advice, direction, encouragement and for discussions which clarified my thoughts and approach 
to this research project and other more matters. Thank you for allowing me the freedom to 
pursue different projects without interference. 
A very special thank you to the academic, research, technical, administrative and ancillary staff 
in the Chemical Engineering Department. Tony Ayre for his fun friendly spirit, his patience and 
understanding, and assistance with designing and building my experimental rig, Sean Creedon 
and lab technician team for assistance with procuring the consumables for my project and for 
providing training on various pieces of equipment in the department. Yasmin, what would I do 
without you, with your cheeky sense of humour, cheerful and infectious personality, thank you. 
To my colleagues in the crystallisation group and the wider CMAC community past and present, 
Ali Saleemi, Ani, Qing Lin, Akos and Elena (Loughborough University), Kate Wittering and Chick 
Wilson (University of Bath), Natalia Dabrowska (University of Strathclyde), thank you for the 
advice on several aspects of my project and your contribution to this work.  
My friends William, Flora, Dimitris and Emmanuel, thank you for all the fun times in 
Loughborough and elsewhere. I had a blast hanging out with all of you, cheers to summer 
barbeques, great nights, a party or two, a drink or few and all the lively discussions on various 
subjects. Thank you also for organising the many social events that made my experience at 
Loughborough University truly memorable. 
To Sean and the subwarden team and the Campus Living staff in Butler Court, thank you all for 
making my experience in Halls a truly amazing one, I will surely miss you all. I had a great time 
during my subwardenship and have learnt so much from the experience. 
To my family and friends in Jamaica, USA, Canada, Ireland, Germany, the Czech Republic and 
the Dutch Caribbean who offered words of encouragement through the tough times and for 
v 
 
sharing a joke or two to cheer me up, thank you for your love and support, for always being there 
and listening to my troubles Brie (my best), April, Saba, Dermot, Florian, Henry and Ronald. 
Finally, I would like to express special thanks to the EPSRC, ERC and the wonderful people at 
CMAC for financial support and equipment thought my PhD project. 
vi 
 
Abstract 
In this thesis novel configurations and operating strategies in the mixed suspension mixed 
product removal (MSMPR) crystalliser are investigated, aided by integrated process analytical 
technologies (PAT) and crystallisation informatics system (CryPRINS) tools. The MSMPR is 
an idealised crystalliser model that assumes: steady-state operation; well mixed suspension 
with no product classification, such that all volume elements contain a mixture of particles 
(small and large) and crystal size distribution (CSD) that is independent of location in the 
crystalliser and is identical of the product withdrawn; and uniform supersaturation thought, 
leading to constant nucleation and growth rates.  Single-stage MSMPR designs with 
continuous recycle/recirculation and modified heat exchanger were investigated and found to 
minimise fouling, encrustation and transfer line blockages. In particular, a modified MSMPR 
with baffled heat exchanger was found to significantly reduce the temperature between 
incoming feed hot feed solution and the cooled crystalliser, leading to a significant reduction 
in fouling, encrustation and blockages.  
In addition, the concept of the periodic mixed suspension mixed product removal (PMSMPR) 
crystallisation process is demonstrated for the first time viz single- and multi-stage cascaded 
operations. This method of operation involves the periodic transfer of slurry (addition and 
withdrawal) at high flow rates from either a single stirred vessel or between a number of stirred 
vessels arranged in series. The PMSMPR is therefore characterised by periodic withdrawals 
of product slurry. Similar to the MSMPR, the product withdrawn from a PMSMPR has exactly 
the same composition as the vessel at the time of removal. The rapid withdrawal of slurry at 
high flow rates in PMSMPR operation leads to the prevention of particle sedimentation and 
blockage of transfer lines. The transfer of slurry (to/from) the PMSMPR is followed by a holding 
(or pause) period when no addition or withdrawal of slurry takes place. The holding period 
extends the mean residence time of the PMSMPR relative to a typical MSMPR, thereby 
increasing the yield and productivity of crystallisation as more time is allowed for consumption 
of available supersaturation viz crystal growth and nucleation. A “state of controlled operation” 
(SCO) in the periodic flow process, defined as a state of the system that maintains itself 
despite regular, but controlled disruptions was characterised using the PAT tools and 
CryPRINS within an intelligent decision support (IDS) framework.  
The crystallisation of paracetamol (PCM) from isopropyl alcohol (IPA) using different 
configurations of a single-stage continuous MSMPR crystalliser that incorporated continuous 
recycle and recirculation loop, and a novel design with baffled heat exchanger was 
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investigated. Crystallisations of PCM-IPA carried out in the MSMPR without heat exchanger 
suffered from severe fouling, encrustation and blockage problems due to the high level of 
supersaturation (S = 1.39) in the crystalliser, which was required for the initial burst of 
nucleation to generate enough particles for later growth, as well as the large temperature 
difference between the incoming feed (45 oC) and the crystalliser (10 oC). Using the modified 
MSMPR design with baffled heat exchanger, the challenges of fouling, encrustation and 
blockage were significantly reduced due to the rapid lowering of the feed stream temperature 
prior to entering the crystalliser. In addition, the closed loop system led to conservation of 
material, which is a great benefit since large amounts of materials would otherwise be required 
if the MSMPR was operated with continuous product removal. This design is great for research 
purposes, in particular, to investigate process design and optimisation.  
Continuous crystallisation of PCM in the presence of hydroxyl propyl methyl cellulose (HPMC) 
additive was investigated in the modified MSMPR design with heat exchanger. HPMC was 
found to improve the crystallisation performance, leading to complete avoidance of fouling, 
encrustation and blockages at a concentration of 0.05 wt%. However, the yield of 
crystallisation was significantly reduced (28.0 %) compared to a control experiment (98.8 %, 
biased due to fouling/encrustation) performed without additive addition. Regardless, the 
productivity of crystallisation was more than four times that achieved in batch linear cooling 
(LC) (0.62 – 0.86 g/L-min) and batch automated dynamic nucleation control (ADNC) (0.24 – 
0.25 g/L-min) runs.  
 Aspects of the periodic flow crystallisation of single- and multi-component (co-crystals) 
molecular systems have also been examined to demonstrate the concept of “state of 
controlled operation”. The single component systems studied were PCM and glycine (GLY), 
each representative of compounds with slow and fast growth kinetics, respectively. The co-
crystal systems investigated were urea-barbituric acid (UBA) and p-Toluenesulfonamide-
Triphenylphosphine oxide (p-TSA-TPPO). UBA is a polymorphic co-crystal system with three 
known forms (I, II and III). Form I UBA was successfully isolated in a three-stage periodic flow 
PMSMPR crystalliser. This study demonstrates the capability of periodic flow crystallisation 
for isolation of a desired polymorph from a mixture. p-TSA-TPPO exists in two known 
stoichiometric co-crystal forms, 1:1 and 3:2 mole ratio p-TSA-TPPO, respectively. The two 
crystalline forms exhibit solution mediated transformation, which proves to be a difficulty for 
separation. For this study, the implementation of temperature cycles in batch and flow control 
in semi-batch and periodic PMSMPR crystallisers were investigated to isolate pure 1:1 and 
3:2 p-TSA-TPPO, respectively. Different regions of the ternary diagram of p-TSA, TPPO and 
acetonitrile (MeCN) were investigated. The desired co-crystal form was isolated all 
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crystallisation platforms investigated. However, greater consistency was observed in the semi-
batch and PMSMPR operations respectively. 
Periodic flow crystallisation in PMSMPR is a promising alternative to conventional continuous 
MSMPR operation, affording greater degrees of freedom operation, slightly narrower RTD 
profiles, consistent product crystal quality (size, shape and distribution), longer mean 
residence times, higher yield and productivity and significant reduction in fouling, encrustation 
and transfer line blockages over prolonged operating periods. Furthermore, the PMSMPR is 
a versatile platform that can be used to investigate a range of different molecular systems. 
Relative to batch operation, the PMSMPR can operate close to equilibrium, however, this is 
dependent on the system kinetics. In addition, retrofitting of batch crystallisers to operate as 
PMSMPRS fairly simple and require only subtle changes to the existing design space. 
The integrated array of PAT sensors consisted of attenuated total reflectance ultra 
violet/visible spectroscopy (ATR-UV/vis), attenuated total reflectance Fourier transform 
infrared spectroscopy (ATR-FTIR), focused beam reflectance measurement (FBRM), particle 
vision microscopy (PVM) and Raman spectroscopy. The results from the studies reported here 
illustrate very well the use of PAT and information system tools together to determine when 
the continuous and periodic MSMPR operations reaches a steady-state or state of controlled 
operation (i.e. periodic steady-state). These tools provided a better understanding of the 
variables and operating procedures that influence the two types of operations. 
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Chapter 1 
Thesis Overview 
Aspects of the industrial crystallisation and manufacture of speciality fine chemicals, 
specifically, pharmaceutical and agrochemical active ingredients are discussed. In particular, 
an assessment of crystallisation methods (batch and continuous), specifically, the benefits 
and limitations of implementing continuous crystallisation methodologies are addressed. 
Process monitoring and control strategies, and the implementation of process analytical 
technologies (PAT) in the design space to tailor product critical quality attributes (CQA) 
applying quality by design principles (QdD) are highlighted. Gaps have been identified where 
process improvements could be made through implementation of innovative continuous 
crystallisation operating strategies, and control approaches aided by PAT. In this thesis, viable 
solutions are proposed that could facilitate a transition from batch to continuous manufacturing 
and crystallisation. A novel continuous crystallisation process known as periodic flow mixed 
suspension mixed product removal (PMSMPR) crystallisation is introduced. A new concept 
“state of controlled operation”, rather than “steady-state” is used to describe when the periodic 
operation is under control. An automated intelligent decision support (IDS) framework, 
enabled by PAT and information systems that were used to monitoring and control the periodic 
flow process is discussed. Experimental investigations and mathematical modelling aspects 
are also reported. The overall aim is to provide an engineering design that is amenable to 
adoption in commercial plants and robust on scale-up to industrial production capacity. An 
overview of the fundamental aspects of the thesis objectives is henceforth presented, and the 
significant contributions of the work highlighted. An outline of the thesis structure is presented 
toward the end of this chapter.  
1.1 Motivation 
Crystallisation is an important unit operation in the chemical industries, widely used for 
separation and purification of active pharmaceutical ingredients (APIs), active agrochemical 
ingredients (AAIs), intermediates and food products, petrochemicals and various other 
speciality and high value products. The primary objective of crystallisation is to produce high 
quality crystalline material from liquids (melt or solution). The process requires specific 
attention to yield, size, shape, distribution and purity of the product crystals. These critical 
quality attributes (CQA) can have a significant impact on downstream unit operations such as 
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filtration, washing, drying, milling and product formulation as well as impact on the 
physicochemical properties of the crystalline material, for example, the solubility, rate of 
dissolution and permeability [1]–[4]. In addition to the aforementioned, pharmaceutical 
products require special attention to the API solid form, specifically: polymorphism (e.g. 
metastable forms), salts, solvates, glycosylated derivatives (i.e. acetals of saccharides), and 
more recently multi-component molecular systems such as co-crystals. Invariably, the 
properties of an API solid form are directly linked to the oral bioavailability of a drug, which is 
very important to pharmaceutical manufacturers, since this will ultimately determine the 
commercial success of the drug product [3]. Figure 1.1 summarises the main aspects of 
industrial crystallisation, and includes the objectives (or functions), product properties (or 
CQA), modes of operation and kinetics of crystallisation. 
 
Figure 1.1: Schematic showing the main aspects of crystallisation including, objectives 
(or functions), product properties (or CQA), operation modes, and kinetics of crystallisation. 
On an industrial scale, crystallisation may be achieved using batch or continuous operation. 
The choice of operation depends largely on the process requirements, for example, the 
physicochemical characteristics of the material to be crystallised, desired production capacity, 
type of solvent system, operating temperature and pressure, supersaturation level, desired 
mixing characteristics, heat exchange and other energy requirements, construction materials, 
cleaning requirements and the desired crystal size distribution (CSD) [5], [6]. In addition, the 
economics of the process is another important factor to consider, for example, the costs of 
construction, materials, utilities and labour [2], [7]. In the fine chemicals sector, crystallisation 
is typically achieved using large stirred tank batch or semi-batch crystallisers. While the 
methodologies for developing these processes are reasonably well understood, there are still 
significant issues with batch-to-batch variability, which leads to disruption of downstream unit 
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operations [8], [9] due to the production of off-spec product that either requires rework or has 
to be discarded. Consequently, in recently years the case for a transition from batch to 
continuous manufacturing and crystallisation has gained momentum. The benefits of 
continuous relative to batch operation is a well debated topic [2], [10]–[12]. For example, 
continuous processes operate at “steady-state”, which could potentially lead to more 
consistent product quality. Other benefits include, smaller equipment size leading to a 
reduction in capital expenditure; and the capacity for recycling, for example, spent process 
liquor and fines to reduce wastage and raw materials usage [2], [13]. However, continuous 
manufacturing (specifically crystallisation) has been an ad hoc research field for the past 
decade, in which there have been campaigns for the development and adoption of next 
generation continuous technologies for pharmaceutical and fine chemical industries [14], [15]. 
In order to develop a good continuous process, all the unit operations being considered should 
be first studied separately in order to develop a better understanding [16]. Generally, there are 
two types of continuous crystallisers that are most investigated, namely the tubular and the 
stirred-tank designs [17]. These two designs help to achieve, ideally, the plug-flow [18] and 
the mixed-suspension mixed-product removal (MSMPR) operations [19], respectively. While 
derivatives of these two designs have resolved some of the practical concerns related to 
continuous crystallisation processes, such as the continuous oscillatory baffled crystalliser 
(COBC) to deal with sedimentation of crystals due to low Reynolds number in straight tubes 
[20], the multi-segment multi-addition plug-flow crystalliser (MSMA-PFC) to implement 
supersaturation control [21], [22] or fines dissolution along the tube [23] and cascaded multi-
stage continuous MSMPR crystallisers to enhance product yield [13], [24] there remains some 
unresolved challenges. For example, the important issue of material residence time in these 
two continuous crystallisation platforms has rarely been addressed. In addition, persistent 
fouling and encrustation on vessel walls and process equipment and transfer line blockage 
[13], [25] are challenges that need to be addressed to successfully demonstrate the merits of 
continuous over batch operation. This thesis project seeks to address some of these 
challenges by providing alternative engineering designs that facility process optimisation and 
control, whilst avoiding some practical operating problems. To this end, a novel periodic flow 
crystalliser was developed using mixed suspension mixed product removal (MSMPR) 
operation. Usually, MSMPR crystallisers are operated with continuous feed supply and 
product withdrawal to and from the vessel(s). With a certain amount of operating volume, it is 
often necessary to reduce the stream flow rates of MSMPR crystallisers to obtain enough 
residence time for crystals to grow, which often leads to particle setting, fouling and transfer 
line blockages between stages. In a periodic flow MSMPR or periodic mixed suspension mixed 
product removal (PMSMPR) crystalliser, periodic disruptions are applied to the inlet and outlet 
flows of an otherwise continuous MSMPR, either synchronously or asynchronously, to 
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manipulate the RTD profile. This is achieved by implementing a holding (or batch) period 
between flow disruptions, which, for example, is able to significantly increase the mean 
residence time for slow growing crystallisation systems. By intermittently increasing stream 
flow rates between stages, sedimentation, fouling and line blockages can be avoided. Notably, 
the PMSMPR crystalliser is a hybrid of batch and continuous MSMPR, and if the transient 
effects caused by periodic flow are controlled within narrow limits in the design space, then 
the final crystal product attributes will be maintained in a “state of controlled operation” (SCO), 
as required by FDA regulations [26].  
In recent years, the development of in situ sensors, that is, process analytical technologies 
(PAT) has led to the widespread application of various measurement techniques in 
pharmaceutical and fine chemical research laboratories [27]–[29]. PAT tools (or sensors) are 
often used simultaneously to monitor crystallisation processes, but often the data acquired are 
not combined, interpreted and applied in real time [29], [30]. Recently, the concept of 
composite sensor arrays (CSA) was introduced [30]. CSA is based on the idea that all sensors 
used in a crystallisation process are components of a single global sensor, which allows 
simultaneous signal acquisition from all devices for the purposes of automation, real-time 
decision support, and feedback control of the process. In the current work, the various sensors 
of the CSA are coordinated by a crystallisation process informatics system tool (CryPRINS) 
[31]. Figure 1.2 (adapted from Nagy et al [29]) provides a schematic showing how multiple 
process and quality properties can be monitored in real-time, and simultaneously using all 
signals from a number of sensors for automated intelligent decision support (IDS), and direct 
feedback control of a crystallisation process. 
 
Figure 1.2: Schematic showing the architecture of the crystallisation process informatics 
system with composite sensor array and industry standard communication interface with 
distributed control system. Adapted from [29], [31]. 
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The application of CSA in the continuous manufacturing and crystallisation design space could 
potentially revolutionise the pharmaceutical and fine chemical processing by directly 
facilitating the Food and Drug Administration’s (FDA) Quality by Design (QbD) principle, and 
leading to better control of product CQA. Until now, the PAT and CSA approach has only been 
applied to batch crystallisers. In this thesis project, an array of PAT tools, including sensors 
for monitoring particle size, distribution and form, as well as temperature and concentration 
sensors integrated with a CryPRINS software tool were used to monitor and improve batch, 
continuous and periodic flow crystallisation processes. In particular, the continuous and period 
flow processes were monitored and controlled in real-time and “steady-state” and “state of 
controlled operation” (SCO) determined viz. the implementation of an IDS framework.  
1.2 Aim and Objectives 
The overall aim of this thesis is to provide novel alternative engineering designs of the 
continuous MSMPR crystalliser that are amenable to adoption in commercial plants and robust 
on scale-up to industrial production capacities. The objectives that support the principal aim 
of this thesis are as follows:  
I. Highlight gaps in the literature where process improvements could be made toward 
the design and development of the next generation of continuous crystallisation 
technologies. 
II. Design and application of a novel periodic flow mixed suspension mixed product 
removal (PMSMPR) crystalliser that addresses the issue of limited residence time 
distribution (RTD) control in continuous MSMPR operation. This PMSMPR operation 
lends itself to robust process control viz. controlled periodic disruption of the feed and 
outlet flow rates.  
III. A further aim is to mitigate fouling, encrustation, and line blockages issues often 
encountered in continuous MSMPR operations, by using innovative operating 
strategies in the PMSMPR. Furthermore, the performance characteristics of PMSMPR 
crystalliser compared to batch and continuous equivalents in terms of residence time, 
yield, productivity, product critical quality attributes (i.e. size, shape and distribution) 
and polymorph control are examined.  
IV. The effect of the amplitude of perturbations caused by PMSMPR operation are 
examined by investigation and comparison of different operating strategies, including: 
operating with and without recycle stream (concentrate or non-concentrated), seed 
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type and loading, and aspects of coupled (or synchronous) versus de-coupled (non-
synchronous operation). 
V. Demonstrate the use of the periodic flow crystallisation process in single-stage and 
multi-stage cascaded PMSMPR operations for the crystallisation of single-component 
and multi-component (i.e. co-crystal) molecular systems that exist as polymorphs or 
other crystalline forms. 
VI. Introduce the concept of “state of controlled operation” (SCO) (or “periodic steady-
state”) instead of “steady-state” operation to describe when the PMSMPR operation is 
under control. Furthermore, experimental and mathematical evaluation of the 
PMSMPR crystallisation process is investigated, aided by PAT and CryPRINS to 
improve process understanding for optimisation of product properties. Parameter 
estimation, process simulation and modelling aspects were implemented using 
Process Systems Enterprise (PSE) gCRYSTAL 4.0 software package. 
VII. Develop multivariate calibration models from spectroscopy data (namely, attenuated 
total reflectance ultraviolet/visible (ATR-UV/vis) and Fourier transform infrared (ATR-
FTIR), and Raman spectroscopy) using statistical approaches such as principal 
component regression (PCR), partial least squares regression (PLSR) and multiple 
linear regression (MLR) for real-time concentration determination and quantification of 
polymorphic or other crystalline forms during batch, continuous and PMSMPR 
crystallisations.  
VIII. Demonstrate the application of an integrated array of PAT tools inclusive of particle 
monitoring techniques, such as focused beam reflectance measurement (FBRM) and 
particle vision microscopy (PVM); and spectroscopy techniques, including ATR-FTIR 
and ATR-UV/vis (used for solution phase monitoring) and Raman (polymorphic form 
identification and solution phase monitoring) together with CryPRINS software within 
an IDS framework for monitoring and implement control in batch, continuous and 
PMSMPR operations. 
1.3 Research Methods 
The modified MSMPR crystalliser design reported in this thesis incorporates a baffled heat 
exchanger to minimise temperature fluctuations as hot feed solution enters the pre-cooled 
MSMPR crystalliser. MSMPR provides a different supersaturation trajectory though the phase 
diagram compared to batch operation, which could allow better product crystal CQA to be 
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attained, that is, in terms of mean size and CSD, polymorphic form and purity [32], whilst 
operating at steady-state. The effect of different operating regimes, in terms of initial saturation 
temperature of feed, MSMPR stage temperatures, seeding and anti-solvent addition are 
investigated.  
The novel periodic flow PMSMPR crystallisation process can create customised elaborate 
RTD profiles in order to tailor the product CQA while applying QbD principles in the design 
space, that is, quality assured by better product and process understanding. Usually, the 
MSMPR is operated with continuous feed supply and product withdrawal to and from the 
crystalliser viz. the continuous MSMPR crystallisation operation. By convention, in order to 
maintain a constant operating volume and sufficient residence time for the crystals to grow in 
the continuous MSMPR, it is necessary to reduce the stream flow rates, which often leads to 
transfer line fouling and blockage issues. The periodic flow crystallisation process using 
MSMPR (or PMSMPR) crystalliser is a novel operation whereby periodic disruptions are 
applied to the inlet and outlet flows of an otherwise continuous MSMPR, either synchronously 
or asynchronously, to manipulate the RTD. In this method of operation, a holding (or batch) 
period is implemented between flow disruptions, which for example is able to significantly 
increase the mean residence time for slow growing systems. In addition, it also benefits from 
the intermittent increase of stream flow rates, which helps to alleviate the usual transfer line 
fouling and blockage issues encountered in existing continuous operations. Periodic flow 
operation can also be applied to cascaded multi-stage PMSMPR crystallisers to facilitate 
controlled nucleation and gradual crystal growth in the phase diagram. Different operating 
strategies are investigated in the PMSMPR to manipulate the product CQA, namely, the length 
of the batch cycle, seed loading and supersaturation (viz. stage temperature manipulation). 
Factors such as temperature, supersaturation, nucleation, growth, breakage and 
agglomeration were controlled by applying different cooling and/or anti-solvent crystallisation 
strategies. Mathematical modelling approaches combined with experimental investigations 
using PAT tools and multivariate statistical methods are also exploited in order to improve 
process understanding. The information gained can then be applied to optimise the MSMPR 
and PMSMPR operations to target specific product CQA. 
1.4 Research Contribution 
The significant contributions of this work are as follows: 
I. Different combinations of pre-treatment/processing methods for chemometrics model 
building, including derivatives, mean centering, auto-scaling, normalisation routines 
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and scatter correction techniques were applied to the spectral data obtained viz. ATR-
UV/vis, ATR-FTIR and Raman spectroscopy, principally for noise reduction and 
baseline correction. Following data pre-treatment, different combinations of model 
development algorithms were (PCR, PLSR and/or MLR) were applied to extract 
information pertaining to the concentration of the analyte (or solute) of interest. 
Multivariate models were developed to determine the concentration of a single analyte 
or multi-analytes concomitantly. This study also demonstrates that Raman 
spectroscopy is capable of monitoring solution concentration when the appropriate 
multivariate techniques are applied to the spectral data. 
II. The IDS framework consisting of integrated array of PAT tools and CryPRINS 
informatics systems software proved very useful for monitoring and control of the 
various crystallisation processes investigated in this thesis whilst also giving an 
indication of when a controlled state of operation (i.e. steady-state or SCO) is achieved. 
The IDS was also able to detected process disturbances and drifts arising from transfer 
line blockages, flow rate changes and fouling. These effects were easily captured as 
large signal fluctuations of the PAT and temperature sensor signals.  
III. The novel periodic PMSMPR crystalliser design shows great promise in addressing 
many of the challenges of adopting current generation continuous crystallisers, such 
as fouling and encrustation, classified slurry withdrawal and insufficient residence time 
for crystal growth. The PMSMPR is a hybrid operation that incorporates the beneficial 
aspects of batch (long residence time for crystal growth) and continuous crystallisation 
(consistent product quality) operation. If the transient effects caused by periodic flow 
operation are controlled within narrow limits in the design space, then the final crystal 
product attributes will be maintained in a “state of controlled operation” (SCO), as 
required by FDA regulations. “State of controlled operation” (SCO) is demonstrated in 
this work for the first time. PMSMPR is able to significantly increase the mean 
residence time for slow growing crystallisation systems without further broadening the 
CSD (i.e. relative to continuous MSMPR operation). There are also benefits from the 
intermittently operated feed addition and slurry withdrawal streams: increasing the flow 
rates of these streams over short periods, helps to alleviate the usual classified product 
withdrawal and transfer line fouling and blockage problems often experienced in 
conventional MSMPR operations. A dynamic residence time distribution model was 
applied to simulate RTD profiles of conventional MSMPR and periodic flow PMSMPR 
crystallisers, respectively. It was proven that the latter extends the mean residence 
time of slurry in the crystalliser without further broadening the RTD. 
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IV. The periodic flow PMSMPR operation was used for the crystallisation of fast and slow 
growing single-component systems, namely, glycine (GLY) and paracetamol (PCM); 
and multi-component co-crystals systems, namely, urea-barbituric acid (UBA) and 
p-Toluenesulfonamide-Triphenylphosphine (p-TSA-TPPO). Crystal growth of PCM 
was marginal in the PMSMPR, whereas significant increase in size was observed for 
GLY. In both cases, narrow CSD were obtained relative to the seed crystals used. UBA 
co-crystal polymorphs, form I and III that exhibit strikingly similar solubilises and overall 
physicochemical properties were crystallised in the PMSMPR and the conditions for 
isolation of UBA form I optimised. The 3:2 and 1:1stoichiometric co-crystals of the p-
TSA-TPPO system were both successfully isolated using the PMSMPR by 
manipulating the mass fraction composition of the starting materials in the crystalliser 
viz. flow rate adjustments. These examples demonstrate the versatility and flexibility 
of the PMSMPR compared to batch and continuous MSMPR operations. 
1.5 Thesis Outline 
This work has sought to improve continuous crystallisation with the aid of PAT tools. In this 
thesis alternative engineering designs of continuous MSMPR crystallisers are presented and 
that were fully characterised using integrated PAT and informatics systems tools to achieve 
better process understanding. This thesis consists of a further seven chapters organised as 
follows: 
I. Chapter 2: Literature Review: Continuous Crystallisation and Multivariate 
Statistical Process Monitoring. This chapter provides a detailed review of the 
literature on different aspects of continuous crystallisation, including the operating 
principles of the different platforms available, application of PAT and multivariate 
methods for process characterisation, parameter estimation and mathematical 
modelling, crystallisation kinetics, polymorphism and co-crystallisation. 
II. Chapter 3: Materials and Experimental Methods. In this chapter detailed 
descriptions of the materials (chemicals and solvents), analytical techniques and 
experimental methodologies employed in the studies reported in this thesis are 
provided. It includes a description of the instrumentation used and experimental 
parameters implemented. Details of multivariate calibration model development using 
various spectroscopy techniques are also included. 
III. Chapter 4: Comparative Investigation of Batch and Continuous Crystallisation 
of Paracetamol Using PAT. In this chapter, optimised batch (viz. linear cooling (LC) 
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and automated dynamic nucleation control (ADNC)) and continuous crystallisation (viz. 
different MSMPR configurations, including the modified MSMPR) methods are 
investigated and compared on the bases of product mean size and CSD, extent of 
agglomeration, process yield, and productivity for the crystallisation of PCM form 
isopropyl alcohol (IPA) and water (used both as solvent and anti-solvent). MSMPR 
seeded crystallisation experiments were carried out in single-stage and two/three-
stage cascaded crystallisers with or without recycle employed. Where a recycle stream 
was used, concentrated or non-concentration streams, respectively, were investigated. 
IV. Chapter 5: Periodic Flow Crystallisation of Paracetamol: Example of a Slow 
Growing API. In this chapter a novel periodic flow crystallisation process, that is, 
PMSMPR, is designed and built. The PMSMPR was used to investigate the 
crystallisation of PCM from IPA. PCM is a well-known slow growing single-component 
API system. Different configurations of the PMSMPR, including, single-stage and 
two/three-stage cascades operated either with or without recycle stream are 
investigated. In addition, the effect of supersaturation, seed type and seed loading are 
investigated. The effects on the different operating strategies on the crystallisation 
outcome are quantified and compared to batch operation. The concepts of “state of 
controlled operation” (SOC) or “periodic steady-state” are introduced and used to 
describe when the PMSMPR operation achieves a controlled state of operation aided 
by PAT tools and CRYPRINS.  
V. Chapter 6: Periodic Flow Crystallisation of Glycine: Example of a Fast Growing 
API. In this chapter, the novel concept of periodic flow crystallisation which is described 
in detail in Chapter 5 was applied to the crystallisation of GLY from water. Dynamic 
RTD models of the continuous single-stage MSMPR and the periodic PMSMPR 
crystallisers are developed and compared. Experimental evaluation of the PMSMPR 
was carried out using single-stage and three-stage cascades. Coupled and decoupled 
modes of period operation were investigated. The effect of product withdrawal location 
(bottom valve versus outlet tube withdrawal) on the product attributes are investigated 
and compared. Mathematical models of the PMSMPR crystallisers are developed 
using Process System Engineering’s gCRYSTAL 4.0 software. The crystallisation 
mechanisms and kinetics of the GLY-H2O system are estimated from batch 
crystallisations and validated with periodic flow crystallisations in three-stage 
PMSMPR. 
VI. Chapter 7: Periodic Flow Crystallisation of Co-Crystals Using PMSMPR: Case of 
Urea-Barbituric Acid. In this chapter the periodic flow crystallisation concept is 
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extended to the crystallisation of the multi-component co-crystal system UBA. 
Co-crystals can often have several polymorphs, just as in single-component molecular 
systems. In this study, the co-crystallisation and isolation of desired polymorphs of the 
UBA co-crystal system, which has three known polymorphic forms, I, II and III is 
investigated and the experimental conditions optimised. Different start-up strategies 
and temperature sets are investigated using different configurations of a three-stage 
cascaded PMSPMR. PAT and off-line solid-state characterisation methods are 
employed to determine when SCO is achieved and to determine the co-crystallisation 
outcomes.  
VII. Chapter 8: Design of Agrochemical Co-Crystallisation Processes: Isolation and 
Characterisation of 1:1 and 3:2 Co-Crystals of p-Toluenesulfanomide 
/Triphenylphosphine Oxide. In this chapter, the selective co-crystallisation and 
subsequent characterisation of stoichiometric forms of the p-Toluenesulfanomide 
/Triphenylphosphine (p-TSA-TPPO) agrochemical co-crystal system is investigated. 
Different regions of the ternary phase diagram of the co-crystals system are explored 
and the conditions optimised for producing the desired form of p-TSA-TPPO in batch, 
semi-batch and PMSMPR crystallisers. Temperature cycling (via direct feedback 
control using a Raman sensor) and flow rate manipulation are investigated to control 
the co-crystallisation outcome in the different crystalliser platforms and the results 
compared.
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Chapter 2 
Literature Review: Continuous Crystallisation and 
Multivariate Methods 
In the pharmaceuticals sector, batch crystallisation is a simplified tried and true approach that 
has been used for decades and has served well for both industry and regulatory bodies [33]. 
In comparison, other industries such as petrochemical and food manufacturing have moved 
to continuous crystallisation technologies for the production of a range of materials, driven 
mainly by cost and quality considerations. A recent comparison of batch and continuous 
manufacturing by Kossik [34] highlights some of the reasons, other than tradition, why the 
pharmaceutical industry is dominated by batch processes. The primary driver for other 
industries that adopt continuous manufacturing is the reduction in operational costs due to the 
economies of scale (i.e. high tonnage, but low value), reduction in labour costs and increased 
use of automation. Other factors that influenced the decision to adopt continuous 
manufacturing include the desire to reduce the size of and number of manufacturing plants, 
enhanced reproducibility and control of physical characteristics of the product and the ability 
to respond rapidly to market demand (i.e. with respect the amount of material 
required/produced). In recent years the pharmaceutical industry and FDA have both come to 
an agreement that an overhaul of the manufacturing regulations that apply to innovative 
processing methods will prove beneficial for the patient that both of them serve [35]. In fact 
the industry and the FDA are working together in several joint initiatives to apply new Quality 
by Design (QdD) approaches to replace existing and less effective Quality by Testing (QbT) 
methods [36]. In this chapter a brief, but detailed review of the current-state-of-the-art in 
continuous manufacturing and crystallisation, including aspects related to process analytics 
and multivariate, structure-based design and isolation of different crystalline forms is 
presented. 
2.1 Introduction 
Continuous crystallisation has long been a standard method used for the purification of bulk 
commodity chemicals such as salt and sugar due to the many practical and economic benefits 
[6]. The earliest attempt at continuous crystallisation was reported back in 1908 by the 
Ukrainian Zapiski Orosianikov who operated eight crystallisers in series for 50 days at a sugar 
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factory in Mironovka, Kiev [37]. In the pharmaceutical and fine chemicals industries, 
continuous crystallisation has only recently become a focus [38], [39]. Historically, 
pharmaceutical companies have competed solely on the basis of innovation through new 
drugs for medical needs [10], [33], [40]. According to a recent study by Tufts Centre for the 
Study of Drug Development capitalising out of pocket costs to the point of marketing approval 
yields a total pre-approval cost estimate of US $ 2.6 billion per new drug [41], a 145 % increase 
(corrected for inflation) over the estimate of US $ 802 million reported in 2003 [42]. This huge 
increase has been attributed to annual increases in total capitalised cost and out-of-pocket 
cost per approved new compound of 8.5 and 9.3 %, respectively. In a best case scenario, the 
R&D costs can be expected to remain the same or increase in the future if the industry does 
not adopt more efficient technologies for drug discovery and development. When combined 
with other factors, such as increases in competition, further increases in proportion of generic 
utilization, opening of new markets, and the socioeconomic pressures for price controls, it is 
evident that the industry is facing significant challenging ahead. 
Currently, new technologies and techniques, including proteomics, genomics, and the use of 
biomarkers, appear to be creating a future where blockbusters, as we currently define them, 
may or may not exist. The future instead will consist of many "customised" small volume drugs 
that take into consideration a patient's specific subcategory of disease and genetic makeup. 
These overall shifts will translate into manufacturing many more new products. When all of 
the above factors are summarised, the same cost and quality drivers that have affected other 
industries are forcing the pharmaceutical industry to look for ways to improve quality while 
maintaining or reducing research and development (R&D) costs. Continuous manufacturing 
technologies provide one possible path forward for the pharmaceutical industry to reduce the 
cost of manufacturing, with the objective to convert selected unit operations and processes 
from batch to continuous along with appropriate real time characterization using state-of-the-
art process analytical technologies (PAT) [10], [33], [43], [44]. However, any transition to 
continuous manufacturing will require process re-design and re-validation [16]. 
Pharmaceutical companies are required by the FDA and EMA to validate their processes and 
equipment to demonstrate that the design space in which they operate can produce drug 
products that conform to design specifications, as described in the following section.  
2.1.1 Regulatory Considerations 
The pharmaceutical industry is heavily regulated, which has led to a culture of conservatism 
that has stifled innovation in process technology development to improve manufacturing [10]. 
According to the FDA regulatory definition, a batch or lot is a specific quantity of a drug or 
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other material that is intended to have uniform character and quality, within specified limits, 
and is produced according to a single manufacturing process during the same cycle of 
manufacture [45]. It would appear from this definition that the regulatory framework is already 
in place to support the concept of a period of time (which is defined by the time required to 
achieve a controlled state of operation and obtain desirable product critical quality attributes) 
being a “batch” for the purpose of tracking and quality assurance. If this interpretation is 
accepted, then it would be an opportunity to make the case for moving to continuous or at 
least periodic (hybrid batch and continuous) manufacturing, which is by definition a single 
processing cycle. Although there are currently no specific regulations or guidance for 
continuous manufacturing, other than the definition of “lot” [45], there is nothing stated that 
prohibits continuous manufacturing of pharmaceutical intermediates or active ingredients. 
However, the FDA has expressed concern about the concept of steady-state which is 
associated with continuous manufacturing. Unlike batch processes which typically attain an 
equilibrium condition, continuous processes operate at steady-state when material properties 
in the system remain constant with time [46]. The time to achieve steady-state largely depends 
upon the flow properties of a system. Therefore, several questions arise, for example: When 
is a product acceptable or not to collect? How to start-up and shut-down a continuous 
process? If disturbances occur in the system (e.g. spike in feed rate), how will rejects be 
handled? When do all component concentrations and physical properties reach steady-state? 
– This may necessitate the measurement of process variables other than concentration of the 
active ingredient(s). The FDA’s most recent position on this issue is that a well-defined system 
for process performance and product quality monitoring should be applied to assure 
performance within a “state of control” (rather than steady-state) and to identify improvement 
areas[26], [47]. Application of PAT tools with integrated information systems, direct design and 
model based design approaches may provide solutions to the challenges of continuous 
processing as posed in the questions earlier. With the appropriate technologies and 
application of robust methodologies, robust systems can be designed to monitor and 
control/maintain steady-state in continuous operations and deliver the desired product critical 
quality attributes (CQA) consistently. There are already well established methodologies that 
are implemented in batch systems that could potentially be applied to continuous operations. 
For example, the use of PAT and information system tools for the control of particle size (or 
aspect ratio) as demonstrated by Saleemi et al [48] using focused beam reflectance 
measurement (FBRM) viz dynamic nucleation control and attenuated total reflectance 
ultraviolet/visible (ATR-UV/vis) spectroscopy viz supersaturation control. Others have 
demonstrated the application of Raman spectroscopy for active polymorphic feedback control 
using [49]. Currently, there are only a few examples of the application of PAT and information 
tools in continuous processing to gain process understanding and implement control over 
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product CQA. Recently, the application of FBRM implement to DNC for particle size/aspect 
ratio control in a cascade of mixed suspension mixed product removal (MSMPR) crystallisers 
was demonstrated [50]. 
Regarding direct design control approaches, there are currently many studies on this topic in 
the area of continuous crystallisation. For example, impurity control using nano-filtration 
membrane [51], polymorphism control by tuning stage temperatures and the residence time 
in a MSMPR crystalliser [52], and particle size control using an inverted dissolution device with 
a MSMPR [53]. More recently, direct design has been applied for particle engineering 
purposes to tailor particle shape/size by spherical continuous crystallisation [54], [55]. 
However, no of these studies have looked into direct design approaches to deal with critical 
issues such as level changes, residence time, flow control, blockages in transfer lines or 
fouling and encrustation. Model-based design approaches are already well established for 
batch processes [30], [56]. In recent years there has been increasing interest in developing 
model-based understanding of continuous processes [13], [21], [57], but to date there are no 
studies on the application to process design.  
Overall, the issue of new technology introduction in pharmaceutical manufacturing has been 
very constrained. However, this has been changing quite rapidly from a regulatory perspective. 
For example, the FDA’s draft guidance to the pharmaceutical industry in “Guidance for 
Industry: PAT – A Framework for Innovative Pharmaceutical Manufacturing and Quality 
Assurance" [35] describes a regulatory framework on which industry and government can 
work together to increase the level of innovative pharmaceutical manufacturing technologies 
by the removal of actual and perceived barriers [33]. The draft guidance document states: 
"Process Analytical Technology, or PAT, should help manufacturers develop and implement 
new efficient tools for use during pharmaceutical development, manufacturing, and quality 
assurance while maintaining or improving the current level of product quality assurance." The 
background of this guidance is centered on the concept that while conventional 
pharmaceutical manufacturing is accomplished using batch mode, new opportunities exist to 
improve the efficiency and quality of the pharmaceutical manufacturing process. This is an 
attempt to introduce 21st century technology into the pharmaceutical industry to better respond 
to the rapidly changing marketplace for pharmaceutical products. The utilizing of new 
approaches to pharmaceutical manufacturing, while maintaining the concept that quality 
cannot be tested into a product, but must be built in by design [33], [44], leads to the concept 
of continuous manufacturing. More specifically, the draft guidance document on PAT states 
that a desired goal of the framework is to assist in "Facilitating continuous processing to 
improve efficiency and manage variability – for example, use of dedicated small-scale 
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equipment (to eliminate certain scale-up issues)." These regulatory statements are reassuring 
and should encourage pharmaceutical manufacturers to exploit the benefits of continuous 
manufacturing.  
2.1.2 Continuous Manufacturing and Crystallisation: Processes and 
Technologies 
Drug Substance Manufacture: The manufacture of a drug substance or active 
pharmaceutical ingredient (API) involves several unit operations or processes. Typically, the 
initial stage involves several molecular synthesis and reaction work-up steps, often involving 
unstable intermediate (s) [43]. In some cases, downstream processing of the reaction mixture 
is required, for example viz. distillation, filtration etc. prior to the next reaction step. The final 
reaction mixture (or mother liquor), goes through multiple stages of downstream processing 
to produce the desired API in solid form. These stages almost always involve distillation, 
precipitation (or reactive crystallisation), crystallisation, filtration, washing, drying and milling. 
Figure 2.1 show a schematic of the typical sequence of stages involved in the primary 
manufacture of an API. Of these, the milling process is inherently continuous in nature. 
Additionally, filtration and distillation can be made to operate in continuous mode without much 
difficulty. In the case of filtration, two equivalent units can be operated alternately to achieve 
continuous operation. Once a fixed pressure drop is reached for the first filtration unit, the feed 
stream can be diverted to the second filter, while the first unit is serviced. Continuous 
distillation is the norm for oil refining and most commodity chemical processes [33]. The 
remaining stages of precipitation, crystallisation, washing and drying may also be converted 
to continuous, but with some challenges which will be discussed later. For the purpose of this 
literature review, a particular focus will be placed on continuous crystallisation processes and 
technologies.  
 
Figure 2.1: Schematic showing the primary manufacturing process for a typical API. 
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R&D and Continuous Drug Manufacture: Recently, there has been a significant shift in R&D 
focus from batch to continuous processes as more and more researchers report on the 
application of continuous manufacturing [13], [19]–[21], [24], [58]–[63]. The change has been 
realised due to a growing number of enterprising collaborative research initiatives between 
established technology companies, pharmaceutical manufacturers, SMEs, academic 
institutions and government agencies. A particularly good example that highlights the extent 
of collaboration is the EPSRC Centre for Innovative Manufacturing in Continuous 
Manufacturing and Crystallisation (CMAC) in the UK. This initiative was established in 2011 
to develop and advance technologies to facilitate a change from batch to continuous 
manufacturing. This national centre initially consists of a team of 14 leading academics from 
across 7 UK institutions and working with a number of multinational pharmaceutical 
manufacturers, technology companies and small-medium enterprises (SMEs). The CMAC 
centre aims to bridge the gaps between development of continuous processes and 
technologies and their implementation in the pharmaceutical industry. So far, the centre has 
pioneered a multi-disciplinary approach to continuous manufacturing and crystallisation, which 
includes: chemical and process engineering; synthetic, physical, analytical, structural and 
materials chemistry; crystallisation science; pharmaceutical science; and manufacturing and 
operations management. The core areas of research within the CMAC centre are outlined in 
Figure 2.2. Continuous crystallisation is a central feature and the primary area of R&D. There 
is a commitment to developing continuous crystallisers for consistent production of high quality 
crystals for later secondary processes and to determinate the most suitable approaches for 
their implementation in the pharmaceutical industry. A further example of enterprising 
collaborative research is the Dutch sustainable manufacturing initiative, which saw a Scottish 
technology company (NiTech), The Netherlands Institute of Sustainable Process Technology 
(ISPT) and three member companies of The Netherlands Group of Users of Technology for 
Separation (NL GUTS) joining forces to investigate the feasibility of scale-up and operation of 
COBCs and other continuous manufacturing technologies [62]. In the Republic of Ireland, the 
Solid State Pharmaceutical Cluster (SSPC) was established as a strategic collaborative 
research initiative between Science Foundation Ireland (SFI), five top Irish universities and 
several pharmaceutical companies. The aim is to carry out research in the area of 
pharmaceutical crystallisation. In addition to the aforementioned research initiatives, the 
Novartis-MIT collaboration is worthy of mention. This 10-year initiative, which started in 2007 
is one of the first to be established for the sole purpose of investigating continuous 
manufacturing alternatives for implementation in the pharmaceutical industry.  
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Figure 2.2: Key R&D areas within the CMAC centre spanning initial inputs and molecular 
synthesis through to crystallisation, formulation and final product manufacture. 
As a result of the many research initiatives mentioned earlier a turning point toward continuous 
processing is now being realised, with many pharmaceutical manufacturers starting to adopt 
continuous processes, converting some unit operations into compact systems with a higher 
degree of automation and fewer manual interventions. For example, secondary production 
steps such as milling, blending, granulation and compression [64]–[66] that were previously 
performed sequentially in batch mode are now being integrated into single a continuous 
process. Primary processing, that is continuous flow chemistry is also well established [43], 
[67], [68]. Companies such as Vertex Pharmaceuticals (VRTX), Amgen (AMGN), 
GlaxoSmithKline (GSK), Novartis (NVS), Johnson & Johnson (JNJ) and others have started 
to build continuous drug manufacturing facilities. For example, GSK is building a US $ 29 
million continuous manufacturing plant in Singapore, which is expected to come online in 
2016. Amgen recently announced it was using some continuous manufacturing processes in 
its plant in Singapore as well. Vertex indicated that its continuous tablet compression process 
could allow the production of 100,000 tablets of a cystic fibrosis drug in an hour, compared to 
4 to 6 weeks using batch processing [69]. The majority of these projects are for making finished 
products and not active ingredients, although Novartis has announced a prototype called 
“Technikum” for beginning-to-end continuous manufacturing, which it has proposed will 
continuously transform raw materials into finished tablets without interruption (24 h/day) in just 
two days, using a single facility with a footprint 1/10 of existing batch plants.  
Continuous Crystallisation: Continuous crystallisers have the built-in flexibility to enable the 
control of temperature, supersaturation, nucleation, crystal growth and other process 
parameters that influence crystal size distribution (CSD). In some cases, continuous has 
advantages when batch is unacceptable, for example where there are highly toxic substances 
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or where mixtures of polymorphs are formed, due ease of automation and consistence. There 
is also the advantage of significant reduced in inventory levels. Intermittent (or semi-
continuous) crystallisation processes often combine the best features of both batch and 
continuous operation, and deserve definite attention. In the past decade, continuous 
crystallisation has been a highly active research field, as part of the campaign aimed at 
developing the next generation continuous manufacturing technologies for the pharmaceutical 
industry [14], [15], [70].  
Generally, there are two types of continuous crystallisers that are most investigated, viz, the 
tubular and the stirred-tank designs [2], [17]. Regardless of recycling, these two designs help 
to achieve idealised flow patterns, namely the plug-flow [18], [21], [71]–[75] and the mixed-
suspension mixed-product removal (MSMPR) operations [8], [13], [19], [24], [53]. Typically, 
continuous stirred tank crystallisers such as the MSMPR operated with continuous feeding of 
a saturated solution to and withdrawing of slurry from the vessel. There are no real crystallisers 
capable of fully representing the MSMPR complete mixing flow model or PF model, but some 
crystallisers behave close enough to the ideal [5]. Recent studies have investigated different 
designs of stirred tank crystallisers to achieve mixing conditions closer to the idealised 
MSMPR model. For example, the introduction of baffles to efficiently shear slurry for more 
improved mixing [76]; fine-tuning of the agitator conditions for better particle suspension [25], 
[77]; and adjustment of the addition and withdrawal point to achieve representative isokinetic 
slurry withdrawal [25]. The relationship between mean residence time and batch mixing time 
[78] has also been investigated in MSMPR. However, a meaningful correlation was not 
established in this study. Although derivatives of the PF and MSMPR crystalliser designs have 
resolved some of the practical concerns over continuous crystallisation, such as the use of: 
(1) a cascade of MSMPR vessels linked in series (slurry flows from one stage to another), with 
gradual temperature change across each succeeding stage leading to direct control over 
supersaturation and enhanced product yield [8], [13], [70] (however a systematic approach to 
selecting stage temperatures for MSMPR cascade has not been demonstration); (2) a 
continuous oscillatory baffled crystalliser (COBC) to deal with the sedimentation of crystals at 
low through-flow Reynolds number in a straight tube [20], [79]; (3) a slug-flow crystalliser 
design wherein liquid and gas are introduced into one end of the tube to spontaneously 
generate alternating slugs of liquid and gas to generate large uniform crystals [80]. Other 
examples include: (4) the multi-segment multi-addition plug-flow crystalliser (MSMA-PFC) to 
tackle problems with supersaturation control [21], [22], [57] or fines dissolution along the tube 
[23]; (5) a continuous MSMPR crystalliser with a fines trap and a product classifier to achieve 
a high production rate and a low polydispersity of the crystals [81]; (6) similar work was also 
reported using an “inverted” product classifier unit in a modified continuous MSMPR 
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crystalliser, wherein small crystals are withdrawn as product, and larger crystals recycled to a 
dissolver [53]; (7) rapid and intermittent pneumatic transfer of slurry in a single-stage MSMPR 
for isokinetic withdrawal and polymorphism control [32], [51], [82]. In continuous crystallisation 
recycle is often used as a means of conserving material and for improving process yield by 
manipulating the recycle ratio, which is defined as the ratio of the volumetric flow rates of the 
recycle stream to that of the feed stream [19]. However, the recycle ratio needs to be carefully 
selected in order to avoid impurity build-up. One way of addressing this issue is to apply nano-
filtration membranes to purge impurities [51] from the recycle stream. Recycling may also 
affect the product crystal properties (i.e. size and CSD), for example the impact of 
concentrated versus non-concentrated recycle stream has not been sufficiently addressed in 
the literature and will be focused on in Chapter 4 of this Thesis. 
One the more important issues for the two continuous crystalliser designs mentioned earlier 
is the material mean residence time and the residence time distribution (RTD). For example, 
although a narrow RTD can be achieved, in a tubular crystalliser, a relatively long tube is 
necessary for slow growing crystals to achieve sufficient residence time and to reach a desired 
large mean particle size. Furthermore, the long tube design also makes difficult the delicate 
control of supersaturation by either multi-section jacket cooling or multi-addition of anti-solvent 
[22], [23], [81]. In contrast, the broad RTD of continuous MSMPR operation adversely affects 
the critical quality attributes of the final products by broadening the crystal size distribution 
(CSD). In order to extend the material RT, large-scale MSMPR crystallisers have to be 
implemented, in which the scaling up of a stirred tank imposes the additional problem of slurry 
mixing uniformity [83]. Based on these observations, continuous crystallisation is seen as the 
limiting step for beginning-to-end continuous manufacturing of drug products [84]. Therefore, 
the main objectives of the work presented in this thesis are to: (1) tailor the RTD and operating 
conditions in MSMPR crystallisers to enhance the critical quality attributes (CQA) of crystals; 
(2) demonstrate a “state of controlled operation” (SCO) in novel designs of single and 
cascaded multi-stage MSMPR crystallisers, thereby promoting a Quality by Design (QbD) 
paradigm shift, such that quality may be assured by better product and process understanding 
for the design of beginning-to-end continuous manufacturing in the pharmaceutical and fine 
chemical industries. Recent studies have examined how to change the mean residence time 
and width of the RTD in MSMPR in order to control polymorphism [82] and crystal size and 
distribution [77]. Typically, long mean residence times lead to crystal growth, however the 
settling of particles in transfer lines becomes an issue [25].  
Where a MSMPR crystalliser is used, for a given operating volume it is often necessary to 
reduce the net inlet and outlet stream flow rates in order to obtain enough RT for the crystals 
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to grow; however, this approach often leads to transfer line fouling and blockage. In this thesis 
periodic flow operation of MSMPR crystallisers whereby periodic disruptions are applied to the 
inlet and outlet flows, either synchronously or asynchronously, will be demonstrated and fully 
explored, with the dual aims of retaining slurry in the crystalliser for longer and to facilitate 
isokinetic (i.e. representative) withdrawal of the product. This approach is different from 
intermittent withdrawal procedures reported in the literature [32], [77], [85], [86], since the 
slurry addition and withdrawal cycle(s) and batch period are tuneable, leading to several more 
degrees of freedom in operation.  
Comparatively speaking, temperature control of an MSMPR is relatively straightforward unlike 
a PFC. In addition, the maintenance of an MSMPR is relatively simple, and the cost of 
operating them quite low. Conversely, PFCs are often more efficient (requires less material 
and gives better yield) than MSMPRs of the same volume [87]. However, temperature control 
is more complicated and expensive with PFCs, and plugging (or blockage) is a common 
problem [2], [88]. In terms of flow and mixing pattern, the MSMPR may be described as a 
completely mixed vessel characterised by a well-defined RTD of exponentially decaying 
function, and possessing identical fluid elements (in terms of liquid and solid composition and 
CSD) in the outlet flow and inside the crystalliser [5], [6]. Randolph and Larson [9] were the 
first to introduce the term MSMPR to represent this ideal flow and mixing crystalliser 
configuration. The flow and mixing pattern of a PFC on the other hand may be characterised 
by uniform velocity and equal residence time of all fluid elements inside the crystalliser [5], 
[89]. For example, the flow patterns achieved in oscillatory baffled flow devices, static and high 
intensity mixers, and Couette-Taylor flow devices under restricted operating flow conditions 
may be approximated to plug flow [5]. 
Recently, several unconventional continuous crystalliser designs have been investigated, 
including:   
(a) Microfluidic devices – typically sub-millimetre scale that are based on the precise 
control and manipulation of fluid flow through micro-fabricated channels [90], [91];  
(b) Solid hollow fibre devices – these consist of several non-porous hollow fibres 
bundled together and enclosed in a shell.  The feed solution for crystallisation in 
these devices is passed through the spaces inside (i.e. hollow fibres) [71], [72], [92], 
[93];  
(c) Static and high intensity mixers – are typically used for the mixing of two fluids. These 
devices consist of a series of mixing elements enclosed in a pipe or tube [21], [94]–
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[96] and are often used in tandem with other crystallisation equipment.  For example, 
as demonstrated recently by Myerson et al [21] in their study on the continuous 
crystallisation of three APIs in a plug flow device consisting of four jacketed tubular 
glass sections packed with Kenics type static mixing elements (to enhance mixing 
and aid particle suspension);  
(d) Couette-Taylor devices – typically consist of two rotating concentric cylinders.  
Couette (or Azimuthal) flow is generated when a viscous fluid is brought into the 
space between the rotating cylinders. Couette and later Taylor [97] were the first to 
use this type of device to investigate the behaviour of viscous fluids;  
(e) Tubular or laminar flow devices – typically these devices have a close resemblance 
to a tube-in-tube heat exchanger. The fluid is transported through the inner tube, 
while a coolant flows counter- or co-currently through the outer tube [98]. Laminar 
flow often dominates fluid motion in these devices, and is characterised by the 
orderly movement of all elements in a straight line parallel to the tube wall with high 
momentum diffusion (axial mixing) and low momentum convection [99]. 
Although there are many promising alternative technologies to conventional MSMPR and PFC 
these are not yet mature. For example, to these devices are not amenable to commercial 
applications and are difficult to scale, whereas industry is more likely to consider retrofitting 
current batch stirred tank reactors into continuous MSMPRs. 
2.1.3 MSMPR Crystallisers: Key Features and Kinetic Considerations 
In many early works, MSMPR crystallisers were most often used for the measurement of 
crystallisation kinetics. In 1980 Garside and Shah [100] published a comprehensive review of 
the literature on crystallisation kinetics derived from MSMPRs and compared nucleation and 
growth rate measurements on a common basis. They found that in general, the range of 
variables studied (for example, supersaturation, slurry density and stirrer speed) for any given 
system were extremely limited. Furthermore, the experimental conditions, particularly those 
related to crystalliser hydrodynamics, were usually poorly defined. Consequently, the scale-
up of kinetics based on such results would often not be possible. Since this review there has 
been significant improvements in the determination of crystallisation kinetics using MSMPR 
[8], [13], but there is still a lack of understanding of the correlation between kinetics and 
crystalliser hydrodynamics. Chen and Larson [86] investigated the kinetics of calcium nitrate 
tetrahydrate in a single stage MSMPR over a wide range of mean residence times and slurry 
densities and obtained kinetic data for the system using the population balance model (PBM) 
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approach. In later work, Jones et al [101] reported on the crystallisation kinetics of potassium 
sulphate. In their study, the supersaturation and slurry density were the independent variables 
investigated, but strong curvature was exhibited in the population density plot (which suggest 
size-dependent product removal). Jones and Mydlarz [102] compared methods proposed in 
the literature for the determination of crystallisation kinetics from CSDs for a number of 
systems that exhibited size-dependent growth rates. These investigators found wide variations 
in inferred kinetic parameters depending on the analytical methods used. Improvements in the 
estimated nucleation and growth rates were observed when the investigators used size-
dependent growth rate models for direct fitting of the differential population density data. 
Larson et al [103] developed a mathematical model relating CSD from a MSMPR to the 
distribution of growth rates (i.e. growth rate dispersion). This same model was used by 
Ramanarayanan [104] to derive analytical expressions for all cases between the completely 
mixed MSMPR to near plug flow state (a cascade of MSMPRs). More recently, Moore et al 
[105] used X-ray scattering technique to determine the kinetics of various forms of perovskite 
(calcium titanium oxide). Zahedi et al [106] used a similar technique to study the kinetics of a 
binary compound of a calcia–alumina (calcium and aluminium oxide).  
Notable kinetic studies on organic systems include work by Sikdar and Randolph [107] who 
reported on secondary nucleation and growth kinetics of citric acid and correlated the results 
to supersaturation and product CSD of the MSMPR. Jinyang and Shuzhong [108] studied 
L-glutamic acid crystallisation from fermentation broth and found that the kinetics of the 
process conformed to a size-independent model (McCabe ΔL law). Alamdari and Tabkhi [109] 
determined the kinetic parameters for the reactive crystallisation of the pharmaceutical 
intermediate hexamine (Meissner process) using data from an industrial MSMPR with a fines 
dissolution loop. The growth and nucleation kinetic parameters were determined by applying 
PBM. Kougoulos et al [110] used a modified MSMPR with product recycle loop to estimate 
‘pure’ crystallisation kinetics of an organic fine chemical. The effects of supersaturation, slurry 
density, impeller speed and configuration on the growth and nucleation rates were examined. 
Hao et al [111] investigated the kinetics of the reactive crystallisation of dexamethasone 
sodium phosphate, an anti-inflammatory and immunosuppressant using a MSMPR. The 
investigators found the growth of product crystals to be size dependent.  Wierzbowska et al 
[112] investigated the kinetics for the cooling crystallisation of L(+)-ascorbic acid from water in 
a laboratory draft-tube (DT) MSMPR. The kinetic parameters were found to conform to 
McCabe ΔL law, which assumes that the crystal growth rate is independent of crystal size. 
Note that the MSMPR gives rate information at a fixed set of conditions (i.e. at steady-state), 
which means that it is difficult to cover a wide range of initial conditions (e.g. supersaturations 
and residence time). In the study mentioned earlier, the effect of supersaturation on the growth 
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and nucleation rates and mean residence time on the extent of crystal growth and nucleation 
were examined. It was found that with increased supersaturation mean crystal size decreased 
while longer mean residence times led to a 3-fold increase in linear growth rate (size 
dependent growth) and 7-fold decrease in nucleation rate. The explanation for these 
observations is that higher supersaturation leads to increased secondary nucleation, on the 
other hand growth is promoted with longer residence times as small crystals dissolve and 
larger ones grow at their expense. Generally, the growth and nucleation kinetics of a given 
system are highly specific and depends on a number of factors, for example the solute-solvent 
system and sensitivity to the hydrodynamics and scale of operation.  
The model identification process is very important since the inclusion of additional effects, 
such as secondary nucleation, agglomeration and breakage can have a strong effect on the 
kinetic parameters for growth and primary nucleation. The growth rate kinetics are derived 
from fundamental rate equations, whereby growth rate is expressed in terms of the free 
energies of the various molecular configurations that the crystal surface passes through during 
growth [113]. Recently, empirical approaches have become more common place for growth 
rate estimation [114]. Regardless of the approach used, inconsistences in the use of either 
size-dependent (proportionate) or size-independent (constant) growth is evident thought the 
literature. These two growth laws can be differentiated as follows; size-dependent growth: the 
relative size difference among crystals is maintained during proportionate growth, leading to 
constant size variance for a CSD as mean crystal size increases; size-independent growth: 
the absolute size difference among crystals is maintained during constant growth, resulting in 
a decrease in size variance [114], [115]. It has been shown that size-dependent growth occurs 
in stirred systems, whereas constant growth occurs in non-stirred systems [115]. It is thought 
that the mechanism of size-dependent growth is related the supply of solution phase solute 
molecules to the surface of crystals by advection, whereas size-independent growth is related 
to supply by diffusion. However, it has been shown that some systems show either size-
dependent or size-independent growth under both stirred and non-stirred conditions. Many 
recent studies have simply assumed size-independent growth for simplification [8], [24]  
A number of assumptions are often associated with the MSMPR model; the most notable is 
that all fluid elements are well mixed with no spatial variation in solution concentration, solids 
concentration or particle size distribution. Invariably, the mixing characteristics of a given 
system will have an effect on local kinetic processes as demonstrated by Rielly and Marquis 
[116]. The study argued that the fluid mechanical environment is not uniform in a MSMPR and 
hence the kinetic rates deduced are a complex weighted average of localised kinetic rates. 
Furthermore, if the distribution of localised kinetic rates changes on scale up, then the design 
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of large scale units could be problematic. Several assumptions are also made when deriving 
crystallisation kinetics from population balance models (PBMs). For example, the influence of 
agglomeration and breakage kinetics are usually ignored. The net result of these assumptions 
is the derivation of widely varying kinetic parameters for a given system. Furthermore, 
agglomeration and breakage can significantly influence product quality, especially for dense 
particle systems and should not be neglected during model development [117].  
Despite those nuances the MSMPR is perhaps the most amenable to incorporation into 
existing plant designs, that is, by retrofitting batch crystallisers [2]. There are a wide variety of 
MSMPR designs available, with configuration being dependent on product specification and 
desired throughput [5], [6].  There are two broad category classifications for MSMPRs based 
on their usage in bulk chemical manufacturing; these are, forced circulation (FC) and draft 
tube baffled (DTB) crystallisers. MSMPR crystallisers used for the investigation of 
pharmaceutical actives are typically of the conventional stirred tank type, with no elaborate 
designs reported in the literature apart from cascaded multi-stage designs [85], and the so 
called “inverted RZ” design reported by Griffin et al [53]. However, many interesting studies 
are beginning to emerge using single- and multi-stage MSMPRs, including: continuous 
spherical agglomeration [54], [55], non-linear model predictive control with cooling and anti-
solvent addition [118], [119], start-up optimisation of a multi-stage MSMPR operated viz 
combined cooling anti-solvent addition [120], chiral separation [121], polymorph isolation [82], 
impact of recycle and the application of membrane filtration on yield and purity [51], 
relationship between seed loading and nucleation kinetics [122], and feedback control 
approaches to stabilise MSMPR operation [123]. Quon et al [24] recently reported high yield 
(92%) and purity (99%). However, the residence time per MSMPR stage investigated were 
quite long, ranging from 2 and 13.33 h, and furthermore the product crystals properties 
obtained showed little difference to the batch. Arguably, at the operation is a series of batch 
crystallisers and proved no significant operational advantage. Alvarez et al [13] conducted a 
similar study using a three-stage MSMPR cascade with and without recycle stream for the 
cooling crystallisation of cyclosporine (an immunosuppressant drug). In this study, the 
residence time of each MSMPR stage was 2.93 h (i.e. 8.8 h combined). The yield and purity 
of the product obtained from with recycle (87% and 94%) and without recycle (71% and 96%) 
were comparable to batch (74% and 95%). Arguably, for the aforementioned MSMPR 
operations to be considered viable alternatives to batch, much shorter mean residence times 
and superior product CQA needs to be demonstrated. Table 2.1 below highlights the main 
advantages, disadvantages and promising features of conventional MSMPR technology. In 
this thesis, novel operating strategies and configurations of MSMPR crystallisers will be 
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demonstrated to improve on the current-state-of-the-art in continuous crystallisation aided by 
PAT and informatics system tools. 
Table 2.1: A perspective on the advantages, disadvantages and promising features of 
conventional MSMPR operation. 
Advantages Disadvantages Promising Features 
 Steady state operation gives 
more consistent product. 
 Allows for fast cooling or anti-
solvent addition while 
maintaining low 
supersaturation. 
 Some configurations allow for 
classified withdrawal of 
product and fines dissolution 
resulting in narrow CSD. 
 Several MSMPR in series 
may approximate near plug 
flow behaviour. 
 Ease of temperature control 
minimises hotspots. 
 Mixed removal of product may 
result in large coefficient of 
variation (CV) in the CSD. 
 Limited multi-product flexibility 
compared to batch 
crystallisers. 
 Sampling systems for quality 
assurance (QA) not fully 
developed. 
 Pumping of slurry between 
crystallisers may lead to 
temperature control issues and 
crystal breakage. 
 Introduction of recycle stream 
may lead to impurity build-up, 
but purges may be used for 
impurity control. 
 Potential to eliminate certain 
downstream processes such 
as milling due narrow 
achievable CSD. 
 For the same yield as a batch 
system, a smaller volume 
crystalliser may be employed.  
 Product yield could be 
increased by employing liquor 
recycle stream. 
 MSMPRs may be more 
amenable to automated 
control, however, these 
technologies are not yet fully 
developed. 
 Flexibility with the level of 
throughput. 
 Reduced down time, energy 
costs and operator 
involvement. 
 Lower operating costs than 
batch crystallisation. 
 Reduction in solvent 
consumption compared to 
batch crystallisation. 
Process Modelling and Simulation: The steady-state CSD for a continuous MSMPR may 
be derived from the population and mass balance equations, as describe in many of the 
studies mentioned earlier. For simplicity, the following assumptions are usually made: perfect 
mixing of the crystalliser contents, constant volume, initial seeding (at t = 0), isothermal 
behaviour with no crystals in the feed stream, all crystals and nuclei have the same shape, 
size independent growth rate of crystals and no agglomeration or breakage. Randolph and 
Larson [9] proposed the following one-dimensional population balance from a transiently 
operated MSMPR with continuous inflow and outflow: 
  
𝜕?̂?
𝜕𝑡
+ 𝐺(𝑆)
𝜕
𝜕𝐿
(?̂?) +
𝜕?̂?
𝑉𝜕𝑡
+ 𝐷(𝐿) − 𝐵(𝐿) + ∑
?̇?𝑖?̂?𝑖
𝑉
𝑘
= 0 2.1  
for which B is the birth function that describes nucleation (or agglomeration if not ignored), D 
is the death function that describes dissolution or attrition (or breakage if not ignored) and V 
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is the volume of the crystalliser. The remaining terms have the usual meaning as described 
for the batch population balance. The expression 𝜕?̂? 𝜕𝑡⁄  describes the change in population 
density, however, this term reduces to zero for a continuously operated steady state MSMPR. 
The expression 𝐺(𝑆)𝜕(?̂?) 𝜕𝐿⁄  describes the difference between crystals growing into and out 
of a crystal size interval dL due to the crystal growth rate 𝐺 = 𝑑𝐿 𝑑𝑡⁄  . Finally, the expression 
∑
?̇?𝑖?̂?𝑖
𝑉𝑘
 gives the sum of the particles flowing in and out of the crystalliser.  
Eqn. 2.1 is difficult to solve since B and D cannot be formulated in a general way, as events 
such as attrition (or crystal breakage) are brought about by mechanical and fluid dynamic 
processes and the kinetics of crystallisation. Where fragmented particles exist in a 
supersaturated solution they can grow and their growth rate will then be influenced by 
supersaturation. The rather complex interaction of mechanical and kinetic effects leads to the 
difficulty in describing the birth and death functions [124]. Hence, the terms B(L) and D(L) in 
Eqn. 2.1 are often disregarded. The steady-state population balance then reduces to: 
 𝐺(𝑆)
𝜕
𝜕𝐿
(?̂?) + ∑
?̂?𝑖?̇?𝑖
𝑉
𝑘
= 0 2.2  
Usually the solution fed to MSMPR is free of crystals (i.e. unseeded) and only one volumetric 
flow ?̇?𝑖 is removed. The population balance therefore reduces to: 
 𝐺(𝑆)
𝜕
𝜕𝐿
(?̂?) + ?̂?
?̇?𝑖
𝑉
= 0 2.3  
The ratio between the volume V and outlet flow rate ?̇?𝑖 is equivalent to the mean residence 
time 𝜏 of the suspension that is assumed to be ideally mixed (not that ?̇?𝑖 = ?̇?0, where ?̇?0 is the 
inlet flow rate), and so Eqn. 2.3 becomes: 
 𝐺(𝑆)
𝜕
𝜕𝐿
(?̂?) +
?̂?
𝜏
= 0 2.4  
From Eqn. 2.4, it is assumed that both the crystals and the solution have the same mean 
residence time in the crystalliser. However, in principle the crystal growth rate G can depend 
on particle size [6], [124]. In addition to other factors, this can be linked to the fact that the 
mass transfer coefficient of particles in the grain size area of 100 µm < L < 2000 µm is slightly 
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influenced by particle size in the case of diffusion limited growth [124]. In many systems the 
crystal growth rate is only slightly affected by the size of the crystals and the parameter G 
(which is in reality a mean growth rate) may be expressed independently of crystal size L 
(McCabe ΔL Law) as above. In order to solve Eqn. 2.4 additional information is required on 
the initial distribution (or density of crystals), nucleation and growth rate respectively, as well 
as on the mass balance of solute being crystallised. The initial distribution of particles sizes, 
the density of nuclei and growth rate are represented by the following equations: 
 ?̂?(0, 𝐿) = 𝑓(𝐿) 2.5  
 ?̂?(𝑡, 0) =
𝐵0(𝑆)
𝐺 (𝑆)
 2.6  
 𝐺 = 𝐺(𝑆) 2.7  
where 𝑓(𝐿) is the normalised one-dimensional distribution function and c is the solute 
concentration. The mass balance of the solute may be written: 
 
𝑑𝑐
𝑑𝑡
=
?̇?𝑖𝑐𝑖
𝑉
−  
?̇?𝑜𝑐
𝑉
−
𝑑
𝑑𝑡
(𝜌𝑐𝑘𝑣 ∫ ?̂?𝐿
3𝑑𝐿
∞
0
) 2.8  
where c is the solute concentration. Applying the method of moments and further reduction 
gives the following expression: 
 
𝑑𝑐
𝑑𝑡
=
1
𝜏
(𝑐𝑖 − 𝑐) − 3𝑘𝑣𝜌𝑐𝐺𝜇2 2.9  
where 𝜇2 is the second moment of (L), which represents the total crystal surface area. The 
kinetic and population balance equations for a well-mixed isothermal MSMPR have been 
extensively studied [102], [119]. Many of these studies, in particularly those on organic 
systems are not suitable for scale-up purposes since they are often based on several 
assumptions (some of which were described earlier). The same can be said for studies carried 
out using non-isothermal MSMPR. In this thesis aspects of kinetic parameter estimation (using 
batch experiments) and process modelling for a novel operating strategy viz the periodic flow 
MSMPR crystallisation approach are examined in Chapters 6. Given the uncertainties with 
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parameter estimation from MSMPR as highlighted earlier, the alternative approach using 
batch crystallisation experiments was explored. 
2.2 Process Analytical Technologies: Analytical Quality by Design 
Approaches 
In the last decade there has been a rapid increase in the number of PAT and informatics 
systems tools to implement QdB for improve product quality, safety and efficacy [125]. Recent 
FDA guidance, for example, ICH guidelines Q8 to Q11 and PAT framework discuss the 
implementation of PAT and QbD for API synthesis and formulation development. The 
“Guidance for Industry PAT — A Framework for Innovative Pharmaceutical Development, 
Manufacturing, and Quality Assurance” [35] clearly highlights the importance of PAT for the 
design and development of well understood process, which is consistent with the basic tenet 
of QbD. Further to this, the ICH Q11 guidelines clearly discuss QbD approach for API 
manufacture with examples [126]. As per ICH guidance, QbD is defined as “A systematic 
approach to development that begins with predefined objectives and emphasizes product and 
process understanding and process control, based on sound science and quality risk 
management”. The QbD life cycle has different tools such as ATP (Analytical Target Profile), 
CQA, Risk Assessment, Method Optimisation and Development with design of experiment 
(DoE), Method Operable Design Region (MODR), Control Strategy and Risk Assessment, 
QdB Method Validation, and Continuous Method Monitoring; Figure 2.3 show the QbD life cycle 
with each of these tools. Detailed discussion on each of the tools can be found in the recent 
review by Raman et al [125]. 
PAT and informatics systems tools can be used for designing, analysing, and controlling 
manufacturing processes through timely measurements (i.e. during processing) of critical quality 
and performance attributes [35], [127]. The measurements may be on raw materials, 
intermediates and products, but often they are of key process parameters which affect the 
efficiency of the process and the quality of the final product of the process [127]. PAT 
measurements can be taken in one of three ways: at-line, where the sample is removed and 
analysed close to the process stream; on-line, where the sample is diverted from the 
manufacturing process to an analyser and possibly returned to the stream; and in-line, an 
invasive or non-invasive process that analyses the sample while it is a part of the process 
stream. A detailed review of the different types of PAT sensors will not be attempted here since 
there are already numerous review papers on this subject [127]–[134] addressing a wide range 
of topics including, spectroscopy [133]: Raman [49], [135]–[137], attenuated total reflectance 
Fourier transform infrared (ATR-FTIR) [32], [138]–[140], attenuated total reflectance 
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ultraviolet/visible (ATR-UV/vis) [141], [142], near infrared (NIR) [135], [143]–[145], terahertz 
[146]–[148]; and imaging and particle monitoring sensors: particle vision microscopy (PVM) 
[135], vibrational chemical imaging (VCI) [149]–[151], process video imaging (PVI) [152], 
endoscopy [153], in-situ microscopy for bioprocess monitoring [154]; focused beam reflectance 
measurement (FBRM) [135], [155]–[157]. 
 
Figure 2.3: QbD tools and life cycle (Adopted from Raman et al [125]). 
The application of various PAT tools for crystallisation monitoring and control of critical process 
parameters (CPP) is well documented in the literature [27], [49], [135], [158]–[162]. In these 
studies many essential crystallisation process parameters are examined, for example: 
polymorphic transformations [49], [163], [164]; phase transformations other than 
polymorphism [165], crystal size, morphology and distribution [166], [167]; quantitative 
monitoring of solute composition in solid and liquid phase [136], [168]–[170], and impurity 
detection and quantification [171], [172]. All of the aforementioned studies involve batch 
systems, and only recently has there been an interest in applying PAT to monitoring, control 
and develop continuous crystallisation processes. In this thesis several aspects of continuous 
crystallisation monitoring, control and development will be investigated applying integrated 
PAT and a crystallisation informatics systems (CryPRINS) tool. The aim is to bring 
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pharmaceutical crystallisation to a state were processes are well understood and 
demonstrated viz control of CPP, which must be within a particular range for the product to 
meet the desired CQA. By bringing the key crystallisation parameters (supersaturation, crystal 
properties (size, shape, distribution and form), yield and purity), to a desired “state of controlled 
operation” (SCO), improved product uniformity and quality can be assured as the process is 
made more consistent. 
2.3 Multivariate Data Analysis 
The interactions in even a single step in a process can be very complex, and there are any 
number of different variables that could be adjusted [173]. Multivariate data analysis (or 
chemometrics) can identify the variable(s) having the greatest effect on the changes/variations 
observed during a process and which factors interact. Multivariate data analysis is a 
particularly useful tool for maximising the information obtained from PAT tools in 
implementation. Multivariate methods have been used to analyse data obtained from various 
instruments including Raman [174], [175], NIR [145], ATR-FTIR [176], ATR-UV/vis [162], high 
performance liquid chromatography (HPLC) [177], and terahertz pulse spectroscopy [178]. 
These techniques have been used in the quality assurance and quality control of 
pharmaceutical solid dosage forms [179]. Applications have also been reported in real-time 
image analysis [180]. However, there are questions over how to handle the vast amounts of 
data generated by PAT tools. The answer lays with data management (or informatics) 
systems. These systems are capable of handling the large volumes and types of data 
generated by a range of PAT tools. In this thesis, the CryPRINS informatics system mentioned 
in Chapter 1 was integrated with ATR-UV/vis and FBRM to monitor and implement 
temperature control in MSMPR crystallisers. In this context CryPRINS is used as an 
automated data acquisition and synchronization system. One of the greatest hurdles involved 
in almost any analysis is generation, integration and organization of data. This is particularly 
true for the pharmaceutical industry where data are often stored in vast repositories but rarely, 
if ever, retrieved and used [181].  
In this thesis, the commonly used multivariate methods for the analysis of spectroscopy data 
(Raman, ATR-PTIR, ATR-UV/vis and NIR) will be described. There are typically three main 
techniques that are involved in the analysis of spectral data [182], namely: 
1. Mathematical pre-processing: used to enhance the information from spectra, and 
decrease the influence of the noise and other redundant information contained in the 
spectra. Since spectra pre-processing is well established in the literature [136], [151], 
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therefore  a detailed description will not be provided here. Classical pre-processing 
methods are normalizations, derivatives and smoothing. For more details, readers are 
referred to [181], [183], [184]. Selection of the appropriate pre-processing techniques 
depends on the instrumentation and experimental conditions employed. Pre-processing 
method selection is covered in greater detail in Chapter 3 of this thesis. 
2. Classification methods: used to group samples together according to their spectra. 
Classification methods can be divided into either of two categories, unsupervised and 
supervised. In the former case, samples are classified without prior knowledge except for 
the spectral information, whereas the opposite is true for the latter [48]. 
3. Regression methods: applied to link the spectra to quantifiable properties of the samples. 
Regression analysis is a statistical process for estimating the relationships among 
variable. It includes many techniques for modelling and analysing several variables 
simultaneously [185], [186]. 
Principal Component Analysis: The basis of most multivariate statistical methods is 
principal component analysis (PCA). PCA was first described by Pearson [187] as a method 
to find the closest fit of lines and planes to points in space. Since then a number of researchers 
have contributed to making PCA an advanced statistical technique for analysis and pattern 
recognition of multivariate data sets [186], [188]–[190]. Through a number of examples, it is 
shown in this thesis that PCA can successful detect similarities and differences between 
spectral data. PCA is a method able to reduce the dimensionality of a problem by projecting a 
high-dimensional space onto a lower dimension space [182], [188]. PCA takes advantage of 
the fact that most industrial data display a high degree of correlation. The principal 
components (PCs) define a space in which the scores (i.e. the projected data) are linear 
combinations of the original measurements and constitute pseudo variables that capture the 
major mechanisms of the process [182]. By reducing the space, irrelevant information (i.e. 
selected variables) are disregarded, however, this does not mean that information is wasted. 
In fact, the fundamental principle of PCA is that adequate information is represented by the 
principal components, whilst the irrelevant information is considered as noise. Usually, data 
are mean centred and scaled so that measurements of different units and numerical 
amplitudes may be compared. If this step is not performed, a variable with high numerical 
significance can affect the model in a disproportionate way. PCA is particularly useful when 
visualizing data. Figure 2.4 shows the application of PCA to a three-dimensional data set, 
which are mainly located within a two-dimensional subspace. PCA was used to visualise these 
data by reducing the dimensionality such that the three original independent variables are 
reduced to a lower number of two new variables (i.e. independent variables) termed (i.e. PCs). 
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Such two-dimensional visualization of the data allows for qualitative conclusions to be drawn 
about the separability of experimental conditions (marked by different colours) [191]. 
 
Figure 2.4: Application of PCA to a three-dimensional data set gives a two dimensional plane 
that optimally describes the highest variance of the data. Adopted from [191]. 
Unsupervised Classification Methods: these methods are typically used to try and find 
hidden structure in unlabelled data. Since the data given to the learner are unlabelled, there 
is no error or reward indicator to evaluate a potential solution. This distinguishes unsupervised 
learning from supervised learning and reinforcement learning. Many of the methods employed 
in unsupervised learning are based on data mining approaches used to pre-process data. 
Methods of unsupervised learning include clustering techniques such as k-means [192], 
Gaussian mixture models [193], hierarchical clustering, for example density based spatial 
clustering of applications with noise (DBSCAN) [194] or Kohonen neural network [195]. 
Supervised Classification Methods: There are three different types of supervised pattern 
recognition algorithms: (1) discriminant methods, such as linear discriminant analysis (LDA), 
and those that place an emphasis on similarity within a class, for example, soft independent 
modelling of class analogy (SIMCA); (2) Linear and non-linear methods, such as neural 
methods; (3) Parametric and non-parametric computations techniques. For the parametric 
techniques such as LDA, statistical parameters of the normal distribution of samples are used 
in the decision rules. The classical methods for the supervised classification are correlation 
based methods, distance based methods, LDA, SIMCA, partial least squares discriminant 
analysis (PLS-DA), and bilinear methods, for example, principle component regression (PCR) 
and partial least squares regression (PLSR) which will be discussed in the thesis [144], [179]. 
The development of bilinear models involves arranging the data in matrices so that each 
vertical column has variables and each horizontal row contains samples [196]. 
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Partial least squares regression (PLSR): these are a widely accepted class of methods 
used for modelling the relations between different sets of observed variables by means of 
latent variables [179], [197]. Projections of the observed data to its latent structure by means 
of PLSR were developed by Wold et al [198], [199]. The basis of PLSR is that it modifies 
relations between sets of the observed variables by a small number of latent variables (not 
directly observed or measured) by incorporating regression, dimension reduction techniques, 
and modelling tools. Generally, these latent vectors maximise the covariance between 
different sets of variables. PLSR is similar to canonical correlation analysis (CCA) and can be 
applied as a discrimination tool and dimension reduction method, similar to principal 
component analysis (PCA) [179]. It can also be related to other regression methods like 
principal component regression (PCR), ridge regression (RR), and multiple linear regression 
(MLR); all these methods can be cast under a unifying approach called continuum regression 
(CR) [183], [200], [201]. PLSR has great acceptance in the field of multivariate data analysis. 
In fact, quite a wide spectrum of chemical data analysis problems are processed using this 
algorithm [178], [190], [202], [203]. However, where there is substantial nonlinearity in a data 
set, PLSR tends to give large prediction errors thereby making nonlinear calibration 
techniques such as nonlinear partial least squares (NPLS), locally weighted regression (LWR), 
alternating conditional expectations (ACE), and artificial neural networks (ANN) more useful 
in such cases[179]. 
Principal Component Regression (PCR): PCR is similar to PLSR in many ways and the 
theoretical relationship between them has been treated extensively in the literature [204], 
[205]. Like PLSR, PCR models the relations between different sets of observed variables by 
means of latent variables. In PCR, data decomposition is done using only the independent 
variables, while PLS employs independent variables (e.g. spectra) and dependent variables 
(e.g. concentration values). Historically, PCR predates PLS, however, since its introduction, 
PLS appears by most accounts to have become the method of choice among chemists [205] 
and engineers. 
2.4 Conclusions 
Continuous manufacturing and crystallisation is a rapidly developing field in the 
pharmaceutical sector. Unlike batch operation, there are several degrees of freedom in 
continuous (as well as semi-continuous) operation. However, continuous crystallisation is a 
highly complex aspect of drug manufacture that requires PAT and informatics systems tools 
for systems characterisation and process understanding. This is necessary to implement 
monitoring and control strategies in order to determine when steady-state or at least as 
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controlled state of operation is achieved as well as to maintain critical process parameters 
(CPP) within acceptable bounds to make sure that the CQA of the product stream are 
maintained. Furthermore, this will have implications for the achievable product yield and 
quality. Therefore, multivariate data analysis is essential for capturing adequate information to 
inform process control, monitoring and optimisation strategies (inclusive of process modelling 
aspects). MSMPR operation is identified as one of the most adaptable continuous 
crystallisation techniques since existing batch capacity can be easily retrofitted to operate as 
continuous stirred tanks that fulfil the MSMPR requirement. However, there are several issues 
with attaining the right mean residence time for crystal growth and improved yield. 
Furthermore, issues such as fouling, encrustation and transfer line blockages are not currently 
well resolved. In order to resolve these issues, novel MSMPR designs and operating strategies 
are required, which will likely encourage uptake in the pharmaceutical industry and facilitate 
“beginning-to-end” continuous manufacturing. 
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Chapter 3 
Materials and Experimental Methods 
3.1 Materials 
In this chapter, the materials used and experimental methods employed in the studies reported 
in Chapters 4 through 8 are described. All substances used in the crystallisation studies 
reported in this thesis were obtained from approved suppliers and are listed in the categories 
chemicals and solvents below: 
Chemicals: 
Measures were taken to obtain chemicals from the same supplier were possible. In some 
cases, chemicals were ordered from the same supplier, but the country of origin differed. 
All chemicals were used as obtained and were of the. 
 Paracetamol (PCM): 4-acetaminophenol, 98 % purity was purchased from Sigma Aldrich 
UK (raw materials originated from China, France and USA). 
 Glycine (GLY; α-Form): ≥ 99 % purity was purchased from Fisher Scientific UK Sigma 
Aldrich UK (raw materials originated from China, Belgium and USA). 
 Barbituric Acid (BA; Form II): ≥ 99 % purity was purchased from Fisher Scientific UK 
(sourced from Acros Organics China). 
 Urea (U): ≥ 99 % purity was purchased from Fisher Scientific UK (sourced from Acros 
Organics Spain). 
 p-Toluenesulfanamide (p-TSA): 99 % purity was purchased from Fisher Scientific UK 
(sourced from Acros Organics Republic of Korea)  
 Triphenylphosphine oxide (TPPO): 99 % purity was purchased from Fisher Scientific UK 
(sourced from Acros Organics Germany) 
Solvents: 
 Isopropyl alcohol (IPA): propan-2-ol, analytical reagent grade, 99.97 % was purchased 
from Fisher Scientific UK. 
 Deionised (DI) water: tap water was purified using either a Millipore Elix® Advantage 
or a Millipore Direct-Q3 Ultrapure water purification system, and use as dispensed.  
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 Methanol (MeOH): analytical reagent grade, 99.9 % was purchased from Fisher 
Scientific UK. 
 Acetonitrile (MeCN): analytical reagent grade (99.9 %) and HPLC grade were 
purchased from Fisher Scientific UK. 
 Formic acid: ACS reagent grade (88 – 91 %) was purchased from Sigma Aldrich. 
3.2 Materials Characterisation 
A combination of off-line solid-state characterisation tools and on-line PAT tools were applied 
in each of the studies reported in this thesis, as described in the following sections. Where 
appropriate and when necessary, analytical equipment were calibrated according to the 
recommended methodology of supplier, unless otherwise stated. The instrument analytical 
conditions were adjusted according to the properties of the sample under investigation. A 
detailed description of the analytical procedures employed for each analysis is provided in the 
relevant sections of this thesis.  
3.2.1 Powder X-Ray Diffraction 
Powder X-ray diffraction (PXRD) is a semi-quantitative technique frequently used for solid 
state characterisation and identification of crystalline samples by their diffraction patterns. The 
technique is based on the elastic scattering of X-rays hitting the sample. Since X-rays are 
electromagnetic radiation with wavelengths of similar size to crystal lattice spacings, crystals 
can act as diffraction gratings. Relative to other solid state methods, PXRD allows for rapid 
non-destructive analysis of multi-component mixtures, without extensive sample preparation 
[206].  
PXRD patterns of raw materials and crystalline samples collected from the cooling 
crystallisation runs were collected using either a Bruker D8 Advanced or Bruker D2 Phaser 
bench-top X-ray diffractometer unit, each equipped with Cu Kα radiation source (λ = 1.54056 
Å), For each analysis, a 3 mm anti-scatter slit was used with a programmable divergent slit of 
1 mm. A 1.5o Soller slit was employed and diffractograms collected between 5 and 90o 2θ with 
a step size of 0.02o. In preparation for PXRD analysis, samples were mounted and spread 
evenly onto 6 or 12 mm discs, depending on the quantity available. Data analysis was carried 
out using the Bruker’s DIFFRAC.EVA version 3.1 software. 
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3.2.2 Differential Scanning Calorimetry 
Differential scanning calorimetry (DSC) is a thermoanalytical technique that monitors heat 
effects associated with phase transitions and chemical reactions as a function of temperature. 
In a DSC analysis the difference in heat flow required to increase the temperature of a sample 
and a reference is recorded as a function of temperature. The sample and reference are both 
heated at a constant rate, and thus maintained at the same temperature during analysis. 
Typically, the reference is an inert material such as alumina (aluminium pan). Since the DSC 
operates at constant pressure, heat flow is equivalent to enthalpy changes [207]. 
DSC analyses were carried out using a Thermal Advantage DSC Q20 fitted with a Thermal 
Advantage 90 cooling system, using nitrogen gas at a flow rate of 18 cm3/min. Data were 
collected and processed using the Instruments-Waters LLC Advantage Qseries version 5.4.0 
software package supplied with the instrument. 
3.2.3 Raman and Hot Stage Microscopy 
Raman spectroscopy is a widely used solid state characterisation technique that observes 
vibrational, rotational, and other low frequency modes in a system [208]. The technique is 
commonly used to provide a “fingerprint” by which molecules can be easily identified. Raman 
relies on inelastic scattering (or Raman scattering) of monochromatic light, typically from laser 
in the visible, near infrared, or near ultraviolet range. Typically, a sample is illuminated with a 
laser beam and the electromagnetic radiation scattered from the sample is collected with a 
lens and then sent to a monochromator (detector). Elastic or Rayleigh scattered radiation at 
wavelengths corresponding to the laser is filtered out and the remaining light is collected and 
dispersed onto the detector. 
A Thermo Scientific DXRTM Raman Microscope equipped with 780 nm laser, Olympus TH4 
200 optical component, and Linkam THMS600 heating/freezing stage was used for phase 
identification, polymorph characterisation and image analysis. The full spectral range of the 
instrument (3500 – 50 cm-1) was capture with a single exposure of the charged-coupled-device 
(CCD). Samples for polymorph screening and imaging were mounted on glass slides and 
analysed using x 4, x 10 or x 50 objective, resulting in spot sizes of 7.9, 3.8 and 1.3 µm, 
respectively. Raman spectra were collected using the 50 µm slit and a laser setting of 15 mW. 
The number of scans and exposure time for each sample was 10 x 10 s. The instrument 
settings led to estimated resolution of 4.7 – 8.7 cm-1. Data processing and analysis was carried 
out using Thermo Scientific OMNICTM Series Raman software and TQAnalystTM  version 8.0 
software. 
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Hot stage microscopy (HSM) studies were carried out using the Linkham THMS600 unit. The 
stage body fitted with a quick-to-fit gas port was connected to a LNP95 cooling pump to control 
the sample atmosphere using a dry nitrogen flow. Samples were loaded onto a 0.17 mm thick 
cover slip and placed on a highly polished pure silver heating element to ensure good heat 
transfer and sensitive temperature measurements. Samples were heated to 100 oC and 
equilibrated, followed by stepwise heating at a rate of 1 oC/min to 180 oC, holding at each step 
for 5 minutes. Images and Raman spectra were captured whenever phase changes were 
detected. 
A Kaiser Optical Systems Raman RXN2 Hybrid with PHAT probe (785 nm InvectusTM NIR 
laser), spectral range 1875 – 100 cm-1, was used to analyses samples taken from the 
crystallisation processes to determine the crystalline form and polymorphic purity. Data 
processing and analysis were carried out with Kaiser iC Raman version 4.1 and TQAnalystTM 
version 8.0 software packages. 
3.2.4 Attenuated Total Reflectance Fourier Transform Infrared Spectroscopy 
Solid state analyses with off-line attenuated total reflectance Fourier transform infrared 
spectroscopy (ATR-FTIR) is widely used to study the interaction of molecules with infrared 
radiation by measuring the absorption, emission and reflection patterns. Specific frequencies 
of the absorbed radiation match the transition energy of the bond or functional group that 
vibrates. ATR-FTIR is a complementary technique to Raman spectroscopy, and is used to 
identify molecules based on their unique vibration patterns.  
Samples were analysed using a Thermo Scientific Nicolet™ iS™50 FT-IR benchtop 
spectrometer with a KBr beam splitter and DTGS ATR detector. The spectral range of the 
instrument was 4000 – 400 cm-1. Prior to analysis a background reading (5 scans averaged) 
was taken in air to eliminate interferences from CO2, H2O and other atmospheric gases. 
Samples were then mounted on the ATR iS50 window and fixed in place with the sample 
holder supplied with the instrument. The instrument was set to absorbance mode and 10 scans 
were recorded and averaged over 10 seconds per sample, leading to a spectral resolution of 
4 cm-1. Data processing and analysis was carried out using Thermo Scientific OMNICTM Series 
FT-IR software and TQAnalystTM version 8.0 software. 
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3.2.5 Scanning Electron Microscopy (SEM) and Energy Dispersive X-ray 
Spectroscopy (EDS) 
In scanning electron microscopy (SEM) an electron beam is focused and scanned across a 
sample’s surface. When the electrons strike the sample, they interact with the atoms, which 
emit a variety of signals that can be detected. Specific signals (secondary electrons, 
backscattered electrons and X-rays) contain information about the sample surface topography 
and composition and are combined to produce an image. The detection and measurement of 
energy from the sample surface as described earlier, permits elemental analysis, that is, 
energy dispersive spectroscopy (EDS). EDS provides rapid quantitative analysis of elemental 
composition with a sampling depth of 1 – 2 µm. X-rays may also be used to form lines, profiles 
or maps, showing the elemental distribution on the sample surface. 
SEM/EDS studies were carried out using a Carl Zeiss 1530 VP high resolution field emission 
gun scanning electron microscope (FEGSEM) fitted with a high energy EDS for chemical 
analysis and an electron backscattering system (EBSD). Samples were prepared for 
SEM/EDS analysis using a bench-top Quorum Q150T ES gold sputter coater/carbon 
evaporator coating system with turbo-molecular pump. The system was used to coat each 
sample with a thin film of gold-palladium prior to analysis. Samples were then mounted on a 
stage in the SEM instrument chamber and analysed under vacuum. 
3.2.6 High Performance Liquid Chromatography and Mass Spectrometry 
High performance liquid chromatography (HPLC is an analytical technique used to separate 
and quantify the components in a mixture. The technique relies on high pressure pumps to 
pass the liquid solvent (mobile phase) containing the sample mixture through a column packed 
with solid adsorbent material (stationary phase). Each component of the sample mixture 
interacts differently with the adsorbent material, leading to different flow rates for the different 
components and hence their separation. 
Mass spectrometry (MS) is an analytical chemistry technique used to identify the quantity and 
type of molecules in a sample by measuring the molecular mass [209]. In order to measure the 
characteristics of individual molecules, the mass spectrometer converts them to ions so that 
they can be manipulated by external electric and magnetic fields. These ions are extracted into 
the analyser region of the mass spectrometer where they are separated according to their mass-
to-charge ratios (m/z). The separated ions are detected and the signal sent to a data system 
where the m/z ratios are stored together with their relative abundance for presentation in the 
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format of an m/z spectrum. The spectrum can then be used to elucidate the chemical 
composition and structure of molecules present in the sample. 
Method 1: analyses on PCM samples for impurities were performed using an Accela 600 
HPLC chromatograph, combined with an Exactive (Orbitrap) MS unit, both from Thermo Fisher 
Scientific (Bremen, Germany). UV detection was performed at 254 nm using HPLC, but due 
to low sensitivity, MS was also implemented. An electro spray ionisation method was used to 
monitor the positive [M−H]+ ions. Mass parameters were optimised as follows: capillary 
temperature 350 °C, sheath gas 50 psi, ion spray (IS) voltage 4500 V. An ACE 111-1503 
column (100 Å, 3.0 µm, 3.0 mm×150 mm) obtained from HiChrom (Reading, UK) was 
employed. 0.1 % formic acid in water was used as for mobile phase A, and 0.1% formic acid 
in MeCN for mobile phase B. The flow rates of the mobile phases were each set to 300 µL/min. 
PCM samples were dissolved in methanol to a concentration of 5 mg/mL, followed by dilution 
with water to 1.25 mg/mL. The sample injection volume was 10 µl, and a gradient elution 
program was applied as shown in Table 3.1. Prior to analysis the column was equilibrated for 
each HPLC condition by running two solvent blanks (mixture of methanol and water (3:1, v/v)). 
Table 3.1: Gradient program 
Time (min) % Mobile Phase A % Mobile Phase B 
0 90 10 
30 0 100 
31 90 10 
35 90 10 
 
HPLC-MS data were screened based on the exact mass of impurities. The list of potential 
impurities has been developed from an extensive literature review and exact mass has been 
calculated using ChemBioOffice software.  
Method 2: analyses on p-TSA and TPPO samples were performed using a Hewlett Packard 
HP1100 Series chromatograph with a DAD.G1315A diode array detector using a Waters 
Spherisorb C8 Column (80 Å, 5 µm, 4.6 mm × 250 mm) eluting with MeCN:H2O (80:20) at 
1 mL/min and UV detection at 254 nm. A small quantity of each sample was dissolve in MeCN, 
the injection volume was 100 µl.  
3.2.7 Laser Diffraction Analyses: Malvern Mastersizer® 
Laser diffraction analysis, otherwise known as laser diffraction spectroscopy (LDS) is one of 
the most popular methods used to determine particle size. The technology utilizes diffraction 
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patterns of a laser beam passed through a dispersed particulate sample to measure particle 
size distributions by calculating the angular variation in intensity of light diffracted as the laser 
beam strikes particles in the sample [210]. Laser diffraction analysis utilizes the Mie theory of 
light scattering to calculate the particle size distribution, assuming a volume equivalent sphere 
model [210], [211]. Mie theory is a closed form solution to Maxwell’s electromagnetic equations 
for scattering from spheres. The solution includes sensitivity to smaller sizes (wide angle 
scatter), a wide range of opacity (that is, light absorption) and light that refracts thorough the 
particle (secondary scattering). Mie theory requires knowledge of the optical properties (that 
is, refractive indices) of the particle and dispersing medium.  
A Malvern Mastersizer® 2000 instrument fitted with Hydro SM dispersion unit was used for 
particle size analysis by laser diffraction. Dried crystalline samples were dispersed in IPA or 
H2O, and introduced into the flow cell of the Mastersizer unit via a circulation system for 
measurement by laser diffraction. Three representative measurements of each sample were 
performed and the average values reported. 
3.3 On-line Process Analysis  
Each of the crystallisation study reported in this thesis were analysed on-line using different 
arrangements of a composite process analytical technology (PAT) array with crystallisation 
informatics systems (CryPRINS) software tool. 
3.3.1 On-line Raman Spectroscopy 
On-line Raman analyses of crystallisations were carried out using either a Kaiser Optical 
Systems RamanRXN analyser with MultiRXN immersion probe (785 nm InvectusTM NIR laser), 
spectral range 3425 – 100 cm-1 or Kaiser Optical Systems RamanRXN2 Hybrid with MR 
immersion probe (785 nm InvectusTM NIR laser), spectral range 1875 – 100 cm-1. Data 
processing and analysis was carried out with Kaiser iC Raman 4.1 software package and 
Thermo Scientific TQAnalyst version 8.0. Chemometric analyses were performed on the 
acquired spectral data for principal component analyses and multivariate model development 
to characterise both the solid and liquid phases of the crystallisations. 
3.3.2 On-line ATR-FTIR Spectroscopy 
On-line ATR-FTIR spectroscopy was used as a complementary technique to Raman for 
monitoring the solution phase of the crystallisations. A Thermo Scientific FT-IR spectrometer 
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with KBr beam splitter, MCT/A detector and artphotonics ATR Silicium SN 210 immersion 
probe was employed. The spectral range of the unit was 2800 – 650 cm-1. Prior to each 
analysis a background reading was taken in the solvent at room temperature. For each 
analysis 23 scans were collected over 30, 60 or 90 s and averaged, leading to a spectral 
resolution of 4 cm-1. Data analysis and processing was carried out using Thermo Scientific 
TQAnalyst version 8.0 software.  
3.3.3 On-line ATR-UV/vis Spectroscopy 
Ultraviolet/visible spectroscopy is a technique used to measure absorbance or reflectance in 
the ultraviolet/visible spectral region. Molecules containing π-electrons or non-bonding 
electrons (n-electrons) can absorb ultraviolet or visible light to excite these electrons to higher 
anti-bonding orbitals and produce an absorbance spectrum in the process.  
On-line attenuated total reflectance ultra violet/visible (ATR-UV/vis) was used as a 
complementary technique to Raman and ATR-FTIR for monitoring solution phase of the 
crystallisations. A Carl Zeiss Multi-Channel MSC621 UV-VIS/CLD 600 spectrometer fitted with 
either a Helma 661.822 or Katana 6 ATR-UV immersion probe was used. The spectral range 
of the unit was 700 – 185 nm. The unit was coupled with an in-house developed LabView 
software program for real-time display of data and for process monitoring.  
3.3.4 Focused Beam Reflectance Measurement Analysis 
Focused beam reflectance measurement (FBRM) is an in situ particle monitoring technique. 
It provides real-time measurements that reflect the number, size and distribution of particles. 
During FBRM analysis a laser beam is focused onto the surface of the probe window in contact 
with the suspended particles and is rotated at a constant speed. The beam scans across 
individual particles or particle structures (such as agglomerates) that pass in front of the 
window. The particles backscatter the laser light which is detected by the probe as a pulse. 
The duration of the pulse of backscattered light multiplied by the rotation speed of the laser 
gives a measure of the length of the intersected particle, referred to as a chord length. After 
numerous scans, a chord length distribution is generated, which shows the number of 
individual chords measured per second as a function of the chord length dimension. The chord 
length distribution is strongly dependent on particle shape, with different distributions 
generated for spheres, ellipsoids or cubes, for example. The technique is capable of 
measuring particle sizes in the range 1 – 1000 µm and can be used to measure the trends in 
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size distributions that evolve with time due to breakage, agglomeration, growth or nucleation 
of particles 
Analyses were carried out using either a Mettler Toledo Lasentec® D600L FBRM® fitted with a 
19 x 400 mm immersion probe or a ParticleTrack G400 FBRM® fitted with a 14 x 200 mm 
immersion probe during the cooling crystallisation studies reported in this thesis. Each 
instrument consisted of an infrared laser, with a wavelength of 785 nm and scan speed of 
2 m/s. Data were record and saved either every 10 or 30 s depending on the system under 
investigation. Mettler Toledo FBRM® Acquisition version 6.7.0 (D600L) software or iC FBRMTM 
software (G400) was used to acquire and save the data. Data analysis and processing was 
carried out using either Mettler Toledo FBRM® Review version 6.7.0 (D600L) software or 
iC FBRMTM. 
3.3.5 Particle Vision Microscopy Analysis 
Particle vision microscopy (PVM) is complementary in situ particle monitoring technique to 
FBRM. This technique is capable of measuring particle sizes from 2 – 1000 µm and provides 
real-time image analysis to quantify particle dimensions or aspect ratios.  
PVM image acquisition and particle analysis was carried out using a Mettler Toledo V819 
PVM® unit fitted with a 19 x 400 mm immersion probe. Mettler Toledo PVM® Image Acquisition 
software 8.3 version software was used to track the particle properties of the system under 
investigation. Image analysis parameters such as thresholding, filter type and decimation 
factor were set using the “Blob analysis” algorithm in the software. The evolution of the particle 
properties, that is, number and size were tracked simultaneously using Mettler Toledo PVM® 
Acquisition software 6.7.0 version 
3.4 Chemometrics: Multivariate Data Treatment and Analysis 
Chemometrics involves performing mathematical and statistical analysis on data obtained 
from chemical measurements. It involves the use of linear or non-linear algebraic methods to 
make either qualitative or quantitative interpretation of chemical data, primarily spectra. 
Applications of chemometrics are varied, and include experimental design, data mining, 
multivariate data analysis, calibration, process modelling, pattern recognition and 
classification, signal correction and compression, and statistical process control [179], [212]. 
Chemometrics can be used to analyse the data obtained from various instruments including 
Raman, NIR, Terahertz, MIR, UV, and HPLC. In this thesis emphasis will be placed on the 
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use of chemometrics approaches for multivariate calibration model development and data 
analysis for Raman, IR and UV. Compared to classical univariate calibration methods, 
multivariate techniques use not only one wavelength / wavenumber, but the whole spectral 
range for the model development. The advantage of these types of calibration methods is the 
amount of spectral information used, so that even minor differences in the sample spectra can 
be identified and correlated to a specific phenomenon [153]. Furthermore, multivariate 
techniques are capable of measuring multiple analytes simultaneously. For this thesis project, 
chemometrics was a useful method for real-time in-process monitoring and characterisation 
and is viewed as a valuable process analytical tool. 
3.4.1 Multivariate Calibration Models for Crystallisation Monitoring 
Chemometrics offers a range of different techniques for data processing, evaluation and model 
building using a variety of algorithms. The different techniques may be divided into two main 
categories referred to as bilinear and multiway models (see Chapter 2). In this thesis various 
bilinear models were used to analyse data and develop multivariate calibrations for the 
qualitative and quantitative evaluation of the different cooling crystallisations that were studied. 
In bilinear modelling the data set is arranged in matrices so that each vertical column has 
variables and each horizontal row contains samples [179], [196]. The bilinear models that were 
applied in the cooling crystallisation studies included PCA, PCR and PLSR (see Chapter 2). 
Models were developed using either Thermo Scientific’s TQAnalyst version 8.0 or 
MathWorks® 2012b or 2013a software packages.  
3.4.2 Paracetamol (PCM): Raman and ATR-UV/vis Spectroscopy Multivariate 
Models 
In order to build a robust calibration model for solution concentration measurement using 
Raman spectroscopy, a few factors must first be taken into account. Raman spectroscopy is 
a scattering technique based on vibrational, rotational, and other low-frequency modes in a 
system [208]. The laser is therefore capable of interacting with molecular excitations in both 
the solid and liquid phases. Therefore, when developing a calibration model for monitoring 
solution phase concentration, the effect of particle scattering on the Raman signal must be 
accounted for. By collecting spectra at known concentrations of PCM in IPA in the presence 
and absence of solid phase (crystallised PCM).  
Raman spectroscopy is rarely used in crystallisation for solution concentration measurement 
[136]. The work reported here is a proof of concept approach whereby the capability of Raman 
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spectroscopy to distinguish solution from solid phase in a crystallisation process is 
demonstrated. Raman spectra of PCM dissolved in IPA solvent were collected using the 
Kaiser RamanRXN analyser unit in the range 3425 cm-1 to 100 cm-1 at a spectral resolution of 
4 cm-1. The number of scans and exposure time for each sample was 7 x 4.9 s over a total 
measurement time of 60 s. PCM-IPA solutions were prepared at saturation temperatures of 
10, 15, 20, 30, 40 and 50 oC. The saturation temperature (Tsat) of PCM in IPA were estimated 
from solubility data published by Hojjati et al. [213]. The same solubility data were also used 
by Saleemi et al. [170] in a study on comparative batch crystallisation control strategies using 
PCM-IPA as a model system. The model equation used to determine the solubility (c) of PCM 
(g / g IPA) in IPA as a function of temperature 𝑇 (oC) is: 
c (T) = 2.742 × 10−5𝑇2 + 1.328 × 10−3 𝑇 + 7.202 × 10−2 3.1  
Figure 3.1 (a) and (b) show typical time diagrams for solid-free solution and solid-liquid 
suspension calibration and validation experiments respectively.  Suspensions of PCM-IPA 
were heated to 10 oC above the desired Tsat and maintained for 15 min. The resulting solution 
was then cooled in steps of 5 oC and held at each step for 30 min. This was continued until 
nucleation was observed in the system. For each experiment, Raman spectra were collected 
from the solid-free solutions before the occurrence of nucleation and used as calibration 
samples in the model development process. For validation purposes, an additional experiment 
at 15 oC saturation was conducted, where solid-free solution Raman spectra were collected.  
In addition to the solid-free calibration and validation experiments, an extended series of 
experiments were conducted whereby Raman spectra from solid-liquid suspensions were 
collected and used in the calibration model development and validation. In a typical 
experiment, shown in Figure 3.1 (b), a suspension of PCM-IPA was heated to 10 oC above 
the desired Tsat and maintained for 15 min. The resulting solution was then cooled to 5 oC at 
a rate of 0.5 oC/min and maintained until nucleation was observed. The system was then 
heated up in steps of 5 oC and held at each temperature step for 2 hours to allow the system 
to equilibrate. Raman spectra were collect from these solid-liquid suspensions prior to 
complete dissolution. 
During each of the calibration experiments, ATR-UV/vis was used to measure solution phase 
concentration using a pre-existing multivariate model developed by Saleemi et al. [170]. FBRM 
was used to detect the onset of nucleation and to track the particle properties of the system 
over time. Solid-free solution spectra used in the calibration model were all taken prior to the 
onset of nucleation, as detected by FBRM (total counts/s) and ATR-UV/vis (concentration; 
g/g), as shown earlier in Figure 3.1 (a). Spectra from the solid-liquid suspension were used to 
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account for particle scattering effects on the Raman signal. Peaks were identified in the 
Raman spectra corresponding to the solution (peak at 1445 cm-1) and solid (peak at 1668 cm-
1) phase, as shown on the time diagram, Figure 3.1 (b). The FBRM data captured during this 
experiment shows curvature in some regions of the ramping steps, which may be an indication 
that particles are sticking on the probe window. As the particle numbers in the system are 
reduced with each heating step, the curvature is noticeably diminished. 
 
Figure 3.1: Time diagrams showing: (a) typical solid-free calibration/validation experimental 
run and (b) typical solid-liquid suspension calibration/validation experimental run. 
The TQ Analyst version 8.0 software was used for Raman spectra pre-treatment, model 
development and concentration determination. Figure 3.2 shows the Raman spectra of PCM 
in IPA along with the selected range of wavenumbers (1750 – 100 cm-1) used for model 
development and validation. In total, 2219 spectra (or samples) were used for the calibration 
model development and validation. Of these, 2009 samples were used as calibration 
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standards, 150 as solid-free validation standards and 60 as solid-liquid suspension validation 
standards.  
The standard normal variate (SNV) normalisation algorithm in TQAnalyst was applied to pre-
treat the Raman spectra. SNV compensated for differences in sample path-lengths and 
removed the effect of scattering caused by the presence of particles. The first derivative (1st 
DV) was then applied to the spectral data. Derivatives (e.g. first or second) are often used in 
multivariate data analysis to enhance spectral resolution, eliminate or reduce linear and 
constant baseline drift effects between samples and also to emphasise pronounced, but small 
spectral features relative to larger broader ones. [214]–[216]. Five regions within the selected 
range of wavenumbers highlighted in Figure 3.2 were used to develop the multivariate model 
post pre-processing. 
 
Figure 3.2: Typical Raman spectrum of PCM in IPA showing the regions selected for the 
multivariate calibration model development (100 – 1700 cm-1). 
The ‘Partial least squares (PLS)’ option in TQAnalyst was applied to build the calibration model 
with the selected regions. This model was used for real-time in situ concentration 
measurement of PCM in the liquid phase during each of the cooling crystallisation 
experiments. In the PLSR analysis, the spectra, temperature, and concentration data were 
first encoded in a matrix form and then reduced to only a few principal components according 
to [217]. In this study, 8 components were applied, which allowed sufficient data to be used to 
correlate changes in the spectra due to temperature and particle scattering effects to the 
sample concentration. Figure 3.3 (a) and (b), shows the calibration plot with validation points 
and percentage errors between the actual and predicted concentrations. For model validation, 
spectral data from solid-free solutions and suspensions containing solids were used. The 
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validation points are circled in Figure 3.3 (a); they indicate that the model is working effectively. 
The maximum error between the predicted and model determined concentration was 3.7%. 
The root mean square error of prediction (RMSEP), which is a measure of the model predictive 
accuracy, was 0.0074 g/g, which is based on the lowest concentration measurement.  
 
Figure 3.3: Raman concentration prediction plots derived from the multivariate calibration 
model development process showing: (a) predicted versus actual concentration values and 
circled model validation points. (b) error plot of predicted versus actual concentrations. 
PLSR is a suitable multivariate method for this case as shown in Figure 3.3, since acceptable 
levels of accuracy were obtained using only 8 principal components to build the calibration 
model, which were 7 composites of Raman wavenumbers plus temperature as an additional 
variable. 
A non-linear multivariate ATR-UV/vis model [170] was used to further validate the Raman 
model described above. The ATR-UV/vis model was of the form:  
C = 𝑏𝑜 +  𝑏1𝑑 +  𝑏2𝑇 + 𝑏3𝑑 𝑇 3.2  
where C is the concentration in (g PCM/g IPA) and 𝑏𝑜, 𝑏1, 𝑏2, and 𝑏3 are fitted regression 
coefficients with values of -0.0290, -3.7889, -0.0002 and -0.0248 respectively, 𝑑 is the 1st DV 
of the absorbance at the selected wavelength (266 nm), and 𝑇 is the process temperature 
(oC). A simple non-linear term expressed as the product of the derivative of the absorbance 
and temperature was also included to improve the accuracy of the calibration model. Further 
details on the  model development using ATR-UV/vis can be found in works by Saleemi et al 
[170], [218]. Figure 3.4 shows the predicted concentration for a batch linear cooling experiment 
showing both the Raman and ATR-UV/vis predicted concentration measurements from the 
respective multivariate models; the data shows good agreement between the two. 
(a) (b) 
50 
 
 
Figure 3.4: Time diagram of a linear cooling crystallisation run showing Concentration was 
monitored with Raman and ATR-UV/vis. 
3.4.3 Glycine (GLY): Raman Spectroscopy Multivariate Calibration Model 
Following the successful use of Raman spectroscopy to develop a multivariate calibration 
model for PCM solution phase concentration monitoring, a similar approach was applied to 
glycine-water (GLY-H2O) system for quantitative measurement of GLY in solution during 
crystallisation. The Kaiser RamanRXN analyser unit was used in this study and spectra were 
collected in the range 3425 cm-1 – 100 cm-1 at a spectral resolution of 4 cm-1. The number of 
scans and exposure time for each sample was 8 x 10 s over a total measurement time of 90 s. 
The for GLY is greater than that used for PCM, which is a direct result of the varying abilities 
of the two substances to scatter Raman light. Note that the exposure time refers to the time 
taken for the integration time for each pixel (i.e. frequency) of the Raman signal. Therefore, 
weak Raman scatters require longer exposure times for collection of a spectrum. Raman 
spectra of GLY were collected at known concentrations of GLY in water in the presence and 
absence of solid phase (crystallised GLY). Potential temperature effects were also considered 
by operating over a wide temperature range (5 – 60 oC). For the training data set GLY-H2O 
solutions and suspensions were prepared at saturation temperatures of 5, 10, 20, 30, 40, 50 
and 60 oC (concentrations, g GLY /g H2O: 0.159, 0.181, 0.228, 0.277, 0.330, 0.385 and 0.446 
respectively). For the validation data set, experiments were carried out at 15, 35 and 50 oC 
saturation (concentration, g GLY/g H2O: 0.204, 0.303 and 0.385 respectively). A total of 1037 
spectra were used for the calibration model development and validation, of these, 766 were 
used as calibration standards, 91 as solid-free validation standards and 180 as solid-liquid 
suspension validation standards. MathWorks Matlab® 2014a software pack was used for 
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spectral pre-processing and model development. A generic set of Matlab® codes used for 
multivariate model development can be found in Appendix I. 
At the pre-processing stage, two methods were applied to select the spectral regions for later 
model development. The first was manual selection of the wavenumbers based on knowledge 
of the chemical shifts of GLY-H2O as shown in Figure 3.5.  
 
Figure 3.5: Typical Raman spectra of GLY in H2O (Tsat of 20 oC) and collected in the presence 
and absence of solids (i.e. crystallised GLY) and at different operating temperatures (for solid-
free solutions only) and constant temperature (for suspensions only). Operating temperatures 
are indicated in brackets. Highlighted regions were used for the model development. 
Figure 3.5 displays three spectra corresponding to the same Tsat of 20 oC. The difference 
between the three spectra are seen from the change in baseline with change in operating 
temperature (T) and the appearance of peaks corresponding to the solid phase relative to 
solution phase spectra in the finger print region (1670 – 100 cm-1), for example small peaks 
appearing at 327, 695, 1140, 1455 and 1564 cm-1. Due to particle scattering, special scatter 
correction algorithms, for example, multiplicative scatter correction (MSC) or standard normal 
variate (SNV) have to be considered in order to eliminate this effect and prevent erroneous 
predictions. 
The second region selection method involved the application of a statistical technique, 
stepwise multiple linear regression analysis (MLR) using the Stepwise Regression toolbox in 
Matlab® 2014a. This is a method for selecting predictor variables, by stepwise addition 
(forward MLR) or removal (backward MLR). The forward MLR method was applied whereby 
an initial screening of variables is performed. With this method, variables are added stepwise 
to the predictor data set by applying partial F-test statistical analysis. In forward MLR variables 
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are selected until no more can be justifiably added to the predictor data set. The cut-off point 
is applied when the root mean squared error (RMSE) can be reduced no further or the 
coefficient of determination (R2) does not improve with the addition of new variables. RMSE is 
a measure of the difference between sample and population values predicted by a model and 
is described by the expression: 
RMSE = √∑(𝑌  𝑚𝑒𝑎𝑠 − 𝑌  𝑐𝑎𝑙)2 3.3  
where 𝑌 
 𝑚𝑒𝑎𝑠 and 𝑌 
 𝑐𝑎𝑙 are respectively, the measured and predicted values [217]. 
The limitations of MLR technique are well known and the final model is not guaranteed to be 
optimal in any specified sense. MLR procedure yields only a single set of predictor variables. 
The danger here is that selected variables may not be useful for prediction and useful ones 
may be ignore. Furthermore, it does not take into account a researcher’s knowledge about the 
predictors. However, in practice, used appropriately in combination with appropriate 
multivariate techniques, for example PLSR and PCR, MLR can lead to the development of 
good quality robust calibration models.  
Unless otherwise stated all mathematical treatments of the spectral data were performed using 
Matlab® 2014a software. Further mathematical pre-processing was done on the predictor 
variables selected by using the manual method or stepwise MLR method, techniques 
investigated included: SNV transformation, MSC, mean centering (MC) and auto-scaling (AS). 
First or second order derivative processing was applied to the data either before or after 
applying SNV or MSC followed my MC or AS. Mathematical pre-processing has several 
advantages that have been widely reported in the literature [136], [160], [216], [219]. Following 
pre-processing, multivariate calibration models were developed using either PCR or PLSR 
analysis. In model development an important step is to compare the performance between 
different methods to determine the most accurate and suitable approach. PCR and PLSR are 
the most widely used multivariate methods. Both methods are used to construct new predictor 
variables (components) by a linear combination of the original variables (pre-processed 
spectral data). In the case of PCR, the components are created to explain variability in the 
predictor variables without consideration of the response variable (in this case, concentration). 
PLSR on the other hand does take into account the response variable. Typically, PLSR leads 
to better models that are able to fit the response variable using fewer components compared 
to PCR [204], [205], [220]. However, both methods have been shown to give comparable 
results, although PCR sometimes uses more components for prediction [205]. The calibration 
models were validated using spectral data captured in the presence and absence of solids 
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according to the procedure outlined earlier. The same data selection and mathematical pre-
treatment procedures were applied to the validation data set as the training set. Table 3.2 
shows a summary of performance analysis on the best PCR and PLSR models identified, with 
remarks. Different combinations of spectral pre-processing methods were applied to achieve 
the best possible model performance. A PLSR model with the lowest RMSEP (0.0032 g/g) 
was selected for use, the maximum error between the predicted and model determined 
concentration was 3.4%. The statistical plots derived from the selected PCR and PLS 
multivariate calibration models can be found in Appendix I. 
Table 3.2: Summary of performance indices for the best PLSR and PCR models 
Model Type 
Pre-Processing 
Applied 
No. C* RMSEP R2 % Error Remarks 
MLR-PLSR MSC =>1stDV =>AS 10 0.0032 0.9999 ± 3.4 optimum 
MLR-PLSR MSC =>1stDV =>AS 7 0.0034 0.9998 ± 3.7 high rank 
MLR-PLSR MSC =>1stDV =>AS 5 0.0054 0.9996 ± 3.8 high rank 
MLR-PCR MSC =>1stDV =>AS 5 0.0064 0.9914 ± 5.0 high rank 
Manual PLSR SNV =>AS 9 0.0106 0.9993 ± 4.8 outliers 
MLR-PCR MSC =>1stDV =>AS 10 0.0109 0.9991 ± 4.7 outliers 
Manual PCR SNV =>AS 10 0.0124 0.9990 ± 5.5 outliers 
Manual PLSR SNV =>1stDV =>AS 10 0.0234 0.9992 ± 5.6 outliers 
Manual PCR SNV =>1stDV =>AS 10 0.0278 0.9992 ± 5.7 outliers 
C* = number of components; 1stDV = first derivative; AS = auto-scaling 
3.4.4 Hierarchical Approach to Model Development 
Multivariate calibration and classification models are ubiquitous in PAT and QbD [221]. They 
are used both in the development of processes and their permissible operating limits, (i.e. 
models used for relating the process design space to product quality), and in manufacturing 
(i.e. models used in process monitoring and control). The hierarchal approach to model 
development involves the division of variables into meaningful blocks to simplify the 
interpretation of multivariate models with many variables [190], [199], [222]. This is a simple 
idea whereby variables measured on the same part of a process or system (e.g. spectra), are 
put in the same block. The block sizes are selected to avoid significant overlapping; typically 
block sizes are kept below 50 [190]. This method is typically used to summarize a few 
components for each block using a PCA, PCR or PLSR model. The resulting block scores are 
then used as variables in the higher level of the hierarchical model [199]. This idea can be 
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easily extended to several levels, thus providing a more robust approach to modelling data 
sets with many variables. However, these algorithms have been shown to be equivalent to 
ordinary PCA or PLSR of all variables, followed by rescaling of the model parameters [202]. 
In this study, a slightly different hierarchical model development approach is proposed that 
consists of multiple levels of conventional bilinear PLSR models. It is based on a hierarchical 
approach whereby a parent model, which consists of four interconnected levels, is used to 
estimate the parameter of interest (in this case concentration) in a stepwise manner. This 
hierarchical approach is implemented for the glycine-H2O system and is an extension of the 
model proposed in Section 3.2.1. The first level (Level 1) of the hierarchical model consists of 
a generic model that spans the range of concentration values of interest and is used for initial 
screening of the variables. For this purpose, the multivariate model described in Section 3.2.1 
was used. The second level (Level 2) consists of three overlapping models, each of which 
spans different concentration ranges, and are characterised by a select set of samples 
(spectra). The spectra and their associated variables (wavenumbers) are first screened at 
Level 1 to establish their value (i.e. concentration). They are then sorted and assigned to 
different concentration ranges at Level 2. Where there are overlapping concentration values, 
predefined model selection criteria were applied using ‘for’ and/or ‘if’ statements in Matlab® 
2014a. A schematic outlining the various stages of the hierarchical model development 
process is shown in Figure 3.6. Raman spectra, Xi, are pre-screened by forward multiple linear 
regression (MLR) to minimise the number of variables to be used for calibration. Mathematical 
pre-processing is then applied to the selected variables, followed by application of a model 
development algorithm (e.g. PLSR) in Matlab® 2014a. This initial model is applied at Level 1 
and provides the initial estimates of concentration, ŷi for the calibration set. The outputs (ŷi) 
from Level 1 are further refined by apply three independent models (1, 2 and 3) at Level 2 of 
the hierarchy. These models are developed independently from each other, but using the 
same data from the Level 1 model, plus additional independently obtained spectra to expand 
the range of each model. The refined calibration set predictions from Level 2 (yM1, yM2 and 
yM3) can then be compared to the results from Level 1 to determine whether there is an 
improvement. The hierarchical model not only provides more accurate predictions, but can 
also act as its own internal fault detection system that can alert the user to changes in the 
predictive capability over time, due to any number of factors, including changes in sample 
matrices or the instrument response [221]. This can then inform the decision to revaluate, 
update and maintain the model as needed to preserve its predictive ability and robustness.  
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Figure 3.6: Schematic of the hierarchical model development process. 
Hierarchical Model Structure: A detailed representation of the hierarchical model structure 
is shown in Figure 3.7, ko represents the pre-processed variables of each sample that are 
separated and grouped into xi predictor variables that are used to build the Level 1 model, 
Mo (MLR-PLSR). Matlab® 2014a was used to execute all mathematical pre-processing and 
model building algorithms. The predictor variables each represent a specific output value of y. 
At Level 2 of the hierarchal model, ko is divided into three overlapping subsets (k1, k2, and 
k3) corresponding to high, medium and low values of y. These variables are combined with 
additional pre-processed variables within each range (new values of y but within the same 
range for each subset). Three independent multivariate models are built with each data set to 
construct Level 2 of the hierarchical model, that is, M1 (MLR-PLSR), M2 (MLR-PLSR) and 
M3 (MLR-PCR). Each model is used to predict a subset of y observations, that is, y1, y2, and 
y3 respectively. 
Wavenumber selection by 
MLR Xi  (λi)
Apply Level 2 
model 2 (PLSR)
Apply Level 2 
model 1 (PLSR)
Apply Level 2 
model 3 (PLSR)
Refined predictions
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Figure 3.7: Hierarchical model structure. 
Variable Selection, Pre-processing and Model Development: the mathematical expression 
of the MLR variable selection routine that was applied to the spectra is of the form: 
ĉ𝑖 = 𝑏0 + 𝑏1𝜆𝑖1 + 𝑏2𝜆𝑖2+ . . .  + 𝑏𝑝𝜆𝑖𝑝 + 𝑒𝑖 3.4  
where 𝑖 = 1, 2 … n, ĉ is the scalar dependent variable (known concentration values), and 𝜆 
represents the explanatory variables (wavenumbers). The regression coefficients 𝑏0, 𝑏1, 𝑏2 
… 𝑏𝑝 represent the independent contributions of each explanatory variable to the prediction 
of the dependent variable. This relationship is modelled taking into account the error term 𝑒𝑖. 
Following MLR, PCA analysis is carried out on each data set for outlier detection. The 
mathematical expression of the PCA model is: 
𝑥𝑖𝑘 = 𝑎𝑖 + ∑ 𝑏𝑖𝑗𝑡𝑗𝑘
𝐴
𝑗=1
+ 𝑒𝑖𝑘 3.5  
The analysis corresponds to a least squares fitting of a straight line (𝐴 = 1), where 𝑥𝑖𝑘 
represents the scaled value of analysis 𝑖 for sample 𝑘; 𝑎𝑖 determines the centre (mean) of the 
data set; 𝑏𝑖𝑗 are the direction coefficients (one for each variable and component) of the line. For 
each sample 𝑘, the parameter 𝑡𝑗𝑘 describes the position of  data points projected to the model. 
Hence, the  𝑡 values (principal components) can be used to relate data points (samples) to each 
other. The values of 𝑏 (loadings), together with the residuals 𝑒𝑖𝑘 give information on how much 
Input (Xi) = 
x1
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descriptor variables contributes to the model. An important result of this empirical modelling is 
that the variance in the data can be described by fewer variables than in the original data set. 
Figure 3.8 shows the scores plots of PC1 vs PC2 obtained for the PCA analysis at levels 1 
and 2 of the model hierarchy, that is, M0 (Level 1) and M1, M2 and M3 (Level 2). In all cases 
PC1 and PC2 combined account for greater that 80 % variance in the data.  
 
Figure 3.8: Scores plots of PC1 and PC2 for data used to build models M0, M1, M2 and M3. It 
shows clustering of variables that have similar characteristics. 
The samples are “grouped” (clustered) according to their similarity to each other. At level 1 of 
the hierarchical model architecture, the samples show 12 distinctive clusters, each 
representing subsets of the original data set. At level 2 clusters are also observed, although 
some clusters are not as distinctive as at level 1, and there is evidence of possible outliers. 
The reason for this is that the PCA analysis is carried out on small subsets of the level 1 data 
set (albeit with some additional samples included), which means that even subtle differences 
between samples of the same subset are captured more easily. This also leads to the 
detection of “outliers” that can be examined further and removed from the sample sets if 
necessary. In this respect PCA is useful as an initial screening tool to identify “bad” samples. 
The development of the Level 1 model of the in the hierarchy was described in Section 3.2.1. 
The Level 2 models were built using the same variables as at Level 1, with additional variables 
included as mentioned earlier. Following MLR and PCA analysis mathematical pre-processing 
was implemented using SNV or MSC, first or second derivative (2nd DV) and MC or AS 
algorithms in Matlab® 2014a. The pre-processed variables are shown in Figure 3.9. In 
M
0
: level 1 M
1
: level 2 
M
2
: level 2 M
3
: level 2 
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comparison to the variables with no pre-processing applied there is a constant baseline (i.e. 
where the first derivative is applied) and minimal sample drift effects. 
 
Figure 3.9: Variables (spectral regions) of multi-level hierarchical model pre-processed by 
different combinations of MSC, 1st DV and AS. Variables with no pre-processing applied are 
shown for comparison.  
PLSR or PCR calibration algorithms were applied to the pre-processed data in Matlab® 2014a. 
k-fold cross validation was applied to the calibration or training data set. During k-fold cross-
validation, the original sample set is randomly partitioned into k equal sized subsamples, with 
each subsample set used to validate the remaining k – 1 subsets that are used to build the 
calibration model. Figure 3.10 shows the predicted residual sum of squares (PRESS) plots, 
which reflects the predictive ability of the optimum PLSR and PCR models identified based on 
different the pre-processing methods, 10-fold cross validation was applied. This is a type of k-
fold cross-validation whereby the calibration or training data set is partitioned into 10 equal 
sized data subsets. Of the 10 subsets, one subset is retained as validation data set for testing 
the model performance, and the remaining 9 subsets were used as calibration data. The cross-
validation process was then repeated 10 times (that is, 10 folds), with each of the 10 subsets 
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used just once as the validation data set. The 10 results from the folds are averaged to produce 
a single estimation. The advantage of this method is that all samples are used for both 
calibration and validation. However, the method was used only as a guide to selecting the 
number of components, since it is an internal validation approach. 
 
Figure 3.10: Predicted residual sum of squares (PRESS) plots of PLSR models for Level 1 
(Mo) and Level 2 (M1, M2, and M3) of the hierarchical model architecture. 
The PRESS plots for PLSR models indicate that a minimum of three or four components are 
required to build useful models. On the other hand, for the PCR models at least five 
components are required to get the same or better prediction accuracy than PLSR. The 
addition of more and more components as demonstrated in the PRESS minimises the mean 
squared prediction error, leading to better calibration models for both PLSR and PCR. It is 
often useful to choose the number of components to minimise the predicted error when 
checking the response from future observations on the predictor variables (calibration or 
training set). Simply using a large number of components will do a good job in fitting the current 
observed data, but is a strategy that can lead to over-fitting, which then leads to poor prediction 
of variables for the validation data set (test set) [205], [223]. Therefore, care was taken when 
selecting the number of components to apply for the purpose of prediction. 
Hierarchical Model Validation and Application: Figure 3.11 shows the calibration plots with 
external validation points for the four multivariate models that make-up the hierarchical model. 
The Level 1 model (M0) spans the entire concentration rage of interest (0.159 – 0.443 g GLY/ 
g H2O). This model was validated with 9 different concentrations of GLY in H2O spanning the 
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calibration set concentration range. At level 2 of the model hierarchy the three constituent 
models constructed covered the concentration ranges 0.159 – 0.228 g GLY/ g H2O (M1), 0.228 
– 0.330 g GLY/ g H2O (M2), and 0.330 – 0.443 g GLY/ g H2O (M3). The level 2 models were 
validated using the same data set applied at level 1 of the model hierarchy, except that the 
data were divided into three sets corresponding to the concentration ranges of each of the 
level 3 models.  
 
Figure 3.11: Multivariate calibration plots derived from the hierarchical models. The circled 
data points represent the validation sets. The data set used to validate the model at Level 1 
(M0) were split into three data sets according to concentration range and applied to validate 
the models at Level 2 (M1, M2 and M3). 
Figure 3.11 gives an indication of the predictive accuracy of each model. For M0 the validation 
set fits very well to the linear calibration fit at low concentrations (0.159 – 0.228 g GLY/ g H2O), 
but drifts slightly at higher concentrations (0.251 – 0.443 g GLY/ g H2O). In comparison, the 
validation sets fit very well with the linear calibration fits of M1, M2 and M3 at level 2 of the model 
hierarchy. These results indicate that the level 1 PLSR model does not capture sufficiently the 
differences between samples in the data set (which is quite large), leading to larger errors due 
to the requirement to fit all the data to the same model. The fitting of the data at level 2 is much 
improved, attributed to the splitting of the data into subsets, and the use of the most appropriate 
pre-processing methods and multivariate model to fit each subset in order to sufficiently capture, 
and account for the differences between samples. The models shown in Figure 3.11 gave the 
lowest RMSEP and error values of several tested models. The best obtained PLSR or PCR 
models were compared, and the model showing optimum performance based on the RMSEPs 
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and error values selected. Table 3.3 gives a summary of the statistical information indicating the 
predicative capability of the optimum PLSR models (as shown in Figure 3.11). The statistics for 
PCR models that show good performance (high) relative to the optimum PLSR models is also 
included for comparison. In general, the PCR approach to model development led to the use of 
significantly more components compared to PLSR. In some cases, the PCR models gave similar 
results to PLSR in terms of the RMSEP and % error values. However, PLSR models were 
selected at all levels of the model hierarchy due to consistently better results with fewer 
components compared to PCR. Another important observation from the results presented in 
Table 3.3 is the improvement in the prediction error by ~ 2 % for the Level 2 models (M1, M2, 
and M3) compared to the Level 1 (M0) model. This suggests that the strategy of dividing the data 
into smaller subsets at Level 2 and applying independent multivariate models to each set has 
leads to an improvement in the overall performance of the Hierarchical model. It is also 
interesting to note that different combinations of pre-processing methods were required to build 
the optimum models. This leads to the development of a distinctive set of principal components, 
thus making each model in the hierarchy unique. The improved predictive accuracy of the 
calibration model may lead to significant improvements in supersaturation monitoring and 
control of crystallisation processes. 
Table 3.3: Summary of performance indices for the best PLSR and PCR models. 
Model Level 
Model 
Type 
Pre-Processing 
Applied 
No. C* RMSEP R2 
% 
Error 
Performa
nce 
M0 1 MLR-PLSR MSC =>1stDV =>AS 7 0.0032 0.9997 ± 3.4 optimum 
M0 1 MLR-PCR MSC =>1stDV =>AS 10 0.0067 0.9993 ± 4.3 high 
M1 2 MLR-PLSR MSC =>AS 9 0.0012 0.9994 ± 1.3 optimum 
M1 2 MLR-PCR MSC =>AS 10 0.0016 0.9987 ± 1.7 high 
M2 2 MLR-PLSR MSC =>1stDV =>AS 9 0.0023 0.9985 ± 1.4 optimum 
M2 2 MLR-PCR MSC =>1stDV =>AS 10 0.0026 0.9975 ± 2.0 high 
M3 2 MLR-PLSR MSC =>AS 8 0.0024 0.9992 ± 1.0 optimum 
M3 2 MLR-PCR MSC =>AS 10 0.0026 0.9977 ± 1.6 high 
C* = number of components; 1stDV = first derivative; AS = auto-scaling 
Figure 3.12 (a) shows the prediction at Level 1 and Level 2 for the validation samples, using the 
hierarchal models M0 (Level 1), and M1, M2 and M3 (Level 2), respectively. Figure 3.12 (b) shows 
the Level 2 model of the hierarchy used to predict and refine the results from the Level 1 
prediction. The Level 1 initial prediction shows significantly more noise in the data when 
compared to the Level 2 refined prediction, an indication of the improvement achieved by 
applying this hierarchical modelling approach. Figure 3.13 (a), (b), and (c) shows the application 
of the hierarchical model to predict concentration during an experimental run. For this 
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experiment, a saturated solution of 0.4729 g GLY/g H2O was prepared by dissolving the required 
amount of materials in a 500 mL crystalliser.  
 
Figure 3.12: (a) Predicted concentration for 178 validation samples obtained from the Level 
1 and Level 2 models and (b) Plot indicating the Level. 
 
Figure 3.13: Application of hierarchical model predict concentration for an experimental run: 
(a) Level 1 and Level 2 initial and refined predictions; (b) Plot indicating the model applied for 
the refined predictions and (c) Time diagram of the experimental run.  
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Temperature ramps were implemented during the solids dissolution phase to test the robustness 
of the model to variations in the process conditions. Once dissolved, the solution was cooled at 
a rate of 1 oC/min until nucleation was detected by FBRM and held at 20 oC. From Figure 3.13 
(b), it is clear that a different model was applied to refine the concentration prediction for each 
stage of this experiment. A significant advantage of the hierarchical approach is the capability 
of modelling large data sets. This means that hierarchical models are scalable, that is, 
applicable to larger and larger data sets. For the hierarchical model approach presented here, 
analogous “blocking” of samples rather than variables (proposed by Wold et al [199]) was 
applied in the observation (y) direction to give a series of cluster models, which grouped the 
observations together (that is, each cluster was summarised by a separate model). Each block 
of variables at the lower level (Level 2) of the hierarchical model architecture were summarised 
by scores from parts of the PLSR model at the higher level (Level 1). The block scores were 
used as variables to predict different ranges of y from Level 1 of the hierarchical model. These 
block scores were separate PLSR models that improved the predictive capability of the 
hierarchical model.  
3.4.5 p-Toluenesulfonamide and Triphenylphosphine Oxide: ATR-FTIR and 
ATR-UV/vis Spectroscopy Multivariate Calibration Models 
ATR-FTIR and ATR-UV/vis were used to build multivariate calibration models to monitor 
concomitantly the solution phase concentration of p-TSA and TPPO during batch, semi-batch 
and period flow MSMPR co-crystallisation studies. Spectra were obtained using the Thermo 
Scientific FT-IR and Carl Zeiss Multi-Channel UV/vis spectrometer units. The model 
development process for a multi-component system involves the same steps as discussed for 
the single-component systems PCM-IPA and GLY-H2O. For the calibration data set, ATR-
FTIR and ATR-UV/vis spectra of p-TSA and TPPO dissolved in MeCN were collected 
simultaneously from solutions with different initial concentrations of the two components. 
Spectra were collected at different temperatures to account for temperature effects on the 
absorbance measurements for both ATR-FTIR and ATR-UV/vis. The effect of particle 
scattering was taken into account by collecting spectra in suspensions of known 
concentrations of p-TSA and TPPO. The validation data set was collected in a similar way to 
the calibration set. The concentration of p-TSA and TPPO were varied in the range 0.010 – 
0.285 g/g MeCN and 0.010 – 0.3084 g/g MeCN respectively, for both the calibration and 
validation sets. For the ATR-FTIR calibration model only, a separate validation data set was 
not acquired; instead cross-validation approach was used to verify the calibration model 
performance. MathWorks Matlab® 2014a software was used for spectral pre-processing and 
model development. This was done in order to test the model performance before carrying out 
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any further experiments since the performance of the ATR-FTIR spectrometer can be affected 
by slight movements of the fibre optic cable. This was found to affect the baseline of spectra 
and can often lead to erroneous predictions from a developed model. 
In order to develop the calibrations models for simultaneously determine of p-TSA and TPPO 
concentrations variables (spectral regions) were selected manually prior to applying 
pre-processing algorithms in Matlab® 2014a. Pre-processing methods including, SNV, MSC, 
first or second derivative and MS or AS were applied to the selected regions of both ATR-
FTIR and ATR-UV/vis spectra. Figure 3.14 shows the pre-processed ATR-FTIR variables in 
the region (1448 – 650 cm-1). For comparison, those variables with no pre-processing applied 
are also shown. The no pre-processed variables show more variability between samples due 
to base line drift effects when compared to the pre-processed variables. An outlier is also 
detected, which was removed from the sample set prior to model development. Pre-
processing of the variables in the order MSC, 1st DV and AS, led to the least variability between 
samples, an indication that this approach is the most suitable for further development of the 
multivariate model. The least reliable pre-processing method appears to be MSC and AS, for 
which there is still a significant baseline drift effect between samples compared to when no 
pre-processing was applied. 
 
Figure 3.14: ATR-FTIR variables with pre-processing by (a) MSC and AS; (b) 1st DV and AS. 
Variables with no pre-processing (d) are shown for comparison. 
PCR and PLSR models were built using the pre-processed variables described earlier. Table 
3.4 gives a summary of the performance of the best obtained models for the prediction of 
p-TSA and TPPO concentrations respectively.  
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Table 3.4: Summary of performance indices for the best PLSR and PCR models 
Model Type 
Pre-Processing 
Applied 
No. C* RMSECV R2 % Error Remarks 
p-TSA Models 
PLSR MSC =>AS 9 0.0017 0.9788 ± 10.5 optimum 
PLSR MSC =>1stDV =>AS 9 0.0013 0.9778 ± 12.9 outliers 
PLSR 1stDV =>AS 9 0.0013 0.9778 ± 12.9 outliers 
PCR MSC =>AS 10 0.0639 0.9660 ± 13.2 outliers 
TPPO Models 
PLSR MSC =>AS 9 0.0043 0.9729 ± 10.0 optimum 
PLSR MSC =>1stDV =>AS 9 0.0011 0.9805 ± 11.2 outliers 
PLSR 1stDV =>AS 9 0.0011 0.9805 ± 11.2 outliers 
PCR MSC =>1stDV =>AS 10 0.0492 0.9665 ± 14.0 outliers 
C* = number of components; 1stDV = first derivative; AS = auto-scaling  
In this study, the root mean squared error of cross validation (RMSECV) was the statistic used 
to compare model performance (i.e. instead of the RMSEP) since a separate validation data 
were not available. The error reported for the optimum model was outside an acceptable target 
limit of ± 5%. Due to poor accuracy, the multivariate model developed using ATR-FTIR data 
were not considered further for validation. Instead, PCR and PLSR models were developed 
using ATR-UV/vis data for the determination of p-TSA and TPPO concentration during the 
co-crystallisation studies. Figure 3.15 shows the variables selected (with and without pre-
processing applied) that were used to develop multivariate models for p-TSA and TPPO 
prediction. 
The 1st DV and MS were the pre-processing methods applied, which takes care of the baseline 
effects observed in the none pre-processed variables. Multivariate models were built applying 
PCR and PLSR algorithms in Matlab® 2014a using either variables with and without pre-
processing. Table 3.5 gives a summary of the performance of the best obtained models for 
the prediction of p-TSA and TPPO concentrations respectively. The models providing the 
lowest RMSEP values (0.0029 g/g, p-TSA and 0.0019 g/g, TPPO) based on the lowest 
calibration standard, and the lowest error values were used for prediction of unknown samples. 
The error reported for the optimum p-TSA and TPPO models were ± 3.2 and ± 1.6 %.  
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Figure 3.15: ATR-UV/vis variables with pre-processing (left) and with pre-processing by 
MSC and MC (right). 
Table 3.5: Summary of performance indices for the best PLSR and PCR models 
Model Type 
Pre-Processing 
Applied 
No. C* RMSEP R2 % Error Remarks 
p-TSA Models 
PCR AS => 1stDV 26 0.0029 0.9993 ± 3.2 optimum 
PCR AS =>1stDV 20 0.0029 0.9993 ± 4.0 high 
PLSR none 18 0.0048 0.9991 ± 7.4 high 
PCR 1stDV 23 0.0080 0.9991 ± 6.7 high 
TPPO Models 
PLSR 1stDV 17 0.0019 0.9988 ± 1.6 optimum 
PCR 1stDV 23 0.0020 0.9988 ± 1.8 high 
PCR AS =>1stDV 21 0.0052 0.9991 ± 3.8 high 
PLSR AS =>2ndDV 25 0.0060 0.9990 ± 4.4 outlier 
C* = number of components; 1stDV = first derivative; 2ndDV = second derivative; MS = mean centering  
3.5 Summary on Multivariate Data Analysis  
In sections 3.4 aspects of multivariate analyses applied to Raman, ATR-UV/vis and ATR-FTIR 
spectroscopy data were discussed. Multivariate analyses were performed in order to extract 
useful information from the different crystallisation processes investigated in this thesis 
pertaining to the change in concentration (i.e. the rate of desupersaturation). Additionally, 
Raman spectroscopy was used to determine the polymorphic form of the solid phases. The 
choice of spectroscopy technique for monitoring process concentration depended on the 
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properties of the system to be investigated. For PCM-IPA crystallisation both Raman and ATR-
UV/vis spectroscopy were employed. The choice of Raman spectroscopy in this case was to 
demonstrate as proof of concept, its use for solution phase concentration measurement during 
a crystallisation process. Raman is typically used for solid phase monitoring and there are no 
robust and fully established multivariate methods in the literature for solution phase monitoring 
during crystallisation [164]. The multivariate Raman model was compared to an independently 
obtained ATR-UV/vis multivariate model in order to validate the developed method. The 
advantage of Raman when compared to ATR-UV/vis is that the spectral signal is more or less 
insensitive to temperature variations. On the other hand, ATR-UV/vis is insensitive to the 
presence of particles when compared to Raman, which leads to a high signal to noise ratio for 
the latter. In the case of GLY-H2O system, Raman was the chosen technique since GLY is a 
non-conjugated system and is therefore not a good UV/vis absorber. For the p-TSA-TPPO co-
crystals system, both ATR-UV/vis and ATR-FTIR were explored for monitoring the solution 
species concomitantly. The latter technique has been widely used in crystallisation for the past 
10 years and multivariate methods are well established. However, ATR-FTIR is not the most 
reliable since is it is very sensitive to stresses or temperature changes along the length of the 
fibre optics [143] compared to other spectroscopy techniques. This often leads to problems 
such as loss of signal or low signal and noisy baseline. For the p-TSA-TPPO system, ATR-
UV/vis was found to be more reliable when compared to ATR-FTIR, hence it was selected for 
monitoring the crystallisation process. The choice of multivariate pre-processing algorithms 
for application to the spectral data from the range of spectroscopy techniques investigated in 
this thesis depended on the effect spectral effects observed. For example, MSC or SNV 
scatter correction techniques were applied to Raman spectra to minimise the effect of particles 
on the spectral signal. First or second derivative pre-processing were applied to take care of 
baseline drift effects observed in in Raman, ATR-UV/vis and ATR-FTIR. Typically, only the 
first derivative was applied, since the increasing order of the derivative can lead to increase in 
spectral noise. The application of MC or AS to the spectral data from all techniques was also 
necessary to inform the selection of the most important variables for prediction. 
3.6 Experimental Apparatus and Configurations 
Different configurations of batch, semi-batch, continuous and period flow crystallisation 
equipment were employed to investigate the cooling crystallisation of the single- and 
multi-component molecular systems reported in this thesis. Details of the basic experimental 
set-up use for each mode of crystallisation operation are reported in the sections following. 
The configurations reported are indicative, since different layouts were used for each study. 
The reader is directed to the chapters following, for more detailed flow diagrams of the 
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experimental set-ups. An integrated array of PAT and in-house developed information 
systems software program, CryPRINS were combined and applied to monitor the 
crystallisations, Figure 3.16, for example to acquire and display real-time FBRM counts/s and 
ATR-UV/vis data and to implement process temperature control. Robust multivariate 
calibration models described earlier in this chapter were applied to determine solution phase 
concentration from Raman and ATR-UV/vis spectroscopy. An Automated Intelligent Decision 
Support (IDS) framework was established for monitoring and controlling each crystallisation 
process based on the concept of integrated PAT array (FBRM and ATR-UV/vis (with 
multivariate models)) in CryPRINS. The CryPRINS interface offers a unique environment that 
provides connectivity to a variety of PAT tools allowing comprehensive monitoring of 
crystallisation processes. The interface also allows for the implementation of a various control 
strategies to achieve desired crystallisation outcomes. The data generated in CryPRINS was 
combined with ancillary PAT (Raman (with multivariate models) and PVM) data to further 
characterise each of the crystallisation processes investigated in real-time. The IDS was used 
to control process temperature and to monitor solution concentration and particle size and 
shape properties. The IDS information display feature also allows the user to monitor and 
determine when a continuous process achieves steady-state or a batch process reaches 
equilibrium condition. In addition, the IDS framework can detect any system deviations due to 
perturbations caused for example by blockages, flow rate changes, fouling or impurity build-
up. 
 
Figure 3.16: Real-time Intelligent Decision Support System with PAT Array and CryPRINS. 
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3.6.1 Batch and Semi-batch Crystallisation Apparatus 
Batch and semi-batch cooling crystallisation studies were carried out using a 500 mL jacketed 
glass vessel. A schematic representation of the experimental set-up used is shown in Figure 
3.17. The batch crystalliser was fitted with a PTFE lid with ports for insertion of an overhead 
PTFE pitch blade stirrer and five PAT probes. The jacket was connected to a Thermofluid bath 
(Huber ministat 230) for temperature control. Temperature profiles were implemented and 
data recorded using CryPRINS software. Raman immersion probes were used for in situ real-
time measurement of both the liquid and solid phases. FBRM® and PVM® probes were used 
for nucleation and dissolution detection, and to tracking the evolution of crystal properties (size 
shape and distribution). ATR-UV/vis and ATR-FTIR immersion probes were used 
complementarily to monitor changes in the liquid phase.  
 
Figure 3.17: Schematic of batch crystalliser used for the cooling crystallisation experiments. 
For a typical batch experimental run, the solvent and raw material(s) of interest were charged 
to the crystalliser and the contents heated at a fixed rate (typically 1 oC/min) until completely 
solubilised (typically 10 oC above the Tsat of the material). The crystalliser was then cooled at 
a pre-specified rate until nucleation was detected and then held for a pre-specified time period 
after which the product slurry was removed by releasing the bottom valve of the crystalliser 
and draining the contents. After each experimental run the vessel was cleaned thoroughly by 
washing with the solvent used to solubilise the starting material. Two to three passes with 
solvent was considered sufficient for cleaning as determined by visual inspection of the vessel. 
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3.6.2 Continuous and Periodic Flow Crystallisation Apparatus 
Continuous and periodic flow cooling crystallisation studies were carried out using either single 
or multi-stage cascaded periodic mixed suspension mixed product removal ((P) MSMPR) 
crystalliser configurations consisting of 500 mL jacketed glass vessel(s) and a 5 L feed tank. 
Schematic representations of the typical (P) MSMPR experimental set-ups used for single-
stage and three-stage cascaded studies are shown in Figure 3.18 (a) and (b).  
 
Figure 3.18: Schematic representations of (a) single-stage (P) MSMPR unit with recycle 
stream and (b) three-stage cascade of (P) MSMPRs used for the continuous and periodic 
flow cooling crystallisation experiments. 
The single-stage (P) MSMPR unit was configured either with or without a recycle stream. The 
feed, (P) MSMPR and recycle units had independent temperature controllers. For the 
three-stage (P) MSMPR unit, the (P) MSMPRs were configured in series as a cascade, with 
each vessel assigned an independent temperature controller. Calibrated and pre-programmed 
Masteflex® pumps fitted with 3.1, 4.8 or 6.4 mm ID platinum cured silicone tubing were used 
to transfer solutions and slurry to/from each (P) MSMPR. Pumps were operated either in 
continuous (normal MSMPR operation) or time-dispense (periodic PMSMPR operation) mode. 
Filtration unit 
Feed MSMPR1 MSMPR2 MSMPR3 
Feed MSMPR Dissolver 
Filtration 
unit 
Recycle 
stream 
(a) 
(b) 
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When operated in time dispense mode the pumps were programmed to switch on and off over 
specific time intervals. The arrangement of PAT tools is indicative, as different combinations 
were employed for each study based on the properties of the molecular system under 
investigation and to acquire the most useful process data and determine when steady-state 
or at least a controlled state of operation is attained. The IDS framework described earlier was 
applied for process monitoring and temperature control. 
Table 3.5 below gives a summary of the performance characteristics of the different in situ 
PAT tools used to monitor the batch, continuous and periodic flow crystallisation studies 
reported here. The best techniques for solid phase monitoring (i.e. crystal size shape and 
distribution) were FBRM and PVM. Solution phase monitoring was excellent with Raman 
(molecules with dipole moment only) and ATR-UV/vis (conjugated molecules only) probes, 
however, ATR-FTIR typically required higher solution concentration. The best technique for 
polymorphism and crystal form detection was Raman. FBRM and PVM could detect changes 
in particle shape, which is sometimes (but not always) indicative of change in crystal form.  
Table 3.5: Summary of PAT application in Batch, Continuous and PMSMPR studies 
Process Parameters 
Monitored 
In situ PAT Techniques with Rating 
FBRM PVM Raman* ATR-FTIR# ATR-UV/vis^ 
Solid Phase Excellent Excellent Good Poor Poor 
Solution Phase Poor Poor Excellent Good Excellent 
Polymorphism / Crystal 
Form 
Good Good Excellent Poor Poor 
Crystal Size / Shape Very Good Very Good Good Poor Poor 
Crystal Size Distribution Good Good Poor Poor Poor 
Raman* - excellent for molecules with dipole moment, not useful for polar molecules; ATR-FTIR# - Typically 
requires high concentrations and rigid/stable fibre optic; ATR-UV/vis^ - excellent for conjugated system only. 
For a typical non-seeded continuous MSMPR experimental run, a feed solution at a pre-
specified Tsat was prepared in a separate feed tank (5 L vessel for continuous removal 
experiments; or 500 mL for continuous dissolver/recycle experiments) and pumped to the first-
stage crystalliser, which is typically held at a lower temperature in order to generate 
supersaturation required for crystallisation. The slurry from the crystalliser was either removed 
continuously and sampled or sent to a dissolver unit (held at high temperature to dissolve the 
solids) and recycled back to crystalliser, in effect creating a closed loop operation. When a 
multi-stage MSMPR was employed each crystalliser vessel was filled sequentially and the 
product slurry subsequently removed and sampled from the final stage. A dissolver unit was 
not employed for cascaded MSMPR studies. For seeded cooling crystallisation experiments 
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in MSMPR, a feed solution was prepared at a pre-specified Tsat by dissolving the raw material 
in solvent at 10 oC above the saturation point.  The resulting solution was then cooled to 1 oC 
below Tsat and the required amount of seed material added to the vessel and aged typically 
for 30 min. The seeded feed suspension was then pumped to the first-stage MSMPR. For a 
cascade of MSMPRs, each vessel was filled sequentially and product slurry removed and 
sampled from the final-stage continuously. At the end of each experimental run, the slurry 
transfer pump between each MSMPR stage and the feed pump were switch off and each 
vessel drained sequentially and cleaned according to the same procedure described for the 
batch studies earlier. 
Seeded cooling PMSMPR experiments were carried out in a similar way as described for the 
seeded MSMPR above. Feed preparation was exactly the same, however, the PMSMPR filling 
procedure was slightly different. The first-stage PMSPMR was filled by pumping slurry at a 
pre-specified rate over a fixed time interval. Once the vessel was filled, a holding period (or 
batch cycle) was implemented whereby the feed pump was switched off. For coupled periodic 
flow experiments in the PMSMPR, at the end of the holding period the feed and outlet pumps 
were switched on simultaneously. Slurry from the crystalliser outlet was sampled in a similar 
way to the MSMPR study described earlier. For a cascade of PMSMPRs, the filling procedure 
was sequential similar to MSMPR, but with cyclic pumping and holding periods. Decoupled 
PMSMPR experiments. Instead of applying simultaneous feed addition and slurry withdrawal, 
the process was staggered such that filling was always followed by removal (asynchronous). 
Typically, 50% of the crystalliser volume was removed and then refilled each cycle, followed 
by a holding period, which was similar to the coupled PMSMPR operation. The cleaning 
procedure for coupled and decoupled operation was the same as for MSMPR study. More 
details of the operating strategies are provided in the chapters that follow. 
3.6.3 Co-Crystal Solubility Studies 
The solubility studies were carried out using either turbidity measurement (i.e. percentage light 
transmission) or gravimetric technique. Real-time, through vial turbidity measurements were 
carried out using an Avantium Crystalline® SE reaction block consisting of 8 parallel ports with 
independent temperature control for insertion of 8 mL vials. For each analysis, an excess of 
the material to be analysed was added to each vial with solvent at 20 oC. The resulting 
suspension was equilibrated at 20 oC for 30 min, and then heated slowly at a rate of 0.25 
oC/min with constant stirring (800 rpm) until the “clear point” was detected. Turbidity of the 
suspension in each reactor was measured independently by monitoring the percentage light 
transmission to determine when the “clear point" was achieved. CrystalClear® version 2.1.3 
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software package was used to set the temperature profiles and stirring rates of each reactor 
with a script. The same software tool was used to analyse the experimental data (experimental 
findings are presented in Chapter 6).  
Solubility measurements by gravimetric analysis were carried out using a 100 mL jacketed 
batch reactor with ports for insertion of a thermocouple and ATR-UV/vis probe (Helma Katana 
6 immersion probe). For each analysis, an excess of the material to be analysed was charged 
to solvent in the reactor at a specific temperature and equilibrated with constant stirring for 3 
hr or until the absorbance measurements from the ATR-UV/vis probe indicated that equilibrium 
was attained. The stirrer was then stopped and the solids allowed to settle over a period of 
1 hr. Three 2.5 mL samples of the clear solution were then collected in pre-weighed glass vials 
(X1) and weighed (X2). The solvent was allowed to evaporate in a vacuum oven at 25 oC for 
24 h before weighing the final dry weight (X3). The formula (X3 − X1) / (X2 – X3) was used to 
obtain the solubility, expressed as g solid/ g solvent (experimental findings are presented in 
Chapter 7). 
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Chapter 4 
Comparative Investigation of Batch and Continuous 
Crystallisation of Paracetamol Using PAT 
In this chapter, batch and continuous crystallisation methods are investigated and compared 
on the bases of yield of crystallisation, productivity, crystal size and distribution. The dynamics 
of these crystallisation strategies are vastly different, due mainly to the difference in rate of 
supersaturation generation and the trajectory through the phase diagram. Since 
supersaturation is the driving force for crystallisation, the different trajectories that are 
accessible using different crystallisation methods can allow the exploitation of a wider range 
of product critical quality attributes (CQA) such as CSD, purity, habit, and, polymorphic or 
other crystalline forms [32], [170]. In this study, batch and continuous crystallisations of 
paracetamol (PCM) from isopropyl alcohol (IPA) were performed. Batch experiments were 
carried out using two control strategies, namely, linear cooling (LC) and automated direct 
nucleation control (ADNC). Continuous cooling crystallisations were carried out with and 
without seeding using either a single-stage MSMPR or a modified version with recirculation 
loop incorporated to conserve materials. Due to difficulties experienced with fouling, 
encrustation and blockage in MSMPR, the additive hydroxyl propyl methyl cellulose (HPMC) 
was investigated to control these phenomena. Overall the results indicate that different CQA 
(mean size, CSD and habit) are attainable in the batch and continuous crystallisers. An 
advantage of the continuous MSMPR is that it operates at steady-state, leading to consistent 
product quality compared to batch. Although the yield of crystallisation was much lower 
compared to batch, the productivity of crystallisation was significantly higher in the steady-
state MSMPR operation. 
4.1 Introduction 
So far it has been established that fine chemicals and pharmaceuticals manufacturing and 
crystallisation are almost always conducted using batch processes, with each unit dosage 
form identified as coming from a unique batch [33]. However, the operation of batch processes 
is very costly and inefficient. In order to address this problem several researchers [31], [153], 
[168], [180], [224] have resorted to high level modelling, monitoring and control strategies 
often aided by process analytical technologies (PAT) to improve batch performance. However, 
similar concepts could be applied to continuous crystallisers, gaining the additional benefits 
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related to operating at steady-state [32], [152], [225], [226], or at least in a controlled dynamic 
state. In this study, an integrated array of PAT tools and CryPRINS informatics system 
software were used together within an IDS framework (described in Chapter 3) to monitoring 
and control the batch (via LC and ADNC) and continuous crystallisation. The solute considered 
was PCM, which is a widely used over-the-counter analgesic and anti-pyretic drug; it is also 
used as an intermediate in the manufacture of azo dyes and photographic chemicals [227]. A 
comparative analysis was conducted to determine the most suitable crystallisation approach 
for producing large uniform crystals at high yield. For the batch LC method, the time rate of 
change of temperature is kept constant by manipulating the coolant temperature to maintain 
a constant level of heat removal. Implementation of an unseeded crystallisation with LC 
requires solubility and metastable zone width (MSZW) information to determine the optimum 
cooling rate to achieve a desired CSD. However, with LC there is limited control over the 
system once nucleation occurs, and this leads to broad CSDs. Fines destruction/removal [6] 
or external seeding [9] methods may be employed to narrow the CSD and suppress 
nucleation. Alternatively, ADNC is a model-free approach that utilises FBRM for direct 
feedback control [170]. It utilises closed-loop feedback control based on a target value of total 
number of counts/s to improve the CSD, via implementation of heating/cooling cycles. ADNC 
leads to larger, more uniform and less agglomerated crystals and prevents solvent and 
impurity inclusion [170], [224]. For ADNC implementation only the solubility data are required 
to determine the level of supersaturation. However, a disadvantage of ADNC is that it can 
often lead to very long batch times (sometimes days) and is not appropriate for systems which 
are acicular or needle shape, because FBRM gives erroneous count/s measurements for 
these systems [157], [228]. 
An alternative strategy to batch approaches is continuous MSMPR crystallisation. With this 
approach there are several degrees of freedom in operation that can be exploited to control 
the supersaturation trajectory through the phase diagram (for example, when operated as a 
cascade), thereby controlling a range of product CQA. For example, the temperature, feed 
flow rate and operating volume of the MSMPR can be varied to achieve different crystallisation 
outcomes. In this study, different continuous cooling crystallisation approaches were 
investigated and compared to the batch approaches mentioned earlier. PAT tools in the form 
of ATR-UV/vis, FBRM and PVM were used to monitor each process. Due to fouling, 
encrustation and blockage issues in the continuous MSMPR, a two-pronged approach was 
taken to mitigate these problems. The first involved the design of a modified MSMPR, 
incorporating a baffled heat exchanger to minimise temperature variations in the crystalliser, 
this is, by avoiding a large temperature difference between the feed stream and slurry within 
the MSMPR as well as temporal variations. The second approach involved the use of a 
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polymeric additive, HPMC to control the crystallisation kinetics (nucleation and growth), and 
thereby avoid fouling and crust formation for extended operation of the MSMPR. 
4.2 Experimental Methods 
The aim of this study was to identify conditions for the production of large, uniform crystals 
with narrow CSD using different configurations of MSMPR crystallisers, and to compare their 
productivity and product crystal CQA to optimised batch crystallisers. PCM was crystallised 
by cooling from IPA in the batch studies. For the MSMPR studies, crystallisation of PCM was 
carried out by cooling from either pure IPA or H2O. Equations for the multivariate models used 
to determine PCM solubility and concentration in IPA from Raman and ATR/UV/vis spectra 
were reported in Chapter 3 Section 3.4.2 (Eqn. 3.1 and 3.2, respectively). PCM solubility in 
water was estimated from data published by Braatz et al [229]. The solubility data were also 
used by Nagy et al [230] in their study on the crystallisation kinetics of PCM in water. The 
model equation for the solubility of PCM in water as a function of temperature (oC) is given by: 
 𝑐(𝑇) = 1.5846 × 10−5𝑇2 − 9.0567 × 10−3𝑇 + 1.3066 4.1.  
The impeller stirring rate for the experimental runs was set to either 300 or 400 rpm. The 
approximate power per unit volume were 0.056 kW/m3 and 0.133 kW/m3, respectively. There 
was no significant difference between particle suspension 300 or 400 rpm, based on visual 
observations. Hou et al [77] conducted a series of investigations to determine the agitation 
rate required to give homogeneous suspensions of PCM-IPA-H2O system in a 530 mL 
continuous MSMPR. The study showed that impeller speeds ranging from 200 – 400 rpm 
(power output per unit volume ranged from 0.0186 – 0.1486 kW/m3) produced homogeneous 
suspensions as confirmed by FBRM measurements from the top, centre and bottom of the 
continuous MSMPR. It is well known that for isokinetic withdrawal of slurry from MSMPR to 
be achieved, there is a requirement to maintain a homogeneous suspension in the crystalliser. 
There are also further requirements for high flow rate and optimal positioning of the outlet dip 
tube to ensure rapid and representative slurry withdrawal.  
4.2.1 Batch Crystallisation Experiments 
Batch experiments were carried out using the experimental configuration described in Chapter 
3 Section 3.6.1 (Figure 3.14). As far as possible, experimental conditions were tailored to 
match those reported by Saleemi et al [170]. A target concentration of 0.207 g PCM/g IPA 
(i.e. saturation temperature (Tsat) of 50 oC) was selected for each experimental run. For each 
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run, 64.8 g of PCM and 314 g of IPA were added to the crystalliser taking care to ensure 
reagents were transferred as completely as possible. The crystalliser was then heated to 60 
oC at a rate of either 1 or 2 oC/min and held for 15 min to ensure complete dissolution of PCM. 
For the batch LC experiments the resulting solution was cooled at a rate of either -1.0 oC/min 
(fast cooling) or -0.5 oC/min (slow cooling) to 10 oC, and held until nucleation was detected 
and stable counts/s observed from FBRM. For the ADNC experiments, the DNC temperature 
control option in CryPRINS was selected to initiate cooling of the solution from 60 oC at a rate 
specified in the software settings. Table 4.1 provides a summary of the experimental 
conditions employed for the LC and ADNC experimental runs, respectively.  
Table 4.1: Summary of experimental conditions employed during the batch crystallisation of 
PCM from IPA. 
Exp. No. 
Exp. 
Type 
PCM 
Raw 
Material 
Stirring 
Rate 
Heating / 
Cooling Rate 
(oC/min) 
kh / kc  
ADNC  
Set-point 
(counts/s) 
+Experiment 
Duration 
(min) 
(1a) / (1b) LC FRnew 300 / 400 1.0 / -1.0 n/a n/a 187 
(2a) / (2b) LC FRnew 300 / 400 1.0 / -0.5 n/a n/a 240 
3 ANDC FRnew 300 0.4 / -0.2 5 / 5  4000 ± 100 625 
4 ANDC FRnew 300 0.4 / -0.2 5 / 5  4000 ± 1000 1190 
5a / 5b ANDC FRnew 300 / 400 0.2 / -0.4 5 / 5  4000 ± 100 642 
6a / 6b ANDC FRnew 300 / 400 0.2 / -0.4 5 / 5  8000 ± 100 650 
7 ANDC CHnew 400 0.2 / -0.4 5 / 5 8000 ± 100 612 
8 ANDC CHnew 400 0.2 / -0.4 5 / 5 4000 ± 100 662 
9 ANDC DEold 400 0.2 / -0.4 5 / 5 8000 ± 100 647 
10 ANDC DEold 400 0.2 / -0.4 5 / 5 4000 ± 100 670 
11 ANDC USnew 400 0.2 / -0.4 5 / 5 8000 ± 100 569 
12 ANDC USnew 400 0.2 / -0.4 5 / 5 4000 ± 100 753 
13 ANDC FRold1 400 0.2 / -0.4 5 / 5 8000 ± 100 611 
14 ANDC FRold1 400 0.2 / -0.4 5 / 5 4000 ± 100 696 
15 ANDC FRold2 400 0.2 / -0.4 5 / 5 8000 ± 100 654 
16 ANDC FRold2 400 0.2 / -0.4 5 / 5 4000 ± 100 628 
+ Experiment time includes the holding period (typically 15 min); () Replicated experimental runs; FRnew = France 
new sample, FRold1 = France sample 1, FRold2 = France old sample2, CHnew = China new sample, DEold = Germany 
old sample, USnew = United States new sample. kh/kc are the proportional gains for the heating and cooling phases. 
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The ADNC runs were performed using different PCM raw material samples obtained from the 
same supplier, but manufactured in different countries (see Chapter 3 Section 3.1). This 
aspect of the study was motivated by the fact that different numbers of ADNC cycles were 
obtained when compared to results of Saleemi et al [170], which suggested that the PCM 
sample characteristics, specifically the impurity profile was contributing to the contrasting 
results. Therefore, experiments were done to establish whether or not there was a link 
between the impurity profiles of the different PCM raw materials and the number of ANDC 
cycles. Industrially, PCM is manufactured by either of four routes, involving the following 
intermediates: Phenol, Nitrobenzene, p-Nitrochlorobenzene, and p-Hydroxy-acetophenone. 
By-products of the different synthetic routes include: Acetic acid, Aniline, and p-Nitrophenol 
sodium salt among other phenolic derivatives reported by Rao et al [231]. 
4.2.2 Continuous Crystallisation Experiments 
Continuous crystallisation experiments were carried out using either a conventional MSMPR 
or a modified version incorporating a recirculation loop so that product slurry withdrawn from 
is sent to a dissolver, which also serves as a feed/recycle unit [19], [110], [152]. Importantly, 
this arrangement leads to the conservation of material and allows operation of the MSMPR as 
a continuous, unseeded system for long periods without using large quantities of material. 
This is particularly useful for research purposes at laboratory scale, given the large amounts 
of materials that can be consumed by continuous crystallisers. The added value of the 
modified MSMPR unit is that continuous crystallisation of high value APIs can be investigated 
using only a small amount of material, in particular, during the pre-clinical and phase I stages 
of drug development. Arguably, a limitation of this operation is the requirement to generate 
particles by primary nucleation, which is not always consistent and results in fouling, 
encrustation and line blockages due to the high supersaturation requirement. However, the 
use of an additive to control the crystallisation shows promise. A number of seeded 
crystallisation experiments were also carried out using conventional MSMPR crystallisers 
operated at low supersaturation for comparison with the proposed modified MSMPR 
operation. Operating at low supersaturation with seeding is advantageous for the alleviation 
of fouling and encrustation whilst producing crystals that exhibit consistent mean size and 
CSD. However, this is highly dependent on the continuous and consistent supply of uniform 
seed material.  
Operation of Modified MSMPR: Figure 4.1 (a) and (b) show respectively, the flow diagram 
and photograph of the experimental set-up used (a schematic layout with PAT tools was 
present in Chapter 3 Section 3.6.2 (Figure 3.15). The modified MSMPR consisted of a 750 mL 
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crystalliser and 400 mL dissolver vessel each with independent temperature controllers. The 
MSMPR was connected to the dissolver using Masterflex® platinum cured silicon tubing (6.4 
mm ID). A heat exchanger consisting of a jacketed 220 mm length glass tube with smooth 
periodic baffle constrictions (5 mm ID with 2.0 mm constrictions) connected to a thermofluid 
circulator bath cooled to 10 oC was incorporated in the design in order to cool the feed sent 
back to the crystalliser and mitigate rapid fouling and encrustation following nucleation. The 
baffled heat exchanger has a high surface, which leads to rapid removal of heat from the 
incoming feed solution. It is an important modification to the MSMPR unit since it prevents a 
large temperature gradient developing when hot solution from the dissolver enters the 
crystalliser held at a much lower temperature to provide the driving force for crystallisation.  
 
Figure 4.1: (a) Flow diagram of modified MSMPR indicating the operating conditions 
employed. (c) Photograph of the lab scale set-up used. 
At start-up a suspension of 0.232 g PCM/g IPA in the MSMPR was heated to 65 oC and held 
for 15 min to allow complete dissolution of PCM. The resulting solution was then cooled to 
45 oC, while simultaneously heating a solution of pure IPA in the dissolver to the same 
temperature. Once both vessels reached 45 oC the solution in each was pumped continuously 
between them using Masterflex® peristaltic pumps at a rate of 60 g/min to homogenise the 
vessel contents. In effect, this created a closed loop system, in which the final solution 
concentration was ~ 0.152 g PCM/g IPA (Tsat = 35 oC). Once the contents of the vessels were 
homogenised, as determined by real-time concentration measurement using multivariate 
calibration models described Chapter 3 Section 3.4.2, solution from the dissolver/feed vessel 
was sent to the baffled tube heat exchanger where it is cooled from 45 oC to 20 oC before 
entering the MSMPR crystalliser, which was cooled to 10 oC. This start-up strategy lead to 
generation of supersaturation required to drive primary nucleation and produce the initial start-
up slurry, while preventing rapid crust formation. It took approximately 35 min for the MSMPR 
to reach 10 oC, i.e., inclusive of the initial start-up period. The MSMPR was maintained at 10 
(a) (b) 
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oC and the dissolver at 45 oC for the duration of each experiment. The experiments were 
carried out either with or without HPMC addition. A control experiment (no additive) was 
carried out using the experimental start-up and operating procedures described earlier. The 
flow rates employed were shown in Figure 4.1 (a), and resulted in mean residence times (RTs) 
of 12.12 and 6.38 min in the MSMPR and dissolver vessels respectively. The duration of each 
experiment was ~ 4.6 hours (inclusive of the start-up period). The process was operated for ~ 
18 RTs from the point of nucleation detection in the MSMPR. Experiments with additive 
addition were carried out in a similar way with HPMC additive added to the system in order to 
control the crystallisation of PCM and prevent fouling, encrustation and potential line blockage 
issues. Fouling and encrustation problems were encountered during the initial development 
stages of the modified MSMPR and during the control experiments. Figure 4.2 shows the 
detrimental effect of fouling observed during preliminary development experiments with a 
closed loop MSMPR design without the heat exchanger modification. Severe fouling and crust 
formation occurred on the PAT probes and vessel walls of the MSMPR. Fouling in the MSMPR 
was a result of the rapid generation of high localised suspersaturation due to the large 
temperature difference between the incoming feed stream (at 45 oC) and the crystalliser (at 
10 oC).  
Figure 4.2: Extent of fouling and crust formation on PAT probe (left) and crystalliser wall 
(right) in MSMPR operated without the baffled tube heat exchanger. 
Three concentrations of HPMC 0.001, 0.003 and 0.05 wt% (i.e., relative to mass of PCM) were 
investigated in the modified MSMPR. For each experiment, the required amount of HPMC was 
added to the MSMPR at the start of the 15 min homogenisation period. For the experiment in 
which 0.05 wt% HPMC was added, the dissolver temperature was elevated to 50 oC. This was 
due to incomplete dissolution of small amounts of large crystals as observed from visual 
inspection of material flowing through the recycle transfer line during preliminary experimental 
runs where the vessel was maintained at 45 oC.  
Effect of HPMC on Raman and ATR/UV/vis Signals: HPMC was found to have no effect on 
the in situ Raman or ATR-UV/vis signals at all applied concentrations. Figure 4.3 shows the 
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Raman spectra of experiments carried out with 0.05 wt% HPMC and with no HMPC addition 
at similar PCM concentrations (0.153 and 0.156 g PCM/ g IPA, respectively). There is no 
evidence of extra peaks or any spectral features (such as peak broadening or distortion) 
related Raman scattering by HPMC. Therefore, the spectra collected during each 
experimental run are thought to be independent of the HPMC concentration. Furthermore, 
signal changes due to the presence of interference can be minimised or eliminated by applying 
mathematical pre-processing techniques (see Chapter 3; Section 3.4.2)  to the data [216]. 
 
Figure 4.3: Raman spectra from solution phase for experiments carried out with 0.05 wt% 
HPMC (straight line) and No HPMC (dashed line) addition at concentrations of 0.153 and 
0.156 g PCM/ g IPA respectively. 
Conventional MSMPR Operation: a number of seeded cooling crystallisation experiments 
were carried out using a conventional continuous MSMPR crystalliser (500 mL). Figure 4.4 
shows the flow diagram of the MSMPR set-up. Experiments were carried out with PCM using 
either water or IPA as solvent. 
 
Figure 4.4: Flow diagram of the MSMPR units used for the crystallisation studies. 
For the cooling crystallisation experiments using water as solvent, a fresh feed solution of 
PCM in water was prepared at 20 oC saturation (0.013 g PCM / g H2O) in a 1 L feed vessel. 
Feed solution was pumped to the MSMPR crystalliser (kept at 10 oC) at a rate of 46.69 g/min 
On filling, the MSMPR was seeded once by manually addition of either 3.5 or 7.0 % (i.e., 1.5 
or 3.0 g) PCM raw material. Following seed addition, a holding period of 30 min was 
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implemented for equilibration with solute in the liquid phase, crystal growth and healing. This 
was followed by restarting of the feed and withdrawal of slurry at a constant rate of 46.69 
g/min, leading to a mean RT of 10.6 min. The feed vessel was replenished as required to give 
extended operation of the MSMPR. For the cooling crystallisation of PCM from IPA, the 
MSMPR was operated at low (20 oC saturation; 0.109 g PCM/g IPA) supersaturation (i.e. 
relative to the modified MSMPR), with continuous feed addition and withdrawal of slurry. The 
MSMPR was fed with a fresh feed each RT followed by rapid manual addition of 0.5 % (i.e., 
0.24 g) portions of homogenised PCM raw material seed. The 1 L feed vessel was replenished 
every second RT to provide an uninterrupted supply solution to the MSMPR. The mean RT of 
slurry inside the MSMPR was 8.42 min due to lower density of the PCM-IPA suspension 
compared to PCM-H2O. Slurry withdrawn from the MSMPR each RT was separated by 
vacuum filtration (20 µm pore filter). Recovered product crystals from all experimental runs 
(PCM-H2O and PCM-IPA) were then dried at 40 oC for 24 hrs in a drying oven and image 
analysis carried.  
4.3 Results and Discussion 
4.3.1 Batch LC and ADNC Experiments  
A summary of the crystallisation experiments performed was presented in Table 4.1. The batch 
LC experiments provided an initial benchmark of total counts/s generated from the nucleation of 
PCM. The total FBRM counts/s from all the LC runs were within the range 13000 to 16000 
count/s. This benchmark range as well as the results reported by Saleemi et al [170] were taken 
into account when selecting the parameters for subsequent ADNC runs. No significant 
difference was observed between the counts/s and square weighted mean chord length 
(SWMCL) of crystals obtained from the LC experiments conducted at low or high stirring rates 
(300 or 400 rpm) and at fast or slow cooling rates (-1.0 and -0.5 oC/min) which was a surprising 
outcome. Table 4.2 provides a summary of results from the LC experiments  
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Table 4.2: Summary of results for batch LC experiments. 
Exp No. 
PCM Raw 
Material 
Stirring 
Rate 
Heating / Cooling 
Rate (oC/min) 
Final FBRM 
counts/s 
SWMCL 
(µm) 
1a FRnew 300 1 / -1.0 15585 48.5 
1b FRnew 400 1 / -1.0 13716 47.6 
2a FRnew 300 1 / -0.5 13007 46.3 
2b FRnew 400 1 / -0.5 15428 47.9 
Figure 4.5 shows the time and phase diagrams respectively of the LC experiment carried out 
at 400 rpm and cooling rate of 0.5 oC/min. The FBRM total counts/s exceeds 16000 and the 
experiment duration was 240 min. The onset of nucleation is marked by a rapid increasing in 
particles over a short time period as expected. 
 
Figure 4.5: Time diagram (left) and phase diagram (right) of LC experiment. 
Several ADNC experiments were carried out to investigate the effect of the impurity profiles of 
six different PCM starting materials on the number of heating/cooling cycles. The PCM 
samples were screened for impurities, based on exact masses using the HPLC-MS method 
described in Chapter 3 Section 3.2.6. A list of potential impurities was developed based on an 
extensive literature review [231]–[236]. The exact masses of impurities were calculated using 
ChemBioOffice software. Table 4.3 provides a summary of the HPLC-MS results, indicating 
the impurities found in each sample.  
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Table 4.3: Normalised % of impurities (based on PCM peak height) detected in PCM 
samples used in the LC and ADNC experiments. 
Impurity FRold1 FRold2 DEold CHnew USnew FRnew 
N-phenylacetamide - - 5.86E-04 - 7.97e-04 - 
Phenol - - - - 1.73e-04 - 
p-nitrochlorobenzene - - - - - - 
N-(4-hydroxyphenyl) 
propanamide 
3.23e-04 3.99e-04 1.45E-04 5.17e-04 3.43e-04 4.38e-04 
diacetylaminophenyl 7.98e-05 7.80e-05 4.06E-04 6.51e-05 5.88e-04 6.86e-05 
Aniline - - - - - - 
N-hydroxyparacetamol - - - 1.31e-05 - - 
4-(Acetylamino)phenyl Acetate - - - - - - 
p-chloroacetanilide - 7.38e-07 - - - 5.64e-06 
p-iminoquinone - - - - - - 
FRold and FRnew samples (each sourced from France) show strikingly similar impurity profiles. 
All other samples exhibit unique impurity profiles. However, N-(4-hydroxyphenyl)-
propanamide and diacetylaminophenyl impurities were detected in all samples analysed. The 
diverse impurity profiles of the PCM samples suggest that they were produced by different 
synthesis routes. In spite of the diverse impurity profiles of the samples, the ANDC profiles 
were strikingly similar for experimental runs carried out at FBRM set-points of 4000 ± 100 and 
8000 ± 100 counts/s, respectively. For example, the number of ADNC cycles obtained and the 
batch time (Table 4.1) were similar at each set-point investigated. The exceptions were 
experiments carried out using DEold sample (sourced from Germany) at 4000 ± 100 counts/s 
set-point, and CHnew sample (sourced from China) at 8000 ± 100 counts/s set-point. Figure 4.6 
show the ADNC time diagrams with temperature, FBRM counts/s and concentration 
measurements for the experimental sets carried out using DEold and CHnew PCM, ADNC set-
points are indicate on each diagram. Corresponding operating regions in the phase diagram 
for these ADNC runs are shown in Figure 4.7. With DEold PCM only two ADNC temperature 
cycles were observed at set-point 4000 ± 100 counts/s (Exp. No. 10) before the system 
stabilised close to the target counts/s. This compares to a total of three temperature cycles all 
other experiments carried out at the same set-point (Table 4.1). For the experiment carried 
out with CHnew PCM at set-point 8000 ± 100 counts/s (Exp. No. 7) two temperature cycles are 
observed before the system reaches the target. This compares to only one cycle in all other 
experiment. The time diagrams (Figure 4.6) also show that the ADNC set-point of 8000 ± 100 
counts/s was not achieved for Exp. No. 9 (DEold 8000 ± 100), the measurement was 6901 
counts/s. This experiment reflects the outcome of all experiments carried out at the ADNC 
set-point of 8000 ± 100 counts/s. All experiments carried out at ADNC set-point of 4000 ± 100 
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counts/s either achieved this target or was very close to it as shown in the summary of results 
presented in Table 4.4. 
 
Figure 4.6: ADNC time diagrams showing the change in temperature, concentration and 
FBRM counts/s at set-points of 8000 ±100 counts/s (top) and 4000 ±100 counts/s. 
 
Figure 4.7: ADNC phase diagrams for experiments carried out with CHnew and DEold PCM at 
set-points of 8000 ±100 counts/s (top) and 4000 ±100 counts/s. 
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Table 4.4: Summary of results for select ADNC experiments. 
Exp 
No. 
PCM Raw 
Material 
Heating / 
Cooling Rate 
(oC/min) 
ADNC 
Set-point 
(counts/s) 
Final 
FBRM 
(counts/s) 
SWMCL 
(µm) 
No. of 
Cycles 
Saleemi 
et al. 
[170] 
Cycles 
3 FRnew 0.4 / -0.2 4000 ± 100 3665 90.0 1 n/a 
4 FRnew 0.4 / -0.2 4000 ± 1000 3677 75.8 2 n/a 
5b FRnew 0.2 / -0.4 4000 ± 100 3573 84.5 1 n/a 
6b FRnew 0.2 / -0.4 8000 ± 100 6580 69.0 3 5 
7 CHnew 0.2 / -0.4 8000 ± 100 7670 67.1 2 5 
8 CHnew 0.2 / -0.4 4000 ± 100 3501 83.4 3 11 
9 DEold 0.2 / -0.4 8000 ± 100 6901 67.5 1 n/a 
10 DEold 0.2 / -0.4 4000 ± 100 3916 83.1 2 11 
n/a = not applicable 
Table 4 also shows the number of ADNC cycles obtained for each experiment and its 
equivalent from Saleemi et al [170]. The latter results show a far greater number of ADNC 
cycles, which is likely linked to the purity profile of the raw material used. The alternative 
explanation is that the different experimental outcomes in terms of numbers of ADNC cycles 
is a result of batch-to-batch variability. For experiments in which the set-points counts/s was 
not achieved, the observed counts/s when each of the systems stabilised was lower than the 
target value. This means that the implementation of a cooling cycle could have increased the 
number of particles via secondary nucleation in the system in order to achieve the target. 
However, in all cases the temperature recorded when the counts/s in the system stabilised 
was roughly 3 oC, which is also the lower temperature limit set in the DNC profile in CryPRINS. 
This means that no further cooling of the process vessel was possible to produce more 
particles. Therefore, each system remained at the final counts/s value and stabilised without 
the implementation of further ADNC cycles. The crystals obtained from experimental runs 
carried out at ADNC set-points 8000 ± 100 and 4000 ± 100 counts/s, respectively, were of a 
similar mean size (SWMCL) for all runs in the same category. However, the SWMCL of 
crystals obtained from 4000 ± 100 counts/s are noticeably larger compared to those from 8000 
± 100 counts/s. This is attributed to the greater extent of fines dissolution achieved at the lower 
ADNC set point, leading to the remaining crystals growing larger still at the expense of the 
dissolved fines. Figure 4.8 (a) shows the evolution of SWMCL with time over the last 400 min 
of Exp. No. 3, 4, 7, and 10. These trends confirm that the largest mean crystal size was 
obtained for Exp. No. 3 (4000 ± 100 counts/s). For this experiment, the ADNC heating/cooling 
rate settings were 0.4 / -0.2 oC/min, whereas for the other experiments they were 0.2 /  - 0.4 
oC/min. This suggests that low cooling growth is more favourable and with fast heating there 
is rapid dissolution of the fines. On assessment of Exp. No. 4 (4000 ± 1000 counts/s), the 
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mean crystal size is smaller compared to Exp. No. 3, a reflection of the wider ADNC boundary 
conditions employed. Figure 4.8 (b) shows the images of crystals obtained at the end of the 
ADNC runs described earlier.  
 
Figure 4.8: FBRM SWMCL measurements (a) and microscope images (b) for Exp. No. 3: 
FRnew (4000 ± 100), Exp. No. 4: FRnew (4000 ± 1000), Exp. No. 7: CHnew (8000 ± 100) and 
Exp. No.10: DEold (4000 ± 100). 
The crystals obtained from Exp. No. 3 show better CQA properties in terms of shape, size and 
extent of agglomeration when compared to crystals from the other experimental runs. Overall, 
the results present indicated that the impurity profile of the PCM samples does not significantly 
affect the behaviour of the system when ADNC control is applied. This is perhaps due to the 
very low impurity concentrations detected. However, the selected ADNC set-point and control 
setting, including the boundary conditions and heating/cooling rates all have an effect on the 
mean size and CSD of the final product. 
4.3.2 Cooling Crystallisation in Conventional MSMPR 
Seeded Cooling Crystallisation Experiments Using Water: PCM crystallisation was 
investigated in the single-stage MSMPR described in Section 4.2.2 (Figure 4.4). Figure 4.9 (a) 
and (b) show the time diagram for the seeding cooling crystallisation of PCM from water at 3.5 
and 7.0 % seed loading, respectively. The data shows that there is unsteady behaviour of the 
FBRM counts/s and 1st derivative of the ATR-UV/vis signal. It appears the system is dominated 
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by secondary nucleation, leading to rapid depletion of concentration as indicated by an 
increase in the 1st derivative of the ATR-UV/vis absorbance at 266 nm. In the 3.5 % seed 
experiment there was an initial decrease in FBRM counts/s signal immediately after the 
holding period, an indication that some crystals were being washed out of the system. In 
comparison, the 7.0 % seed experiment shows a steady signal, followed by a steady increase 
soon after the commencement of slurry withdrawal. These experiments suffered from 
persistent fouling on the vessel walls and probes in spite of the low supersaturation employed. 
This can be attributed to the hydrophobicity of PCM crystals, which tended to form clusters in 
the presence of water. Figure 4.10 shows the microscope images of the homogenised raw 
material seed and product crystals obtained from the 3.5 and 7.0 % seed addition experiments, 
respectively. The product crystals appear larger than the seed crystals. However, there are 
clearly a lot of agglomerates present. This is attributed partly to the poor quality of the seed 
material, but also to the hydrophobicity of PCM in water leading to aggregation of the seed 
crystals.  
 
Figure 4.9: Time diagrams show the change in temperature, 1st derivative ATR-UV/vis 
absorbance at 266 nm and FBRM counts/s for PCM crystallisation from water: (a) 3.5 % 
seed added manually at start-up (b) 7.0 % seed added manually at start-up. 
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1  
Figure 4.10: Microscope images of crystals (x4) of (a) seed material, (b) product crystals 
from of 3.5 % seed experiment, and (c) product crystals from 7.0 % seed experiment. 
The product crystals from 3.5 % seed experiment appear larger in comparison to the 7.0 % 
seed experiment. This suggests that the amount of seed has an effect on the nucleation and 
growth kinetics of the system, where by at lower seed loading the growth of crystals appears 
to be favoured. Eder et al [75], [237] showed in their study that increasing seed loadings 
resulted in decreased differences between the mean seed and product crystal sizes. This is 
attributed to the fact that more particles are introduced into the system which leads to 
increased competition to consume the same amount of supersaturation available. 
Seeded Cooling Crystallisation Experiments Using IPA: Figure 4.11 shows the time 
diagram for the seeding cooling crystallisation of PCM from IPA. The MSMPR was seeded 
periodically as opposed to once at the beginning to avoid washing out issues and uncontrolled 
secondary nucleation. Preliminary MSMPR experimental runs showed that the amount of 
crystals obtained from IPA solvent was greater, due to the higher solubility of PCM in this 
solvent compared to water. Furthermore, the CQA of the product crystals were much better 
for crystallisations from IPA, evidenced from the presence of fewer aggregates and more 
uniformly shaped and sized crystals in spite of the poor quality seed used. It was evident that 
the single-stage MSMPR required optimisation of the seed addition method, based on 
experience from the experiments carried out in water.  
 
Figure 4.11: Time diagram showing the change in temperature, ATR-UV/vis concentration 
and FBRM counts/s for the seeded cooling crystallisation of paracetamol from IPA. 
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Figure 4.11 shows that manual periodic seed addition results in several spikes in the FBRM 
counts, and more minor fluctuations in the concentration, whilst the temperature remains 
constant. However, the change in concentration recorded from the second seed addition to the 
end of the experiment was ~ 2.66 %, although there is a slight increasing trend. This was a 
promising result, which indicated that the system may have achieved steady-state if the 
experiment was continued for a longer period, but this was not possible due to a limited supply 
of material. As intimated earlier, many published studies on MSMPR crystallisation have relied 
FBRM statistics [8], [13], [110], [152], periodic concentration measurement [19], [24], [53] and 
the yield of crystallisation [8], [13] to characterise steady-state behaviour. However, there are 
very few studies that have reported on real-time monitoring of concentration in the MSMPR 
coupled with particle monitoring techniques to determine the exact time to steady-state. In this 
study, it is clear that steady-state FBRM counts/s and concentration were not attained. This was 
perhaps due to the intermittent addition of seed to the system. According to Johnson et al [60] 
seeding is not required at steady-state, because there is steady-state birth rate of nuclei. 
Therefore, it is likely that the intermittent addition of seed prevented the attainment of steady-
state in the MSMPR. However, it was shown earlier for PCM crystallisation from water that the 
seeding once at start-up approach did not work and instead encouraged secondary nucleation 
and prevented the attainment of steady-state. It is likely that further optimisation of the 
intermittent seeding strategy could lead to steady-state operation. For example, the use of a 
larger seeded feed vessel could minimise the variations caused by intermittent addition. This 
strategy will be explored further in Chapter 5. Figure 4.12 shows the change in SWCLDs 
between seed additions from the 2nd to 22nd RT. The results show that the distributions overlap 
significantly from the 2nd to 15th RT. Further information can be drawn from the microscope 
images of the product crystals shown in Figure 4.13 (b). There is a significant amount of crystal 
growth observed from the initial seed crystals through to the 2nd RT(45.15 min) and 22nd RT (230 
min) sample. The crystals are also less agglomerated and more uniform in size compared to 
the product crystals obtained for PCM crystallisation from water. 
The overall assessment of the cooling crystallisation experiments in water and IPA is that the 
seed addition method requires further improvement for better crystallisation outcomes in terms 
of attainment of steady-state. Recent studies using single-stage MSMPR have relied on 
intermittent pumping of feed solution or suspension, and lengthy residence times to achieve 
desired crystal properties [8], [13], [19], [24]. The crystallisation times in many of these studies 
are similar to that achievable in batch crystallisers. The challenge therefore is to develop an 
MSMPR process that produces crystals of the desired CQA within a short time scale to reduce 
residence time burden, whilst also achieving representative and isokinetic product withdrawal. 
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Figure 4.12: Evolution of SWCLD during the seed cooling crystallisation of PCM from IPA in 
a single-stage MSMPR. 
 
Figure 4.13: Microscope images of crystals (x4) of (a) seed material, (b) product crystals 
from the 2nd RT, and (c) 22nd RT. 
Comparative Assessment of Batch and MSMPR Operations: In order to quantify the 
performance and efficiency of each crystallisation process reported in this study, the fractional 
yield (Eqn. 4.2) and productivity of crystallisation (Eqn. 4.4) were calculated.  
𝑃𝑟𝑜𝑑𝑢𝑐𝑡𝑖𝑣𝑖𝑡𝑦 𝑜𝑓 𝐶𝑟𝑦𝑠𝑡𝑎𝑙𝑙𝑖𝑠𝑎𝑡𝑖𝑜𝑛 =
𝑀𝑎𝑠𝑠 𝑜𝑓 𝑃𝑟𝑜𝑑𝑢𝑐𝑡 𝑅𝑒𝑐𝑜𝑣𝑒𝑟𝑒𝑑
𝑃𝑟𝑜𝑐𝑒𝑠𝑠 𝑅𝑒𝑠𝑖𝑑𝑒𝑛𝑐𝑒 𝑇𝑖𝑚𝑒
 4.2  
Note that for the fractional yield calculation of seeded crystallisation processes, co includes 
the seed contribution in addition to the initial solute concentration of feed solution. Table 4.5 
provides a summary of the yield and productivity of crystallisation data for selected batch and 
continuous crystallisations. The data shows that while the yield of optimised LC and ADNC 
batch crystallisations are significantly high compared to the continuous MSMPR operated at 
steady-state (i.e., modified MSMPR with 0.05 wt% additive addition), the productivity of the 
latter is far superior. The steady-state MSMPR was ~ 16 times more productive than ANDC 
and ~ 5 times more productive than LC. Kim [238] reported productivity of crystallisation ~ 7 
times greater than batch using a MSMPR crystalliser. Compared to the MSMPR, product 
crystals obtained from the LC runs show poor CQA due to variable crystal size and shape 
properties and broad CSD as shown in Figure 4.14 (a) and (b), respectively. The SWCLD plot 
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(Figure 4.14 (a)) confirm that larger mean crystal sizes are obtained from the batch ADNC 
experimental runs compared to the batch LC and continuous experimental runs, respectively. 
Although the SWCLD of the continuous crystallisation run is shifted towards smaller sizes, it 
is much narrower compared to all the batch experimental runs. It is also clear that the fast 
cooling batch LC run (Exp. No. 1a) produced much smaller particles when compared to the 
other experiments. In contrast, the slow cooling batch LC run (Exp. No. 2a) produced larger 
crystals, but the SWCLD is bimodal and significantly broadened. The microscope images 
(Figure 4.14 (b)) of crystals obtained from each of the experimental runs show good 
agreement with the SWCLD data.  
Table 4.5: % Yield and volumetric productivity of batch and continuous crystallisations. 
Exp. Type Description % Yield 
Heating/ 
Cooling 
Rate 
(oC/min) 
Residence 
Time 
(min) 
Productivity of 
Crystallisation 
(g/L-min) 
Batch LC Exp. No 1a 98.5 1 / -1.0 187 0.8570 
Batch LC Exp. No 2a 95.7 1 / -0.5 240 0.6228 
Batch ADNC Exp. No. 3 95.0 0.4 / -0.2 625 0.2474 
Batch ADNC Exp. No. 6b 94.6 0.2 / -0.4 650 0.2366 
Modified MSMPR No Additive 98.8* n/a 12.12 n/a* 
Modified MSMPR 0.05 wt% HPMC 28.0 n/a 12.12 4.002 
Conventional 
MSMPR 
water; 3.5 % seed 
88.6* 
n/a 10.60 
n/a* 
Conventional 
MSMPR 
water; 7.0 % seed 
90.2* 
n/a 10.60 
n/a* 
Conventional 
MSMPR 
IPA; 0.5 % seed 
18.6* 
n/a 8.42 
n/a* 
n/a = not applicable; n/a* = not applicable due to unsteady state behaviour; * unsteady-state operation observed 
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Figure 4.14: FBRM SWCLD measurements (a) and microscope images (b) Exp. No. 1a (LC), 
Exp. No. 2a (LC), Exp. No. 3 (ADNC), Exp. No. 6b (ADNC) and 0.05 wt% HPMC (MSMPR). 
4.3.3 Continuous Crystallisation in Modified MSMPR 
Crystallisation in Modified MSMPR (No Additive): Several challenges were encountered 
during the development stages of the continuous crystallisation apparatus: 1) particle settling 
and blockage of transfer lines, particularly at the peristaltic pump gears; 2) fouling and 
encrustation on the walls of the MSMPR and dip tube; and 3) fouling on PAT probes. These 
issues were mainly due to the narrow bore size of transfer lines (3 mm ID); low flow rate 
requirement to achieve long residence times leading to particle settling in product discharge 
lines; and operation of the MSMPR with a recirculation loop, which resulted in the creation of 
localised regions of high supersaturation, uncontrolled nucleation and eventually fouling and 
encrustation. The issues reported here have been encountered by several other investigators 
[13], [25], [32], but were largely avoided by using the modified MSMPR (Figure 4.1). However, 
fouling on the PAT probes and mild encrustation on the vessel walls persisted over prolonged 
operation. Figure 4.15 shows the process time diagram for a control experiment (no additive). 
The changes in temperature, FBRM counts/s and concentration are shown.  
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Figure 4.15: Time diagram showing temperature, FBRM counts/s and Raman concentration 
measurements obtained from the modified MSMPR. 
Points during the process where fouling was detected on the PAT probes are indicated by 
circles. Periodic cleaning of the probes was necessary when to avoid the recording of 
erroneous results, a practice not often reported in the literature. The start-up phase is indicated 
as the initial period prior to nucleation. The nucleation phase and region of controlled operation 
(i.e. steady-state) are also indicated. The crystallisation proceeded without any washout 
issues, which are often reported in the literature [78]. This is attributed to the start-up method 
employed that was described in Section 4.2.2. During the nucleation phase there is rapid 
increase in FBRM counts/s; this dynamic state of the system leads to varied size distributions 
with time as confirmed by the SWCLD data shown in Figure 4.16 (a). After ~ 127 min (6th RT 
onwards) the FBRM counts stabilise and the system appears to arrives at a steady-state mean 
particle size and CSD. This is confirmed by overlapping of the SWCLD from the 6th to 18th RT 
onwards as shown in Figure 4.16 (b). The Raman concentration data (Figure 4.15) paints a 
different picture of the process when compared to the SWCLD data. There is a decreasing trend 
from the onset of nucleation (0.153 g PCM / g IPA) to the end of the experiment (0.089 g PCM/ 
g IPA). The ATR-UV/vis data also indicated that the concentration was decreasing over the 
period (Figure 4.17). Figure 4.17 shows the phase diagram of the process with the trajectory of 
concentration change. At the point of intersection with the indicative metastable curve, 
nucleation is observed. The final recorded concentration of the process indicated with a 
dot/arrow is close to the solubility curve, indicating that available supersaturation is almost 
completely depleted. The FBRM counts/s appear to show steady-state behaviour until a fouling 
event was detected at approximately 200 min (Figure 4.15). Following a cleaning procedure, an 
apparent drift from steady-state can clearly be observed, which complements the decrease in 
Raman concentration and is a further indication that the system is not at steady-state as 
suggested by the FBRM SWCLD measurements shown in Figure 4.16. 
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Figure 4.16: Evolution of SWCLD: (a) dynamic state of change in the MSMPR (1st to 5th RT); 
and (b) steady-state operation of the MSMPR (6th to 18th RT). 
 
Figure 4.17: Phase diagram showing solubility and operating curves and indicative 
metastable width as displayed in CryPRINS. Initial (Start) and final (End) recorded 
concentrations are indicated by dots/arrows. 
Raman and ATR-UV/vis with their respective multivariate calibration models gave similar 
concentration measurements. The concentration data from both methods (Figures 4.15 and 
4.17) indicated that the system was in a dynamic state of change and that steady-state had 
not been attained. This is an important observation, since many recent studies on the subject 
of continuous crystallisation monitoring characterised steady-state by relying solely on FBRM 
[8], [20], [32], [77], [85], [110] and/or imaging techniques (for example, low angle light 
scattering (LALLS) and PVM[77], [78]) or “calibration free” spectroscopy approaches [32]. 
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Arguably, real-time determination of concentration using multivariate models supported by on-
line particle measurements provides a more robust measure of steady-state operation, as 
opposed to just tracking changes in FBRM statistics, or using ‘calibration-free’ methods. Since 
these are qualitative measures, they may not reliably determine the attainment of steady-state 
operation. In some studies, off-line concentration measurements [8], [21], [24] or gravimetric 
mass balance analysis and/or off-line particle size analysis[13], [225] [63] are used to 
determine steady-state operation. These methods are not only laborious, but prone to error 
due to the amount of sample handing involved. Furthermore, losses often occur during the 
sample filtration step. The use of PAT with multivariate models, as demonstrated here 
provides a robust approach for characterising the MSMPR operation in addition to using 
FBRM, and PVM technologies. Potentially, other image analysis techniques such as bulk 
video imaging (BVI) [239], [240] or endoscopy-stroboscopy [153] in concert with multivariate 
image analysis methods could replace PVM to provide more useful information for further 
process characterisation, in particular, of nucleation and growth phenomena. The advantages 
of multivariate methods is well documented for batch processes [141], [213], [241], however, 
the application in continuous processing remains limited. 
Crystallisation in Modified MSMPR (HPMC Additive): Although many of the challenges 
encountered during the development stages of the MSMPR were alleviated by employing the 
modified configuration (Figure 4.1), problems persisted with fouling and mild encrustation in the 
MSMPR. The use of additive was therefore explored as a means of eliminating these problems. 
In a study on the effect of  different polymers on the crystallisation of PCM from aqueous 
solutions Wen et al [242] showed that HPMC inhibited nucleation and growth to a significant 
degree by adsorbing on to the (010) face of monoclinic form I crystals. It was thought that HPMC 
developed hydrogen-bonding interactions with PCM crystals in the direction of the a-axis on the 
(010) face, thereby disrupting the surface diffusion of PCM molecules in this direction and 
changing the etching patterns on the crystal surface. HPMC was therefore seen as a variable 
additive to use for controlling PCM crystallisation and thereby prevent fouling and encrustation 
in the MSMPR. Figure 4.18 shows the process time diagram for the 0.05% HPMC continuous 
crystallisation experiment. The start-up phase was extended due to the presence of HPMC, 
when compared to the control experiment that was evaluated earlier. Following this is the 
nucleation phase where the FBRM counts/s increases rapidly with simultaneous depletion of 
concentration. The maximum FBRM counts/s attained in the nucleation phase was about 2,660 
counts/s, which is almost an order of magnitude lower compared to the maximum value of 
23,800 counts/s recorded during the control experiment (see Figure 4.15).  
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Figure 4.18: Time diagram showing temperature, FBRM counts/s and Raman concentration 
measurements obtained from the modified MSMPR. Start-up, nucleation, agglomeration and 
growth (A & G) phases and region of steady-state operation are indicated. 
Figure 4.18 indicates that HPMC not only delays the onset of nucleation in the system, but 
also suppresses it significantly. These observations corroborate findings from previous studies 
[242]–[244] on HPMC suppression of PCM nucleation. The “A & G phase” as show in Figure 
4.18 refers to a period when there is both agglomeration (A) and/or growth (G) taking place, 
indicated by a decrease in FBRM counts/s and corresponding decrease in concentration. 
Following the A & G phase, the system achieves steady-state whereby the FBRM counts and 
solute concentration are stabilised and remain constant for the duration of the experiment. 
Compared to the control experiment with no additive added (Figure 4.15), the change in 
concentration when nucleation occurs is small, a further confirmation that HPMC is 
suppressing nuclei formation. The concentration decreased gradually from start-up from the 
level of 0.156 to 0.150 g PCM/ g IPA after 154 min. The steady-state concentration (0.147 g 
PCM/ g IPA) was reached after ~ 170 min and was maintained at that level until the end of the 
experiment. The FBRM SWCLD also confirmed steady-state operation was attained as shown 
in Figure 4.19 (a) and (b) (1st to 15th RT). The significant overlap of the distributions between 
the 6th and 15th RT is an indication of steady-state. 
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Figure 4.19: Evolution of SWCLD showing: (a) dynamic state of change in the MSMPR (1st 
to 5th RT); and (b) steady-state operation of the MSMPR (6th to 15th RT). 
Figure 4.20 shows the phase diagram of the process, indicating the region of steady-state 
operation. Compared to the control experiment, the level of supersaturation remains quite high 
(S = 1.015 control; S = 1.665 HPMC at 0.05 %), confirming the effect of HPMC on the 
nucleation suppression [242], [243]. Due to the dramatic effect of 0.05 wt% HPMC on the 
delay and suppression of PCM nucleation, further investigations were conducted at lower 
concentrations (0.001 and 0.003 wt%). Table 4.5 gives a summary of the results from all 
experiments carried out using the modified MSMPR. The supersaturation (S) as reported is 
defined as ci/c
*. The data shows that there is a direct correlation between HPMC concentration 
in the system and induction time. Conversely, and as expected, there is an inverse correlation 
between HPMC concentration and FBRM counts/s data and fractional yield (Y) of 
crystallisation. 
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Figure 4.20: Phase diagram showing solubility and operating curves and indicative 
metastable width as displayed in CryPRINS. Initial (Start) and final (End) recorded 
concentrations are indicated by arrows/dots. 
Eqn. 4.3 shows the formula used to calculate the Y. The fractional yield represents the amount 
of product obtained from each crystallisation process relative to the amount of available 
supersaturation, and is described as: 
𝑌 =
 𝑐𝑜 −  𝑐𝑖
 𝑐𝑜 −  𝑐𝑖
∗ × 100 4.3  
where  𝑐𝑜 , 𝑐𝑖 , and 𝑐
∗, and  are respectively, the dissolver/feed stream concentration (g PCM 
/ g IPA), MSMPR steady-state concentration, and equilibrium concentration at the specified 
operating temperature, respectively. The data presented in Table 1 shows there is a direct 
correlation between the HPMC concentration and the level of supersaturation at which the 
MSMPR operates. Steady-state was not observed for either the 0.001 or 0.003 wt% HPMC 
additive experiments, due to the persistence of fouling and encrustation problems.  
Table 4.6: Summary of experimental results showing the effect of HPMC additive on the 
continuous cooling crystallisation of PCM. 
HPMC   
(wt%) 
Induction time: from 
the onset of cooling 
(min) 
Nucleation Phase 
Max. FBRM 
(counts/s) 
Fractional Yield of 
Crystallisation 
(%) 
Supersaturation 
(ci/c*) 
0 58 23800 98.8 1.015 
0.001 59 15119 56.6 1.314 
0.003 64 7146 40.7 1.536 
0.050 97 2656 28.0 1.665 
Characterisation of Crystal Properties from FBRM Statistics and Image Analysis: CQA of 
product crystals obtained from the modified MSMPR crystalliser were investigated further using 
FBRM statistical trends, real-time PVM and off-line microscope image analysis. Figure 4.21 (a) 
to (d) provides a comparison between the FBRM statistical trends for the control and 0.05% 
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HPMC additive experiments. These time diagrams show the fraction of total counts/s for each 
size range. In the early stages of each experiment, just following the onset of nucleation, the 1 
– 5 and 6 – 25 µm size fractions accounted for greater than 90 % of the total counts/s. However, 
as growth becomes the dominant crystallisation mechanism, a large reduction in the smaller 
size fractions for the 0.05 % HPMC experiment is observed. This compares to a much smaller 
reduction in the amount of fine crystals for the control experiment. 
 
Figure 4.21: FBRM statistics showing the fraction of particle counts/s for a range of size 
fractions for the modified MSMPR control (No Additive) and 0.05 wt% HPMC experiments, 
respectively: (a). No weighted counts/s 1 – 5 µm; (b). No weighted counts/s 6 – 25 µm; (c). 
No weighted counts/s 27 – 50 µm; and (d). No weighted counts/s 54 – 100 µm. 
The contribution of each size fraction to the CSD as the system approaches steady-state 
operation provides further evidence of the effect of HPMC on the suppression of nucleation 
and subsequent growth of crystals. Figure 4.21 (a) further indicates that the 1 – 5 µm size 
fraction contributes only a small amount (~ 13.1 %) to the total counts/s for the 0.05 wt% 
HPMC experiment. This compares to a much larger contribution (~ 31.3 %) to the total 
counts/s from crystals in the same size range for the control experiment. The 6 – 25 µm fraction 
contribution to the total counts/s for the control and 0.05 wt% HPMC additive experiments 
were similar (~ 55 % and 50 % respectively). The 27 – 50 µm and 54 – 100 µm fractions 
combined contributed ~ 35.3 % to the steady-state total counts/s for the 0.05 wt% HPMC 
experiment, while the contribution was only 13.7 % for the control experiment. These results 
indicate that whilst HPMC is suppressing nucleation to a significant degree and much larger 
product crystals are obtained compared to the control experiment. It is likely that due to the 
severe suppression of nucleation, the few crystals present in the system have less competition 
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for solute molecules and thus can grow larger. However, it is likely that the rate of growth of 
these crystals is also suppressed. Therefore, the overall deduction is that HPMC suppresses 
the nucleation, as well as growth kinetics of PCM. Femi-Oyewo and Spring [243] studied the 
effect of HPMC and other additives on PCM crystallisation from aqueous solutions and 
reported a high degree of nucleation and crystal growth inhibition. In this study, ‘microcrystals’ 
with low yield were observed. The investigators reported crystal size reduction from 4.28 mm 
(length) without HPMC addition (control) to between 0.3 and 0.42 mm (length) when HPMC 
additive in the concentration range 0.1 – 0.7 wt% was used. In these studies, the effect of 
HPMC on the product crystal size is rather dramatic compared to the results reported here. 
However, this is not surprising given the much higher concentrations that were employed in 
aqueous solution. Trends of the FBRM mean square weighted chord length (MSWCL) statistic 
shown in Figure 4.22, provide further evidence that larger product crystals are obtained from 
the 0.05 wt% HPMC experiment compared to the control experiment. The mean size of 
crystals at the end of the control experiment was 35.2 µm, which compares to 60.6 µm for the 
0.05 wt% HPMC experiment.  
 
Figure 4.22: Real-time FBRM mean square weighted chord length (MSWCL) trends for the 
0.05 wt% HPMC and control (No Additive) experiments respectively. 
Real-time PVM images also indicate that there are larger crystals for the 0.05 wt% HPMC 
experiment relative to the control experiment. Figure 4.23 (a) shows the change in appearance 
of crystals from the onset of nucleation (~ 58 min) to the end of the control experiment. There 
is a rapid increase in the number of crystals up to 130 min, after which the PVM probe has 
become saturated due to the high particle density. On the other hand, Figure 4.23 (b) shows 
the change in crystal properties captured by PVM from the onset of nucleation (~ 97 min) to 
the end of the 0.05 wt% HPMC experiment. These crystals are clearly larger than those from 
the control experiment. PVM also indicated that steady-state was achieved from 170 min 
onwards, since the crystals are of similar size and shape. Figure 4.24 (a) and (b) show 
microscope images of samples taken from the control and 0.05 wt% HPMC experiments. The 
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differences in product crystal CQA between the two experimental runs can be more clearly 
identified. Comparatively, the crystals obtained from the 0.05 wt% HPMC run are significantly 
larger than those from the control run. It is also evident that the crystals are predominantly of 
a tabular habit with smoother edges, an indication that HPMC may be affecting the growth 
rate to a different degree on each crystal face.  
 
Figure 4.23: PVM images captured during: (a) the control experiment (No Additive), and (b) 
the 0.05 wt% HPMC additive experiment. 
 
Figure 4.24: Offline microscope images of samples taken from the continuous crystallisation 
experiments: (a) control experiment and (b) 0.05 wt% HPMC. 
The effect of additives on crystal growth and morphology is well documented in the literature 
[245]–[247]. Thompson et al [245] investigate the effect of structurally related additives on 
different crystal faces of form I PCM. They found that the growth of the (001) face, and hence 
the crystal morphology was affected to different extents by acetanilide and metacetamol 
(a)  (2) 70 min  
(3) 80 min  (4) 100 min  
(5) 130 min  (6) End 
(1) 97min  (2) 120 min  
(3) 140 min  (4) 170 min  
(5) 200 min  (6) End 
(b) 
(1) 120 min  (2) 140 min  
(3) 170 min  (4) 200 min  
(5) 230 min  (6) End 
(b)  (1) 70 min  (2) 100 min  
(3) 130 min  (4) 160 min  
(5) 190 min  (6) End 
(a) 
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additives respectively, due to different interactions with the NHCOCH3 and OH functional 
groups. It may be that at the applied concentration of HPMC, surface interactions that lead to 
suppression of growth on specific crystal faces occurs, leading to a subsequent change in the 
crystal habit. For the control experiment, the microscope images show crystals of several 
different habits, including, prismatic, tabular and cuboid morphologies. There is also evidence 
of agglomerated and twinned crystals present. Ristic et al. [248] examined the morphology of 
form I PCM crystals grown from aqueous solutions and concluded that the habit changes of 
PCM was due principally to changes in the growth mechanism of the (110) and (001) faces 
which exhibit markedly different growth rates at high and low supersaturations. Crystal growth 
was found to be dominant on the (110) face at low supersaturations, which gave way to 
increasing dominance of the (001) as the supersaturation increased. At low supersaturations 
(<10%) crystals exhibiting a columnar or prismatic morphology elongated along the (001) axis, 
while at high supersaturations (>15%) crystals of a tabular morphology were reported. Wen et 
al [242], [249] later showed that the mechanism of HPMC effect on PCM morphology was via 
hydrogen bonding interactions. It is likely that HPMC interacts differently with PCM on the 
different crystal faces at high and low supersaturations leading to the crystal control 
morphological evolution of PCM crystals. While these are interesting observations, 
investigation of those phenomena related to the crystal habit of PCM in the presence of HPMC 
were outside the scope of the study. 
4.4 Conclusion 
In this chapter, optimised batch and continuous crystallisation approaches were investigated 
under different operating conditions. Batch crystallisation of the model compound PCM from 
IPA solvent was investigated using two different control policies, LC and ADNC. As expected, 
the latter approach produced larger, uniform crystals with narrower CSD compared to the 
former, which showed more fines, agglomerates and broad CSD. However, although the 
crystallisation results were as expected, in the ADNC experiments, fewer temperature cycles 
and thus shorter batch times were observed when compared to results from Saleemi et al 
[170] with similar crystal CQA. It was initially conceived that the unusual outcome of the ADNC 
experiments reported here was due to the presence of impurities in the raw material used. 
HPLC-MS analyses on the PCM raw material sourced from the same manufacturer, but 
produce in several different countries showed different impurity profiles based on their origin. 
Further investigation of ADNC control policy using the different PCM raw materials revealed 
no clear link between the impurity profiles and the number of temperature cycles or the quality 
of the product crystals obtained.  
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The crystallisation of PCM was further investigated in a continuous MSMPR operation. These 
studies were carried out using either a modified MSMPR or a conventional MSMPR 
crystalliser. The modified MSMPR crystalliser configuration consisted of a dissolver/feed unit, 
in-line heat exchanger and recirculation loop was employed for the continuous cooling 
crystallisation of PCM. In this closed loop operation slurry is continuously dissolved and 
recycled/fed back to the MSMPR leading to the conservation of materials. The heat exchanger 
was able to minimise, but not completely eliminate fouling and encrustation at start-up, leading 
to prolonged operation. Furthermore, start-up of the MSMPR was achieved without any wash-
out issues as is often reported in the literature[32], [78], since nuclei were generated by 
primary nucleation. Wash-out was avoided due to the start-up strategy employed, whereby 
material is circulated between the dissolver and MSMPR until nucleation is detected, as 
opposed to starting up with a suspension already in the MSMPR[77], [78]. Due to the 
persistence of fouling and encrustation issues over prolonged operation of the modified 
MSMPR, HPMC additive was explored as means of controlling the crystallisation and thereby 
preventing these problems. More stable operation of the MSMPR was observed in the 
presence of HPMC additive and steady-state was achieved more readily when compared to a 
control experiment. However, HPMC shows a significant effect on the suppression of PCM 
nucleation and crystal growth. In the presence of HPMC, the product crystals obtained were 
tabular shaped and of similar size. For the control experiment in which no HPMC was added, 
predominantly fine crystals with a range of different morphologies were obtained. A direct 
correlation was observed between HPMC concentration, induction time and MSMPR steady-
state supersaturation, while an inverse relationship was found between HPMC concentration, 
the fractional yield and number of particles detected. The application of an IDS framework with 
integrated and ancillary PAT array, and informatics software CryPRINS tool were used to 
monitoring the MSMPR operation. Robust multivariate models were applied using Raman and 
ATR-UV/vis spectroscopy for solution concentration measurement. The application of 
multivariate methods for real-time monitoring of a continuous crystallisation process is rarely 
reported. Furthermore, Raman spectroscopy is rarely used in crystallisation to monitor solution 
phase concentration. The results further indicate that the combined use of PAT tools within 
the IDS framework can indicate when steady-state is achieved. The PAT array provides a 
more robust approach for characterisation of steady-state compared to the use of standalone 
PAT monitoring frameworks or ‘calibration-free’ approaches. 
Due to the dramatic effect of HPMC on the suppression of PCM crystallisation in the modified 
MSMPR even at very low applied concentrations, another approach involving seeded cooling 
crystallisation in a conventional MSMPR crystalliser operated at low supersaturation was 
explored. In these studies, either water or IPA was used as solvent and different seeding 
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strategies were investigated. Steady-state was not achieved in any of the experimental runs 
conducted using water as solvent due to problems with aggregation of PCM during the 
crystallisation, leading to persistent fouling on the vessel walls and PAT probes and poor 
product crystal CQA. A secondary factor was the once-only seeding strategy employed at 
start-up, which meant that the system took a long time to achieve steady state due to wash-
out issues. However, useful information was gained for further optimisation of the conventional 
MSMPR operation. According to Frawley et al. [237], the effect of seed loading and the 
mechanism of secondary nucleation is crucial to the successful operation of continuous 
crystallisers. For the cooling crystallisation of PCM from IPA a manual seeding policy was 
implemented whereby seed material was added to the MSMPR each RT, to avoid wash out 
in the initial stages of the operation and also to control the extent of secondary nucleation. 
Data acquired from each of the PAT tools employed to monitor the crystallisation show that 
the system experienced oscillations. In particular, the FBRM counts/s data showed the effect 
of the intermittent seed addition. However, the system appeared to have been close to 
achieving steady-state, which was supported by the ATR-UV/vis data, which showed that the 
concentration varied by no more than 2.66 % from the 1st RT to the end of the experiment. 
The product crystals obtained from this experiment were of better quality than previous 
experimental runs using water as solvent. Overall, the results from this experiment were 
promising, but optimisation of the seed addition method from intermittent manual addition to 
continuous addition may be necessary.  
A comparison of batch crystallisation approaches with the conventional and modified MSMPR 
approaches was conducted. It was found that while the batch operations gave superior yield, 
the continuous crystallisation at steady-state lead to higher productivity of crystallisation. 
Furthermore, the product crystals obtained from the steady-state MSMPR had a narrower 
CSD compared to batch, although the mean crystal size was significantly smaller. Further 
work is required to optimise the single-stage MSMPR operation to achieve desired 
crystallisation outcomes, such as improved yields and better crystal properties in terms of size, 
shape and distribution. The results reported provide a better understanding of the parameters 
and operating procedures that influence the batch and continuous operations. The use of 
integrated PAT tools within an ISD framework with CryPRINS was very useful for real-time 
monitoring and control of the batch and continuous crystallisation operations. In addition, it 
gives an indication as to whether or not steady-state operation is achieved in the latter. 
An overall assessment of the results presented so far in this Chapter indicate that steady-state 
MSMPR operation offers superior productivity, and much narrower CSD compared to 
optimised batch crystallisation processes, but suffers from low crystallisation yield. However, 
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a more useful comparison could have been made if steady-state operation was achieved in 
the majority of MSMPR experiments reported. The problems of encrustation, fouling and line 
blockage significantly hindered the MSMPR operation. Therefore, the design of an 
optimisation operation to overcome these challenges is critical. In Chapter 5 such an optimised 
MSMPR operation is proposed which could lead to significant improvements in continuous 
crystallisation outcomes in terms of attainment of steady-state or at least a controlled state of 
operation. 
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Chapter 5 
Periodic Flow Crystallisation of Paracetamol: 
Example of a Slow Growing API 
In Chapter 4 various operating strategies were explored for the crystallisation of paracetamol 
(PCM) with desired critical quality attributes (CQA) using continuous MSMPR operations. In this 
chapter, a novel concept involving periodic flow operation of a MSMPR is explored to achieve 
better control over the product CQA of PCM (a slow growing API) in IPA whilst avoiding the 
problems of fouling, encrustation, line blockage and limited residence time for crystal growth. 
The term periodic mixed suspension mixed product removal (PMSMPR) is used to describe the 
novel process reported here. A “state of controlled operation” in operation is attained in the 
system when the transient effects caused by the periodic operation (i.e. periodic, but controlled 
disruptions) are minimised such that consistent product CQAs are attained. This study further 
illustrates the concept of “state of controlled operation” (SCO) instead of “steady-state operation” 
as a state that can characterise a continuously or periodically operated process.  
5.1 Introduction 
During a periodic flow crystallisation controlled disruptions are applied to the inlet and outlet flow 
streams of an otherwise continuous MSMPR, either synchronously (viz. coupled addition and 
withdrawal) or asynchronously (viz. decoupled addition and withdrawal), with an aim to retain 
the slurry for a longer period in the crystalliser. In this way, the residence time distribution (RTD) 
can be manipulated by having a tuneable holding period within each periodic cycle, which, for 
example, is able to significantly increase the mean residence time for slow growing systems 
without broadening the crystal size distribution (CSD) too much. Unlike the idealised continuous 
MSMPR operation described by Randolph and Larson [9], [250], in which product slurry is 
continuously withdrawn and has exactly the same composition as the vessel, the PMSMPR 
operation is characterised by periodic transfer of slurry (addition and withdrawal) at high flow 
rates. Similar to a continuous MSMPR, the product withdrawn during the PMSMPR operation 
has exactly the same composition as the vessel at the time of withdrawal. The rapid transfer of 
slurry at high flow rates during the PMSMPR operation prevents particle sedimentation and 
transfer line blockages, and is more likely to lead to isokinetic product withdrawal. The transfer 
of slurry is followed by a holding (or pause) period when no addition or withdrawal of slurry 
to/from the crystalliser takes place, but the suspension continues to be agitated. Comparisons 
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of batch, continuous and periodic flow operations in a stirred tank crystalliser (STC) are 
summarised in Table 5.1. 
Table 5.1: Comparison of batch, continuous and periodic flow operations in a stirred tank 
crystalliser (STC). 
Stirred Tank Operation System States Remarks 
 
 
 Easy, flexible and universal 
 Perfect control of residence time 
 Accepted by regulators 
 Batch-to-batch variations 
 Low productivity 
 Labour and cost intensive 
 Significant inventory  
 
 
 Steady-state operation 
 High productivity, but low yield 
 Safe and agile 
 Short mean residence time 
 Broad RTD profiles 
 Fouling and encrustation 
 Transfer line blockage  
 Resistance from industry 
 
 
 Controlled state of operation 
 High productivity and yield 
 Hybrid of batch and continuous 
 Improved control of RTD 
 Broad RTD profiles, but better 
than continuous 
 Reduced fouling, encrustation 
and transfer line blockages 
A significant challenge associated with continuous crystallisation processes involves the 
generation of nuclei for later growth. Often seed nuclei are generated in situ, which demands 
high levels of supersaturation to encourage primary nucleation. The problem with this approach 
is that primary nucleation dominates the process at start-up and can ultimately lead to fouling 
on process equipment and encrustation problems. Furthermore, the preferential removal of fines 
and transfer line blockages are a common feature in continuous MSMPR operation due to the 
low flow rate and narrow transfer line requirements to achieve crystal growth, improve 
productivity and promote representative and isokinetic withdrawal of slurry. Preferential fines 
removal tends to occur due to the slower settling velocities and shorter response times of small 
crystals compared to larger crystals [25]. Furthermore, the varied properties of crystals 
represented by a given CSD in the MSMPR can lead to localised size distributions, in particular, 
where non-ideal mixing conditions predominate [25], [100]. Such classification phenomena 
ultimately lead to instabilities (i.e. oscillations) in the CSD, in which case high withdrawal 
velocities help to achieve representative sampling [25]. The effective control of slurry 
classification during withdrawal can lead to a narrower CSD with larger mean crystal size. A 
solution to the problems mentioned earlier is to operate the MSMPR at low supersaturation with 
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seed addition to encourage controlled secondary nucleation and growth. However, the limitation 
here is that the MSMPR productivity and yield are significantly reduced.  
Periodic flow crystallisation is an alternative approach that could alleviate the problems typically 
encountered in continuous MSMPR operation. High productivity and yield of crystallisation could 
potentially be achieved by tuning the periodic addition, holding and withdrawal cycles of the 
periodic flow mixed suspension mixed product removal crystalliser (PMSMPR). Since there is 
direct control over the mean residence time of slurry in the PMSMPR crystalliser the CQA of 
product crystals can be better tuned to achieve desired specifications. For example, the mean 
residence time could be shortened or extended to control mean crystal size and CSD. The 
PMSMPR differs from MSMPR operation in that periodic disruptions are applied to the feed and 
product flow stream viz periodic shutting off of the transfer pumps for predefined time period. 
Effectively, the PMSMPR is a hybrid operation that combines the best aspects of the batch and 
continuous STC, respectively, that is, long mean residence time and flow of materials (albeit 
periodically) in a controlled state of operation. Additional benefits can be gained from the 
PMSMPR by using a multi-stage cascade of crystallisers to facilitate control over nucleation and 
growth mechanisms of the crystallisation, in particular for slow growing APIs, by carefully 
selecting the PMSMPR stage temperatures. The concept of periodic flow crystallisation 
demonstrated here is different from intermittent addition/withdrawal methods reported in the 
literature recently [32], [77], which involve the rapid addition/withdrawal of 10 % or less of the 
crystalliser volume every one tenth of the mean residence time. Such a strategy was developed 
to enable the isokinetic withdrawal of slurry, and prevent transfer line blockage in “continuous” 
MSMPR crystallisers some years ago [251]. In this study, the PMSMPR operation is 
demonstrated as proof of the period flow crystallisation concept for particle size control viz. the 
balance of growth and secondary nucleation for the model API system (PCM in IPA solvent). 
The PMSMPR crystalliser used in the study was configured and operated as a single- or multi-
stage unit, and operated either with or without a recycle stream to determine the effect on 
product CSD during the crystallisations. Further aims were to determine the effect of seed 
properties (crystal size, shape and distribution) and supersaturation on the product CSD. During 
the process development stages feeding strategy, that is, constant versus intermittent feed 
supply was found to have an effect on the time to achieving a periodic steady-state operation 
(i.e. SCO) so these results are presented as a significant finding. The IDS framework described 
in Chapter 3 Section 3.6 was applied viz. CryPRINS and integrated array of PAT sensors (ATR-
UV/vis, FBRM, PVM and Raman) to monitor and implement temperature control during the 
periodic flow crystallisations, and to determine when SCO was attained. 
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5.2 Experimental Methods 
The cooling crystallisation of PCM from IPA in batch, continuous MSMPR and periodic flow 
PMSMPR crystallisers was investigated to provide a robust analysis of the different methods. 
Aspects related to seed properties (size, shape and CSD), seed loading, supersaturation, 
recycle and feed addition strategy were investigated. The aim is to demonstrate as a proof of 
concept study, the potential benefits of the periodic flow process in comparison to batch and 
continuous operations, respectively. The multivariate models used to determine solubility and 
concentration were reported in Chapter 3 Section 3.4.2. The experimental set-up used for the 
batch, continuous and period flow experiments were described in Chapter 3 Section 3.6. The 
impeller stirring rate for the experimental runs was set to 300 rpm with, power per unit volume 
as stated in Chapter 4 Section 4.2.  
5.2.1. Seed Preparation 
All crystallisation experiments reported were seeded. In order to determine the effect of seed 
properties (size and CSD) on the crystallisation outcomes for PCM, the seed crystals were 
prepared according to the following methods:  
(1) Sieving raw material to within the size range 100 – 125 µm (referred to as “raw material 
seed”). 
(2) Sieving recrystallised PCM to within the size range 75 – 125 µm (referred to as 
“recrystallised seed”.  
Figure 5.1 shows the microscope images of PCM seed prepared from “raw material seed” (A) 
and “recrystallised seed” (B), respectively. The images clearly show the varied size and shape 
properties of the former compared to the latter. The recrystallised seed crystals were of better 
quality, showing more uniform size and shape crystals and fewer fines. For all experiments 2.5 
% seed (relative to dissolved material) was used based on common industrial practice, whereby, 
between 0.1 and 10% seed loading is typically employed [155]. 
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Figure 5.1: Top, microscope images of dry seed crystals used in the periodic flow 
crystallisation study: (A) “raw material seed” (100 – 125 µm fraction); and (B) “recrystallised” 
(75 – 125 µm fraction); Bottom, FBRM SWCLDs for raw material and recrystallised seed. 
5.2.2. Periodic Flow Crystallisation Experiments 
Periodic flow crystallisation experiments were carried out in single-stage, two-stage and three-
stage PMSMPR crystalliser configurations. The PMSMPR can be operated in coupled or 
decoupled periodic flow mode. Figure 5.2 (a) and (b) provides schematic representations of the 
two different operating regimes, showing the change in operating volume with time. In the 
coupled operation, Figure 5.2 (a), the volume of the crystalliser remains unchanged due to 
simultaneous addition of feed and withdrawal of slurry. On the contrary, in the decoupled 
operation, Figure 5.2 (b), the volume of the crystalliser changes due to decoupling of the feed 
addition and slurry withdrawal cycles, providing an additional degree of freedom in operation 
compared to the coupled process. Additional benefits of the decoupled over the coupled periodic 
flow operation include, the ability to further extend the mean residence time of the PMSMPR, 
and minimise the amount of feed slurry to be directly washed out to the next stage, thus reducing 
the amount of fine crystals in the SCO product. In both the coupled and decoupled operations 
an adjustable holding or batch period is implemented in the PMSMPR to control the mean 
residence time of slurry inside the crystalliser. The batch operation cycle refers to that time 
period during which the pumps are switched off and there is no inflow of feed or outflow of slurry 
to/from the PMSMPR (coupled or decoupled). In this study, single-stage PMSMPR experiments 
were carried out in coupled operation mode. The operating volume of each single-stage 
PMSMPR was ~ 500 mL. Cascaded three-stage PMSMPR experiments were also performed, 
the operating volume of each stage was ~750 mL. The sum of the addition/withdrawal and batch 
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operation periods represents the periodic operation mean residence time (RTPO) for each 
experimental run.  
 
Figure 5.2: Schematic representations showing: (a) Coupled periodic flow operation of 
three-stage PMSMPR (constant operating volume); (b) Decoupled periodic flow operation of 
three-stage PMSMPR (variable operating volume due to asynchronous slurry addition and 
withdrawal at each stage). 
The mean RTPO of slurry in the single-stage PMSMPRs (coupled operations) was 20 min, 
corresponding to an addition/withdrawal cycle of 9.36 min, and holding cycle of 10.64 min. For 
the coupled three-stage PMSMPR operation (~750 mL per stage), the addition/withdrawal cycle 
(9.36 min) and holding cycle (15.09 min) led to a mean RTPO of 24.45 min. In case of the de-
coupled operation, the sum of the addition/withdrawal (18.72 min) and holding (5.40 min) cycles 
led to a mean RTPO of 24.12 min. The RTPO for the coupled operation was tuned to almost match 
that of the decoupled operation. In both operations, partial addition/withdrawal of 66.7 % of the 
PMSMPR (~ 500 mL) was implemented each cycle for all three stages. The decoupled operation 
had a shortened holding period of 5.40 min. Furthermore, due to the decoupling of the 
addition/withdrawal cycle, the pumping period was extended to 18.72 min (which corresponds 
to 9.36 min each for addition and subsequent withdrawal of material from each stage). Note that 
for the three stage PMSMPR operations, coupled and decoupled, 33.3 % (250 mL) of the 
crystalliser contents was retained each addition/withdrawal cycle, which would contribute a 
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further 4.68 min and 9.36 min, respectively to the mean RTPO. However, for simplicity only the 
RTPO of 500 mL operation has been considered. The overall aim of these studies is to 
demonstrate as proof of concept, the potential benefits of periodic flow cooling crystallisation 
using PMSMPR. Another important aim is to determine the experimental conditions that promote 
crystal growth and supress secondary nucleation in order to produce large crystals.  
Periodic Flow Seeded Cooling Crystallisation in PMSMPR: The PMSMR unit, Chapter 3, 
Section 3.6.2, Figure 3.19 (a) was reconfigured as required to operate either as a single-stage 
or multi-stage cascade unit. Figure 5.3 shows the process flow diagrams of the single-stage 
PMSMPR configurations employed, and operated with and without recycle/dissolver stream, 
respectively. Also shown are the mass flow rates, Q (i.e. of slurry) employed as well as the 
operating temperature and supersaturation (S) for the feed and PMSMPR. S is the 
supersaturation ratio defined as co/c*, where co is the initial solute concentration of the feed or 
PMSMPR and c* is the equilibrium concentration at the specified operating temperature. For 
the feed stream, either a 1 L or 5 L vessel was used to deliver seeded saturated feed 
suspension to the first-stage PMSMPR. Masterflex® pumps operating in time dispense mode 
and platinum cured tubing (3.1 mm ID) were used for suspension transfer between vessels 
and from the PMSMPR to the filtration unit. 
 
Figure 5.3: Flow diagrams showing the configuration of the single-stage PMSMPR units 
used for the periodic flow crystallisation studies. The PMSMPR was operated either without 
recycle stream (M-P1); or with recycle stream (M-P2a, M-P2b, M-P3 and M-P4). 
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Experimental Conditions for Batch and PMSMPR Crystallisations: Table 5.2 gives a 
detailed summary of the experimental conditions used for each of the batch and PMSMPR 
(single- and two-stage) cooling crystallisation experiments conducted during the study. 
Recycle ratio (Q4/ Q1) was set to 0.25 during the study to avoid significant dilution of the 
system and prevent impurity build-up that can occur for total recycle. 
Table 5.2: Summary of experimental conditions used for the cooling crystallisation of PCM in 
the in singe- and two-stage PMSMPR and batch crystallisers. 
Experimental 
Conditions 
M-P1 M-P2a M-P2b M-P3 M-P4 M-P5 M-PC M-PD B-C1 
Mode of operation cp/no cp/ncr cp/ncr cp/ncr cp/cr cp/no cp/no dc/no n/a 
Feed temp. (°C) 19 19 19 19 19 19 19 19 n/a 
PMSMPR temp. (°C) 10 10 10 10 10 (15; 10)* 
(17; 14; 
10)* 
(17; 14; 
10)* 
n/a 
Dissolver temp. (°C) n/a 30 30 30 30 n/a n/a n/a n/a 
Feed conc. (g/g) 0.110 0.112 0.110 0.111 0.111 0.110 0.111 0.111 n/a 
Seed loading (%): raw 
material seed+ 
n/a 2.5 2.5 n/a n/a n/a n/a n/a n/a 
Seed loading (%): 
recrystallised  seed++ 
2.5 n/a n/a 2.5 2.5 2.5 2.5 2.5 2.5 
Flow rate: feed stream, 
Q1 (g/min) 
46.69 37.34 37.34 37.34 37.34 46.69 46.69 46.69 n/a 
Flow rate: MSMPR1 
outlet, QM1 (g/min) 
46.69 46.69 46.69 46.69 46.69 46.69 46.69 46.69 n/a 
Flow rate at MSMPR2 
outlet, QM2 (g/min) 
n/a n/a n/a n/a n/a 46.69 46.69 46.69 n/a 
Flow rate at MSMPR3 
outlet, QM3 (g/min) 
n/a n/a n/a n/a n/a n/a 46.69 46.69 n/a 
Flow rate of recycle 
stream, Q4 (g/min) 
n/a 9.35 9.35 9.35 9.35 n/a n/a n/a n/a 
Recycle ratio (Q4/ Q1) n/a 0.25 0.25 0.25 0.25 n/a n/a n/a n/a 
Addition and withdrawal 
period (min) 
9.36 9.36 9.36 9.36 9.36 9.36 9.36 18.72 n/a 
Holding period (min) 10.64 10.64 10.64 10.64 10.64 10.64 15.09 5.40 n/a 
Mean residence time 
(min) 
20 20 20 20 20 40 73.35 72.36 423 
tube size (mm ID)  3.1 3.1 3.1 3.1 3.1 3.1 3.1 3.1 n/a 
No. of PMSMPR stages 1 1 1 1 1 2 3 3 n/a 
Seed type recry raw raw recry recry recry recry recry recry 
()*Temperature of 1st, 2nd and 3rd stage PMSMPR respectively; +100 – 125 µm raw fraction; and  ++75 – 125 µm 
fraction; cp = coupled operation; dc = decoupled operation; no = no recycle; ncr = non-concentrated recycle; 
cr = concentrated recycle; recry = 2.5 % recrystallised seed; and raw = 2.5 % raw material seed). 
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Crystallisation in Single-stage PMSMPR without Recycle (M-P1): The process flow diagram 
of the experimental set-up used for the single-stage PMSMPR experiment is shown in Figure 
5.3 (M-P1). Prior to start-up a fresh feed solution saturated at 20 oC (0.110 ± 0.002 g PCM/g 
IPA) was prepared in the feed vessel. The feed solution was then cooled to 19 oC, seeded with 
2.5 % (11.19 g) “recrystallised seed” and held for 30 min to give the crystals time to heal by 
Ostwald ripening [252]. The supersaturation of the feed stream to the PMSMPR was 1.02. At 
start-up the single-stage PMSMPR was cooled to 10 °C, thereafter, feed suspension was added 
to give a SCO operating volume of 500 mL. This was then followed by a holding period of 10.64 
min (batch period). Thereafter, a period of simultaneous addition of feed (at a rate of 46.69 
g/min) to, and withdrawal of slurry (at a rate of 46.69 g/min) from the PMSMPR was initiated for 
a period of 9.36 min (continuous period). The slurry withdrawn from the PMSMPR was filtered 
and the product crystals collected and dried at 40 oC for 24 hours. The periodic 
addition/withdrawal and holding cycles were continued for the duration of the experiment. The 
holding cycle refers to that time period during which the pumps are switched off and there is no 
net inflow of feed or outflow of slurry to or from the PMSMPR. The sum of the addition/withdrawal 
time period (9.36 min) and the holding period (10.64 min) is defined as the mean RTPO of the 
single-stage PMSMPR (20 min). 
 
Single-stage PMSMPR Crystallisation with Recycle (M-P2a, M-P2b, M-P3 & M-P4): For 
these experiments, the feed preparation and seeding procedure was the same as that 
described for the single-stage PMSMPR without recycle (M-P1). The purpose of these 
experiments was to determine the effect of having a recycle stream on the yield of 
crystallisation. The single-stage PMSMPR configurations with recycle M-P2a, M-P2b, M-P3 
and M-P4 were operated as follows: 
M-P2a and M-P2b: seeded with “raw material seed” and operated with a 
non-concentrated recycle stream, that is, without the use of stream 6 as shown in 
Figure 5.2 (M-P2a) and (M-P2b). 
M-P3: seeded with “recrystallised seed” and operated with a non-concentrated recycle 
stream, that is, without the use of stream 6 as shown in Figure 5.3 (M-P3). 
M-P4: seeded with “recrystallised seed” and operated with a concentrated recycle 
stream, that is, using stream 6 as shown in Figure 5.3 (M-P4). 
The start-up procedure for each single-stage PMSMPR operated with recycle stream was 
exactly the same as described earlier for experiments carried out without recycle. The slurry 
withdrawn from the PMSMPR each cycle was filtered rapidly and the filtrate solution added to 
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the recycle vessel, which was kept at 30 oC to dissolve any fines present. Once sufficient 
filtrate was collected, the periodic addition and withdrawal operation of the PMSMPR was 
continued, but with an adjustment of flow rate from the feed stream to the PMSMPR, that is, 
reducing from 46.69 to 37.34 g/min. This was done to compensate for the additional inlet flow 
from the recycle stream at a rate of 9.35 g/min. This resulted in a recycle ratio of 0.25 
(i.e. Q4/Q1; based on Figure 5.3), which was selected to minimise too much impurity build-up 
in the crystalliser and also to avoid too much dilution when non-concentrated filtrate is used 
for recycle. The effect of recycle stream supersaturation level on the crystallisation outcome 
was investigated viz. two methods:  
(1) Non-concentrated whereby filtrate solution was added directly to the PMSMPR after 
filtration and dissolution; and  
(2) Concentrated whereby PCM raw material was added to the filtrate solution and 
dissolved to increase the concentration level to the equilibrium concentration of the 
feed stream.  
The experiment with concentrated recycle (M-P4) was designed to investigate the effect on 
process yield. For this study, the filtrate liquor collected from the waste stream of the 
experiment carried out with non-concentrated recycle stream (M-P3) was weighed and the 
concentration determined by ATR-UV/vis (0.104 ± 0.001 g PCM/g IPA). The filtrate liquor was 
then concentrated to the equilibrium concentration of the feed stream liquor entering the 
PMSMPR. The overall rate of addition of PCM to the recycle stream was estimated at 0.126 
g/min as shown in Figure 5.3. The concentrated recycle stream liquor was added to the 
PMSMPR at a rate of 9.35 g/min Overall, the operating principle of M-P2a, M-P2b and M-P4 
was the same as described for M-P1. 
Two-stage PMSMPR Crystallisation without Recycle (M-P5): Figure 5.4 shows the process 
flow diagram of the two-stage PMSMPR crystalliser set-up. The feed preparation and start-up 
procedure were similar to those employed for the coupled single-stage PMSMPR study 
without recycle (M-P1), except that an additional PMSMPR vessel was used and at start-up 
the first- and second-stage PMSMPR vessels were cooled to 15 and 10 oC, respectively. After 
filling and equilibration in the first-stage PMSMPR, the pumps from the feed vessel to the first-
stage and from the first-stage to the second-stage PMSMPR were switched on simultaneously 
for 9.36 min This procedure allowed sufficient time for one working volume of the first-stage 
to be transferred to the second stage. Following this, there was a holding period (10.64 min). 
Thereafter, the pumps for all transfer lines were operated periodically over the time intervals 
mentioned earlier, until the end of the experiment (i.e. coupled operation). Slurry withdrawn 
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from the second-stage PMSMPR vessel each period was filtered and the crystals collected 
and dried for off-line microscope image analysis. The sum of the addition/withdrawal time 
period (9.36 min) and the holding period (10.64 min) for each stage of the two-stage PMSMPR 
is defined as the mean RTPO, which is 40 min 
 
Figure 5.4: Flow diagram showing the block configurations of the two-stage PMSMPR unit 
used for periodic flow crystallisation studies without recycle stream (M-P5). 
Three-stage PMSMPR Crystallisation Coupled and De-Coupled Periodic Flow 
Operations (M-PC and M-PD): Figure 5.5 shows the process flow diagram of the three-stage 
PMSMPR crystalliser set-up used for the coupled (M-PC) and de-coupled (M-PD) 
experimental runs, respectively. A description of the addition/withdrawal and holding cycles 
implemented was provided earlier. For the coupled PMSMPR operation the start-up and 
operating procedure was the same as employed for the two-stage process described earlier, 
but with an additional process stage and different temperatures implemented at each stage 
as indicated in Figure 5.5. The decoupled PMSMPR operation was carried out in 750 mL as 
opposed to 500 mL vessels to allow withdrawal of 500 mL of slurry each cycle without 
emptying the vessel. The coupled periodic flow experiment was also carried out 750 mL 
volume, in order to achieve similar RTPO to the decoupled operation. 
 
Figure 5.5: Flow diagram showing the block configurations of the three-stage PMSMPR unit 
used for the coupled and decoupled periodic flow crystallisation studies (M-PC and M-PD). 
Batch Crystallisation of PCM (B-C1): A batch crystalliser was configured and used to 
conduct studies under similar conditions to those of the periodic flow studies. The seeded 
batch cooling crystallisation experiment was carried out for comparison with, and further 
characterisation of the PMSMPR. At start-up a suspension of 0.109 g PCM/g IPA was 
dissolved at 30 oC (10 oC above the desired saturation temperature) in a 500 mL vessel and 
M-PC & M-PD 
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held for 15 min The solution was then cooled to 19 oC, seeded with 2.5 % PCM seed and held 
for 30 min The resulting seed suspension was then cooled to 10 oC and held for 423 min The 
batch crystallisation experiment can be used to examine further the crystallisation phenomena 
observed in the PMSMPR. 
5.3 Results and Discussion 
5.3.1 Periodic Flow Crystallisation in PMSMPR 
Several challenges were encountered during the development of a continuous MSMPR 
crystalliser unit for the crystallisation of PCM from IPA, including washing out, fouling and 
encrustation, and transfer line blockages, as reported in Chapter 4. To overcome these 
difficulties a novel strategy involving periodic mixed suspension removal was developed, 
which leads to the illustration of the concept of SCO. This type of operation involves alternating 
periods of true continuous and batch operations; hence the RTPO of crystals in the case of 
periodic operation can be extended with the duration of batch operation period (tbatch), which 
is combined with the addition/withdrawal period (RTconti), such that RTPO =  tbatch + RTconti. Note 
that RTconti refers to addition/withdrawal period. The periodic flow method of operation has two 
main advantages: 
(1) For a seeded system, it allows for addition of seed suspension and the high flow rates 
are more likely to lead to representative and isokinetic withdrawal of product crystals; 
and  
(2) Extends the RTPO of slurry inside the MSMPR, which can lead to improved yield and 
larger product crystals.  
In addition, issues such as fouling on process equipment, encrustation and blockage of 
transfer lines are avoided, particularly when operating at low supersaturation with seeding. 
These advantages allow an extended operating time, without interruptions that necessitate, 
for example, cleaning of PAT probes, transfer lines or vessel walls due to the issues mentioned 
earlier. Figure 5.6 (a) – (f) shows the process time diagrams for the periodic flow crystallisation 
experiments conducted in the single- and two-stage PMSMPR configurations; the batch 
crystallisation experiment (B-C1) is also show for comparison. 
Single-stage PMSMPR without Recycle (M-P1): Recrystallised seed was used in the study 
and the process time diagram for the single-stage PMSMPR experiment without recycle 
stream (M-P1) is shown in Figure 5.6 (a). The start-up period is rapid, leading to rapid 
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attainment of periodic conditions. The cyclic behaviour of the concentration, temperature and 
FBRM counts data reflects the periodic mode of operation.  
 (a) M-P1 
 
(b) M-P2a 
 
(c) M-P2b 
 
 (d) M-P3 
 
(e) M-P4 
 
(f) M-P5 
 
 (g) B-C1 
 
Figure 5.6: Process time diagrams showing real-time temperature, FBRM counts/s and 
Raman concentration data for: (a) M-P1: single-stage PMSMPR, no recycle stream; (b) M-
P2a and (c) M-P2b: single-stage PMSMPR, non-concentrated recycle; (d) M-P3: single-
stage PMSMPR, non-concentrated recycle; (e) M-P4: single-stage, concentrated recycle; 
(f) M-P5: two-stage PMSMPR, no recycle stream; (g) B-C1: Batch crystalliser. 
The concentration in the PMSMPR decreased gradually from start-up until the 5th 
addition/withdrawal cycle, to a SCO value of 0.104 g PCM/g IPA (S = 1.07) as determined by 
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Raman measurements. This was a result of the seed material consuming available 
supersaturation, primarily by promoting secondary nucleation, but also growth on the surfaces 
of crystals surface already present. Thereafter, the concentration change was only small after 
the 5th addition/withdrawal cycle (marked by the vertical dashed line in Figure 5.6 (a)). The 
concept of periodic steady-state (or SCO) has not yet been defined in the literature in 
reference to MSMPR crystallisation. A SCO operating region is shown in Figure 5.6 (a), where 
the concentration changes by less than 3 %, a SCO FBRM boundary (± 270 counts/s) is also 
defined. The FBRM counts/s, concentration and temperature data from Figures 5.6 (a) – (f) 
also give an insight into the effect of periodic flow operation on the particle properties and 
supersaturation level of the system. At the start of each experiment the empty crystalliser is 
filled with slurry from the feed tank. The saving of data begins when the vessel has sufficient 
material to immerse all the PAT probes (i.e. from time, t = 0). After filling to the required 
operating volume the holding period commences. During each holding cycle there is a slow 
but sustained increase in the number of particles detected by FBRM. This is due to secondary 
nucleation occurring in the PMSMPR, which is the result of a rapid generation of 
supersaturation (S = 1.24) from the feed suspension added in the previous cycle that was 
subsequently cooled (i.e. 9 oC undercooling), thus leading to an increase in crystal density. 
On the other hand, during each addition/withdrawal cycle, there is a decrease in the FBRM 
counts/s, indicative of a reduction in crystal density. Slurry is withdrawn from the PMSMPR 
and the supersaturation reduced (S = 1.02) due to the addition of fresh feed which is at an 
elevated temperature (19 oC) relative to the PMSMPR (10 oC). The reduction of 
supersaturation in the PMSMPR then leads to suppression of secondary nucleation. Once the 
addition/withdrawal cycle ends and the equilibration cycle (or pause period) begins, the 
suspension cools more rapidly leading to high supersaturation, which leads to an increase in 
secondary nucleation. It appears that for PCM, secondary nucleation is the dominant 
crystallisation mechanism under the prevailing operating conditions. However, it appears that 
due to periodic operation, the extent of secondary nucleation is controlled. Evidence of this is 
drawn from the batch crystallisation experiment (Figure 5.6 (g); B-C1) process time diagram, 
which shows that as the system starts cooling from 19 oC, there is a slow increase in counts, 
indicative of secondary nucleation. Once the system cools to the final operating temperature 
(10 oC), a rapid and sustained increase in counts occurs, indicating the rapid onset of 
secondary nucleation. This temperature was selected to generate just enough supersaturation 
to encourage growth and avoid uncontrolled nucleation. With periodic operation, a rapid and 
sustained increase in the numbers of secondary nuclei is avoided and the system rapidly 
attains SCO due to simultaneous feed addition and slurry withdrawal.  
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Single-stage PMSMPR with Non-concentrated Recycle (M-P2a & M-P2b): The process time 
diagrams of the single-stage PMSMPR experiments with recycle stream, in which PCM raw 
material seed was used (M-P2a and M-P2b) are shown in Figures 5.6 (b) and (c), respectively. 
M-P2a was one of a series of initial process development experiments conducted to investigate 
periodic flow operation of the single-stage PMSMPR and was carried out using a 1 L feed vessel 
as opposed to the 5 L feed vessel used for M-P2b and all subsequent PMSMPR experiments 
reported. The process time diagram for M-P2a indicates a complex behaviour of the FBRM 
counts/s data and it appears that SCO has not been achieved. In contrast, the Raman 
concentration data indicates a decrease in concentration during the start-up phase, which then 
stabilises from the 5th addition/withdrawal cycle to a periodic steady-state (0.102 ± 0.002 g 
PCM/g IPA), that is, SCO until the end of the experiment. The FBRM counts/s data highlights 
an operating weakness in this initial PMSMPR crystalliser design (M-P2a). The use of the 1 L 
feed vessel to supply seed slurry to the PMSMPR may have led to variations in the mass fraction 
of seed crystals delivered. The 1 L tank had to be refilled periodically to continue supplying feed 
suspension to the 500 mL PMSMPR. For each refill, a fresh batch of saturated solution (1.2 L) 
was prepared in a separate vessel and cooled to 19 oC. This solution was then added to the 
feed tank, followed by addition of dry seed crystals (2.5 %) to make the seed slurry. In contrast, 
the 5 L tank used in M-P2b provided a more consistent supply of feed suspension, since only a 
single preparation of saturated solution and seed crystals was necessary. Moreover, the longer 
residence time of slurry in the 5 L feed tank, allowed for aging of the seed crystals and surface 
healing via Ostwald ripening mechanism.  
A fundamental limitation of the FBRM technique is that it measures chord lengths rather than 
true particle sizes; typically, a large number of chords of different sizes can be obtained from 
any given particle [218]. Furthermore, different intensity profiles are often obtained from 
crystals of different sizes and shapes. Therefore, it is likely that in suspensions of crystals with 
a wide variety of morphologies, an even greater number of different chords may be obtained 
compared to a suspension of crystals with a more uniform shape. It is also likely that the 
frequency of refilling the 1 L feed vessel used to in M-P2a experiment contributed to the 
variations in the FBRM counts/s, due to non-uniform and inconsistent transfer of seed 
suspension to the PMSMPR. This may be attributed to changes in mass fraction content of 
seed crystals in the feed suspension during discharge from the feed vessel, as a result of 
variations that occurred in the seed slurry preparation each cycle, and changes in the 
properties of the seed slurry on refilling of the feed vessel due to the presence of small 
amounts of seed suspension left over from previous refills.  
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In contrast, the process time diagram of experiment M-P2b shows a FBRM counts/s profile 
that can be more easily interpreted: there is an initial increase in FBRM counts from start-up 
due to secondary nucleation. The same phenomena can be observed in the time diagram for 
M-P2a experiment. However, in M-P2b the FBRM counts/s profile then shows a steady, but 
sustained decrease in particle number until the 7th addition/withdrawal cycle, indicative of the 
occurrence of crystal growth and/or agglomeration in the system. From the 7th 
addition/withdrawal cycle onwards the counts/s levels off, except for the occurrence of 
dampened cycles due the periodic operation. In Figure 5.6 (c), this is highlighted as the point 
of attainment of SCO for M-P2b. This was also confirmed by the Raman concentration 
measurements, which showed that SCO was attained over the same period. The change in 
concentration from the 7th RTPO to the end of the experiment was less than 4 % (± 0.0041 g 
PCM/g IPA). The results from M-P2b experiment suggests that the most probable cause of 
the complex behaviour of the FBRM counts/s data obtained from M-P2a experiment was the 
frequency of refilling the 1 L feed vessel. The results therefore indicate that selection of a 
stable and consistent feed delivery system is important from the perspective of attaining SCO 
in the PMSMPR. It is also evident from both M-P2a and M-P2b that the FBRM counts/s in both 
systems at start-up is more than twice that observed for the experiments in which recrystallised 
seed was used. The raw material seed contains many small particles in comparison to the 
recrystallised seed (Figure 5.1), even though it was sieved to a narrower size fraction (100 – 
125 µm). This is because the dry raw material seed had a tendency to aggregate even during 
sieving. When added to the feed solution, the raw material seed aggregated even more 
initially, but these aggregates broke up over the aging time (30 min), revealing much finer 
particles. Another observation from M-P2b is that the system takes a longer time to achieve 
SCO, compared to the other PMSMPR experiments. This suggests that the seed properties 
have an effect on the time to achieving SCO. A reasonably straightforward phenomenon 
whereby the smaller sized raw material seed (SWMCL 49-50 µm; Figure 5.1) used in M-P2b 
(and M-P2a) is capable of consuming supersaturation more quickly compared to the 
recrystallised seed material (SWMCL 66 – 70 µm; Figure 5.1) used in the other PMSMPR 
experiments. Since the time required to achieve SCO depends on the kinetics of the 
crystallisation process, faster growth can lead to smaller time constants. It is accepted in 
general that smaller sized seeds exhibit larger overall active surface area thus higher active 
site concentration, which can lead to faster mean growth rates in an MSMPR exhibiting growth 
rate dispersion. The SCO product size of crystals from M-P2b was 67 µm. A mean SCO crystal 
product size could not be determined for M-P2a. This is because the process shows 
significantly amplified cyclic behaviour of the particle counts determined by FBRM, which is 
linked to the periodic refilling of the feed vessel, which leads to inconsistent delivery of seed 
to the PMSMPR. For experiment M-P2b, the SCO FBRM boundary (± 80 counts/s) is indicated 
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in Figure 5.6 (c). The FBRM cycles are significantly dampened on approach to SCO, due to a 
minimisation of disturbances affecting the system. This is an indication that the seed properties 
also have an effect on limiting the disturbances caused by periodic flow operation.  
Single-stage PMSMPR with Non-concentrated Recycle (M-P3): The process time diagram 
of the single-stage PMSMPR experiment with non-concentrated recycle stream (M-P3) and 
using recrystallised seed supplied from a 5 L feed vessel is shown in Figure 5.6 (d). The 
system rapidly achieves periodic steady-state operation after the 5th addition/withdrawal 
cycle. The initial concentration of (recrystallised PCM) seed suspension delivered to the 
PMSMPR was (0.111 g PCM/g IPA). The process concentration decreased from start-up until 
the 5th addition/withdrawal cycle to 0.104 g PCM/g IPA. Thereafter, the concentration 
decreased only marginally from the 5th addition/withdrawal cycle, marked by the vertical 
dashed line in Figure 5.6 (d); periodic steady-state operating region was established and the 
concentration changes by less than 3 %. A periodic steady-state boundary (± 300 counts/s) is 
defined for the FBRM counts as indicated by parallel dashed lines in Figure 5.6 (d).  
Single-stage PMSMPR with Concentrated Recycle (M-P4): The process time diagram, 
Figure 5.6 (e), of the single-stage PMSMPR experiment with concentrated recycle stream (M-
P4) shows that the system rapidly achieves SCO after the 5th addition/withdrawal cycle, as 
indicated by the vertical dashed line. The concentration of the feed decreased from 0.111 g 
PCM/ g IPA to 0.101 g PCM/ g IPA by the 5th addition/withdrawal cycle in the PMSMPR and 
thereafter was changed by less than 3 %. The FBRM counts/s remained steady within a 
defined SCO boundary (± 400 counts/s) from the 5th addition/withdrawal cycle to the end of 
the experiment. The amplitude of the FBRM cycles are increased when compared to the 
experiment conducted with non-concentrated recycle (M-P3), an indication that secondary 
nucleation in the system has increased due to the increased concentration of PCM in the 
recycle stream to the PMSMPR. 
Two-stage PMSMPR without Recycle (M-P5): The process time diagram of the two-stage 
PMSMPR without recycle and with recrystallised seed is shown in Figure 5.6 (f). The system 
achieves SCO after the 5th addition/withdrawal cycle in the second-stage PMSMPR. The 
concentration of seed suspension delivered to the first-stage PMSMPR was (0.111 g PCM/g 
IPA) and the feed concentration decreased to 0.109 g PCM/g IPA in the first-stage and then 
to 0.095 g PCM/g IPA in the second-stage PMSMPR. Figure 5.6 (f) shows the change in 
concentration and FBRM counts/s from 0 to 11 min in the first-stage PMSMPR. The probes 
were then transferred to the second stage PMSMPR as indicated in the time diagram. The 
temperature cycles as shown in Figure 5.6 (f) are dampened compared to the previous 
experiments where the single-stage PMSMPR unit was used, indicating more efficient 
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temperature control in the two-stage PMSMPR due to the smaller temperature difference (5 
oC) between the feed and subsequent two stages. Figure 5.6 (f) further shows that attainment 
of SCO is rapid in the two-stage PMSMPR. Both the FBRM counts/s and the Raman 
concentration are stabilised from the 5th addition/withdrawal cycle (3rd RTPO) until the end of 
the experiment, with a variation of less than 2 %, the FBRM SCO boundary (± 190 counts/s) 
is also shown. 
Batch Crystallisation Study: The batch crystalliser was operated as close as possible to 
conditions employed during the periodic flow crystallisation experiments. Figure 5.6 (g) shows 
the process time diagram of the batch crystallisation experiment (B-C1). At start-up, a 
suspension of 0.110 g PCM/g IPA was dissolved at 30 oC and maintained at that temperature 
for 10 min The resulting solution was then cooled at a rate of 1 oC/min to 19 oC and seeded with 
2.5 % recrystallised seed. At that stage in the process, the FBRM counts/s increased from 0 to 
1750 counts/s. The vessel was maintained at 19 oC for 30 min and then cooled at a rate of 1 
oC/min to 10 oC. On cooling, the concentration starts to decrease and there is a simultaneous 
increase in FBRM counts, which occurs gradually until the system reaches 10 oC, at which point 
there is a dramatic increase in the counts/s due to secondary nucleation. The increase in 
counts/s continues until ~225 min into the process. Thereafter, the FBRM counts/s starts to 
decrease as concentration continues to decrease, indicating that the system has entered a 
growth and/or agglomeration dominated phase. This is then followed by a period after ~460 min 
where the FBRM counts and concentration begin to stabilise. The batch crystallisation 
experiment gives some insights into the effect of periodic operation on the crystallisation 
outcome. In the PMSMPR, the addition/withdrawal cycles inadvertently impose control over the 
secondary nucleation kinetics of the system. In contrast, the batch process is dominated by 
uncontrolled secondary nucleation in the early stages of the process, which ultimately leads to 
fine particles and a broad CSD. In the periodically operated PMSMPR there is greater control 
over the CSD due to suppression of secondary nucleation during the addition/withdrawal cycles. 
A discussion on the FBRM square weighted chord length distributions (SWCLD), which gives 
an indication of the CSD obtained from each of the crystallisation experiments can be found in 
the section following. The batch process attains an equilibrium condition (close to the solubility 
curve), whereas MSMPR processes operate at steady-state at a fixed point in the metastable 
zone. Therefore, it is always possible to get a higher yield from a batch process (i.e. depending 
on the batch time) compared to a continuous MSMPR operated under similar conditions. 
However, a continuous MSMPR can be operated closer to the solubility curve if the residence 
time is extended. This is usually done by increasing the number of MSMPR stages (which may 
prove impractical for systems with slow growth kinetics) or by using low flow rates. The former 
may lead to a significant increase in the number of crystallisation process equipment and by 
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extension the overall cost of operation, whereas the latter option leads to sedimentation and 
therefore classified slurry withdrawal and eventual blockage of transfer lines [13]. Periodic flow 
operation extends the residence time of the MSMPR without the use of additional stages whilst 
also ensuring isokinetic withdrawal of slurry. 
The following important observations were made based on the results assessed from all the 
PMSMPR experiments described in this chapter so far: 
(1) Re-crystallised seed shows better quality properties in terms of size and shape relative 
seed prepared from PCM raw material. 
(2) A consistent supply of seed slurry is required in order to avoid unsteady behaviour and 
encourage attainment of SCO in a short time frame. 
(3) Generally, SCO is attained after 4 – 7 RTPO, both in terms of the solute concentration 
and the FBRM count/s measurements. 
5.3.2 Comparison of Crystallisation Methods 
Product Crystal Size and Overall Process Yield: In this section the crystallisation 
experiments discussed earlier are compared. A summary of experimental results from each 
of the crystallisation experiments is presented in Table 5.3. 
Table 5.3: Summary of results for the cooling crystallisation of PCM in the single- and 
two-stage PMSMPR and batch crystallisers. 
Parameters Measured M-P1 M-P2a M-P2b M-P3 M-P4 M-P5 B-C1 
Mean SCO conc., 
c1 (g/g) 
0.103 0.102  0.101 0.104 0.101 0.095 0.089 
% Yield of process 35.3 ± 1.9 43.3 ± 1.9 41.5 ± 1.1 31.1 ± 1.0 37.5 ± 0.5 68.9 ± 0.4 96.1 ± 0.1 
Time to SCO  
(min / RTPO) 
89.5 / 5th  n/a 140 / 7th  89.0 / 5th  90.0 / 5th  89.0 / 5th  460 / n/a 
Seed Size: FBRM 
SWMCL (µm) 
70.1 ± 0.1 48.7 ± 0.2 49.9 ± 0.7 70.1 ± 0.1 66.3 ± 0.1 70.1 ± 0.1 66.7 ± 0.2 
SCO mean crystal size: 
FBRM SMWCL (µm) 
74.5 ± 0.4 n/a 67.4 ± 0.3 71.5 ± 0.1 64.6 ± 0.1  77.7 ± 0.2 59.6 ± 0.1 
M-P1 = Single-stage PMSMPR without recycle stream (2.5% recrystallised seed); M-P2a and M-P2b = Single-
stage PMSMPR with non-concentrated recycle stream (2.5% raw material seed); M-P3 = Single-stage PMSMPR 
with non-concentrated recycle (2.5% recrystallised seed); M-P4 = Single-stage PMSMPR with concentrated recycle 
stream (2.5% recrystallised seed); M-P5 = Two-stage PMSMPR without recycle stream (2.5 % recrystallised seed); 
RTPO = mean residence time; and n/a = not applicable. 
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The yield reported for each experiment is the fractional yield of crystallisation (Y), which refers 
to the amount of product obtained from the crystalliser relative to the amount of available 
supersaturation. Y is therefore defined as: 
𝑌 =
 𝑐𝑖 𝑓0 + 𝑐𝑅1𝑓𝑅1 −  𝑐1 𝑓1
 𝑐𝑖 𝑓0 + 𝑐𝑅1𝑓𝑅1 − 𝑐∗𝑓1
× 100 5.1 
where 𝑐𝑖  , 𝑐1 , 𝑐
∗ and 𝑐𝑅1 are respectively, the feed stream concentration (g PCM / g IPA), 
PMSMPR SCO concentration, equilibrium concentration at the specified operating temperature, 
recycle stream concentrations (where the recycle stream is non-concentrated 𝑐𝑅1 = 𝑐1; 
otherwise 𝑐𝑅1 is calculated using a mass balance around the dissolver unit in Figure 5.3).  𝑓0,  𝑓1 
and 𝑓𝑅1 are the solute free mass flow rates of IPA from the inlet, outlet, and recycle streams of 
the PMSMPR respectively, that is, based on time-averaged flow. The data shown in Table 5.3 
indicates that the configuration of the PMSMPR (single- or two-stage), seeding strategy and the 
use of recycle stream (concentrated or non-concentrated) can affect the crystallisation outcome 
in terms of yield, mean crystal size and the achieve time to SCO. The time taken to reach SCO 
in each PMSMPR experiment is more or less similar (90 min), with the exception of M-P2b (as 
discussed in section 0). With respect to configuration, the highest SCO yield (68.9 ± 0.4 %) and 
SCO mean crystal size (77.7 ± 0.2 µm) is obtained from the two-stage PMSMPR without recycle 
stream (M-P5). Of the single-stage PMSMPR configurations the largest SCO mean crystal size 
(74.5 ± 0.4 µm) was obtained from M-P1 (operated without recycle stream), which was 
marginally larger than the seed material (70.1 µm) used. The process yield from M-P1 
experiment was 35.3 ± 1.9 %. In comparison, the configuration with a non-concentrated recycle 
stream (M-P3) gave a marginally smaller SCO mean crystal size of 71.5 ± 0.1 µm and an overall 
SCO product yield of 31.1 ± 1.0 %. The single-stage PMSMPR configuration with concentrated 
recycle stream (M-P4) gave a higher yield of 37.5 ± 0.5 %. However, the mean crystal size was 
smaller (64.6 ± 0.1 µm) compared to the recrystallised seed material used (66.3 ± 0.1 µm) and 
products from experiments M-P1 and M-P3 for which the same seed material was used. This is 
an indication that concentrating the recycle stream improves the process yield, but leads to 
smaller crystals, because of additional secondary nucleation. In all of the PMSMPR experiments 
reported, there was evidence of growth of product crystals relative to the seed crystals used, 
except for M-P4 where the product crystals were marginally smaller than the seed material used. 
The extent of crystal growth observed in the PMSMPR was marginal for all experiments based 
on the FBRM SWMCL data, that is, with the exception of M-P2b where a significant increase in 
product crystal size (67.4 ± 0.3 µm) relative to the seed material (49.9 ± 0.2 m) used is 
observed. In the batch crystallisation experiment, it is clear that the process yield is higher (96.1 
± 0.1 %) and the product crystal size (59.6 ± 0.1 m) much smaller than obtained from all the 
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PMSMPR experiments. The issue of crystal growth in the PMSMPR experiments relative to 
seed crystals used (matured for 30 min in a 5 L vessel) will be discussed further in the section 
following. The process yield of M-P2a and M-P2b (43.3 ± 1.9 % and 41.5 ± 1.1 %) were higher 
compared to M-P3 even though the experimental conditions were almost identical. The main 
reason for this difference is down to the properties of the seed materials used. M-P3 was seeded 
with recrystallised PCM seed (75 – 125 µm) while M-P2a and M-P2b was seeded with PCM raw 
material (100 – 125 µm). Although sieved to within a narrower size fraction, the size of the seed 
obtained from the raw material was much smaller (Figure 5.1). This was due to the amorphous 
and powdery consistency of the raw material, which gave very fine crystals that had a tendency 
of sticking together and therefore were not broken up sufficiently in the sieving process. Aamir 
et al [142] showed that the material used to prepare seeds can affect the quality of the seed 
produced (the compound investigated was potassium dichromate); seed prepared from sieving 
recrystallised material had a distinctive shape, uniform size, and had fewer fine particles 
compared to seed prepared from sieving milled material. The higher process yield obtained from 
M-P2a and M-P2b is therefore attributed to the properties of the seed crystals used (PCM raw 
material), which has a large surface area due to the presence of many fine particles. Therefore, 
this fine seed is able to consume supersaturation and grow more rapidly than the larger 
recrystallised seed material used in other experiments. However, these small seeds can also 
promote secondary nucleation and agglomeration according to Fujiwara et al [229] in their study 
on the control of batch cooling crystallisation of PCM from aqueous seeded solutions. The 
investigators found that seeding the system with small seed crystals (less than 100 µm) resulted 
in the promotion of secondary nucleation and agglomeration leading to a product of varying 
sizes and broad CSD at 5 % seed loading. On the other hand, seeding with large seed crystals 
(sieve sizes 125 – 250 µm and 250 – 350 µm) led to the suppression of secondary nucleation 
and agglomeration, resulting in product crystals of more uniform size and shape and hence a 
narrower CSD. However, a limitation with using large seed as shown in the study is the long 
batch times that are required before significant growth is observed (3 – 5 hours). This would 
translate to impractically long residence times in the PMSMPR. Furthermore, the use of coarse 
as opposed to fine seed as demonstrated in this study, may lead to only marginal growth. 
Operating Trajectories in the Phase Diagram: Figure 5.7 shows the process phase diagrams 
for each of the single- and two-stage PMSMPR and batch experiments. Shown are the solubility 
[170] and indicative metastable curves, PMSMPR operating points, the mean SCO point for 
PMSMPR operation / equilibrium point for batch operation, and the theoretical batch trajectory 
through the phase diagram. These results show that the dynamics of batch and PMSMPR 
operations are markedly different, both giving different trajectories through the phase diagram. 
Since supersaturation is the driving force for crystallisation, variations in the supersaturation 
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trajectory can allow for the exploitation of more crystal attributes in terms of size [32], shape, 
distribution and polymorphic form. This observation is particularly true for the PMSMPR 
crystalliser.  
 
Figure 5.7: Process phase diagrams for the PMSMPR and batch crystallisation experiments 
showing operating region for each system: (a) M-P1: single-stage PMSMPR, no recycle 
stream; (b) M-P2a and (c) M-P2b: single-stage PMSMPR, non-concentrated recycle; (d) M-
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P3: single-stage PMSMPR, non-concentrated recycle; (e) M-P4: single-stage, concentrated 
recycle; (f) M-P5: two-stage PMSMPR, no recycle stream; (g) B-C1: Batch crystalliser. 
MSMPR crystallisers are usually operated continuously (at steady-state) or in this study 
periodically (at SCO), which means there is no progression in terms of time or spatial position. 
This means that the system is operated at a fixed supersaturation, which is also the point at 
which slurry is removed from the crystalliser. Compared to batch crystallisation, which operates 
towards an equilibrium there is no supersaturation continuum in the MSMPR. However, if the 
MSMPR is operated periodically as done in this study, then the supersaturation is no longer 
fixed, but oscillates periodically between upper and lower limit values. So long as the oscillations 
are small, the system can be controlled as shown in this study to maintain a narrow 
supersaturation limit range (controlled state of operation). It is also important to note that the 
trajectories for the PMSMPRs are all within the MSZW and quite far from the region of primary 
nucleation. 
The phase diagrams for each of the PMSMPR experiments (Figure 5.7 (a) – (f)) show the 
effect of periodic operation as the system is disturbed at set time intervals due to slurry 
addition/withdrawal. Each system approaches the SCO condition rapidly as the 
supersaturation boundaries narrow. It is evident from the phase diagrams that the process 
yield from each PMSMPR is lower than that of the batch crystallisation process. M-P5 
(two-stage PMSMPR, recrystallised seed) shows the least variation in steady-state 
concentration (measurements from second-stage PMSMPR) of all the PMSMPR operations. 
This is because of better temperature control due to the smaller temperature difference (5 oC) 
between stages, when compared to the single-stage PMSMPR operations (9 oC difference 
between PMSMPR and feed vessel). Of the single-stage PMSMPR operations, M-P1 (single-
stage without recycle stream) shows the least variation in concentration in the operating region 
of the phase diagram, this is attributed to the absence of a recycle stream in this experiment. 
All of the single-stage PMSMPR experiments employing a recycle stream showed more 
variation in concentration due to the additional inlet flow creating slightly more disturbance in 
the system. Furthermore, this additional inlet flow from the recycle stream, is at a lower 
supersaturation (S ranges from 0.75 – 0.80) and higher temperature (30 oC) relative to the 
feed stream (S = 1.02, at 19 oC) and PMSMPR (S = 1.24, at 10 oC). These differences in 
supersaturation also contribute to the greater disturbance seen in each of the systems 
employing the recycle stream. However, these disturbances are maintained with reasonably 
narrow bounds, so that the operation is still being controlled within the metastabe zone. The 
merits of PMSMPR compared to continuous MSMPR have already been outlined. There also 
exists a significant potential with this mode of operation to explore different regions in the 
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phase diagram and to determine the effect on crystallisation outcomes in terms of product 
CQA. 
Comparison of FBRM SWCLD: Figure 5.8 shows the normalised FBRM SWCLD of the final 
products obtained from the batch crystallisation experiment and the SCO products from the 
PMSMPR crystallisation experiments. Compared to the batch experiment all the distributions 
obtained for the PMSMPR are shifted to the right (towards larger sizes). The distributions for 
M-P1, M-P3 and M-P5 are quite similar and appear to overlay, indicating that the product 
crystals are of similar mean size, in agreement with the SWMCL data reported in Table 5.3. 
The similarity between the SCO product SWCLDs for M-P1, M-P3 and M-P5 also indicates 
that the number of stages employed (single- or two-stage) and the mode of operation (with or 
without recycle) do not have a significant effect on the CSD in the PMSMPR. This is an 
interesting observation, since typically one would expect that an increase in the number of 
stages would lead to longer RTPO and thus more time for crystals to grow. It must be noted, 
however, that although the distributions are similar for M-P1, M-P3 and M-P5, there is a very 
small but notable shift towards larger sizes in the two-stage PMSMPR (M-P5). Overall, the 
results suggest that the growth and secondary nucleation kinetics of PCM are the main 
variables affecting the crystallisation. It appears that the secondary nucleation kinetics of the 
system is the dominant crystallisation mechanism, while the growth kinetics is extremely slow. 
This was noticed early on in development studies in a seeded continuous MSMPR crystalliser 
(Chapter 4). 
S  
Figure 5.8: Comparison of FBRM SWCLD for the PMSMPR SCO products and batch 
crystalliser end stage product. 
A strategy was developed employing low supersaturation and moderate seed loading (2.5 %) 
in the PMSMPR. Typically, seed loadings used in crystallisation processes range from as little 
as 0.1 % to as much as 5 % and even more depending on the requirements [253]. Although 
each PMSMPR was operated at low supersaturation with moderate seed loading, this strategy 
did not lead to significant crystal growth, with the exception of the M-P2b experiment where 
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significant growth appears to have occurred due to the larger surface area of the raw material 
seed used. It is well known that low seed loading can contribute to undesirable secondary 
nucleation, leading to an increase in the number of small particles in solution [254]. Therefore, 
an investigation of periodic flow crystallisation in the single-stage PMSMPR without recycle at 
a higher seed loading (5 % recrystallised seed) was conducted to determine the effect on the 
product crystal properties. The experimental conditions for this run were the same as reported 
for M-P1, only the seed loading was changed. Figure 5.9 shows a comparison between the 
SWCLD of the seed and product crystals from this experiment. The result indicates that even 
at a higher initial seed loading level, the product CSD has not shifted significant to the right (i.e. 
towards larger sizes) relative the seed CSD. It is also likely that due to the high density of crystals 
in the system the competition for solute molecules is sufficiently high that the product crystals 
show no noticeable increase in size. The mean size of seed and SCO product crystals, that is, 
the SWMCL observed for this experiment were 66.2 ± 0.3 µm and 61.8 ± 0.4 µm, respectively. 
The marginally smaller size of the product crystals relative to the seed crystals used confirms 
the deductions made earlier regarding the effect of secondary nucleation and competition for 
solute molecules. The results further confirm that the growth kinetics of PCM is extremely slow, 
whereas the secondary nucleation kinetics is much faster. Therefore, secondary nucleation may 
be the dominant crystallisation mechanism. An important variable that was no investigated in 
this study is the time allowed for the periodic flow addition/withdrawal and holding cycles. These 
cycles could be adjusted to determine the effect on crystal growth in future work. 
 
Figure 5.9: Comparison of SWCLD of seed material (5.0 %) and PMSMPR SCO product. 
Figure 5.10 shows the normalised FBRM SWCLD of product crystals relative to the initial seed 
crystal distributions for the other PMSMPR experiments. Evidently, only marginal crystal growth 
is observed relative to the seed crystals used for M-P1, M-P3 and M-P5, respectively. This is 
indicated by a narrower SWCLD compared to the seed crystals. However, for M-P4 the product 
crystals obtained from the PMSMPR were marginally smaller than the seed crystals. Although 
the crystals were smaller, the SWCLD for M-P4 SCO product was narrower than that that of the 
seed crystals. For the batch experiment (B-C1) the product crystal SWCLD (not shown) showed 
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a significant shift to the left and was significantly broadened relative to the seed size distribution, 
which is further evidence that secondary nucleation is the dominant crystallisation mechanism 
for PCM. Overall the results indicate that the PMSMPR produces marginally larger crystals with 
narrower CSD when compared to seed crystals used; PCM is known to exhibit slow growth 
crystallisation kinetics [229]. It may be that longer RTPO in cascaded PMSPMRs with narrow 
temperature transitions between process vessels is required to achieve significant crystal growth 
of PCM.  
(a) M-P1 
 
(b) M-P2a 
 
(c) M-P2b 
 
(d) M-P3 
 
(e) M-P4 
 
(f) M-P5 
 
Figure 5.10: Comparison of FBRM SWCLD for seed material and PMSMPR SCO products 
and batch crystalliser end stage product. 
It is evident from the results of M-P5 (two-stage PMSMPR) experimental run that the crystal size 
increases by extending the residence time in the PMSMPR simply by numbering up stages in a 
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cascade, which has the added advantage of applying more gradual stage temperature 
transitions. This allows for smaller changes in supersaturation, which is more suitable for slow 
growing systems [24] like PCM. Preliminary experiments in the PMSMPR unit with a fast growing 
system showed that significant growth of product crystals was achieved relative to seed crystals 
when compared to PCM (see Chapter 6), which further indicates that the slow growth kinetics 
of the latter system. 
An important variable which affects the product crystal quality from the PMSMPR is the 
seeding protocol employed. In a recent review paper, O’Sullivan et al [253] highlighted some 
of the key seeding strategies used in industry to achieve desired product crystal attributes in 
batch crystallisers, which may also be applied to the PMSMPR. The authors highlighted that 
seeding with crystals of the correct size, mass and form at the right point in a process can lead 
to more consistent and repeatable crystallisations. Selecting the appropriate seeding 
conditions (for example, seeding temperature), at the appropriate supersaturation level can 
lead to improved crystallisation outcomes. Here, information on the metastable zone width 
(MSZW) of the crystallising system is necessary to determine whether to seed close to the 
solubility curve or the metastable curve. Another important consideration is the appropriate 
seed loading and seed size for a process, which depends on the desired product crystal size, 
distribution and polymorphic form. Typically, if large crystals are desired less seed material of 
larger size is added to encourage growth. On the other hand, if small crystals are desired then 
a large seed loading of small sized particles are used. In the PMSMPR experiments discussed 
earlier and preliminary experiments not reported here, both of these seeding strategies were 
utilised to determine the effect on the crystallisation outcome for the PCM-IPA system. The 
best results, in terms of crystal growth were observed using a lower seed loading of 2.5 % and 
either 75 – 125 µm recrystallised seed fraction or 100 – 125 µm raw material seed fraction. 
For the former case the overall CQA of the product crystals were better compared to the latter. 
However, only marginal growth was observed in the majority of experiments conducted.  
Comparison of PVM and Off-line Microscope Images: PVM images were captured in real-
time and off-line microscope images taken of the dried product crystals after each RTPO in each 
of the PMSMPR experiments. Figure 5.11 shows the off-line microscope images and real-time 
PVM images of the seed and product crystals from the 1st and 10th RTPO, respectively for M-P1 
(single-stage PMSMPR without recycle), and M-P2a and M-P2b (single-stage PMSMPRs with 
non-concentrated recycle). The 1st and 10th RTPO images for M-P1 show evidence of crystal 
growth relative to the seed crystals although there are also many fine crystals present, indicative 
of secondary nucleation, which contributes to reducing the overall SWMCL of the product, there 
are also agglomerated crystals present. Significantly more agglomerated crystals are observed 
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in the microscope images compared to the PVM images. This is not entirely surprising since 
microscope images were obtained after filtration and drying of product crystals. On filtration, 
crystals have a tendency to stick together, forming agglomerates due to cementation of crystals 
as mother liquor associated with the wet filter cake becomes supersaturated from solvent 
evaporation.  
 
 
 
Figure 5.11: Microscope (rows from top 1, 3 and 5) and PVM images (rows 2, 4 and 6) of 
seeds crystals from feed stream, and crystals from the 1st RTPO (20 min) and 10th RTPO (200 
min) for M-P1 (rows 1 and 2), .M-P2a (rows 3 and 4) and M-P2b (rows 5 and 6). 
Feed vessel seed 1st RTPO (20 min) 10th RTPO (200 min) 
Feed vessel seed 1st RTPO (20 min) 10th RTPO (200 min) 
Feed vessel seed 1st RTPO (20 min) 10th RTPO (200 min) 
Feed vessel seed 1st RTPO (20 min) 10th RTPO (200 min) 
Feed vessel seed 1st RTPO (20 min) 10th RTPO (200 min) 
Feed vessel seed 1st RTPO (20 min) 10th RTPO (200 min) 
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Furthermore, the outlet slurry is supersaturated when exiting the PMSMPR as shown from the 
operating region in the phase diagram (Figure 5.7). Compared to M-P1 seed which shows 
predominantly regular shaped and sized rhombic crystals, the M-P2a and M-P2b seed crystals 
appear irregular in shape and size.  
As discussed earlier in this thesis, seed crystals used for M-P2a and M-P2b experimental run 
were prepared from PCM raw material rather than recrystallised material. The product crystals 
from the 1st and 10th RTPO indicate that there is growth relative to the seeds evidenced from a 
number of large crystals present. However, there are also a number of agglomerates and fine 
crystals present. The fine particles present in both the 1st and 10th RTPO products are indicative 
of some secondary nucleation, which was confirmed by the time diagrams, Figure 5.6 (b) and 
(c). These observations agree with the findings from the assessment of the FBRM SWMCL 
(Table 5.3) and SWCLD (Figures 5.8 and 5.10). The seed and product crystals from M-P3 and 
M-P4, that is, single-stage PMSMPR with non-concentrated and concentrated recycle, 
respectively, are shown in the Figure 5.12. The PMSMPR product crystals show a 
characteristic rhombic shape, similar to the recrystallised seed material used. Once again, 
there is evidence of agglomeration from the microscope images of both the seeds (sampled 
from feed stream) and product crystals, which may be due to the sample preparation process. 
However, this is not the only cause of crystal agglomeration. It appears that PCM has a natural 
tendency to agglomerate when many fine crystals are produced from secondary nucleation. 
There is evidence of agglomeration and crystal twinning from the in situ PVM images of the 
1st and 10th RTPO product crystals. The images of product crystals for M-P4 show more 
agglomerates and fines present, although there are also a few large crystals present as well. 
In particular, the PVM images of the 1st and 10th RTPO samples show a significant number of 
fine crystals present as well as some large ones. This suggests that the contribution from 
secondary nucleation is more significant than from crystal growth, which is attributed to the 
concentration of the recycle stream. The operating supersaturation level in M-P4 is higher 
(1.28) than that of M-P3 (1.23), which was operated with a non-concentrated recycle stream. 
This is an indication that only a small change in supersaturation can significantly affect the 
crystallisation outcome. The large number of fines observed from the microscope and PVM 
images also support the SMWCL and SWCLD data from FBRM, both of which indicated that 
the mean size of the product crystals from M-P4 was smaller compared to the initial seed 
crystals used. The SCO product crystals obtained from the two-stage PMSMPR without 
recycle (M-P5) were of the best quality for all PMSMPR configurations investigated. The 
images show that relative to the seed crystals there is a small, but noticeable amount of crystal 
growth, which was also confirmed from FBRM SWMCL and SWCLD. Overall, the results from 
M-P5 indicate that with a more controlled and smaller stepwise temperature change in the 
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two-stage PMSMPR, led to better product properties in terms of crystal size and yield are 
attainable compared to the single-stage PMSMPR operated with and without recycle stream. 
 
 
 
Figure 5.12: Microscope (rows 1, 3 and 5) and PVM images (rows 2, 4 and 6) of seeds aged 
crystals, and crystals from the 1st RTPO (20 min) and 10th RTPO (200 min) of the single-stage 
PMSMPR operated with non-concentrated (M-P3, rows 1 and 2) and concentrated (M-P4, 
rows 3 and 4) recycle stream, and two-stage PMSMPR without recycle (M-P5). 
Feed vessel seed 1st RT (20 min) 10th RT (200 min) 
Feed vessel seed 1st RT (20 min) 10th RT (200 min) 
Feed vessel seed 1st RT (20 min) 10th RT (200 min) 
1st RT (20 min) 10th RT (200 min) Feed vessel seed 
Feed vessel seed 1st RTPO (20 min) 10th RTPO (200 min) 
Feed vessel seed 1st RTPO (20 min) 10th RTPO (200 min) 
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Period Flow Crystallisation in Coupled and Decoupled Three-stage PMSMPR (M-PC and 
M-PD): Table 5.3 provides a summary of the experimental results from the two experimental 
runs. The data shows that a higher process yield was obtained from the decoupled operation 
(M-PD), compared to the coupled operation (M-PC) due the extended RTPO of the former 
compared to the latter. These experiments were conducted to see whether significant crystal 
growth of PCM could be achieved relative to the previous PMSMPR experiments.  
Table 5.4: Summary of results for the cooling crystallisation of PCM in a three-stage 
PMSMPR operated in coupled and decoupled modes, respectively. 
Exp. 
Mean SCO 
Conc.(g/g) 
SCO Conc. 
Change (g/g) 
% Yield of 
Process 
Seed Size: FBRM 
SWMCL (µm) 
SCO Mean Crystal Size: 
FBRM SMWCL (µm) 
M-PC 0.093 ± 1.96 77.7 ± 0.3 66.8 ± 0.1 55.3 ±  0.3 
M-PD 0.091 ± 1.12 85.8 ± 0.2 68.0 ± 0.2 53.8 ± 0.1 
The mean sizes of product crystal were similar for the coupled and decoupled operations. 
However, the product crystals obtained were of smaller size compared to the initial seed material 
used, which suggests that under the prevailing operating conditions, secondary nucleation is 
promoted over growth. The process time diagrams for M-PC and M-PD experiments are shown 
in Figure 5.13 (a) and (b), respectively. SCO was achieved in the former, but process deviations 
were detected in the latter, attributed to the difficulty in controlling the volume changes in the 
PMSMPR each RTPO.  
 
Figure 5.13: Process time diagrams showing real-time temperature, FBRM counts/s and 
Raman concentration data for coupled (M-PC) and decoupled (M-PD) experiments in a 
three-stage PMSMPR. 
The RTPO per stage for M-PC and M-PD It is also confirmed that secondary nucleation was the 
dominant mechanism in both cases, leading to a shift in the product CSD to smaller sizes (i.e. 
to the left) relative to the seed, and first- and second-stage PMSMPR product crystals. 
respectively. Process measurements were taken initially from the first-stage, followed by the 
second-stage, and finally the third-stage PMSMPR. The concentration of feed suspension 
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charged to the coupled and decoupled PMSMPR was 0.111 g PCM/g IPA. The SCO 
concentrations were 0.091 and 0.093 g PCM/g IPA, respectively, confirming the higher yield of 
M-PD relative to M-PC. Figure 5.14 (a) and (b) shows the operating trajectory in the phase 
diagram for M-PC and M-PD experiments. The profiles are slightly different with a more rapid 
decrease in concentration observed for M-PD from the first- through third-stage PMSMPR 
compared to the M-PC.  
 
Figure 5.14: Process phase diagrams for the three-stage PMSMPR operated in (a) coupled 
(M-PC) and 9b) de-coupled (M-PD) modes, respectively. 
The SWCLD plots, Figure 5.15 (a) – (d) show that there is little difference between the product 
CSD obtained from M-PC and MPD, with, exception that the latter gave narrow CSD relative 
to the former. It is also confirmed that secondary nucleation was the dominant mechanism in 
both cases, leading to a shift in the product CSD to smaller sizes (i.e. to the left) relative to the 
seed, and first- and second-stage PMSMPR product crystals.  
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Figure 5.15: Comparison of FBRM SWCLD for three-stage PMSMPR operated in coupled 
(M-PC) and decoupled (M-PD) modes, respectively. 
5.4 Conclusions 
Periodic flow crystallisation in a novel PMSMPR was demonstrated as a feasible method of 
producing crystalline material with desired CQA, without encountering operating problems 
such as fouling, encrustation and blockage of transfer lines. Periodic flow crystallisation is a 
relatively new method whereby controlled disruptions are applied to the crystalliser primarily 
to increase the mean residence time and control crystal product attributes such as size and 
distribution. For the PMSMPR, conventional MSMPR operation is alternated with batch 
operation to increase the mean residence time. This operation illustrates a new paradigm of 
continuous operation whereby the process is in controlled state of operation (i.e. periodic 
steady-state or SCO) rather than steady-state. The application of an integrated array of PAT 
tools and in-house developed information system software CryPRINS within an IDS 
framework to the monitoring and characterisation of the PMSMPR was also demonstrated. 
The indicative CSDs for single-stage PMSMPR (operated with and without recycle stream), 
two-stage PMSMPR (operated without a recycle stream) and three-stage (coupled and 
decoupled flow) were determined from FBRM SWCLD data. The indicative mean crystal sizes 
were determined from FBRM SWMCL data. SCO was characterised using Raman, ATR-
UV/vis, FBRM and PVM. The results indicate that the configuration of the PMSMPR (single-, 
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two- or three-stage), seeding strategy and the use of recycle stream (concentrated or non-
concentrated) can affect the crystallisation outcome in terms of yield and mean crystal size 
attainable. The time taken to reach steady-state in the PMSMPR is more or less similar for all 
experiments except M-P2b, which was conducted using non-concentrated recycle and raw 
material seed, which was variable in size and shape. This result suggests that the seed 
properties can influence the time to achieving steady-state. With respect to configuration, the 
highest yield and mean product crystal size were obtained from the two-stage PMSMPR 
operated without a recycle stream. Furthermore, the crystal properties in terms of size and 
shape were noticeably better as observed from PVM and off-line microscope images of 
product crystals when compared to the product crystal from single-stage PMSMPR 
experiments. Of the single-stage PMSMPR configurations investigated, the largest mean 
crystal size was obtained from the system without recycle stream (M-P1). In comparison, the 
configuration with non-concentrated recycle stream (M-P3) gave a marginally smaller mean 
size. Although the single-stage PMSMPR with concentrated recycle stream (M-P4) gave a 
higher yield, the mean crystal size of the SCO product was markedly smaller. This is a further 
indication that concentrating the recycle stream improves process yield, but leads to smaller 
crystals due to increased secondary nucleation in the system. In all of the other PMSMPR 
experiments reported there was evidence of growth relative to the seed crystals used. 
However, the extent of crystal growth observed in all experiments, except M-P2b was marginal 
due to the strong influence of secondary nucleation on the crystallisation mechanism of PCM. 
The result from M-P2b showed a significant shift of the SCO product SWCLD to larger sizes 
relative to the seed crystals used. This result suggests that the seed properties can also 
influence the SCO product CSD. Agglomeration and growth were both evident in the SCO 
product as confirmed by PVM and microscope images. A batch crystallisation experiment was 
also conducted under similar conditions to that of the PMSMPR experiments for evaluation 
and comparison. As expected, the yield of the batch crystallisation process was higher than 
in all of the PMSMPR experiments. However, the product crystals were significantly smaller 
size, indicative of a broad CSD as confirmed by FBRM, PVM and off-line microscope image 
analysis. This was due to a significant amount of secondary nucleation in the batch system 
compared to the PMSMPR systems. Information from the batch crystallisation experiment 
gave further evidence that secondary nucleation is the dominant crystallisation mechanism of 
PCM even at low supersaturation levels. It was inferred from the observations in the batch 
crystallisation study, that PMSMPR is effective at controlling the extent of secondary 
nucleation leading to crystals of larger size compared to the seed materials used, albeit 
marginal in most cases. Three-stage PMSMPR experimental runs carried out in coupled and 
decoupled periodic flow modes, respectively gave comparable but smaller crystals relative to 
the seed materials used. It appears that under the experimental conditions employed, 
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secondary nucleation was favoured over crystal growth. Robust monitoring and temperature 
control using integrated PAT array and CryPRINS information systems software was also 
demonstrated for the periodic flow crystallisation in the PMSMPR. The results indicate that the 
combined used of PAT and information systems within an IDS framework can indicate when 
the periodic flow process attains SCO and also provides a better understanding of the 
parameters and operating procedures that influence the periodic operation. While the periodic 
operation was demonstrated here for seeded cooling crystallisation, a similar approach can 
be applied for anti-solvent or combined cooling and anti-solvent systems. The periods of 
alternating continuous and batch operation can also be tailored to accommodate systems 
belonging to different classes based on their growth and nucleation kinetics. 
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Chapter 6  
Periodic Flow Crystallisation of Glycine: Example 
of a Fast Growing API 
The novel concept of periodic flow crystallisation whereby controlled periodic disruptions are 
applied to the inlet and outlet flow of a MSMPR crystalliser was demonstrated in Chapter 5; 
various operating strategies were explored for the crystallisation of a slow growing active 
pharmaceutical ingredient (API), paracetamol (PCM). In this chapter, the same concept of 
periodic flow crystallisation in a mixed suspension mixed product removal (PMSMPR) 
crystalliser is exploited to achieve better control over the product CQA of a fast growing API 
glycine (GLY), whilst maintaining a “state of controlled operation” (SCO) in the design space. 
Experiments were conducted using glycine-water (GLY-H2O) as a model system in single- and 
three-stage cascaded PMSMPR crystallisers. A dynamic model of the residence time 
distribution (RTD) was developed to demonstrate the periodic flow operation in terms of the 
extended mean residence time in periodic flow (RTPO) and RTD broadening. Process models of 
the periodic flow crystallisations were also developed, with an aim to provide a better 
understanding and improve the performance of the PMSMPR. The modelling framework was 
based on the Process System Enterprise’s gCRYSTAL 4.0 software. The crystallisation 
mechanisms and kinetics of the GLY-H2O system were estimated from batch crystallisations. 
The process models were validated with experimental data from periodic flow crystallisations. 
Good agreement was observed between the model predictions and experimental data. 
Furthermore, larger crystals with mean size > 125 µm (i.e. larger than the highest sieved seed 
fraction: 75 – 125 µm) were obtained experimentally and in simulations, demonstrating the 
advantages of using periodic flow operation. 
6.1 Introduction 
The potential advantages of continuous crystallisation using cascaded multi-stage MSMPR 
crystallisers have been widely investigated [2], [11], [13], [25], [255], for example, steady-state 
operation for consistent product quality [11], [255], intensified production [87], [112], improved 
scalability [25], and reduction of equipment footprint, energy usage and capital cost. However, 
the challenges of insufficient mean residence time for crystal growth, fouling on the crystalliser 
walls and process monitoring equipment, transfer line blockages [13], particle settling and 
classification [25] and broadening of the crystal size distribution (CSD) in the conventional 
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MSMPR operation are still not well addressed. Tubular flow designs such as the continuous 
oscillatory baffled crystalliser (COBC) [20], [89] and plug flow crystalliser (PFC) [21] are 
promising alternatives. However, these technologies also suffer from issues with blockage of 
constricted orifices, encrustation on the vessel walls, slow attainment of controlled state of 
operation and operational instabilities [75], [256]. Furthermore, it is often difficult to adopt 
process analytical technologies (PAT) to COBC and PFC platforms [73] for the purpose of 
gaining process understanding. Other researchers have investigated novel configurations 
and/or operating strategies using MSMPR [32], [53], [82] and tubular flow devices [18], [257], 
[258]. For example, Griffin et al [53] modified a continuous MSMPR crystalliser by 
incorporating an “inverted” product classifier unit whereby small crystals are withdrawn as 
product, and larger crystals are recycled to a dissolver. In their studies, Ferguson et al [32], 
[51] and Lai et al [82] investigated a single-stage MSMPR design incorporating intermittent 
rapid product withdrawal  in which a differential pressure is set-up across the system. Harji 
[257] designed a oscillatory mixed tubular vessel incorporating several baffles and channels; 
the model substance investigated was lactose monohydrate, and crystal sizes of ~50 µm were 
obtained. In the vast majority of the aforementioned studies there was a focus on producing 
small crystals (< 100 µm). While there are advantages to be gained from this approach, for 
example, in the development of inhalable pharmaceutical drugs, large crystal sizes (typically 
above 100 µm) are still required, for example, to improved filterability and for tablet and 
capsule formulations where controlled release is a requirement. Typically, seeded 
crystallisation approaches are applied to produce crystals of appropriate size and form due to 
tighter control over crystal growth and secondary nucleation mechanisms, leading to a desired 
CSD [259]–[261].  
Periodic flow crystallisation using PMSMPR provides a promising alternative to the methods 
mention earlier, whereby (1) representative isokinetic slurry transfer can be achieved using 
intermittent increase in flow rates during transfer between stages, and (2) the mean residence 
time can be increased by having a tuneable holding (or batch) period between transfers. In 
the periodic operation, increased flow rates during transfer between PMSMPR stages helps 
to mitigate transfer line fouling and blockage without shortening the residence time of slurry 
inside the crystalliser. The work presented here also seeks to address some of the challenges 
encountered during continuous crystallisation development at laboratory scale using 
experimental approaches aided by the integrated PAT array and CryPRINS software within 
the IDS framework (described in Chapter 3) for process monitoring and temperature control 
in the PMSMPR crystalliser. Complementary off-line particle size analyses were carried out viz. 
laser diffraction using a Malvern MasterSizer® 2000 instrument, the experimental procedure 
employed was described in Chapter 3 Section 3.2.7. The seeded cooling crystallisations were 
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carried out in single- and multi-stage PMSMPRs applying coupled and decoupled operations 
(see Chapter 5). The work aims to demonstrate the application of the PMSMPR for control of 
particle size through the balance of growth and secondary nucleation for a fast growing model 
system (GLY-H2O). Further aims were to determine the effect of seed properties (crystal size, 
shape and distribution), supersaturation and sample withdrawal method on the product CSD. 
The concept known as “state of controlled operation” (SCO) instead of “steady-state operation” 
is used to describe the periodic flow process [262]. A dynamic model was also developed for 
the RTD determination in the PMSMPR crystalliser to demonstrate the concept of periodic 
flow operation. Flowsheet process models were then developed for the periodic flow 
crystallisation of GLY using single- or three-stage PMSMPR crystallisers in order to provide a 
better understanding and improve the performance of SCO. The modelling framework was 
based on the Process Systems Enterprise’s gCRYSTAL 4.0 platform wherein crystallisation 
mechanisms and kinetics of the model GLY-H2O system were estimated from batch cooling 
crystallisation experiments from which solute concentration and CSD measurements were 
obtained. The models developed in gCRYSTAL were compared to experimental observations. 
The aim was to provide a benchmark periodic flow crystallisation that could contribute to the 
optimal design and control of PMSMPR crystallisers in the future. 
6.2 Experimental Methods 
The metastable zone width (MSZW) of GLY was first determined by using the polythermal 
method, for which unseeded batch cooling crystallisation experiments were carried out with 
initial concentrations ranging from 0.2801 to 0.4120g GLY/g H2O (i.e. Tsat range 30 to 55 oC), 
and with constant cooling rates of 0.1 and 0.7 oC/min The crystalline product for the batch runs 
were isolated at a final temperature of either 25 or 6 oC. Note that no holding period was 
implemented up on reaching the final temperature. A stirring speed of 400 rpm was found to 
be sufficient for particle suspension, and applied to all experimental run reported in this 
chapter. The solubility data for GLY was obtained from literature, Mullin [263]. The MSZW can 
be thought of as a reflection of crystallisation mechanism and kinetics, that is, nucleation and 
crystal growth of a crystallising system. Hence, it has been widely used for crystallisation 
kinetic studies, for example, Mitchell et al [264], [265] estimated the primary nucleation and 
crystal growth kinetics for PCM crystallisation from ethanol. In this study, however, not only 
the MSZW data, but the complete experimental data sets of a series of batch cooling 
crystallisations were used to estimate the crystallisation kinetics, including primary nucleation, 
secondary nucleation, and crystal growth. A population balance model [230], [265] was 
developed and applied to estimate the kinetic parameters from four representative batch 
experiments, as shown in Table 6.1. The crystallisation kinetics obtained from these batch 
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experiments were independently verified by simulating single- or three-stage cascaded 
periodic flow crystallisations and comparing the results with experiments performed in the 
PMSMPR crystallisers described earlier. 
Table 6.1: Summary of GLY batch MSZW experimental conditions. 
Exp. 
No. 
Initial Conc. 
C0 (g/g) 
Cooling 
Rate 
(oC/min) 
Sat. Temp., 
Tsat (oC) 
Initial 
Temp. (oC) 
Final 
Temp.  
(oC) 
Batch Time  
(min) 
BG-C1 0.4120 0.70 55 70.0   6.0 107.0 
BG-C2 0.3248 0.65 40 50.0   6.0   90.0 
BG-C3 0.3246 0.10 40 50.0 25.0 250.0 
BG-C4 0.2801 0.55 30 40.0   6.0   93.0 
6.2.1 Periodic and Continuous Flow Crystallisation Experiments 
Figure 6.1 (a) and (b) provides schematic representations of the coupled and decoupled 
periodic flow operating regimes, respectively, showing the change in operating volume with time.  
 
Figure 6.1: Schematic representations showing: (a) Coupled periodic flow operation of 
PMSMPR (constant operating volume); (b) Decoupled periodic flow operation of PMSMPR 
(variable operating volume due to asynchronous slurry addition and withdrawal). 
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The two approaches were investigated for the crystallisation of GLY in the single- and three-
stage PMSMPR crystallisers. The operating volume of the crystalliser was set to 500 mL for 
both the decoupled and coupled operations. The coupled operation was performed as described 
in Chapter 5 for PCM crystallisation. However, a higher flow rate (52.7 g/mL) was employed for 
the addition/ withdrawal cycle to compensate for suspension density differences (i.e. PCM-IPA 
versus GLY-H2O) and to have complete suspension of the GLY crystals in the transfer line to 
ensure rapid and isokinetic withdrawal. For the decoupled operation, half the volume of the 
crystalliser is removed at a rate of 52.7 g/min during the withdrawal cycle for a period of 4.68 
min. This is immediately followed by the addition cycle (also 4.68 min), during which the vessel 
is refilled at the same flow rate and over the same time period as employed during the withdrawal 
cycle. Holding (or batch) periods of 10.64 min was implemented following the addition/ 
withdrawal cycle in both the coupled and decoupled operations, respectively.  
Seed Preparation: The effect of seed properties was investigated during the periodic and 
continuous flow crystallisation of GLY using seed materials prepared as follows:  
(1) Sieving recrystallised GLY to within size range < 75 µm (‘broad CSD seed’). 
(2) Sieving recrystallised GLY to within size range 53 – 75 µm (‘narrow CSD seed’). 
(3) Sieving recrystallised GLY to within size range 75 – 125 µm (‘bimodal CSD seed’). 
Recrystallised material was used to prepare seed due to the better quality compared to seed 
prepared from pulverised raw material as demonstrated in Chapter 5. Figure 6.2 shows the 
Malvern CSDs of the three types of GLY seed materials used during the periodic flow 
crystallisation studies. 
 
Figure 6.2: Malvern CSD for the three types of seed materials used in the study: broad CSD 
seed (< 75µm), narrow CSD seed (53 – 75 µm), and bimodal CSD seed (75 – 125 µm). 
Periodic Flow Seeded Cooling Crystallisation in PMSMPR: Periodic flow crystallisation 
experiments were carried out using the PMSMPR described in Chapter 3, Section 3.6.2, Figure 
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3.19 (a) and (b). The process flow diagrams of the experimental set-ups used for the PMSMPR 
experiments are shown in Figure 6.3. Prior to start-up a fresh feed solution saturated at 20 oC 
(0.2278 ± 0.001 g GLY / g H2O) was prepared in the 5 L feed vessel. The feed solution was then 
cooled to 19 oC, seeded with 2.5 % (28.47 g GLY) broad, narrow or bimodal CSD seed material 
and held for 30 min or until equilibration was observed, as determined by the FBRM D600 probe 
used. The holding period allows the seed suspension to equilibrate, and for crystal aging (by 
crystal growth and dissolution) [262] and surface healing via Ostwald ripening mechanism [252]. 
The supersaturation S of the feed steam was 1.0221 ± 0.003 (i.e. the average S of all 
experiments performed). At start-up the single-stage PMSMPR, Figure 6.3 (a), was cooled to 
10 °C. Thereafter, feed suspension was added to give a SCO operating volume of ~500 mL by 
pumping at a rate of 52.7 g/min (pump 1) over a period of 9.36 min. This was then followed by 
a holding period in the PMSMPR of 10.64 min. Thereafter, periodic flow operation at a fixed rate 
of 52.7 g/min was initiated for 9.36 min, with cyclic holding periods of 10.64 min (coupled 
operation). For the decoupled periodic flow operation, the slurry addition and withdrawal cycles 
were each set to 4.68 min, and the holding period to 10.64 min. In the three-stage PMSMPR 
experiments, Figure 6.3 (b), the temperature of the first- (MSMPR 1), second- (MSMPR 2) and 
third- (MSMPR 3) stage of the PMSMPR were set to 17, 14 and 10 oC, respectively. The idea 
here is to implement a step-wise cooling profile, with an aim to reduce the supersaturation level 
gradually, and also increase the total mean RTPO of slurry inside the PMSMPR, thus improving 
both the product mean crystal size and yield.  
 
Figure 6.3: Flow diagrams showing the block configuration of: (a) single-stage PMSMPR; 
and (b) three-stage PMSMPR used during the periodic flow crystallisation studies. 
The start-up procedure for the three-stage PMSMPR experiments was exactly the same as 
explained for the single-stage PMSMPRs. The three-stage PMSMPR units were operated in 
coupled or decoupled periodic flow crystallisation mode, Figure 6.1 (a) and (b). In the coupled 
operation, MSMPR 1 is filled with fresh feed suspension following the same procedure applied 
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for the single-stage PMSMPR described earlier. Coupled or decoupled periodic flow procedure 
was implemented soon after filling of the first-stage PMSMPR (MSMPR 1) until the second-
stage (MSMPR 2) and third-stage (MSMPR 3) were filled. Thereafter, the coupled or decoupled 
periodic addition/withdrawal and batch operating cycles were continued for 10 or more RTPO, 
that is, based on the last stage (MSMPR 3) only. The operating volume of each PMSMPR stage 
was ~500 mL. The sum of the addition/withdrawal and holding periods (mean RTPO) of the 
single-stage PMSMPRs was 20 min. The RTPO for each stage of the coupled three-stage 
PMSMPR was 20 min, therefore the total RTPO was 60 min. In case of the decoupled periodic 
flow crystallisations (Figure 6.1 (b)) a rapid withdrawal of ~50 % of slurry from the crystalliser is 
implemented every cycle (flow rate: 52.7 g/min for 4.68 min), followed by rapid addition of fresh 
feed to refill the vessel, by employing the same flow rate/time interval. Once filled the vessel is 
allowed to operate in batch mode for 10.64 min. This results in a RTPO of 20.00 min per 
PMSMPR stage, effectively giving a total RTPO similar to the coupled operation. The periodic 
withdrawal, addition and batch operation cycles are repeated for the duration of each 
experimental run. Samples were taken at regular intervals from each stage during the coupled 
and decoupled PMSMPR experiments for off-line imaging and laser diffraction analyses. Table 
6.2 provides a summary of the experimental conditions used for each of the PMSMPR 
experimental runs. Two sampling methods were employed during the study to determine the 
effect of slurry withdrawal location on the mean crystal size and CSD of product obtained from 
the PMSMPR. The first method, involved taking samples during the continuous operation 
period (cop) from each PMSMPR stage. For the second method, a representative sample was 
taken from the PMSMPR during the batch operation period (bop). 
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Table 6.2: Summary of experimental conditions used for the seeded cooling crystallisation of 
GLY in single- and three-stage PMSMPR crystallisers, respectively. 
Experimental 
Conditions 
M-G1 M-G2 M-G3 M-G4 M-G5 M-G6 M-G7 
PMSMPR operation 
mode 
C C C DC C C C 
Sampling method cop cop/bop cop cop/bop cop/bop cop cop/bop 
Feed temperature (°C) 19 19 19 19 19 19 19 
Feed concentration 
(g/g) 
0.2288 0.2279 0.2278 0.2286 0.2278 0.2279 0.2279 
PMSMPR temperature 
per stage (°C) 
10 10 10 10 
17; 14; 
10 
17; 14; 10 17; 14; 10 
PMSMPR SCO mean 
concentration (co) 
0.1868 0.1882 0.1842 0.1847 0.1888 0.1859 0.1874 
Seed material (2.5 %)++ broad narrow bimodal bimodal broad narrow Bimodal 
Feed stream flow, Q1 
(g/min) 
52.7 52.7 52.7 52.7 52.7 52.7 52.7 
MSMPR 1 outlet flow, Q2 
(g/min) 
n/a n/a n/a n/a 52.7 52.7 52.7 
MSMPR 2 outlet flow, Q3 
(g/min) 
n/a n/a n/a n/a 52.7 52.7 52.7 
MSMPR 3 outlet flow, 
QM1 (g/min) 
52.7 52.7 52.7 52.7 52.7 52.7 52.7 
Slurry withdrawal period 
(min) 
9.36 9.36 9.36 4.68 9.36 9.36 9.36 
Slurry addition period 
(min) 
9.36 9.36 9.36 4.68 9.36 9.36 9.36 
Holding (or batch) 
period (min) 
10.64 10.64 10.64 15.32 10.64 10.64 10.64 
Mean RTPO (min) 20.00 20.00 20.00 20.00 60.00 60.00 60.00 
M-G1, M-G2, M-G3 and M-G4 = single-stage PMSMPR; M-G5, M-G6 and M-G7 = three-stage PMSMPR; C = coupled 
operation; DC = decoupled operation; cop = sampling from outlet transfer line during continuous operation period; 
bop = sampling from bottom valve during batch operation period; n/a = not applicable. 
Continuous Seeded Cooling Crystallisation of GLY in MSMPR: Continuous single- and 
three-stage MSMPR experiments were conducted under similar conditions to the periodic flow 
experiments described earlier. The saturation level of the feed (1.02 ± 0.03) and PMSMPR 
vessels were maintained at a similar level to the equivalent periodic flow experiments. Only 
‘bimodal CSD seed’ (75 – 125 µm) seed was investigated for these studies. Flow rates employed 
were the same as that for the periodic flow experiments, therefore, the residence time of the 
continuous process was approximately half that of the coupled PMSMPR process. It was not 
possible to operate the continuous experiments at the low flow rates required to achieve 
comparable residence time to the periodic flow experiments due to the setting of particles, in 
particular, larger ones as determined by visual inspection of the transfer lines. Particle settling 
is attributed to the higher settling velocities of large particles compared to smaller ones [262]. 
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Using the continuous MSMPR, there is a trade-off between the residence time and parameters 
such as product yield and crystal growth. To achieve sufficient product yield and crystal growth 
long residence time is a requirement. However, long residence time requires low flow rates 
between transfer lines, which can lead to classified product withdrawal due to particle settling. 
This then leads to the blockage of transfer lines, and hence frequent interruptions to the process 
that can cause erratic and unsteady-state (or uncontrolled) behaviour. Periodic sampling of the 
continuous flow process was conducted for off-line analyses and comparison with the PMSMPR 
operations. Experimental conditions for the continuous MSMPR runs are summarised in Table 
6.3.  
Table 6.3: Summary of experimental conditions used for the continuous seeded cooling 
crystallisation of GLY in single- and three-stage MSMPR crystallisers. 
Experimental 
Conditions 
M-CG1 M-CG2 M-CG3 M-CG4 M-CG5 
Sampling method cop bop cop cop bop 
Feed temperature (°C) 19 19 19 19 19 
Feed concentration (g/g) 0.2286 0.2275 0.2278 0.2287 0.2278 
PMSMPR temperature 
per stage (°C) 
10 10 10 
17, 14, 
10 
17, 14, 
10 
MSMPR SCO mean 
concentration (co) 
0.2074 0.2034 ◊0.1962 ◊0.1928 ◊0.1970 
Seed material (2.5 %) bimodal bimodal bimodal bimodal bimodal 
Feed stream flow, Q1 
(g/min) 
52.7 52.7 52.7 52.7 52.7 
MSMPR 1 outlet flow, Q2 
(g/min) 
n/a n/a n/a 52.7 52.7 
MSMPR 2 outlet flow, Q3 
(g/min) 
n/a n/a n/a 52.7 52.7 
MSMPR 3 outlet flow, QM1 
(g/min) 
52.7 52.7 52.7 52.7 52.7 
Mean RTPO (min) 9.36 9.36 28.08 28.08 28.08 
M-CG1, M-CG2 and M-CG3 = single-stage continuous MSMPR; M-CG4 and M-CG5 = three-stage continuous 
MSMPR; cop = sampling from outlet transfer line during continuous operation period; bop = sampling from bottom 
valve during batch operation period; ◊ = “steady-state operation” not achieved. 
The mean residence time for continuous flow crystallisation in the MSMPR is the same as the 
addition/withdrawal cycle of the coupled PMSMPR operation. Due to the coupled 
addition/withdrawal of slurry applied during the coupled PMSMPR operation, the 
corresponding RTD would be as broad as that of continuous flow MSMPR crystallisation. 
However, the latter requires a vessel of about twice the operating volume of the former to 
achieve a comparable mean residence time. In this regard, the periodic flow operation shows 
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the benefits of reducing the equipment footprint and cost, compared to the continuous 
operation. The continuous flow single- and three-stage MSMPR crystallisations carried out in 
this study served as benchmarks to demonstrate the advantages of periodic flow 
crystallisation. For the continuous crystallisations, in all cases, the steady-state product slurry 
withdrawn during each experiment was filtered and the crystals collected for off-line image 
analysis and measurement of the CSD using laser diffraction.  
6.3 Mathematical Modelling 
6.3.1 Dynamic Model of Residence Time Distribution 
The RTD in continuous flow MSMPR and periodic flow PMSMPR crystallisers were simulated 
taking into account the following assumptions: steady-state (i.e. in the continuous MSMPR), 
SCO (i.e. in the PMSMPR), transports at the inlet and the outlet takes place only by advection, 
and incompressible flow (i.e. closed boundary conditions). Although a continuously operated 
stirred tank crystalliser (STC) is usually assumed to attain perfect micro-mixing for liquid-solid 
phases in the vessel [83], the effect of macro-mixing due to addition and withdrawal of slurry 
plays a more critical role, in particular, shaping the final crystal attributes (e.g. crystal size, shape 
and CSD). Accordingly, the RTD of the slurry provides useful information on the mean residence 
time, and its corresponding standard deviation is often studied for many innovative continuous 
crystallisation techniques [266], [267]. Thus, a generic dynamic model was first developed for 
the RTD of a STC subject to different slurry addition and withdrawing operating patterns. The 
system governing equations of the RTD in a well-mixed stirred tank [268], [269] can be 
represented as follows: 
𝜕(𝑉𝑊)
𝜕𝑡
= −
𝜕(𝑉𝑊)
𝜕𝜃
+ ∑ 𝑣𝑖
𝑚
𝑖=1
𝐹𝑖 − ∑ 𝑣𝑗
𝑛
𝑗=1
𝐸𝑗 
 
6.1  
𝑑𝑉
𝑑𝑡
= ∑ 𝑣𝑖
𝑚
𝑖=1
− ∑ 𝑣𝑗
𝑛
𝑗=1
 6.2  
where t represents time (s); V is the operating volume (m3); θ is the residence time inside the 
vessel(s); vi is the feeding flowrate of the ith stream (m3s-1); vj is the withdrawing flowrate of 
the jth stream (m3s-1); W (t, θ) is the corresponding RTD (s-1); Fi (t, θ) is the RTD of the ith 
stream (s-1); Ej (t, θ) is the RTD of jth exceeding stream (s-1) and is identical to W(t, θ) for a 
well-mixed stirred tank. The corresponding initial and boundary conditions are: 
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𝑊(0, 𝜃) = 𝑊0(𝜃) 6.3  
𝑉(0) = 0 6.4  
𝑊(𝑡, 0) = 0 6.5  
where W0(θ) is the initial RTD in the vessel (s-1). If the vessel starts from empty as in Eqn. 6.4, 
W0(θ) is a Dirac delta function (or distribution), δ, such that W0 is zero everywhere except at 
zero, with an integral of one over the entire residence time, θ. Fi(t, θ), is also a δ function if 
there is fresh feed into the vessel (used to characterise the impulse response curve). Owing 
to the simple convection term of 𝜕𝜃 𝜕𝑡⁄ = 1, the backward finite difference method (BFDM) 
was used here to discretise the above partial differential equation (PDE) (1) and solve together 
with Eqn. 6.2 in MATLAB using “ode45”. 
6.3.2 Flowsheet Models of Periodic Flow Crystallisation Operation 
Towards better process understanding and design of the novel periodic flow crystallisation in 
PMSMPR, rigorous population balance based mathematical modelling and flowsheet 
simulations were employed in this study by implementing the gCRYSTAL 4.0 software 
package, which offers various particle size change mechanisms and kinetics for 
characterisation of crystallisation processes, as well as convenient toolboxes for parameter 
estimation and process optimisation. The main steps involved in the implementation of 
gCRYSTAL for kinetic parameter estimation using the batch cooling crystallisation 
experiments and the simulation of periodic flow crystallisations is described. Firstly, the system 
information and material properties of GLY-H2O, for example, molecular weights, densities 
and solubility that could be obtained elsewhere in the literature or chemical handbooks [270], 
were configured in the “global specification” module in gCRYSTAL. By adopting the 
“Crystalliser MSMPR” module in the model library, configurations of the batch STC were set-
up according to the actual experimental conditions. In terms of the crystallisation mechanisms 
and kinetics, instead of using theoretical first-principles models for nucleation, crystal growth, 
and agglomeration, semi-empirical power-law kinetic models were used here for chemical 
engineering purposes. For example, a secondary nucleation model based on the work of 
Evans et al. [271] was used to describe the nucleation effect due to attrition. For crystal 
agglomeration, the A50 parameter was introduced to represent the combined effect of material 
strength, point of contact between two crystals and vessel geometry [272]. Details of the 
crystallisation mechanisms and kinetic models selected in gCRYSTAL are summarised in 
Table 6.4. Further information about the model equations can be found in the help 
documentation of the gCRYSTAL software and the references therein. 
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Table 6.4: Summary of the crystallisation mechanisms and kinetic models. 
Mechanism Kinetics Options Parameters 
Primary nucleation 
Customised power 
law kinetics 
Relative 
supersaturation 
(C-Csat)/Csat 
 Rate constant 
 Supersaturation order 
 Activation energy 
 Order with respect to 
solute concentration 
Secondary 
nucleation 
Evans kinetics 
Collision type: 
Crystal-Impeller (CI) 
 Rate constant 
 Size above which crystals 
undergo attrition 
 Order with respect to 
supersaturation 
Crystal growth Power law kinetics 
Relative 
supersaturation 
 (C-Csat)/Csat 
 Growth rate constant 
 Order with respect to 
supersaturation 
 Activation energy 
Agglomeration Mumtaz kinetics - 
 Agglomeration parameter 
(A50) 
For the model development, data from the four unseeded experiments listed in Table 6.1 were 
imported into the gCRYSTAL folder of “Experiments>Performed”. Therein, the in situ 
measurements of GLY concentration and temperature, and off-line CSD measured by laser 
diffraction for each of the batch experiments were saved. “Perfect control” was chosen in the 
gCRYSTAL temperature controller so that the actual temperature profiles measured in the 
batch experiments could be imported as set points and were exactly tracked in the parameter 
estimation. Upon the successful input of the batch experimental data, the group of kinetic 
parameters listed in the Table 6.4 could be estimated using the “Parameter Estimations” tool 
in the software. Multiple tries of initial guesses were necessary to obtain a good agreement 
between model predictions and experimental measurements. In some cases, it was critical to 
re-examine the selected crystallisation mechanisms by referring to the experimental 
observations, for example, the effect of impeller stirring speed on nucleation based on FBRM 
total counts/s; and the effect of crystal agglomeration based on PVM and microscopy images.  
Modelling of the periodic flow PMSMPR crystalliser was also implemented in gCRYSTAL 4.0 
using multiple placements of transfer pumps and “Crystalliser MSMPR” stages in the 
flowsheet. A customised control module of the “Intelligent Decision Support (IDS)” framework 
was also developed in this study to logically switch on or off the pumps to realise the sequential 
start-up of a three-stage cascade of PMSMPR crystallisers, and to fulfil the periodic flow 
operating condition. Both single- and three-stage PMSMPR crystallisation simulations were 
performed according to the actual experimental operating conditions as described earlier in 
the experimental methods section. Their flowsheets are illustrated in Figure 6.4. Note that the 
same kinetic parameters estimated from the batch cooling crystallisations were incorporated 
here. 
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Figure 6.4: Flowsheet of the periodic flow crystallisation experiments: single-stage PMSMPR 
crystalliser (top); cascaded three-stage PMSMPR crystallisers. 
Unlike the simulation of the unseeded batch crystallisations, seeded feed suspensions were 
used in the periodic flow PMSMPR crystallisations, which required the specification of initial 
seed loading and CSD in gCRYSTAL. This was done by importing the CSD measurements 
into the saved file “Seed CSD.txt” in the “Miscellaneous Files” folder. It is worth mentioning 
that conversion of the discrete histogram of laser diffraction CSD measurements of seed 
crystals to volume-based density distributions was required in the saved text file. In addition, 
proportional and integral (PI) controllers were introduced in the gCRYSTAL temperature 
controller. The parameters of “Gain” and “Integral time” were fine-tuned to agree well with the 
dynamic response of the temperature measured in the respective periodic flow experiments. 
This is because dynamic changes in temperature (for example, due to changes in liquid level 
and wall fouling) were possibly affected by the thermal capacity of the cooling jacket of each 
PMSMPR vessel. 
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6.4 Results and discussion 
6.4.1 Residence Time Distribution in Periodic Flow Crystalliser 
It would be of interest to demonstrate the RTD of periodic flow operation in the PMSMPR 
crystalliser and to compare it with that of a conventional continuous flow MSMPR crystalliser, 
when it is claimed that the periodic flow operation has the capability of extending the mean 
residence time without broadening the corresponding RTD. The dynamic RTD model reported 
in Section 6.3.1 has been applied to simulate the RTDs of a continuous flow MSMPR, and 
periodic flow PMSMPRs operated in coupled and decoupled modes, respectively. The operating 
principles were described earlier in the experimental methods section and depicted in Figure 6.1 
(a) and (b). Their RTD results are shown in Figure 6.5. It was found that the coupled periodic 
flow operation approximately doubled the mean residence time, τ, from 9.17 min under 
continuous flow operation to a time-averaged value of 19.96 min, but with a much more 
broadened RTD, that is, the standard deviation, σ, of the distribution changed from 9.50 min to 
19.91 min However, if one reduces the flow rates for feed addition and withdrawal in the 
continuous flow MSMPR, thereby doubling the mean residence time to 18.34 min, the 
corresponding standard deviation increases to 18.81 min On the other hand, if one compares 
the coefficient of variation (c.v.) of their respective RTDs, c.v. = σ/τ, the c.v. for continuous flow 
operation is 9.50/9.17 = 1.04, or 18.81/18.34 = 1.02; while the c.v. for coupled periodic flow 
operation is averaged at 19.91/19.96 = 1.00. In this respect, the coupled periodic flow operation 
did extend the residence time, but without broadening the RTD too much. For the decoupled 
periodic flow operation, the time-averaged mean residence time was increased to 35.05 min 
with a standard deviation of about 28.15 min, and c.v. of around 0.8031. This is because of the 
decoupling of pumping during addition and withdrawal of slurry, in such a way that minimises 
the possibility of direct washing-out of the fresh feeding suspension. However, the productivity 
of the decoupled periodic operation would be significantly affected because the interruption 
between withdrawal periods is prolonged and may merely show marginal advantages when 
compared to batch operation with respect to productivity. Furthermore, a very long time to a 
controlled state of operation (or SCO) is required during the start-up phase, based on the 
standard deviation of the RTD as shown in Figure 6.5. It should be emphasised once again that 
only half of the slurry in the crystalliser was withdrawn and subsequently refilled in the decoupled 
periodic flow operation (Figure 6.1). However, if larger volumes of slurry are involved, shorter 
mean residence times and narrower RTDs would be observed with limits approaching batch 
operation; while smaller volumes would result in longer residence time and broader RTD. In 
practice, the slurry withdrawal and refilling of the coupled or decoupled PMSMPR operation 
should be designed and optimised with profound process understanding. It therefore follows that 
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a systematic study and optimisation of the effect of RTD on CSD seem interesting and deserve 
more investigative effort. Future work may look to optimise the periodic flow operation for direct 
design and to tailor the RTD in order to achieve desired product CQAs. 
 
 
 
Figure 6.5: RTD of continuous MSMPR (top three), coupled periodic PMSMPR (middle 
three), and decoupled periodic PMSMPR (bottom three) crystallisers. Bold solid blue lines 
indicate final minutes of addition/withdrawal time period. 
E(θ) from the start of 
pumping until “steady-state 
operation” is achieved 
E(θ) from the start of 
pumping until a “state 
of controlled operation” 
is achieved 
E(θ) from the start of 
pumping until a “state 
of controlled operation” 
is achieved 
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6.4.2 Comparison of Periodic and Continuous Flow Crystallisations  
Single-stage periodic PMSMPR and continuous MSMPR Crystallisation Experiments: It 
is well-know that factors such as seeding strategy, residence time, and rate of supersaturation 
generation can significantly affect the mean product size and CSD in MSMPR crystallisers. In 
addition, the product withdrawal strategy can also influence the product mean size and CSD. 
In this study, the factors influencing product mean size and CSD mentioned earlier were 
experimentally investigated in the period flow process (PMSMPR). The effect of seed crystal 
properties on the product size and the time to achieve a “state of controlled operation” (SCO) 
was investigated by using the three types of seed materials mentioned in Section 6.2, applied 
at the same seed loading (2.5 wt%). Figure 6.6 (a) – (e) shows the process time diagrams for 
the single-stage periodic PMSMPR and continuous MSMPR experiments.  
 
Figure 6.6: Process time diagrams for the single-stage coupled, (a) – (c) and decoupled, (d) 
PMSMPR experiments and equivalent continuous MSMPR experiment (e). 
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The effect of seed characteristics on the time to achieving SCO in the single-stage PMSMPR 
experiments is quite apparent from the change in FBRM counts/s. Two types of experiments 
were conducted, that is, coupled and decoupled periodic flow (Section 6.2.1). Broad, narrow 
and bimodal CSD seed were used for experiments M-G1 (a), M-G2 (b), M-G3 (c) and M-G4 (d) 
(Figure 6.6). The approach to SCO is fastest in the order M-G3 < M-G2 < M-G1 < M-G4, 
indicating that the seed properties (specifically size and CSD) and the mode of operation 
(coupled or decupled), affects the approach to a controlled state, with larger seed size leading 
to faster control. This appears to be a surface area effect, where by large seed crystals consume 
supersaturation at a slower more gradual rate compared to smaller seeds, which have a higher 
surface area (size dependent growth). Note that unlike batch operation, the periodic flow 
process does not operate at equilibrium. The time to a controlled state with respect to seed 
material is in the order bimodal CSD < narrow CSD < broad CSD seed. This is not entirely 
surprising since the mean size of the seed materials are in the order bimodal CSD > narrow 
CSD > broad CSD seed. Furthermore, aging of the seed and the Oswald’s ripening process 
leads to preferential dissolution of fines and growth of large crystals at their expense. Although 
M-G4 appeared to achieve SCO early on based on FBRM and concentration measurements, 
there is an obvious drift from controlled operation that occurs from approximately 150 min, which 
is perhaps linked to the decoupled mode of operation. The RTD study, Section 6.4, showed that 
decoupled operation takes a longer time to achieve SCO. Table 6.5 shows the particle size of 
the crystalline seed materials before and after aging, as determined by Malvern Mastersizer® 
volume based mean particle size D[4, 3], and FBRM mean square weighted chord length 
(MSWCL) measurements and analyses. In addition to the seed material properties, the mode 
of periodic flow operation also affects the time to achieving SCO, with faster approach to control 
in the decoupled process.  
Table 6.5: Summary of experimental results for the cooling crystallisation of GLY in 
single-stage periodic PMSMPR and continuous MSMPR crystallisers. 
Parameters Measured M-G1 M-G2 M-G3 M-G4 M-CG1 
Seed material type Broad Narrow Bimodal Bimodal Bimodal 
Mean seed size before aging: 
D[4, 3] Malvern® (µm) 
50 ± 0.2 61.8 ± 1.7 115.5 ± 1.6 119 ± 1.7 119 ± 1.7 
Mean seed size after 30 min 
aging: D[4, 3] Malvern® (µm) 
125.1 ± 1.2 171.5 ± 1.7 249.8 ± 4.2 232.4 ± 1.9 250.7 ± 2.2 
Mean seed size after 30 min 
aging: FBRM MSWCL (µm) 
53.1 ± 2.1 65.6 ± 1.3 79.9 ± 0.5 86 ± 0.4 84.2 ± 0.7 
¥Mean product crystal size: 
D[4, 3] Malvern® (µm) 
167.5 ± 3.3 220.0 ± 1.2 287.6 ± 1.6 519.0 ± 22.5 248.5 ± 8.8 
Mean product crystal size: 
FBRM MSWCL (µm) 
76.2 ± 1.1 95.3 ± 1.1 104.6 ± 0.8 114 ± 2.0 94.6 ± 1.4 
% Yield of crystallisation (Y) 88.9 85.2 94.5 93.0 44.8 
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Experiments M-G3 and M-G4 were carried out under identical conditions using the same 
bimodal CSD seed, with the exception that the latter was operated in decoupled period flow 
mode. It would appear that there is a faster approach to control in M-G4 run, based on the 
concentration data. However, it is clear there is a significant drift in the FBRM total counts/s 
away from SCO operation due perhaps to the decoupling of the addition and withdrawal cycles 
leading to oscillations, and therefore a longer time to achieve control. This result would appear 
to agree with the predictions from the RTD simulations. The equivalent continuous MSMPR 
experiment carried out with bimodal CSD seed, Figure 6.6 (e) (M-CG1), did not achieved SCO 
due to line blockage issues, that is, despite the high flow rate and transfer velocities employed. 
This was perhaps a result of nucleation in the transfer lines leading to blockage at pump gears 
where the transfer tube is constricted. Table 6.5 also shows the percentage yield of 
crystallisation (Y), which is described in Chapter 5 and in [262]. The yield of crystallisation is 
similar for each of the single-stage PMSMPR experiments, and as expected the continuous 
single-stage MSMPR (M-CG1) show significantly lower yield. Figure 6.7 shows the operating 
trajectory though the phase diagram for a periodic flow PMSMPR (M-G3), and equivalent 
continuous MSMPR (M-CG1), which gives further evidence of the higher yield of crystallisation 
for the former case. The phase diagrams also give an insight into the crystallisation behaviour 
of both systems. In the periodic operation there are more oscillations in concentration relative 
to the continuous run.  
 
Figure 6.7: Process phase diagrams for PMSMPR (left, M-G3) and equivalent continuous 
MSMPR (right, M-CG1) crystallisations showing operating regions for each system. 
The data in Table 6.5 further shows that for all seed materials used in the study, following the 
aging process, a larger mean size of particles is obtained compared to the pre-aged materials. 
The dramatic increase in mean crystal size is attributed not only to the growth of large particles 
at the expense of the smaller ones that dissolve, but also to two other factors: (1) the small 
but significant amount of supersaturation (1 oC) generated in the feed vessel at start-up (feed 
solution saturated at 20 oC, but held at 19 oC followed by addition of seeds); (2) aggregation 
of fine seed particles, which later form cemented agglomerates. This phenomenon was 
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evident particularly with finer seed materials, for example, the broad CSD (> 75 µm) seed. 
Evidence of the preferential agglomeration of the fine particles is shown in the microscope 
images of the aged seed materials (Figure 6.8). Of the aged seed materials, the bimodal CSD 
crystals show the least amount of agglomeration. On the other hand, a significant amount of 
agglomerates can be observed in the aged broad CSD seed material. Overall, the images 
appear to be consistent with an increase in mean crystal size of aged seed materials as 
determined by Malvern® and FBRM (Table 6.5). Relative to the aged seed crystals, significant 
crystal growth is observed for the product crystals obtained from each experiment as shown 
in Figure 6.9. The largest and most uniform crystals are obtained from M-G3 and M-G4 
PMSMPR experiments in which the bimodal CSD seed material was used. The crystals exhibit 
the usual bipyramidal hexagonal prism morphology of the α-polymorphic form, which typically 
grows from aqueous solutions [273], [274]. 
 
Figure 6.8: Microscope images of seed crystals used in the periodic PMSMPR and 
continuous MSMPR experiments: dry seed material before adding to feed vessel (first row); 
seed crystals obtained from feed vessel after 30 min aging (second row). 
 
Figure 6.9: Microscope (first row) and PVM (second row) images of product crystals from the 
periodic PMSMPR and continuous MSMPR experiments. 
The product crystals obtained from M-G1 (broad CSD seed) show variable shapes and have 
many agglomerates. In comparison, the product crystals from M-G2 have a well-defined 
Dry seed – Bimodal CSD 
Feed seed – Bimodal CSD 
Dry seed – Broad CSD Dry seed – Narrow CSD 
Feed seed – Broad CSD Feed seed – Narrow CSD 
M-G3 Product (200 min) M-G1 Product (200 min) 
M-G1 Product (200 min) M-G3 Product (200 min) 
M-G2 Product (200 min) M-G4 Product (200 min) M-CG1 Product (200 min) 
M-G4 Product (200 min) M-CG1 Product (200 min) M-G2 Product (200 min) 
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shape, but there is a mixture of large, small and agglomerated crystals. The crystalline 
products obtained from M-CG1 (continuous MSMPR), M-G3 (coupled PMSMPR) and M-G4 
(decoupled PMSMPR) show similar well-defined crystal shapes and few agglomerates. The 
normalised product crystal CSD profiles obtained from laser diffraction measurements 
(Malvern Mastersizer®) on samples from each experimental run is show in Figure 6.10. For all 
experimental runs, crystal growth is observed as a shift of the CSD to the right relative to the 
aged seed materials. The product size is largest for the decoupled PMSMPR run (M-G4), while 
marginal growth is observed for the continuous MSMPR run (M-CG1). Collectively, the results 
presented indicate that glycine is a fast growing API, and that the kinetics of the crystallisation 
is suited to the PMSMPR operation. Furthermore, the quality of seed material can affect the 
extent of agglomeration and formation of well-defined crystals. In this section, the effect of 
seed properties on the time to achieve a SCO and on the product crystal size and quality was 
addressed. In the sections following, the effect of residence time, supersaturation, and product 
withdrawal strategy on the time to attain a SCO and CSD properties are discussed. 
 
Figure 6.10: Normalised CSD profiles for the aged seed materials and 1st (20 min) and 
10th (200 min) RTPO product crystals obtained from the PMSMPR and continuous MSMPR 
experiments, data obtained by laser diffraction (Malvern Mastersizer®). 
Three-Stage Periodic PMSMPR and Continuous MSMPR Crystallisations: The Time 
diagrams of the three-stage periodic PMSMPR and continuous MSMPR experimental runs are 
presented in Figure 6.11 (a) – (d), showing the FBRM counts/s and temperature recorded in the 
first- and third-stage of each experiment. Also shown are the FTIR ChemiGram and Raman 
concentration measurements from the second- and third-stage, respectively. The FTIR 
ChemiGram is generated from integrated absorbance over a specific frequency range, in this 
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case 1414 – 650 cm-1. It shows the change in the relative absorbance of solution phase glycine 
from the accumulated spectra, which permits the monitoring of the time taken to attain SCO in 
the second-stage. In the three-stage operation, residence time increases threefold compared to 
the single-stage equivalents. There is also a more gradual change in supersaturation over the 
three stages, from 19 oC (feed vessel) to 17 oC (MSMPR 1), 14 oC (MSMPR 2) and 10 oC 
(MSMPR 3). SCO is observed for M-G5 (Figure 6.11 (a); broad CSD seed) and M-G6 (Figure 
6.11 (b); narrow CSD seed), almost immediately from start-up to the end of each PMSMPR run. 
In the case of M-G7 (Figure 6.11 (c); bimodal CSD seed), SCO is achieved much later after 
~104 min in all PMSMPR stages. Interestingly, the time taken to achieve SCO matches well with 
the equivalent single-stage PMSMPR (M-G3) experiment reported earlier.  
 
Figure 6.11: Process time diagrams for the three-stage cascade PMSMPR, (a) – (c) and 
equivalent continuous MSMPR (d) experiments. 
The results suggest that the small amount of supersaturation generated at each PMSMPR stage 
is rapidly consumed when fine seed crystals (broad and narrow CSD) are used, leading to a 
much faster approach to a controlled state compared to when the bimodal CSD seed is used. 
Furthermore, it appears that not only the seed crystal properties (for example, mean size, shape 
and CSD) are affecting the time to achieving a SCO (also observed in the single-stage PMSMPR 
runs), but also the amount of supersaturation generated. For the equivalent continuous MSMPR 
experiment, steady-state was not observed due to line blockage issues, for the same reason as 
explained for the single-stage continuous MSMPR runs. 
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A summary of results from the three-stage experiments is present in Table 6.6. Interestingly, 
parameters such as mean product crystal size obtained from MSMPR 3, and the yield of 
crystallisation are very similar to the results observed for the single-stage experiments. The 
exception is the continuous three-stage MSMPR experiment (M-CG3), where the mean crystal 
size is smaller and the crystallisation yield much higher compared to the equivalent single-stage 
continuous MSMPR (M-CG1) run. Normally, one would expect a significant increase in mean 
crystal size and process yield in the three-stage operation due to the extended residence time. 
Regarding the mean product crystal size, it appears that despite the difference in the rate of 
supersaturation generation in the single- versus the three-stage PMSMPR operations, there is 
little effect on the crystal growth and nucleation rates. In the single-stage PMSMPR, 
supersaturation is generated rapidly, going from 19 oC (feed stream) to 10 oC saturation, that is, 
S = 1.23. For the three-stage PMSMPR, the change in S was more gradual, change from 1.04 
(MSMPR 1) to 1.07 (MSMPR 2) and then 1.10 (MSMPR 3). However, for the continuous 
MSMPR operation, it appears that the rate of supersaturation generation is more significant. 
This explains why the product size and process yield for the continuous single- and three-stage 
MSMPRs are different. The results provide further evidence that the operating region in the 
phase diagram for the PMSMPR is different from that of the continuous MSMPR as indicated 
earlier (Figure 6.7; M-CG1). 
Table 6.6: Summary of experimental results for the cooling crystallisation of GLY in 
three-stage periodic PMSMPR and continuous MSMPR crystallisers. 
Parameters Measured M-G5 M-G6 M-G7 M-CG3 
Seed material type Broad Narrow Bimodal Bimodal 
Mean seed size before aging: 
D[4, 3] Malvern® (µm) 
50 ± 0.2 61.8 ± 1.7 115.5 ± 1.6 119 ± 1.7 
Mean seed size after 30 min 
aging: D[4, 3] Malvern® (µm) 
139.6 ± 2.2 170.8 ± 2.0 248.2 ± 0.4 214.8 ± 4.3 
Mean seed size after 30 min 
aging: FBRM MSWCL (µm) 
66.7 ± 3.0 70.2 ± 1.8 75.2 ± 1.9 82.6 ± 1.3 
¥Mean product crystal size: 
D[4, 3] Malvern® (µm) 
210.0 ± 4.3 216.8 ± 1.9 288.0 ± 14.7 227.9 ± 9.6 
Mean product crystal size: 
FBRM MSWCL (µm) 
83.3 ± 2.1 83.3 ± 2.7 103.5 ± 3.0 101.4 ± 5.4 
% Yield of crystallisation (Y) 83.4 89.5 90.3 76.1 
                  ¥Mean product crystal size = samples taken from crystalliser outlet tube 
Figure 6.12 shows the microscope images of the product crystals obtained from the first- through 
third-stage for each experimental run as well as real-time PVM images from the third-stage. As 
expected the largest and best quality crystals are obtained from M-G7 run due to the larger 
mean size of the seed crystals used (Table 6.6). The CSD profiles of seed crystals from the feed 
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and each of the three stages of the PMSMPR and continuous MSMPR experimental runs are 
shown in Figure 6.13. In all experimental runs, growth was observed progressively from the first 
to final-stage MSMPR, indicated by a shift in the distributions to the right relative to the aged 
seed materials. For the continuous MSMPR operation, there is a noticeable increase in fines 
through to the final stage (MSMPR 3), attributed to secondary nucleation (in MSMPR 1) and the 
short residence time of slurry in each stage of the process.  
 
Figure 6.12: Microscope (rows 1 – 4) and PVM (last row) images of seed and product 
crystals from the PMSMPR and continuous MSMPR experiments. 
M-G5 MSMPR1 (200 min) 
M-G5 MSMPR3 (200 min) 
M-G5 MSMPR2 (200 min) 
M-G5 MSMPR3 (200 min) 
M-G5 Feed Seed (200 min) 
M-G6 MSMPR1 (200 min) 
M-G6 MSMPR2 (200 min) 
M-G6 MSMPR3 (200 min) 
M-G6 Feed Seed (200 min) 
M-G7 MSMPR1 (200 min) 
M-G7 MSMPR2 (200 min) 
M-G7 MSMPR3 (200 min) 
M-G7 Feed Seed (200 min) 
M-CG3 MSMPR1 (200 min) 
M-CG3 MSMPR2 (200 min) 
M-CG3 MSMPR3 (200 min) 
M-CG3 Feed Seed (200 min) 
M-G6 MSMPR3 (200 min) M-G7 MSMPR3 (200 min) M-CG3 MSMPR3 (200 min) 
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Figure 6.13: Normalised CSD profiles for the aged seed materials and the three stages of 
the PMSMPR and MSMPR experiments after 85 and 200 min, respectively, in the final 
stage. Data were obtained by laser diffraction using (Malvern Mastersizer®). 
Effect of Sample Withdrawal Method on Product Crystal Properties: It was found that the 
sampling method employed is an important operational aspect of the PMSMPR. The way that 
slurry is collected can impact on the CSD and mean size of product crystals determined by 
the off-line laser diffraction (Malvern Mastersizer®). Furthermore, the sampling strategy can 
give an indication of the most suitable product withdrawal method to employ for PMSMPR and 
continuous MSMPR operations. Sampling of the PMSMPR was done in two ways: (1) 
withdrawal of a small amount of material from the outlet tube in the first minute of the 
continuous flow period (cop); (2) withdrawal from the bottom drain valve of the product vessel 
at the end of the holding operation period (bop) for PMSMPR operation. Continuous MSMPR 
experiments were sampled in a similar way for comparison. Table 6.7 provides a summary of 
results for each experimental run carried out using different seed material types. The data 
shows that the two sampling methods produce significantly different results. When samples 
were withdrawn from the outlet tube during the cop of the PMSMPR, the mean size determined 
by laser diffraction is markedly smaller compared to samples withdrawn during the batch 
operating period from the bottom drain valve, regardless of the properties of the initial seed 
material used. Four continuous MSMPR runs are included for comparison (M-CG1 – M-CG4). 
Evidently, the sample withdrawal location has a similar impact on the mean size. The CSD 
profiles and microscope images, Figure 6.14, for selected experiments provide evidence that 
the withdrawal method affects product crystal properties. 
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Table 6.7: Summary of results for two sampling methods investigated during the PMSMPR 
and continuous MSMPR experimental runs with bimodal CSD seed. 
Exp. No. 
Sampling 
Method 
Seed Type 
Particle Size: Malvern Mastersizer® (µm) 
Aged Seed MSMPR1 MSMPR2 MSMPR3 
M-G2 cop narrow 171.5 ± 1.7 220.0 ± 1.2 n/a n/a 
M-G2 bop narrow 171.5 ± 1.7 357.8 ± 1.2 n/a n/a 
M-G4 cop bimodal 232.4 ± 1.9 519.0 ± 22.5 n/a n/a 
M-G4 bop bimodal 232.4 ± 1.9 683.9 ± 10.5 n/a n/a 
M-G5 cop broad 139.6 ± 2.2 175.5 ± 4.4 215.3 ± 3.1 210.0 ± 4.3 
M-G5 bop broad 139.6 ± 2.2 201.8 ± 4.1 239.9 ± 7.7 348.3 ± 6.8 
M-G7 cop bimodal 248.2 ± 0.4 277.5 ± 1.7 288.8 ± 4.6 311.7 ± 3.5 
M-G7 bop bimodal 254.4 ± 8.7 277.3 ± 2.1 386.4 ± 2.5 696.8 ± 18.3 
M-CG1 cop bimodal 250.7 ± 2.2 248.5 ± 8.8 n/a n/a 
M-CG2 bop bimodal 250.7 ± 2.2 708.6 ± 12.1 n/a n/a 
M-CG3 cop bimodal 214.8 ± 4.3 198.6 ± 5.0 218.0 ± 4.8 227.9 ± 9.6 
M-CG4 cop bimodal 248.8 ± 4.2 235.3 ± 1.6 257.7 ± 0.9 342.2 ± 1.7 
cop = sampling from outlet transfer line during continuous operation period; bop = sampling from bottom valve 
during batch operation period; n/a = not applicable. 
 
Figure 6.14: Normalised CSD profiles (left) and microscope images (right) of samples taken 
during the continuous operation period (cop) from outlet line and batch operation period 
(bop) from the bottom valve for the PMSMPR runs (M-G4 and M-G7). Samples were taken 
in a similar way during the MSMPR runs (M-CG1, M-CG2, M-CG3 and M-CG4). 
The results from the slurry withdrawal study show there are large differences between the 
mean crystal size and CSD of samples taken from the transfer line tube and from the bottom 
valve of the continuous MSMPR and periodic flow PMSMPR crystallisers, respectively. 
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Consistently larger crystals were obtained when from the bottom valve withdrawal (bop) 
experiments. This reason for this is that large crystals due their mass and hence faster settling 
velocities are preferentially withdrawn when the bottom valve is released. This phenomenon 
occurs in spite of complete (or homogeneous) mixing in the crystalliser, since the law of gravity 
favours larger particles of greater mass being pull downward at a faster rate when the valve 
is released in comparison to smaller particles. Therefore, withdrawal from the bottom valve 
inadvertently leads to classification regardless of whether the bulk mixing in the crystalliser is 
complete or incomplete. On the other hand, withdrawal from the transfer line tube (cop) 
appears to be the best option for achieving representative isokinetic withdrawal and is 
therefore recommended on the basis that the bulk mixing conditions are better represented in 
terms of a complete distribution of particles pulled into the transfer line. However, further 
studies are required to demonstrate the physics and hydrodynamics that govern particle 
withdrawal: (1) from the vessel bottom valve, and (2) using a dip tube positioned above the 
impeller which is then connected to an outlet transfer line.  
6.5 Process Modelling of Periodic Flow Crystallisation 
6.5.1 Kinetic Parameter Estimation from Batch Experiments  
The four unseeded batch crystallisation runs reported in Table 6.1, spanning a range of initial 
concentrations with different cooling rates were used to infer the major crystallisation kinetics. 
Since no significant crystal agglomeration was observed by PVM or microscopic image analysis 
for the batch experiments, see images inset, Figure 6.15, the agglomeration kinetics by 
“Mumtaz” in Table 6.4 was deactivated in the simulation and hence was not included in the 
parameter estimation at this stage. The final results of the parameter estimations are shown in 
Table 6.8 and Figure 6.15. Fouling on the Raman probe may occur due to the long operating 
time of over 4 hours in Batch 3, potentially resulting in slight uncertainties in the concentration 
predictions from the multivariate model (Chapter 3; Section 3.4.3), particular in the later stage. 
The same reasoning explains the deviation in Batch 4 concentration measurements recorded 
below the solubility limit in the later stage of the experiment (Figure 6.15). As a result, only the 
first half of Batch 4 was used for parameter estimation.  
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Table 6.8: Results of kinetic parameter estimations from four batch experiments. 
Kinetics Parameter Estimate Unit 
Primary nucleation: 
Customised power 
law kinetics 
 
Rate constant 1673.83 ± 22.82 LOG(#/s) 
Supersaturation order 4.23 ± 0.013 - 
Activation energy 1284.64 ± 147.4 J/mol 
Order with respect to 
solute concentration 
3.41 ± 0.013 - 
Secondary nucleation: 
Evans kinetics 
Rate constant 16.40 ± 0.009 LOG(#/s) 
Size above when 
crystals undergo attrition 
798.35 ± 1.174 µm 
Order with respect to 
supersaturation 
1.00* - 
Crystal growth: 
Power law kinetics 
Growth rate constant 1.49×10-5 ± 3.52×10-8 m/s 
Order with respect to 
supersaturation 
1.71 ± 0.0010 - 
Activation energy 0.00* J/mol 
Agglomeration: 
Mumtaz kinetics 
Agglomeration 
parameter (A50) 
60.00 × 10-3 N/m 
        *The final estimates hit the lower bound. 
In general, reasonably good agreement was observed between the measured and the predicted 
data for the solute concentration and CSD measurements at the end of Batch 1 and 2 
experiments. Uncertainties in the CSD may relate to the non-spherical and non-uniform crystal 
morphologies of the samples analysed by laser diffraction (i.e., crystal shape is approximated 
to that of a sphere), and the use of a single characteristic size for the one-dimensional population 
balance model in gCRYSTAL 4.0. Additionally, it is interesting to note that the major peak of the 
final product CSD for Batch 1 is due to mild primary nucleation when GLY concentration enters 
the metastable zone with moderate relative supersaturation of 0.25; while the minor peak in the 
small crystal size range is attributed to secondary nucleation caused by crystal-impeller 
collisions (which occurs at low supersaturation) and the existence of large crystals, as observed 
in Figure 6.15 microscope image inset, Batch 1. On the contrary, in Batch 2 more intensive 
primary nucleation was triggered and faster crystal growth rate observed later on, due to the 
higher relative supersaturation at 0.55 (notice the steep drop in concentration), which resulted 
in a broad CSD. 
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Figure 6.15: Kinetic parameter estimations using unseeded batch cooling crystallisations. 
6.5.2 Model Validation Using Periodic Flow PMSMPR Experiments 
Validation of the crystallisation mechanisms and kinetic parameters estimated from the batch 
experiments were considered using periodic flow crystallisation experiments that were 
conducted in either single- or cascaded three-stage PMSMPR crystallisers, as described in 
the earlier sections of this chapter. Two of the coupled periodic flow single-stage PMSMPR 
experiments were used, M-G1 (broad CSD seed) and M-G3 (bimodal CSD seed). In the 
unseeded batch crystallisation, the nuclei were generated initially by primary nucleation and 
were well dispersed in the slurry by stirring. In contrast, for the seeded PMSMPR 
crystallisations, in some cases a significant amount of agglomerates was observed from PVM 
and microscopic images. This was partly due to the seed preparation method whereby the 
material was ground and sieved to the desired size fraction. When these seed crystals were 
added to the feed vessel, initially they were found to agglomerate, especially the broad CSD 
Batch 1 
Batch 2 
Measured 
Predicted 
Predicted 
Measured 
Batch 1 
Batch 2 
Batch 3 Batch 4 
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seed. The imperfect and rough surface of the seed crystals, which were reduced in size by 
grinding, may provide a low enough energy barrier for surface nucleation and bridging, thus 
leading to agglomeration of the crystals. For example, the initial seed and final crystals of M-
G1 experiment were illustrated in Figure 6.8 (broad CSD) and Figure 6.9 (M-G1) earlier. For 
the purpose of this work, to account for the agglomeration kinetics, “Mumtaz kinetics” option 
in gCRYSTAL 4.0 was applied whenever agglomeration was observed in the PMSMPR 
experiments. In this regard, the agglomeration parameter (A50) was fine-tuned in the 
simulation of M-G1 to fit the CSD measurement at SCO while using the crystallisation kinetic 
parameters listed in Table 6.8. A value of 60 × 10-3 N/m for A50 resulted in good agreements 
for both GLY concentration and CSD measurements, as shown in Figure 6.16 for M-G1 
experiment. Further to this, another independent verification of all the kinetic parameters 
obtained so far was demonstrated with M-G3, which was also affected by agglomeration; 
Figure 6.8 (bimodal CSD) and Figure 6.9 (M-G3). Although larger seed crystals with bimodal 
CSD seed were used in M-G3, the model predictions agreed well with the experimental CSD 
measurements, which provides further confirmation of the predictive capability of the 
crystallisation mechanism and kinetic parameters that were estimated here. 
 
Figure 6.16: Comparison of predicted and measured data for period flow single-stage 
PMSMPR runs, M-G1 (‘fine seed’) and M-G3 (bimodal CSD seed). CSD measurements 
were taken at the start of pumping period (i.e., by cop method) after reaching SCO. 
M-G3 
M-G1 
Fine seeds 
Bimodal seed 
Measured 
Predicted 
Predicted 
Measured 
M-G3 
M-G1 
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Validations with coupled periodic flow cascaded three-stage PMSMPR experiments, that is, M-
G5* (broad CSD seed) and M-G7* (bimodal CSD seed), are shown in Figures 6.17, 6.18 and 
6.19, where solute concentration was measured in the third-stage (MSMPR 3) only. Three 
samples were taken at the end of the holding period from each PMSMPR stage and analysed 
by laser diffraction. It should be noted that for a continuous flow MSMPR crystalliser, there is no 
concern when to take samples for off-line CSD measurement, so long as the system reaches 
steady-state. However, in a periodic flow operation, SCO is achieved viz. the system variables 
continuously varying in a limited range. Hence, in order to achieve better matches between 
predicted and measured CSD data, samples should be taken with special care. As the two 
periods of holding and addition/withdrawal are alternately applied during the operation it is better 
to take samples from the cascaded PMSMPR when the crystalliser reaches the end point of the 
holding period, that is, just before the start of the addition/withdrawal period, and in sequence 
from the third-, second and first-stage. In such a way, the crystalliser is most likely to achieve 
the best mixing conditions and also avoid the experimental perturbations caused by macro-
mixing condition resulting from addition and withdrawal of slurry or from sampling the outlet 
streams. Furthermore, taking the samples from the vessel bottom valve is faster compared to 
sampling from the outlet stream transfer lines. The proposed sampling procedure has proven to 
be effective, with better matches between the model predictions and experiments.  
 
Figure 6.17: Comparison of predicted and measured solute concentration in the third-stage 
PMSMPR (MSMPR 3) for M-G5* and M-G7* experimental runs. 
In spite of some uncertainties in the sampling and mixing conditions and the fact that the 
crystallisation kinetic parameters were previously estimated from batch crystallisation 
experiments without further tuning or re-estimations, the proposed model predicted the solute 
concentration and CSD very well, with the exception of sample 3-3 in Figure 6.19 (M-G7*) 
experiment. This may be a consequence of the large bipyramidal hexagonal prism shape 
crystals present, which exhibit varying aspect ratios. This phenomenon will be discussed 
further in Section 6.5.3.   
M-G5* M-G7* 
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Figure 6.18: Comparison predicted and measured CSDs for M-G5* three-stage PMSMPR 
experiment (solid line: predicted; dash line: measured). 
 
Figure 6.19: Comparison of predicted and measured CSDs for M-G7* three-stage PMSMPR 
experiment (solid line: predicted; dash line: measured). 
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In case of the model validation with decoupled periodic flow crystallisation, the single-stage 
PMSMPR, M-G4* (bimodal CSD seed) was used. The model predictions and their comparison 
to the experimental measurements, that is, solute concentration and CSD are illustrated in 
Figures 6.20 and 6.21, show good agreement, with the exception of sample 1-3. As mentioned 
above, this may be due to the existence of very large crystals with varying aspect ratios. 
Furthermore, as shown in the RTD profile (Figure 6.5) of the decoupled periodic PMSMPR, 
the process would take almost 4 hrs. to achieve SCO. Interestingly, in Figure 6.21, the three 
samples taken at 0.36, 2.00 and 2.70 h show a gradual increasing in the measured mean 
crystal size (357.8 µm, 601.8 µm, 683.9 µm, respectively) and broadening of the CSD, which 
is consistent with the increasing values of mean residence time and standard deviation in 
Figure 6.5. 
 
Figure 6.20: Comparisons of predicted and measured concentration for M-G4* decoupled 
flow single-stage PMSMPR experiment. 
 
Figure 6.21: Comparison of predicted and measured CSD for M-G4* decoupled flow 
single-stage PMSMPR experiment (solid line: predicted; dash line: measured). 
It is also interesting to compare periodic flow crystallisation in PMSMPR to continuous flow 
crystallisation in MSMPR. The product CSDs and model prediction for the coupled cascaded 
three-stage MSMPR crystallisers using bimodal CSD seed are shown in Figure 6.22. The 
mean residence time was doubled from 9.36 × 3 = 28.08 min in the continuous flow three-
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stage MSMPR to 20.00 × 3 = 60.00 min in the coupled periodic flow three-stage PMSMPR, 
as discussed in the experimental methods section of this chapter. This corresponded to an 
increase in the experimentally measured volume-based mean particle size, D[4, 3]exp, from 
342.16 µm to 696.76 µm, while the corresponding predicted value, D[4, 3]pred, showed an 
increase from 184.38 µm to 407.64 µm. Although the periodic flow operation has shown the 
benefits over the continuous flow operation, experimentally and in the simulations, there is a 
large mismatch between the measured and model predicted CSD. However, the mismatch is 
even greater for the continuous flow crystallisation. Besides the effect of crystal shape as 
mentioned for the mismatch of periodic flow CSD, the kinetic parameters estimated from the 
batch crystallisation experiments in this study may not be appropriate for the continuous 
MSMPR process since the mixing conditions are so different and may have played a critical 
role in the kinetic parameter estimation. The applicability of these crystallisation kinetics to the 
periodic flow operation may be due to the fact that this is a hybrid operation incorporating both 
batch and continuous operations.  
 
Figure 6.22: Comparisons of predicted and measured CSD for continuous and periodic flow 
operations in cascaded three-stage MSMPR and PMSMPR crystallisers, respectively. 
6.5.3 Uncertainty Analyses and Summary 
There has long been a concern with laser diffraction method for CSD measurement due to 
sometimes significant mismatches between experimental measurements and model predicted 
data (Su et al [275] and the references within). For the most part there is good agreement 
between the experimental CSD measurements and model predictions of the volume-based 
mean particle size D[4, 3], as summarised in Table 6.9, but there are some significant 
M-G7* 
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differences between D[4, 3]exp and D[4, 3]pred in some of the cases. In order to objectively reveal 
the model accuracy, the relative errors were calculated as: 
𝑅𝑒𝑙. 𝑒𝑟𝑟𝑜𝑟 =
𝐷[4, 3]𝑝𝑟𝑒𝑑 − 𝐷[4, 3]𝑒𝑥𝑝
𝐷[4, 3]𝑒𝑥𝑝
× 100 % 6.6  
Table 6.9 provides a summary of the experimental and predicted volume-based mean particle 
sizes for each of the evaluated experiments. The relative error in Eqn. 6 provides a reasonable 
and fair metric for evaluating the model prediction accuracy in each crystallisation experiment, 
provided that the CSD measurements are acquired in a similar way as reported in this work. In 
this regard, the model prediction capability was mostly good, except for the continuous flow 
crystallisation (rel. error of -46.11 %) and PMSMPR bop (rel. error of -23.09 to -41.49 %) 
experiments. For the continuous experiment, the difference in mixing conditions relative to the 
PMSMPR may have played a critical role. In case of the PMSMPR bop runs, classified 
withdrawal due to removal of slurry from the bottom valve is the crucial factor, which is reflected 
more prominently in the results from the last stage of the three-stage PMSMPR cascade 
experiments where the mean particle size is largest. 
Table 6.9: Comparisons of volume-based mean particle size D43 
Experiments D[4, 3]exp (µm) D[4, 3]pred  (µm) Rel. error 
Batch 
 
Sample at end Batch 1 498.99 454.62 -8.89 % 
Sample at end Batch 2 447.86 360.00 -19.62 % 
Sample at end Batch 3  - 321.99 - 
Sample at end Batch 4  - 319.27 - 
M-G1 Controlled state average 167.48 183.21 9.39 % 
M-G3 Controlled state average 287.64 216.60 -24.70 % 
M-G5* 
Sample 3-1 238.10 226.67 -4.80 % 
Sample 3-2 278.70 264.55 -5.08 % 
Sample 3-3 348.30 267.87 -23.09 % 
M-G7* 
Sample 3-1 364.41 362.34 -0.57 % 
Sample 3-2 519.54 409.39 -21.20 % 
Sample 3-3 696.76 407.64 -41.49 % 
M-G4* 
Sample 1-1 357.83 362.89 1.41 % 
Sample 1-2 601.78 431.65 -28.27 % 
Sample 1-3 683.88 418.52 -38.80 % 
M-CG4 Steady-state 342.16 184.38 -46.11 % 
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The relative error shows an increasing trend in experiments M-G5*, M-G7*, and M-G4* when 
the crystals grow into large size domains, which results in an obvious mismatch in the mean 
D[4, 3] crystal size and CSD, for example, sample 3-3 in Figure 6.19 and sample 1-3 in Figure 
6.21. One of the possible reasons argued was that the GLY crystals shows a bipyramidal 
hexagonal prism morphology with varying aspect ratios, as illustrated by the PVM images 
taken for M-G7* experiment in Figure 6.23, as an example. The adverse effect of varying 
aspect ratio on CSD measurements by laser diffraction method can be significant when the 
particles are large enough, which could also explain the increasing trend in relative prediction 
errors. In future work, a multiple dimensional population balance model would be necessary 
to reduce the prediction error and control the crystal shape, for example along the lines of 
Majumder and Nagy [276], Kwon et al [81], and Jiang et al [140]. Potentially, in situ PVM 
images which provide crystal shape and size measurements could provide the required 
information as demonstrated by Zhou et al [166]. Herein, it has been shown that the estimated 
crystallisation mechanism and kinetics from batch cooling crystallisation experiments give 
good predictive capability when tested on either coupled periodic flow crystallisation in single- 
and three-stage PMSMPR or decoupled periodic flow crystallisations in a single-stage 
PMSMPR, which proves that they can be implemented for process design, optimisation, and 
control. 
 
Figure 6.23: PVM images taken for the third-stage PMSMPR (MSMPR 3) of M-G7*. 
6.6 Conclusions 
The seeded cooling crystallisation of a fast growing API (GLY) was demonstrated using single- 
and three-stage cascaded configurations of the novel periodic flow PMSMPR crystalliser 
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operated in either coupled or decoupled mode. Conventional continuous MSMPR 
crystallisations were also conducted for comparison. The seed crystal properties (size, shape 
and CSD) affected the product size and overall quality and the time to achieve SCO in the 
single-stage PMSMPR, with larger seed sizes producing more uniform product crystals, and 
leading to a faster approach to a controlled state of operation. For cascaded three-stage 
crystallisations the opposite result was observed whereby the smaller seed crystals led to a 
faster approach to a controlled state of operation, that is, SCO in the PMSMPR. It appears 
that not only do the seed properties affect the approach to a controlled state, but also the rate 
of change of supersaturation. For the three-stage crystallisations, supersaturation was 
generated at a slower more gradual rate compared to the single-stage crystallisations. This 
leads to a more rapid approach to a controlled state of operation when fine seed material was 
used. There was no clear correlation between the yield of crystallisation and number of 
PMSMPR stages. However, the yield of crystallisation was significantly higher for PMSMPR 
crystallisations compared to the equivalent continuous MSMPR crystallisations in all cases. 
This was due to longer residence time for crystal growth in the former by introducing holding 
or batch operating cycles. The product crystals were also of better overall quality, having larger 
mean sizes and more uniform shape. The two different modes of PMSMPR operation 
demonstrated, that is, coupled and decoupled periodic flow showed markedly different results. 
Under decoupled periodic flow single-stage PMSMPR operation a longer time to SCO, and 
larger mean crystal sizes were observed based on FBRM counts/s measurements, compared 
to the equivalent coupled operation. Furthermore, the mean crystal size and CSD determined 
by laser diffraction did not show SCO behaviour. The results may be a reflection of the different 
mixing conditions and problems with flow control in the decoupled experiment. 
The effect of sample collection point on mean product crystal size and CSD in the PMSMPR 
and continuous MSMPR operations was also investigated. For the PMSMPR crystallisations, 
samples taken from the crystalliser bottom valve during batch operation periods were of 
consistently larger size compared to samples taken from the crystalliser outlet transfer line 
during continuous operation periods. Laser diffraction analysis showed that the volume 
weighted mean sizes of crystals were significantly larger for the former case (343 - 709 µm) 
compared to the latter (161 - 519 µm). Sampling from the equivalent continuous MSMPR 
experimental runs confirmed that withdrawal from the bottom valve resulted in larger crystals 
compare to withdrawal at the crystalliser outlet transfer line. The straightforward explanation 
is that large crystals settle at a faster rate when product is withdrawn from the bottom valve. 
Arguably, withdrawal from the outlet transfer line leads to more representative product, in 
particular, where high withdrawal rates are employed that lead to high particle transfer 
velocities. The sampling results require further investigation to determine the best product 
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withdrawal strategy for the PMSMPR operation. The combined used of integrated PAT array 
in with CryPRINS information systems software package within the IDS framework led to 
effective monitoring and characterisation of the periodic flow process, and determination of 
when SCO was attained. 
Simulation of the RTD profiles of the periodic flow operation (PMSMPR) was demonstrated 
and compared to that of the conventional continuous flow operation (MSMPR). The merit of 
extending the mean residence time without broadening the RTD too much in periodic flow 
operation makes it an attractive crystallisation system, especially since the mean residence 
time is an important design variable. Mathematical modelling and simulation of the periodic 
flow crystallisation processes using the single- and three-stage PMSMPR crystallisers 
(operated in coupled and decoupled modes) were demonstrated. The crystallisation 
mechanisms and kinetic parameters for GLY crystallised from water were estimated from 
unseeded batch crystallisation experiments and verified with periodic flow single- and three-
stage PMSMPR experiments. Reasonably good agreements were obtained between the 
experimental measurements and model predictions for concentration and CSD evolution. The 
model uncertainties were analysed and future work suggested. Moreover, the advantages of 
periodic flow crystallisation were proven through both experiments and simulations. 
Overall, results of this study indicate that coupled periodic flow crystallisation in the PMSMPR 
is the most efficient mode of operation, leading to better process control, faster approach to 
SCO and the mitigation of crystalliser wall fouling, crust formation and transfer line blockages. 
This is attributed to the intermittent operation which utilises high flow rates for isokinetic slurry 
transfer, whilst maintaining constant volume. In addition, the tuneable hold or batch cycle can 
lead to rapid desupersaturation (solute depletion) and crystal growth (system dependent), 
thereby producing more consistent particles (size and shape) relative to batch, MSMSR and 
decoupled PMSMPR operations. 
179 
 
Chapter 7 
Periodic Flow Crystallisation of Co-Crystals 
Using PMSMPR: Case of Urea-Barbituric Acid 
In this Chapter, periodic flow crystallisation of the polymorphic Urea-barbituric acid (UBA) 
co-crystal system is investigated. Pharmaceutical co-crystals are multi-component molecular 
systems typically formed through hydrogen bonding of a benign co-former molecule with the 
active pharmaceutical ingredient (API). Just as single component molecular systems can 
exhibit polymorphism due to the geometry of hydrogen bond donors and acceptors, the same 
is true for pharmaceutical co-crystals. In this study, the selective co-crystallisation of UBA 
forms I and III polymorphs is demonstrated, applying the novel periodic mixed suspension 
mixed product removal (PMSMPR) crystalliser described in Chapters 5 and 6. The PMSMPR 
was operated as a cascade of three-stage crystallisers. Three different start-up strategies 
were employed and their ability to produce selectively a particular polymorphic form of UBA 
evaluated. The experimental conditions for producing pure UBA form I were optimised, but the 
isolation of pure UBA form III remained elusive. The crystallisations were monitored using the 
integrated process analytical technologies (PAT) and CryPRINS informatics systems software 
within the IDS framework described in Chapter 3, to determine when a “state of controlled 
operation” (SCO) was achieved. Off-line characterisation of the UBA polymorphs was carried 
out using several solid-state characterisation techniques.  
7.1 Introduction 
Modification of the structure and molecular composition of an API by applying crystal 
engineering principles can lead to significant improvements to the stability, bioavailability and 
polymorphic properties of a drug. Pharmaceutical co-crystal formation has gained popularity in 
recent years as a feasible method for modifying APIs primarily to improve solubility and hence 
their bioavailability. Pharmaceutical co-crystallisation involves the formation of a crystal 
containing the API with a benign co-former molecule in specific stoichiometric ratios [277]. 
Similar to single component systems, co-crystals may exist in two or more polymorphic forms, 
which present an added complexity to the manufacture of these molecular systems for 
specialised use. This study looks at the selective co-crystallisation of UBA co-crystal polymorphs 
at laboratory scale using a PMSMPR crystalliser [262] operated in coupled periodic flow mode. 
The PMSMPR was configured and operated as a three-stage cascade in order to selectively 
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isolate the polymorphic forms of the UBA co-crystal system. There are three known polymorphs 
of UBA, as discovered by Krawczuk et al [278], [279] using small scale evaporative 
crystallisation techniques. The mole ratio of urea to barbituric acid (BA) is 1:1 for all three co-
crystal polymorphic forms of UBA. Forms I and III exhibit similar physicochemical properties, 
such as solubility and melting points and often crystallise together as a mixture, from which it is 
really difficult to isolate either of the co-crystal forms. Form II appears to be metastable and is 
the most elusive of the three co-crystal forms [278], [279]. Figure 7.1 show the chemical 
structures of urea and BA, and the crystal structures of UBA forms I and III.  
 
Figure 7.1: Chemical structures of BA (a) and (b) and urea (c) and (d), and crystal structures 
showing hydrogen bonding network of UBA form I (e) and UBA form III (f). 
Anhydrous BA itself is known to form four polymorphs [277], [278], [280]; the crystal structures 
of form I and II have been determined by single crystal X-ray diffraction [277], [281]. Many of 
the derivatives of BA also crystallise in several different polymorphic forms [278] and are also 
capable of forming a variety of co-crystal polymorphs. Zerkowski et al [282]–[287] used BA 
derivatives such as barbital and a series of melamine derivatives to generate a range of 
different hydrogen bonded supramolecular motifs [288], [289], isolating and structurally 
characterising more than 60 co-crystals. These studies illustrate the potential diversity of 
co-crystal forms that can exist for a particular API. This diversity can offer exciting 
opportunities to develop novel and improved crystalline forms of APIs [288]. However, the 
preparation of co-crystals as described in the literature indicates the notoriously difficult 
situation these systems present [289].  
Pharmaceutical co-crystals are typically discovered by solvent evaporation [290], [291], 
cooling crystallisation [292], [293], precipitation [294], dry grinding [293], [295]; solvent-
assisted grinding [296] or sonication (applied to either to wet or dry solid mixtures) [297], [298]. 
However, cooling crystallisation is the most commercially feasible of these methods and can 
(a) (b) (c) (d) 
(f) (e) 
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afford superior control in preparation of co-crystals on an industrial scale. Polymorph control 
is critical in industrial crystallisation of fine chemicals [82], where the polymorphic form has a 
significant influence on the physical attributes of the material, and this can prove even more 
challenging for multi-component co-crystal systems. Therefore, from an industrial perspective, 
the polymorphic UBA co-crystal system proves particularly interesting and is utilised in this 
study as a model multi-component system to investigate polymorph control in multi-
component cooling crystallisation using periodic flow operation. In this approach the concept 
of “state of controlled operation” (SCO) is used to describe the periodic flow process [262].  
7.2 Experimental Methods 
In this study, control over the crystallisation of UBA co-crystal polymorphs that exhibit similar 
physicochemical properties is demonstrated viz cooling co-crystallisation in periodic flow 
PMSMPR crystallisers. The concept of SCO instead of “steady-state” is used to describe when 
the periodic flow operation is under control. Figure 7.2 provides a comparison of the trajectory 
through the phase diagram for the crystallisation of UBA in batch, continuous flow MSMPR 
cascade and periodic flow PMSMPR cascade modes, respectively. 
 
Figure 7.2: Phase diagram showing trajectory of batch, MSMPR and PMSMPR operations. 
UBA forms I and III in methanol. 
7.2.1 Barbituric Acid and Co-Crystals Physicochemical Properties 
Analyses of the solubilities and melting points of UBA forms I and III and their parent API, BA 
were carried out. These studies showed that UBA forms I and III have very similar 
physicochemical properties, but are markedly different from BA in this respect. 
Solubility Studies in Methanol and Water: The Avantium benchtop Crystalline® with 8 parallel 
reactors was used for solubility determination viz turbidity measurements as described in 
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Chapter 3, Section 3.6.3. Figure 7.3 (a) and (b) show the solubility curves obtained for UBA 
forms I and III, and BA in methanol (MeOH) and water, respectively. The solubility curves for 
UBA form I and III are strikingly similar in both solvent systems. 
 
Figure 7.3: Solubility curves obtained in MeOH and water for UBA forms I and III and BA. 
Melting Point Studies: Melting point studies were carried out using the TA Instrument Q10 
Differential Scanning Calorimeter (DSC). Experimental conditions and data treatment were 
described in Chapter 3, Section 3.2.2. Different scan rates were implemented, ranging from 
0.5 to 10 oC/min. Figure 7.4 show the DSC profiles for UBA forms I and III, and indicates the 
melting temperatures were 191.5 oC and 193.4 oC, respectively.  
 
Figure 7.4: DSC profiles of UBA forms I (left) and III (right), 10 oC/min heating rate.  
Recrystallisation points at 195.3 oC for UBA I and 196.0 oC for UBA III indicate that there may 
be a “high temperature” polymorph of the UBA co-crystal system that has not been previously 
isolated. Immediately following recrystallisation, a melt event is detected in both systems. 
These DSC profiles provide further evidence of similarities between UBA forms I and III. While 
the DSC results were interesting, the aim of the study was not structure elucidation. Work is 
ongoing as part of a separate project with collaborators from the University of Bath to isolate 
the suspected “high temperature” polymorph of UBA. 
Water MeOH 
UBA I UBA III 
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7.2.2 Off-line Solid-State Characterisations 
To complement on-line PAT measurements, off-line solid-state techniques were used to aid 
characterisation of the batch, semi-batch and PMSMPR crystallisations of UBA co-crystals from 
MeOH. Samples were removed from each vessel at regular time intervals using a 10 mm ID 
glass pipette and transferred immediately onto a vacuum filter to minimise time for polymorph 
conversion. Samples were immediately washed with cold methanol to prevent cementation due 
to evaporation of the process liquor. Laser diffraction (particle size, shape and distribution), 
Powder X-ray diffraction (PXRD) and Raman microscopy (method reported in Chapter 3; PXRD 
and Raman results reported in Appendix II) analyses were carried out to identify the UBA 
co-crystal polymorph obtained from each experiment. UBA forms I and III exhibit characteristic 
morphologies under the crystallisation conditions employed in this study. Figure 7.5 shows 
microscope images of UBA forms I and III captured under normal and polarised light. UBA form 
I crystallises as semi-transparent crystals that readily agglomerate, exhibiting a rosette type 
morphology. UBA form III crystallises from MeOH as opaque crystals which show a greater 
tendency to agglomerate compared to UBA form I. The crystal agglomerates of UBA form III 
exhibits “coffee bean” type morphology. 
 
Figure 7.5: Polarised microscope images of UBA forms I (top left) and III (top right). Normal 
microscope images of UBA forms I (bottom left) and III (bottom right) single crystals. 
7.2.3 Semi-Batch, Batch and Periodic Flow Crystallisation Studies 
The crystalliser configurations used for the semi-batch, batch and periodic flow crystallisation 
experiments were presented in Chapter 3, Sections 3.6.1 and 3.6.2. The operating volume of 
the laboratory scale crystallisers was 500 mL. A number of smaller scale batch studies were 
also carried out at 5 mL volume. Stirrer speed was set to 450 rpm at 500 mL scale unless 
otherwise state. The approximate power per unit volume from the selected impeller speed was 
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0.084 kW/m3. The selected impeller power input leads to homogeneous suspension of slurry 
inside each crystalliser, satisfying the MSMPR assumption. Due to fouling issues, data 
obtained from in situ Raman and ATR-UV/vis probes were not sufficiently reliable for 
characterising the systems studied.  
Small Scale Co-Crystallisation Experiments: The small scale batch cooling 
co-crystallisation experiments were conducted using the Avantium Crystalline® system. 
Duplicate experiments were carried out using the 8 parallel reactors operated at five different 
cooling rates (0.05, 0.5, 1, 2 and 3 oC/min) and stirring speeds (400, 600, 800, 1000 and 1200 
rpm). For each experimental run a suspension of urea and BA in MeOH was equilibrated at 
20 oC for 30 min with stirring, followed by heating at a rate of 1oC/min to 60 oC and holding for 
60 min. The sample was then cooled at a pre-determined rate to a final temperature of 10 oC. 
Samples were collected, filtered and dried overnight at 40 oC and stored in borosilicate glass 
vials for subsequent solid-state characterisation.  
Semi-Batch and Batch Co-Crystallisation Experiments: Experiments were carried out to 
guide later development of a three-stage periodic flow PMSMPR process. A number of seeded 
and unseeded co-crystallisation experiments were carried out to determine the most suitable 
conditions for obtaining UBA forms I and III, respectively. The crystalliser temperature was 
adjusted over different experimental runs to determine the effect on the polymorphic composition 
of the end product. A 2:1 mole ratio of urea:BA was used throughout this work due to the high 
solubility of urea in methanol. Without an excess of urea only the BA starting material 
crystallises. Therefore, it was necessary to ensure that urea concentration was high enough 
to encourage co-crystallisation with BA. The experiments were carried out in three ways: 
1. Method 1 (batch): A 2:1 mole ratio solution of urea:BA was prepared in the 500 mL 
crystalliser (0.014 g urea/g MeOH and 0.015 g BA/g MeOH) at 55 °C. 
2. Method 2 (semi-batch): 130 mL of urea (0.078 g urea/g methanol) solution and 400 
mL of BA (0.018 g BA/g methanol) solution were prepared in separate vessels. Urea 
solution was then added to BA solution at a rate of 10 g/min to give a final solution 
composition of 2 moles urea to 1 mole BA.  
3. Method 3 (semi-batch): The same solutions as in Method 2 above were prepared. 
However, urea solution was added rapidly to BA solution by manual addition to give a 
final solution composition of 2 moles urea to 1 mole BA.  
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Figure 7.6 shows the flow diagram of the semi-batch experimental configuration used in the 
co-crystallisation studies. Table 7.1 provides a summary of the experimental conditions 
employed during the batch and semi-batch co-crystallisation studies.  
 
Figure 7.6: Flow diagram showing of the semi-batch configuration used for the 
co-crystallisation studies. 
The batch experiments were carried out with seed addition viz Method 1, using 10 % of either 
UBA form III as seed (i.e. based on theoretical mass of UBA with 1:1 mole ratio of urea:BA in 
solution). The crystalliser containing urea-BA solution was cooled from 55 oC to the saturation 
temperature of UBA (43 °C) and seeded with 10 % UBA form III. The vessel was then cooled 
at a specific rate as indicated in Table 7.1 and then held at the specified final temperature. For 
the unseeded semi-batch experiments, urea and BA solutions were dissolved separately and 
held at either 30 or 35 oC. At the start of each experiment, urea was added to BA solution in the 
crystalliser (Method 2 or Method 3) held at the temperatures specified in Table 7.1. 
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Table 7.1: Experimental conditions employed for the batch and semi-batch co-crystallisations. 
Exp. 
No. 
Exp. 
Type 
Exp. 
Method 
Temperature (°C) 
Exp. Time 
(h) 
Cooling 
Rate 
(°C/min) 
UBA 
Form 
Obtained 
Urea 
Soln. 
BA 
Soln. 
Start Final 
1a unseeded 3 30 30 10 10 #2.8 rapid I 
1b unseeded 3 30 30 10 10 #2.8 rapid I 
2a unseeded 2 30 30 10 10 #2.8 rapid I 
2b unseeded 2 30 30 10 10 #2.8 rapid *mix I-III 
3a unseeded 3 30 30 20 20 #2.8 rapid I 
3b unseeded 3 30 30 20 20 #2.8 rapid I 
4a unseeded 2 30 30 20 20 #2.8 rapid ●mix I-III 
4b unseeded 2 30 30 20 20 #2.8 rapid ●mix I-III 
5a unseeded 2 30 30 30 30 #2.8 n/a ◊mix I-III 
5b unseeded 2 30 30 30 30 #2.8 n/a ◊mix I-III 
6a unseeded 2 35 35 35 35 #2.8 n/a ◊mix I-III 
6b unseeded 2 35 35 35 35 #2.8 n/a ◊III 
7a unseeded 2 35 35 35 35 #2.8 n/a ◊III 
7b unseeded 2 35 35 35 35 #2.8 n/a ◊III 
10 unseeded 2 30 30 30 30 1 n/a ◊mix I-III 
11 unseeded 2 35 35 35 35 1 n/a ◊mix I-III 
12 unseeded 2 35 35 35 23 ŧ24 DNC I 
13 unseeded 2 30 30 30 30 1 n/a ●mix I-III 
14 unseeded 2 30 30 30 30 1 n/a ‡mix I-III 
15 seeded (III) 1 n/a n/a 43 10 2.8 0.5 III 
16 seeded (III) 1 n/a n/a 43 10 2.8 0.5 ▼mix I-III 
17 seeded (III) 1 n/a n/a 43 10 2.8 0.5 ▼mix I-III 
18 seeded (III) 1 n/a n/a 43 10 2.8 0.5 ●mix I-III 
19 seeded (III) 1 n/a n/a 43 10 14.3 0.06 I 
(I) UBA form I; (III) UBA form III; #Sampling at 2.8 h followed by holding for 24 h; ‡dynamic nucleation control (DNC) 
[224], [260], [299] performed on final mixture for 24 h (set-point was 3000 ± 1000 counts/s); *mix I-III (prevalent form 
I, increasing with time); ▼mix I-III (prevalent form III, form I increases as temperature is decreased); ◊mix I-III 
(prevalent form III, form I increasing with time); ◊III (pure form III after 2.8 h, form I starts to appear after 24 h) and 
●mix I-III (~50:50 mixture of form I and form III). 
 
Unseeded Periodic Flow Co-Crystallisation Experiments: These studies were carried out 
using the configurations described in the flow diagram of Figure 7.7 (Config. 1) and (Config. 
2) below. The PMSMPR was configured with either four or five vessels depending on the 
method used to combine the urea co-former with the BA target material. In Config. 1, four 
vessels were arranged in series, consisting of a 6 L capacity feed vessel with premixed UBA 
solution and a cascade of three 500 mL PMSMPR crystallisers. Config. 2 consisted of a feed 
stream with two vessels, one 6 L (working volume 5.3 L) and one 1.3 L capacity containing 
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BA and urea solutions, respectively. The solutions were fed to a cascade of three 500 mL 
PMSMPR crystallisers. The temperature sets used over the three-stages of PMSMPR were 
tuned to obtain either pure UBA form I or III based on preliminary findings from the batch and 
semi-batch co-crystallisation runs. 
Figure 7.7: Flow diagram showing the configurations of the PMSMPR cascade units used 
during the unseeded periodic flow co-crystallisation study (sat. temp. = saturation 
temperature with respect to UBA co-crystal). 
For Config. 1, 6 L of UBA solution (0.014 g urea/g methanol and 0.015 g BA/g methanol) was 
prepared in the feed vessel to give a 2:1 molar ratio of the urea:BA. The urea and BA starting 
materials were dissolved together at 55 °C, then cooled and held at 43 °C (saturation 
temperature of UBA at the specified concentration of feed solution). At start-up, all three 
PMSMPR crystallisers were initially empty and held at the pre-specified operating 
temperatures as shown Figure 7.7 (note that the conditions are indicative as a range of 
different temperature sets were investigated). UBA feed solution was pumped at a rate of 52.7 
g/min for 7.40 min to the first-stage PMSMPR crystalliser (MSMPR 1, which acts as the 
nucleator stage). The MSMPR 1 was held at its pre-specified temperature for 12.60 min 
(holding period) before the resulting slurry was transferred to the second-stage (MSMPR 2). 
The third-stage (MSMPR 3) was filled from the MSMPR 2 in a similar way. A coupled periodic 
flow operating procedure (described in Chapters 5 and 6) was implemented once all vessels 
were filled and for the duration of each experimental run. 
For Config. 2, solutions of 0.078 g urea/g methanol (1.3 L) and 0.018 g BA/g methanol (5.3 L), 
respectively, were prepared in separate feed vessels by heating the materials in each vessel 
to 30 oC and holding for 15 min to ensure complete dissolution. The two feed solutions were 
Config. 1 (sat. temp. = 43 oC)  
Config. 2 (sat. temp. urea = 43oC) 
) 
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then cooled to 20 oC and held at this temperature. The separate urea and BA streams were 
combined in either of two ways: 
1. Method 1: Pumping concurrently at rates of 10.00 g/min (urea solution) and 42.72 
g/min (BA solution), respectively to the first-stage PMSMPR for 7.40 min This resulted 
in a solution composition of 0.014 g urea/g methanol and 0.015 g BA/g methanol (2:1 
molar ratio). 
2. Method 2: BA solution pumped to the first-stage PMSMPR at a rate of 42.72 g/min for 
7.40 min, followed by rapid manual addition of the required amount of urea solution, 
to give a 2:1 molar ratio of the urea to BA. Rapid manual addition was done only once 
(i.e. at start-up). Subsequent to this, a concurrent pumping procedure as described 
for Method 1 above was implemented for the duration of the experiment. 
For each operation (i.e. Config. 1 or Config. 2), Method 1 or Method 2, the same overall feed 
rate flow was maintained (52.7 g/min). The solution(s) are mixed instantaneously on entering 
the first-stage, creating supersaturation for subsequent nucleation of UBA co-crystal(s). The 
nucleated suspension is held in the first-stage for 12.60 min following the procedure described 
for Config. 1. Subsequent transfer of slurry from the first- to the second-stage and from the 
second- to the third-stage employed the same operating procedure as described for Config. 1. 
For both Config. 1 and Config. 2, the sum of the addition/withdrawal and holding periods (20 
min) represent the overall periodic flow mean residence time (RTPO) in each stage of the 
PMSMPR cascade; hence, the total RTPO is 60 min for all three stages combined.  
Unseeded continuous crystallisation experiments were carried out for comparison with the 
periodic flow approaches described above. The continuous flow MSMPR cascade unit was 
configured as shown in Figure 7.7 (Config. 1). The continuous addition and withdrawal flow 
rates for each stage of the MSMPR cascade during the co-crystallisations were the same as 
those used in the periodic flow experiments. Therefore, the continuous flow mean residence 
time (RT) achieved per MSMPR stage was only 7.40 min, as opposed to 20 min. Table 7.2 
gives a summary of the experimental conditions for each of the unseeded periodic and 
continuous flow co-crystallisations carried out during the study.  
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Table 7.2: Experimental conditions employed for the unseeded and periodic flow and 
continuous co-crystallisation experiments. 
Expt. 
No. 
Exp. 
Config. 
Mixing 
Method 
Expt. 
Type 
Temperature (°C) 
MSMPR 1 MSMPR 2 MSMPR 3 
1 1 n/a unseeded 20 30 10 
2 2 ʬ1 unseeded 20 30 20 
3 2 ŧ2 unseeded 20 30 20 
4 2 ŧ2 unseeded 15 10 5 
5a Conti ʬ1 unseeded 20 30 20 
5b Conti ʬ1 unseeded 20 30 20 
n/a - not applicable; Conti - continuous co-crystallisation run; ʬslow addition of urea to BA at 10 g/min from start-up 
to the end of experiment;  ŧrapid manual addition of urea to BA at start-up, thereafter addition rate of 10 g/min. 
Seeded Periodic Flow Co-Crystallisation Studies: Figure 7.8 (Config. 3) shows the block 
configuration of the PMSMPR crystalliser used for the seeded co-crystallisation of UBA. Prior to 
start-up, 6 L of UBA solution (0.014 g urea and 0.015 g BA/g methanol, in a 2:1 mole ratio) was 
prepared in the feed vessel at 55 °C. The vessel was cooled to 43 °C and then seeded with 10 
% UBA form I or III. The seed material used was either UBA form I or III obtained from prior 
batch cooling crystallisation experiments. The UBA seed suspension was held at 43 °C for 30 
min prior to start-up to allow time for crystal healing and Ostwald’s ripening [300]. Seed 
suspension was then pumped to the first-stage PMSMPR at a rate of 52.7 g/min for all 
experiments except for run 6 for which the flow rate was 41.7 g/min. Table 7.3 gives a summary 
of the experimental conditions for each of the seeded periodic flow co-crystallisation runs carried 
out during the study. Note that initial method development experiments were carried out at 41.7 
g/min, however, due to particle settling (based on visual inspection) the higher flow rate of 
52.7g/min was selected. A periodic operation as described for the unseeded experiments was 
employed during the seeded co-crystallisation study; the flow rates, slurry addition/withdrawal 
and holding periods were also the same. 
 
Figure 7.8: Flow diagram showing the block configuration of the PMSMPR cascade unit 
used during the seeded periodic flow co-crystallisation studies (sat. temp. = saturation 
temperature with respect to UBA). 
Config. 3 (sat. temp. = 43 oC) 
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Table 7.3: Experimental conditions employed for the seeded periodic flow and continuous 
co-crystallisation experiments. 
Expt. 
No. 
Exp. 
Config
. 
Expt. 
Type 
Temperature (°C) 
MSMPR 1 MSMPR 2 MSMPR 3 
6 3 seeded (I) 27 17 10 
7a 3 seeded (I) 33 23 10 
7b 3 seeded (I) 33 23 10 
8 3 seeded (III) 20 20 10 
9 3 seeded (III) 35 30 25 
(I) UBA form I co-crystal seed; and (III) UBA form III co-crystal seed. 
7.3 Results and Discussion  
7.3.1 Small Scale Batch Co-Crystallisation Experiments 
The small scale experiments using the Avantium Crystalline® system produced pure UBA forms 
I and III, and mixtures over a range of mixing and cooling rates. A total of 50 experiments, which 
included duplicates were conducted; the results in terms of the polymorphic outcomes are 
presented in Table 7.4. The results from the small scale cooling co-crystallisation study did not 
show any obvious pattern in terms of the mixing and cooling rate effects on the polymorph 
outcomes, which is perhaps due to the high degree of similarity between energies of the two co-
crystals (i.e. assumption based on their similar solubility profiles). However, the experiments did 
shed some light on the behaviour of the UBA co-crystal system at high and low stirring rates. 
Although, the results are not consistent over all the duplicate experimental runs as shown in 
Table 7.4, it appears that at very high stirring rates (800 – 1200 rpm), UBA form III is the more 
favoured polymorph. The inconsistencies observed during the small scale experimental runs 
can be attributed to nucleation on the walls of the reactor due to turbulent mixing, particularly at 
high stirring rates. This leads to the formation of crusts that then act as seed promoting 
secondary nucleation in the reactor. Another factor to take into account is that at small scale, 
the mixing behaviour is much different compared to large scale. 
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Table 7.4: Results from small scale batch (Avantium Crystalline®)  co-crystallisation 
experiments. 
Exp. No. 
Cooling Rate 
(°C/min) 
Stirring Rate 
(rpm) 
UBA Form Obtained 
Run 1 Run 2 
1 0.05 400 mix I-III (prevalent III) mix I-III (prevalent III) 
2 0.05 600 mix I-III (prevalent III) mix I-III (prevalent III) 
3 0.05 800 mix I-III (prevalent I) I 
4 0.05 1000 *mix I-III (prevalent I) n/a 
5 0.05 1200 *mix I-III (prevalent III) *mix I-III (prevalent III) 
6 0.5 400 mix I-III mix I-III (prevalent III) 
7 0.5 600 I III 
8 0.5 800 *mix I-III (prevalent I) III 
9 0.5 1000 *mix I-III (prevalent I) mix I-III (prevalent III) 
10 0.5 1200 III I, trace III 
11 1 400 III I, trace III 
12 1 600 I III 
13 1 800 I, trace of III *mix I-III (prevalent I) 
14 1 1000 I, trace of III III 
15 1 1200 III III, trace I 
16 2 400 mix I-III (prevalent III) I 
17 2 600 *mix I-III (prevalent I) III 
18 2 800 I, trace of III mix I-III (prevalent I) 
19 2 1000 *mix I-III (prevalent I) I 
20 2 1200 I mix I-III (prevalent III) 
21 3 400 III I 
22 3 600 III I 
23 3 800 I III 
24 3 1000 I *mix I-III (prevalent III) 
25 3 1200 III, trace of I mix I-III (prevalent III) 
          *Result affected by encrustation caused by splashing on vessel walls from vigorous stirring  
7.3.2 Batch and Semi-Batch Co-Crystallisation Experiments  
The complexity of separating polymorphic systems that exhibit similar properties (e.g. 
solubility, in the case of enantiotrophic systems) in continuous flow has recently been studied 
[52], [82]. Due to the unusual similarity in the physicochemical properties of UBA forms I and 
III co-crystal polymorphs has highlighted in Section 7.2.1, these systems present a unique 
challenge for separation in the periodic flow PMSMPR crystalliser. Therefore, a series of batch 
and semi-batch co-crystallisations were performed to identify conditions suitable for the 
selective crystallisation of UBA forms I and III, respectively. The outcome of the various batch 
and semi-batch co-crystallisations under different experimental conditions was presented 
earlier in Table 7.1. The results highlight batch-batch variabilities, however, UBA form I could 
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be isolated under certain conditions. For example, experiments 1a – 3b show that UBA form I 
was more favourably obtained at low temperatures and with rapid initial mixing of urea and BA 
(Method 2). However, isolation of UBA form III was more complex and required intensive 
investigation. It appears that UBA form III is favoured at high temperatures and with slow initial 
mixing of urea and BA. The co-crystallisation outcomes reported (Table 7.1) were based on 
off-line PXRD and Raman microscopy analyses on samples collected after each batch run. 
Experiments 11 – 14 were carried out under unseeded conditions using Method 2 whereby 
urea solution was added to BA solution at a rate of 10 g/min to give a solution composition of 
2:1 moles urea:BA. The effect of manipulating three variables was investigated in these 
experiments: (1) the addition rate of urea solution, (2) the impeller stirring speed and (3) the 
process temperature. The urea addition rate can determine the local rate of supersaturation 
generation and also influences the initial mixing of urea and BA. The stirring speed affects 
mixing dynamics of the process, and hence the distribution of supersaturation. Finally, 
temperature is a crucial variable since there are some indications that the co-crystals 
polymorphs may be enantiotropic. In the preliminary small-scale experiments, UBA form III 
was found to be more stable at higher temperatures compared to UBA form I, hence the 
operating temperature range was restricted to between 30 – 35 °C in the lab scale batch and 
semi-batch operations. With respect to urea addition rate to BA, a slow rate (10 g/min) favours 
nucleation of UBA form III, whilst a fast rate favoured UBA form I. When impeller mixing speed 
was investigated, there was no clear relationship to the polymorphic outcome. For the majority 
of the unseeded semi-batch cooling co-crystallisation experiments, mixtures of UBA forms I 
and III were obtained. Pure UBA form III was the primary product soon after nucleation, with 
UBA I crystals appearing and increasing over time, as determined by off-line Raman and 
PXRD. This suggests a solution phase mediated transformation from UBA form III to I. 
Experiments 11 and 12 both resulted in predominantly UBA form III product, with only a trace 
of UBA form I detected. For experiment 12, step-wise rapid cooling (at -1.0oC/min; holding at 
each step for 60 min) was undertaken from 35 °C to 32 °C, 28 °C and 23 °C, followed by 
application of dynamic nucleation control (DNC) for 24 h to examine the effect on the amount 
of UBA form I. Samples were taken at each step and after implementation of DNC. The amount 
of UBA form I was found to increase with each successive cooling step. The mixture was then 
held at 23 °C for 60 min, which led to a further slight increase in the amount of UBA form I, but 
with the mixture remaining predominantly UBA form III. DNC was conducted on this final 
mixture at 23 oC for 24 h to determine the effect of this temperature cycling approach on the 
polymorphic composition. DNC is a concept proposed by Nagy et al. [260], [299] and uses 
information on particle numbers (counts/s) provided by FBRM in a feedback control strategy 
that adapts the process temperature to promote dissolution, nucleation or crystal growth so 
that the desired quality of product is achieved, for example large crystals with a narrow crystal 
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size distribution (CSD) [299]. However, the objective here was to determine the effect of DNC 
cycles on the polymorphic composition of the mixture of UBA forms I and III. At the end of the 
DNC experiment, pure UBA form I was obtained, an indication that it is the more stable co-
crystal polymorph. Experiments 15 – 19 were carried out under seeded conditions. For 
experiments 15 – 18 a cooling rate of -0.5 °C/min was implemented. Despite the similar 
operating conditions for these runs, different polymorphic outcomes were obtained, confirming 
that the batch crystallisation process is inherently variable. In experiment 19, a slower cooling 
rate (0.06 °C/min) was employed, and resulted in pure UBA form I product, although the 
experiment was initially seeded with UBA form III. The results from the small-scale batch, and 
lab scale batch and semi-batch experiments indicated that the co-crystallisation of urea with 
BA is very complex, producing mainly mixtures of UBA forms I and III co-crystals. These co-
crystals exhibit strikingly similar physicochemical properties, which makes them difficult to 
isolate. It was therefore quite difficult to identify conditions in batch and semi-batch 
experiments that were suitable for obtaining the two co-crystal forms independently of each 
other. 
7.3.3 Periodic and Continuous Flow Co-Crystallisation Experiments  
Unseeded Co-Crystallisations: A number of unseeded periodic flow co-crystallisation 
experiments were carried out to determine the most suitable conditions for obtaining UBA 
forms I and III. The start-up method and the temperatures of the first- (MSMPR 1), second- 
(MSMPR 2) and third-stage (MSMPR 3) of the PMSMPR cascade were manipulated with the 
aim to obtain a desired polymorphic form of UBA co-crystal, with results as shown in Table 
7.5. A typical goal in industrial crystallisation is to maximise yield whilst also improving filtration 
rates and avoiding downstream bottlenecks [155], [301]. The yield of co-crystallisation as 
presented in Table 7.5 is defined as: 
𝑌 =
𝑀𝑈𝐵𝐴 − 𝑀𝑠
 𝑐𝑜 𝑓0 −  𝑐∗𝑓1
× 100 (1) 
where  𝑀𝑈𝐵𝐴 and  𝑀𝑠 are the mass flow of co-crystal product obtained from MSMPR 3 and seed 
crystals from the feed stream, respectively (𝑀𝑠 = 0 for unseeded experiments); 𝑐𝑜  and 𝑐
∗ are, 
the feed stream concentration (g UBA/g MeOH; calculated on the basis of 1:1 co-crystal 
stoichiometry) and theoretical equilibrium concentration of UBA at the specified operating 
temperature in MSMPR 3, respectively;  𝑓0 and  𝑓1 are the mass flow rates of MeOH from the 
inlet and outlet streams of the PMSMPR, respectively. Since the inlet and outlet flow rates are 
equal when time averaged, then 𝑓0 =  𝑓1 = 𝑀𝑀𝑒𝑂𝐻𝑄1, where 𝑀𝑀𝑒𝑂𝐻 represents the mass 
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fraction of MeOH in each flow stream and  𝑄1 is the total mass flow rate of the inlet or outlet 
stream.  
Table 7.5: Results of unseeded periodic and continuous flow co-crystallisation experiments. 
Exp. 
No. 
Exp. 
Config. 
Mixing 
Method 
Stage 
Temps. 
(oC) 
Yield 
(%) 
Product 
Size 
1st RT 
(µm)Mal 
Product 
Size 
10th RT 
(µm)Mal 
Product 
Size 
1st RT 
(µm)FBRM 
Product 
Size 
10th RT 
(µm)FBRM 
UBA 
Co-crystal 
Product 
1 1 n/a 20/30/10 92 207 245 105 91 *mix I-III 
2 1 ʬ1 20/30/20 100 183 244 101 88 *mix I-III 
3 2 ŧ2 20/30/20 86 190 223 101 87 I 
4 2 ŧ2 15/10/5 79 186 252 104 93 I 
5a Conti ʬ1 20/30/20 66 202 259 104 92 ♦mix I-III 
5b Conti ʬ1 20/30/20 62 181 234 101 95 ♦mix I-III 
ʬslow addition of urea to BA at 10 g/min from start-up to the end of experiment;  ŧrapid manual addition of urea to 
BA at start-up, thereafter addition rate was 10 g/min; MalVolume moment mean size (D4,3) of dry product from 
MSMPR 3 analysed by laser diffraction; FBRMSquare weighted mean chord length (SWMCL) of particles in MSMPR 
3 obtained via in situ measurements with FBRM; *mix I-III (prevalent form I, increasing with time); ♦mix I-III 
(predominant form I with only traces of III); and n/a - not applicable. 
The yields of co-crystallisation from experiments 3 and 4 were slightly lower (86 % and 79 %, 
respectively) compared to experiments 1 and 2 (100% and 92 %, respectively). This can be 
attributed to the supersaturation differences that exist between PMSMPR stages due to the 
different operating temperature of each stage. For example, in experiment 2 the level of 
undercooling going from stage 2 to 3 is -10 oC, this compares to a level of undercooling of -20 
°C for experiment 1. In the former case equilibrium is approached more quickly compared to 
the latter case due to the lower level of undercooling between stages and hence low available 
supersaturation that is rapidly consumed by the crystals already present. Note that a lower 
yield than expected was observed for experiment 3, due perhaps to losses that occurred 
during the solid recover stage (filtration of the slurry collected from MSMPR 3). For experiment 
5a and 5b, the yield of co-crystallisation was significantly less than that reported for 
experiments 1 – 4. This is attributed primarily to the shorter RT of the slurry in the crystalliser, 
due to the continuous operation (as opposed to periodic operation). It appears that the 
polymorphic outcome of co-crystallisation depends on the feeding regime employed for 
combining urea and BA in MSMPR 1 (Table 7.5), and the initial operating temperature. Equally 
important as well, is the operating temperature of subsequent PMSMPR stages, in particular 
MSMPR 2. When either a combined urea-BA feed stream (experiment 1) or separated flow 
with slow addition of urea to BA (experiment 2) is employed at temperatures of 20 oC or higher 
in MSMPR 1, a mixture of UBA form I and III was always observed. This was also confirmed 
by the semi-batch experiments conducted using a similar start-up strategy as the PMSMPR 
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experiments. This is perhaps due to better mixing, leading to a homogeneous solution, which 
allows equal chance of both co-crystal forms nucleating. This is a plausible conclusion since 
the two co-crystal forms display very similar physicochemical properties. On the other hand, it 
appears that rapid initial mixing of urea and BA streams in MSMPR 1 at operating 
temperatures of 20 oC and lower leads to the preferential formation of the UBA form I 
(experiment 4), although traces of UBA form III were also detected. This was also confirmed 
from the semi-batch experimental runs conduct under similar conditions.  
Table 7.6: Evolution of UBA polymorphic form during experiments 1 – 5 for the first- through 
third-stage PMSMPR and MSMPR, analysed by off-line Raman spectroscopy and PXRD. 
Sampling Time 
Exp. 1 – 4  
(min) 
MSMPR 1 
Exp. 1 Exp. 2 Exp. 3 Exp. 4 Exp. 5a 
30 mix I-III* mix I-III♦ mix I-III♦ mix I-III♦ mix I-III* (11 min) 
60 I mix I-III♦ mix I-III♦ mix I-III♦ mix I-III* (22 min) 
90 I mix I-III♦ mix I-III♦ mix I-III♦ mix I-III♦ (33 min) 
120 mix I-III* mix I-III* I I mix I-III* (45 min) 
150 I I I I mix I-III♦ (56 min) 
 MSMPR 2 
40 mix I-III* mix I-III* mix I-III* mix I-III♦ mix I-III* (15 min) 
70 mix I-III♦ mix I-III* mix I-III* mix I-III♦ mix I-III* (26 min) 
100 mix I-III mix I-III* mix I-III* mix I-III♦ mix I-III* (37 min) 
130 I mix I-III* mix I-III♦ mix I-III♦ mix I-III♦ (48 min) 
160 mix I-III♦ mix I-III* mix I-III♦ I I (60 min) 
 MSMPR 3 
50 mix I-III* mix I-III♦ mix I-III* mix I-III♦ mix I-III* (19 min) 
80 mix I-III* mix I-III♦ mix I-III* I mix I-III* (30 min) 
100 mix I-III* mix I-III* mix I-III* I mix I-III* (36 min) 
120 mix I-III* mix I-III* mix I-III♦ I mix I-III♦ (42 min) 
140 mix I-III* mix I-III♦ mix I-III♦ I I (48 min) 
160 I mix I-III♦ mix I-III♦ I mix I-III♦ (54 min) 
180 mix I-III♦ I I I I (60 min) 
200 I I I I mix I-III♦ (66 min) 
220 mix I-III♦ mix I-III♦ I I mix I-III♦ (72 min) 
(I) UBA form I co-crystal; (III) UBA form III co-crystal; *mix I-III (prevalent form I, increasing with time); ♦mix I-III 
(prevalent form I with only traces of III); and I (form I only). 
Table 7.5 also shows the product mean crystal size as determined by off-line particle size 
analysis viz laser diffraction and real-time in situ process monitoring with FBRM. The final 
product crystal sizes are similar for all experimental runs with no clear correlation between 
product crystal size and the process variables. Further discussion on the mean product size 
and CSD is provided late in this section. Periodic sampling of each PMSMPR stage was 
performed during the unseeded experiments (Table 7.5) in order to understand better the 
behaviour of the system. Samples were analysed using off-line Raman spectroscopy and 
PXRD. Evolution of the polymorphic outcome over time for experiments 1 – 5b, as determined 
by Raman spectroscopy and PXRD are presented in Table 7.6. For experiments 1, 2, 5a and 
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5b mixtures of UBA forms I and III were initially present, but as the reaction time progress there 
is a reduction in the amount of UBA form III, as UBA form I becomes the dominant polymorph. 
For experiment 3 and 4 Raman and PXRD confirmed that pure UBA form I was obtained from 
the final stage PMSMPR. The experimental results (Tables 7.5 and 7.6) indicate that increasing 
the temperature of MSMPR 2 leads to dissolution of the small amount of UBA form III initially 
formed in MSMPR 1 and propagated to subsequent stages of the PMSMPR. For experiment 4, 
there is a rapid transition from a mixture of UBA form I and III in MSMPR 1 to pure UBA form I 
in MSMPR 3. In this experiment, the temperature was progressively lowered in 5 °C steps from 
15 oC in MSMPR 1 to 5 °C in MSMPR 3. This is an indication that rapid mixing of urea and BA 
at start-up and the high initial supersaturation generated in MSMPR 1 by cooling to 15 oC, 
favours the nucleation of UBA form I. Further cooling in subsequent stages of the PMSMPR 
then leads to a complete suppression of UBA form III crystallisation as UBA form I nucleates 
and grows. 
The time diagrams for the FBRM counts/s and temperature profiles, Figure 7.9 (a) and (b), show 
that for all experiments a SCO is achieved in the early stages. Spikes in the time profiles of 
Figure 7.9 (a) indicate discontinuities where fouling of the FBRM probe was suspected and a 
cleaning procedure then implemented. For example, experiments 1 and 2 were most affected 
by fouling and crust formation compared to experiments 3, 4 and 5a. Interestingly, for the former 
two experiments, there was a mixture of co-crystals at all times, with significant amounts of UBA 
form III when compared to the latter three experiments. This suggests that fouling is more 
pervasive when UBA form III crystals are present in significant amounts, which can be correlated 
to the batch experiments discussed earlier where crust formation was observed. It appears that 
UBA form III has a greater tendency to stick on the sapphire probe window, (which appears to 
have an electrostatic charge surface charge [302]), compared to UBA form I.  
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Figure 7.9: FBRM counts/s (a) and temperature (b) time profiles recorded in MSMPR 3 stage 
of the unseeded PMSMPR and MSMPR for experiments 1 – 4 and 5a. Spikes in the FBRM 
profiles indicate cleaning of the probe due to fouling. Temperature profiles reflect the periodic 
flow operation. Experiment 5a is a continuous MSMPR run included for comparison. 
Fouling affected ATR-UV/vis to a greater extent compared to the other PAT probes, such that 
the signal was not stable and reliable, due to a need to clean the probe regularly. Evidence of 
this is given by ATR-UV/vis spectra collected during the periodic flow and batch 
co-crystallisation experiments, which show spectral distortion in the presence of UBA form III. 
Despite the incidence of fouling on the PAT probes, SCO was deemed to be achieved for all 
experimental runs, with sight drift toward the end of experiments 1, 2 and 5a. The ATR-UV/vis 
spectra captured subsequent to detection of fouling in these experiments were compared to 
pure Methanol, Methanol + Urea, and Methanol + Urea-BA spectra respectively, as shown in 
Figure 7.10. It is evident from the ATR-UV/vis spectra that UBA form III co-crystal had a 
tendency to stick on the sapphire probe window causing significant distortion of the signal. It 
has previously been reported that in the presence of solids, a small part of the ATR-UV/vis 
signal can be reflected resulting in baseline effects [145]. This effect becomes more 
pronounced after the onset of nucleation when solid particles have a greater tendency to stick 
on the probe window [303].  
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Figure 7.10: ATR-UV/vis signals for (a) Methanol; (b) Methanol + Urea; (c) Methanol + Urea-
BA; (d) Methanol + Urea-BA solution and UBA Form III – experiment 15 (batch); (e) Methanol 
+ Urea-BA solution and UBA Form I + III (trace of I) – experiment 16 (batch); and (f) Methanol 
+ Urea-BA solution and UBA Form I + III (trace of III) – experiment 2 (periodic flow). 
In situ PVM images captured from MSMPR 1 in real-time and off-line microscope images from 
MSMPR 3 (Figure 7.11) show the visual appearance of crystal growth over time. There is clear 
evidence of agglomeration of the UBA co-crystals from the PVM and microscope images, with 
UBA form I in particular having a tendency to agglomerate soon after nucleation. The apparent 
slight shifts to the left of the FBRM SWCLD plots (Figure 7.12) are not consistent with this visual 
evidence, indicating instead a slight reduction in particle size. Therefore, the FBRM results must 
be treated with caution, as it is well known that different particle sizing techniques can often give 
contradictory results [304]–[306] and the chord length measurements made in FBRM are highly 
dependent on the shape and roughness of particles scanned by the probe’s laser beam. The 
PVM and microscope images (Figure7.11) show better agreement with the CSD data obtained 
from laser diffraction (Figure 7.13). 
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Figure 7.11: In situ PVM images (left) captured from MSMPR 1 and Off-line microscope 
images (right) of samples collected from MSMPR 3 for experiments 1 – 4 and 5a. 
Together, these results show that crystal size increases from the 1st (20 min) to 10th (200 min) 
RTPO in all PMSMPR experiments, mainly due to agglomeration, but also with evidence of crystal 
growth. From the PVM and microscope images in Figure 7.11, UBA form I crystals are identified 
as semi-transparent particles that often agglomerate forming rosette type structures. On the 
other hand, UBA form III crystals are more difficult to identify, but occur as dark agglomerated 
particles that appear to coat onto any UBA form I crystals present (see Figure 7.5). Evidence of 
the presence of UBA form III is seen in the microscope images for the 1st and 10th RTPO of 
experiments 1 and 2. For experiments 3, 4 and 5a, there is little evidence of the presence of 
UBA form III in the 10th RTPO samples. However, for experiment 5a there is evidence that UBA 
form III is present in the 1st RTPO sample, but this is not the case for experiment 4. These 
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observations are in agreement with the off-line Raman and Powder XRD data presented earlier 
(Table 7.6). 
 
Figure 7.12: Evolution of FBRM SWCLD in MSMPR 3 stage for experiments 1 – 4 and 5a. 
 
Figure 7.13: Normalised CSD profiles for the 1st and 10th RTPO product of the third-stage 
PMSMPR (MSMPR 3) for experiments 1 – 4 and 5a, analyses by laser diffraction. 
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Seeded Co-Crystallisation Periodic Flow Experiments: A parallel strategy of seeded 
co-crystallisation in the PMSMPR was implemented for isolation of pure UBA forms I and III. 
Urea-BA feed solutions were seeded with the desired co-crystal form. Table 7.7 provides a 
summary of the experimental results obtained using the seeded co-crystallisation approach. The 
seeded experiments 6 – 9 were carried out using the periodic flow crystallisation approach in 
the PMSMPR cascade unit described in Section 7.2.3 (Figure 7.8). Different temperature sets 
were implemented across the stages of the PMSMPR based on the preliminary batch and semi-
batch studies. In each case, the first-stage (MSMPR 1) does not behave as a nucleator vessel, 
which was the case in the unseeded experiments; instead secondary nucleation and growth are 
the main driving force. MSMPR 1 was fed with seed suspension from the 6 L feed vessel to 
promote secondary nucleation and growth. The feed solution (saturated at 43 °C) was seeded 
with 10 % of either UBA form I or III, ensuring modest fines dissolution whilst promoting growth 
and healing of the larger seed crystals viz aging and Ostwald ripening. Table 7.7 provides a 
summary of the results from each experimental run. The co-crystal polymorphic form at the end 
of each process was confirmed by Raman spectroscopy and PXRD.  
The yields of co-crystallisation for experiments 6 – 9 shown in Table 7.7 reflects the 
experimental conditions that were applied during the study. High yields are achieved in the 
periodic operation because the mean RTPO inside the PMSMPR crystalliser is extended with 
the holding period. Note that all experiments were seeded with 10 % co-crystal seed 
regardless of the polymorphic form. The yields of co-crystallisation of UBA form I for 
experiments 6, 7a, and 7b (seeded with UBA form I) are slightly different due to the different 
addition/withdrawal and holding periods, flow rates, and the temperature sets employed over 
the PMSMPR cascade. For experiment 6, the yield is lower due to: (1) the shorter holding 
period and lower flow rate, which caused settling of large crystals in the transfer line; and (2) 
the smaller temperature difference (7 oC) between MSMPR 2 and 3. 
Table 7.7: Results for the seeded periodic flow co-crystallisation experiments. 
Exp. 
No. 
PMSMPR 
Stage 
Temps. 
(oC) 
Process 
Yield 
(%) 
Seeds 
Crystal 
Size 
(µm)Mal 
Product 
Size 
1st RT 
(µm)Mal 
Product 
Size 
10th RT 
(µm)Mal 
Seeds 
Crystal 
Size 
(µm)FBRM 
Product 
Size 
1st RT 
(µm)FBRM 
Product 
Size 
10th RT 
(µm)FBRM 
UBA 
Product 
6 27/17/10 85 287 (I) 339 343 120 103 99 I 
7a 33/20/10 94 278 (I) 217 279 110 108 123 I 
7b 33/20/10 92 254 (I) 235 260 106 102 113 I 
8 20/20/10 92 156 (III) 164 187 94 96 88 ●mix I-III 
9 35/30/25 100 193 (III) 173 245 101 101 103 ●mix I-III 
 (I) UBA form I co-crystal seed; (III) UBA form III co-crystal seed; MalVolume moment mean size (D4,3) of dry product 
from MSMPR 3 analysed by laser diffraction; FBRMSquare weighted mean chord length (SWMCL) of particles in 
MSMPR 3 obtained via in situ measurements with FBRM; ●mix I-III (~50:50 mixture of form I and III). 
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The yield is higher for experiment 7a and 7b compared to experiment 6, due to the longer 
holding period and higher flow rate, leading to better suspension of crystals (based on visual 
observation); the larger temperature difference (10 oC) between MSMPR 2 and 3 led to a 
higher level of supersaturation in the final stage for crystal growth and secondary nucleation. 
For experiments 8 and 9, (seeded with UBA form III), the holding and addition/withdrawal 
periods and the flow rates were held constant. The only difference between these two 
experiments was the temperature change between the PMSMPR stages; the differences in 
yield may be attributed to the temperature change between MSMPR 1 and 2. These are the 
same in experiment 8, but not experiment 9, leading to further generation of supersaturation 
in the latter allowing enhanced crystal growth and nucleation. Raman and PXRD confirm that 
UBA form I was obtained from experiments 6, 7a and 7b, whereas mixtures of UBA form I and 
III were confirmed for experiments 8 and 9. For the former three experiments, seeding has 
ensured secondary nucleation of UBA form I in MSMPR 1. The resulting crystals are then 
grown in subsequent stages (MSMPR 2 and MSMPR 3). For experiment 6, temperatures were 
kept at 27 °C, 17 °C and 10 °C in MSMPR 1, MSMPR 2 and MSMPR 3, respectively. The 
temperatures employed in experiments 7a and 7b for each successive PMSMPR stage were 
33 °C, 20 °C and 10 °C, respectively. The need to manipulate the temperature of each 
PMSMPR stage in this case was dictated by the trade-off between avoiding the blockage of 
transfer lines and achieving high product yield and crystal growth. The temperature set used 
during experiment 7a and 7b was found to be suitable for the purposes of avoiding blockage 
of the transfer lines. The narrowing of the temperature gap between the feed vessel and 
MSMPR 1 led to controlled secondary nucleation, thus preventing crystals clogging the 
transfer line to MSMPR 2. For experiments 8 and 9, a feed suspension of UBA form III was 
prepared and fed to MSMPR 1, with the aim of obtaining the pure co-crystal polymorph in the 
same manner as achieved in the successful outcome of experiments 6, 7a and 7b for UBA 
form I. However, for both experiments 8 and 9 mixtures of UBA forms I and III were obtained 
from MSMPR 3. As expected, UBA form III was the prevalent co-crystal form detected in the 
early stages of both experiments, that is, from start-up to the end of the 3rd RT (60 min). Table 
7.8 shows the evolution of UBA co-crystal polymorphic form for experiments 8 and 9; the 
results are based on Raman and PXRD analyses.  
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Table 7.8: Evolution of UBA co-crystal polymorphic form in the final stage PMSMPR 
(MSMPR 3) during experiments 8 and 9, analyses by off-line Raman and PXRD. 
Sampling Time 
(min) 
UBA Co-crystal Form in MSMPR 3 
Exp. 8 Exp. 9 
1st (20 min) ◊mix I-III ◊mix I-III 
2nd (40 min) ◊mix I-III ●mix I-III 
3rd (60 min) ◊mix I-III ●mix I-III 
4th (80 min) ●mix I-III ●mix I-III 
5th (100 min) ●mix I-III ●mix I-III 
6th (120 min) ●mix I-III ●mix I-III 
7th (140 min) ●mix I-III ●mix I-III 
8th (160 min) ●mix I-III ●mix I-III 
9th (180 min) ●mix I-III ●mix I-III 
10th (200 min) ●mix I-III ●mix I-III 
◊mix I-III (prevalent form III, form I increasing with time); and ●mix I-III (~50:50 mixture of form I and III). 
The amount of UBA form I co-crystal in experiment 8 and 9 increased gradually with time. 
From the 3rd (60 min) – 10th (200 min) RTPO, mixtures of UBA I and III were detected by off-line 
Raman and PXRD. A solution mediated transformation [165], [307], [308] takes place in each 
system, which results in an increase in the amount of UBA form I. Interestingly, for experiments 
8 and 9, SCO was achieved after the 3rd and 2nd RTPO, respectively, with an SCO polymorphic 
ratio of ~50:50, suggesting equal transformation between UBA forms I and III. The 
temperature set used in experiment 9 (35 °C, 30 °C and 25 °C for MSMPR 1, MSMPR 2 and 
MSMPR 3, respectively) was chosen to avoid this situation, by elevating the temperatures and 
maintaining small temperature step changes between each PMSMPR stage to suppress 
nucleation of UBA form I. However, this did not have an effect on the polymorphic outcome 
when compared to experiment 8. 
The time diagrams for the FBRM counts/s and temperature profiles are shown in Figure 7.14 
(a) and (b), respectively. The time profiles for each experiment are indicated by number. 
Similar to the unseeded co-crystallisation experiments, there are spikes in each of the FBRM 
counts/s time profiles due to the removal and cleaning of the probe whenever fouling was 
detected. Fouling was most frequently observed during experiments 6 and 9, in comparison 
to experiments 7a and 8. For experiment 6, the FBRM and other PAT probes were cleaned a 
total of 8 times. The frequent fouling of the probe was attributed to the low flow rate employed 
(41.7 g/min) compared to the other experiments (52.7 g/min). This resulted in the settling of 
larger crystals and the preferential propagation of smaller crystals in the transfer lines as 
observed from visual inspection. This resulted in an accumulation of fine crystals in the final 
stage MSMPR, which are more prone to sticking, aggregation and agglomeration. Experiment 
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6 was the first of a series of exploratory experiments to determine the minimum flow rate required 
to achieve particle suspension. A flow rate of 52.7 g/min was found to be a good particle 
suspension flow rate based on visual observations, and was therefore selected for all other 
experimental runs. In the case of experiment 9, a different scenario arises whereby significant 
fouling is observed despite the higher flow rate and smaller temperature step changes between 
the PMSMPR stages. The explanation for fouling in experiment 9 is the presence of UBA form 
III. During this experiment, the PAT probes were cleaned a total of 11 times due to persistent 
fouling. The effect of fouling from UBA form III on the ATR-UV/vis signal has previously been 
demonstrated. In the case of experiment 7a, only 3 incidences of fouling on the PAT probes 
were observed. During this experiment only UBA form I was detected, furthermore the flow rate 
employed between PMSMPR stages was sufficiently high compared to experiment 6 to prevent 
preferential propagation of smaller particles. In addition, the step changes in temperature 
between PMSMPR stages were smaller compared to experiment 6. For experiment 8, fouling 
on the PAT probes was detected 7 times, although this is not very obvious from the FBRM time 
profile. Similar to experiment 9, the occurrence of fouling is attributed to the presence of UBA 
form III, which has been shown to stick more readily to the probes, due perhaps to an attraction 
for the electrostatically charged surface of the sapphire windows (e.g. of the FBRM and ATR-
UV/vis). The FBRM time profiles show that a SCO is achieved from the 2nd RT (40 min) in 
experiment 6 and is maintained until the 7th RT (140 min) where there begins a slight drift, 
marked by an increase in FBRM counts/s. For experiment 7a and 9 it takes approximately 30 
min to achieve a SCO. However, for both of these experiments the system drifts from the SCO 
from approximately 95 min (experiment 7a) and 120 min (experiment 9) until the end. For 
experiment 8, SCO is achieved after approximately 80 min and is maintained until the end of 
the run. Also, the particle counts detected by FBRM are almost twice that observed in the 
other experiments. This is attributed to a significant amount of secondary nucleation in the 
early stages of the process due to the larger temperature gap (23 °C) between the feed and 
MSMPR 1. Consequently, the system is more sensitive to perturbations cause by the periodic 
operation and this leads to higher oscillation amplitudes observed in the FBRM signal 
compared to the other runs. 
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Figure 7.14: FBRM counts/s (a) and temperature (b) time profiles recorded in MSMPR 3 of 
the seeded PMSMPR for experiments 6 – 9. 
The particle size and distribution results (Table 7.7; Figure 7.15), show clear evidence of 
crystal growth and/or agglomeration. As discussed earlier, these results were not fully 
consistent with the FBRM SWCLD; the CSD plots from the laser diffraction experiments are 
more reliable and are interpreted here. For all experiments, with the exception of run 7a there 
is a significant shift of the product CSD to the right compared to that of the seed crystals used. 
These observations agree with the mean crystal size obtained by laser diffraction analyses 
(Table 7.7) and the off-line microscope images of the seed and product crystals from MSMPR 
3 shown in Figure 7.15. 
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Figure 7.15: Normalised CSD profiles for the 1st (20 min) and 10th RTPO (200 min) product of 
the third-stage PMSMPR (MSMPR 3) for experiments 6 – 9, analyses by laser diffraction. 
The mean sizes of seed crystals for experiments 6 and 7a are quite similar with evidence of 
growth confirmed from microscope images (Figure 7.16). However, the CSD for experiment 
7a is slightly broader compared to experiment 6. This is attributed to the seed properties at 
the start of each experiment. The seed CSD is slightly broader for experiment 7a, which may 
explain why the product CSD remains broad. It is also likely that the smaller temperature step 
between MSMPR 1 and MSMPR 2 and MSMPR 3 in experiment 6 (7 °C) compared to 
experiment 7a (10 °C) leads to lower supersaturation levels, reducing secondary nucleation 
and favouring more growth, thereby leading to maintenance of a narrow CSD. In experiment 
7a, the temperature steps between each stage of the PMSMPR cascade are large, which is 
likely to contribute to more secondary nucleation compared, and hence broadening of the 
CSD. The CSD for the product of UBA form I appears to be narrower when compared to the 
CSD of mixtures of UBA form I and III (i.e. where UBA III is the more prevalent form present), 
which appear broader. This would suggest that the extent of secondary nucleation is greater 
when UBA III nucleates, thus, leading to a broadening of the CSD. Therefore, it would appear 
that laser diffraction could be used in a qualitative manner to determine when between UBA 
III is present in a mixture of the two co-crystal forms. For example, the significant broadening 
of the product CSD relative to the seed crystals for experiments 9 and 10 appears to be related 
to the presence of UBA form III. Off-line microscope images of the seed and product crystals 
from MSMPR 3 (Figure 7.16) agree with the CSD data obtained using the laser diffraction 
(Table 7.7; Figure 7.15). 
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Figure 7.16: Off-line microscope images of the seed and product crystals from MSMPR 3 for 
experiments 6 – 9. 
Overall, more consistent results in terms of polymorphism control were achieved using the 
periodic flow co-crystallisation approach reported in this study. The periodic flow PMSMPR 
process provided a different trajectory through the phase diagram compared to batch and 
continuous MSMPR, respectively. In each stage of the PMSMPR cascaded, the 
supersaturation oscillates, but in a controlled manner between narrow boundaries in the 
metastable zone. The operating boundaries of the periodic flow process can be expanded or 
reduced by manipulating the degree of undercooling, or the holding (batch) and/or 
addition/withdrawal (continuous) periods at each PMSMPR stage. This leads to additional 
degrees of freedom in operation that can be exploited to control the co-crystallisation as 
demonstrated in this study, when compared to batch and continuous MSMPR operations. The 
PMSMPR provides the flexibility of adjusting the supersaturation trajectory in the metastable 
zone to control the co-crystallisation outcome (i.e. polymorphic form), whilst producing 
consistent product in a relatively short time. This is not possible in batch operation without 
applying complex control strategies, for example, DNC [170], [224] and supersaturation 
control  [31], [49] over very long periods. In comparison to continuous MSMPR operation, the 
periodic PMSMPR achieves much higher process yields (similar to batch operation) due to 
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the longer achievable RT, with the added advantage of controlling polymorphism, given that 
enough time is allowed for solution mediated transformation from one polymorphic form to 
another. 
7.4 Conclusions 
The co-crystallisation of the urea and BA to form UBA forms I and III co-crystal polymorphs 
was demonstrated under periodic flow conditions using a cascaded three-stage PMSMPR 
crystalliser. Batch and semi-batch co-crystallisations were used to identify conditions suitable 
for isolate pure UBA forms I and III. Significant variability from batch-to-batch was observed 
in both small scale batch (5 mL) and lab scale batch and semi-batch (500 mL) crystallisers. 
Continuous flow co-crystallisations in MSMPR were carried out for comparison with the 
periodic flow PMSMPR experiments. In the continuous experiments, mixtures of UBA forms I 
and III were consistently obtained. The PMSMPR provides a different operating trajectory 
through the phase diagram (i.e. it oscillates within a tight boundary) compared to batch and 
continuous processes, and has a tenable residence time that can be exploited for control over 
crystal growth and secondary nucleation. These system attributes can be exploited to 
manipulate the product crystal properties and lead to control over the crystallisation process. 
The PMSMPR was used to investigate the co-crystallisation of UBA forms I and III, which 
exhibit unusually similar physicochemical properties, for example, solubility and melting point. 
Pure UBA form I polymorph was successfully isolated, but pure UBA form III remained elusive. 
The periodic flow process seems to be a promising operating strategy for the isolation of pure 
polymorphs of APIs in the pharmaceutical industry. The study also demonstrated the 
application of PAT tools and CryPRINS informatics systems software to give information about 
the performance of the different crystallisation platforms studied. These tools were used 
together with off-line techniques (such as PXRD, Raman and laser diffraction) to characterise 
each process further. The information from these combined analyses confirmed that UBA is a 
complex polymorphic system. Despite this challenge, pure UBA form I could be isolated under 
strictly controlled conditions using the PMSMPR. Furthermore, the on-line PAT tools and off-
line analytical methods are able to indicate when the process achieves SCO, that is, when 
transitory effects caused by the periodic but controlled disruptions are minimised. The reported 
results provide evidence that a PMSMPR cascade, with a suitably designed dissolution stage 
can produce consistently, the desired polymorphic form of the model co-crystal system, 
decreasing significantly product variability compared to batch operation. 
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Chapter 8 
Design of Agrochemical Co-Crystallisation 
Processes: Isolation and Characterisation of 
1:1 and 3:2 Co-Crystals of p-Toluenesulfonamide 
/Triphenylphosphine Oxide 
In Chapter 7 the application of a periodic flow mixed suspension mixed product removal 
(PMSMPR) operation to selectively isolate polymorphs of a pharmaceutical co-crystal drug 
with similar physicochemical properties was examined. In this chapter, the selective 
crystallisation and characterisation of the stoichiometric forms of the agrochemical co-crystal 
system p-Toluenesulfonamide/Triphenylphosphine oxide (p-TSA-TPPO) is demonstrated 
using batch, semi-batch and PMSMPR crystallisers. Regions of the ternary phase diagram of 
p-TSA/TPPO/MeCN corresponding to the stability of the 1:1 and 3:2 co-crystal forms of p-TSA-
TPPO were explored. In the batch study, solution mediated transformation of the co-crystals 
was monitored and directed towards the desired crystalline form using a Raman spectroscopy 
approach coupled with temperature cycling. A change in temperature can modify the relative 
stability of each co-crystal form or mixtures and induce a solvent mediated transformation 
towards the most stable species. The proposed strategy allows for obtaining the pure 
stoichiometric co-crystals, even when nucleation of a mixture occurs. Furthermore, mixtures 
of the two forms in specific ratios can be produced to better tailor the physical-chemical 
properties of the final product. In the semi-batch and PMSMPR studies better control over the 
co-crystal form was achieved compared to batch. The desired co-crystal form or mixture of 
forms could be produced consistently by manipulating the flow rates of the co-formers p-TSA 
and TPPO to these crystallisers. Raman, ATR-UV/vis and ATR-FTIR spectroscopy, FBRM 
and PVM were used as an integrated array with CryPRINS within the IDS framework to 
monitor and control the co-crystallisations. Complementary off-line solid-state techniques 
were used to characterise samples obtained from each process. 
8.1 Introduction 
In the agrochemical industry there is a need to develop and apply new active ingredient design 
strategies to deliver solutions for the discovery of agrochemicals that are fit for purpose in the 
21st century [309]. For example, there is a need to reduce absolute usage of active 
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agrochemical ingredients (AAIs) to minimise environmental impact. To achieve this, a 
structure-based design approach to AAI production is required [310], [311]. Structure-based 
design is an iterative and multi-disciplinary process that is well established in the 
pharmaceutical industry. It has played an important role in the development of several 
registered drugs and clinical candidates [309], [311], for example, zanamivir [312], lopinavir–
ritonavir and nelfinavir [313]. In contrast, structure-based design is a relatively new concept in 
the agrochemical industry, and there are currently no products on the market that are the direct 
result of this approach [309]. In recent years’ structure-based design of multi-component 
molecular systems has gained popularity in the pharmaceutical sector as a viable alternative 
to traditional design approaches used to modify active pharmaceutical ingredients (APIs) for 
more effective performance. Modifications of the structure and molecular composition of an 
active ingredient by applying structure-based design principles can lead to significant 
improvements to the stability, solubility and release profile. This could lead to a reduction in 
use rates of AAIs, and hence a minimised environmental impact. For example, the release 
profile of an AAI could be controlled through the design of multi-component molecular systems 
such as co-crystals. Furthermore, multi-component systems offer the opportunity to delivery 
not just one, but two or more AAIs simultaneously, which could potentially minimise operating 
cost and equipment foot print through simplification of the manufacturing processes. 
In this study, the selective co-crystallisation of two model AAIs, p-Toluenesulfonamide (p-TSA) 
and Triphenylphosphine oxide (TPPO) is demonstrated. p-TSA and its derivatives are widely 
used as raw materials for the synthesis of pesticides, drugs and fluorescent colorants [314], 
[315]. There are two known polymorphs of p-TSA: the α form (monoclinic) differs from the β form 
(triclinic) which has a unusual arrangement of layers [316]. TPPO finds use in the production of 
crop protection products, anti-fungal coatings, vitamins, and APIs [317], [318]. There are three 
known polymorphic forms of TPPO [319], [320], one orthorhombic and two monoclinic forms. 
Etter and Baures [320] were amongst the first to isolate co-crystals of TPPO. They were able to 
successfully co-crystallised TPPO with 15 different molecular entities, including of several 
derivatives of p-TSA. There are two known stoichiometric forms of the p-TSA-TPPO co-crystal 
system; composed of 1:1 and 3:2 mole ratios of p-TSA and TPPO respectively. Glidewell et al. 
[321], [322] isolated the 3:2 form of p-TSA-TPPO and reported on the crystal and molecular 
structures. The authors used a small scale reactive crystallisation method whereby 
triphenylphosphine (TPP) was reacted with Chloramine-T(n-Chloro p-Toluenesulfonamide 
sodium salt) in ethanol; the product was then recrystallised from anhydrous benzene. Croker et 
al. [323] isolated and reported the crystal structure of the 1:1 form of p-TSA-TPPO. In their work 
the ternary phase diagram for p-TSA/TPPO/MeCN was constructed at 20 oC. Subsequent 
studies examined the nucleation behaviour [324], isothermal suspension conversion [325] and 
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solution-mediated phase transformation [326] of the two co-crystal forms. The work presented 
here further examines the co-crystallisation of p-TSA-TPPO, but with the aid of PAT tools and 
CryPRINS within the IDS framework. Some aspects of this study were carried out as part of a 
personal development project (PDP). Specifically, solubility and multivariate calibration model 
development studies were carried out by MEng student Nyet Vun. The PDP project was 
supervised by the author of this Thesis who assisted the student with day-to-day planning of 
experimental work and interpretation of the results. 
8.2 Experimental Methods 
In the current work, the ternary phase diagram of p-TSA/TPPO/MeCN, Figure 8.1, developed 
by Croker et al [323] was explored in the regions where 1:1 and 3:2 p-TSA-TPPO co-crystal 
forms (Regions 1 and 2), and a mixture of both forms (Region 3) show stability. The aim is to 
demonstrate control over the co-crystallisation process in the different optimised crystalliser 
platforms, and to provide a comparative assessment of the performance of each platform.  
 
Figure 8.1: Ternary phase diagram for the p-TSA/TPPO/MeCN (axes in mass fraction) at 20 
°C. Regions selected for this study: (1) 3:2 co-crystal form stable; (2) 1:1 co-crystal form 
stable; (3) Mixtures of 1:1 and 3:2 forms stable. Adopted from Croker et al. [323]. 
Figure 8.2 shows the chemical structures of the starting materials and crystal structures of the 
co-crystals. The structure of 1:1 p-TSA-TPPO consists of cyclic centrosymmetric aggregates 
in which two molecules of p-TSA are linked to two molecules of TPPO via two-point hydrogen 
bonds of the type :O…..H–N(SO2Ph)–H…..O: as shown in Figure 8.2, with a lone pair of 
electrons on the oxygen of TPPO. The 3:2 p-TSA-TPPO co-crystal is also made up of cyclic 
centrosymmetric aggregates, but with three molecules of p-TSA linked to two molecules of 
 
1 2 
3 
3:2 1:1 
   p-TSA TPPO 
MeCN 
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TPPO via a network of six linear hydrogen bonds of the type O…..H–N(SO2Ph)–H…..O, with no 
lone pair electrons on the oxygen of TPPO. 
 
Figure 8.2: Chemical structures of p-TSA and TPPO (top) and crystal structures of 1:1 and 
3:2 p-TSA-TPPO co-crystals (bottom). Adopted from Croker et al. [325]. 
Figure 8.3 shows the extended crystal structures of the two co-crystal forms, showing their 
distinctive molecular packing arrangements and hydrogen bonding network. Crystal structure 
calculations show that 1:1 and 3:2 p-TSA/TPPO [321], [323] belong to the monoclinic and 
trigonal crystallographic space groups, respectively. Figure 8.4 shows the SEM micrographs 
and microscope images of the two co-crystal forms obtained from experiments reported later 
in this chapter. The crystals of 1:1 and 3:2 p-TSA-TPPO show distinct crystal morphologies. 
1:1 p-TSA-TPPO crystals have a rhombic shape, while 3:2 p-TSA-TPPO exhibits an elongated 
prismatic morphology.  
 
Figure 8.3: Extended crystal structures of 1:1 and 3:2 p-TSA-TPPO showing the distinctive 
molecular packing arrangement and hydrogen bonding networks [321], [323]. 
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Figure 8.4: SEM micrographs (top) and microscope images (bottom) of 1:1 p-TSA-TPPO (a) 
and (c) and 3:2 p-TSA-TPPO (b) and (d) respectively. 
8.2.1 Solubility and Supersaturation of Co-crystals 
The co-crystallisation of p-TSA with TPPO from MeCN was carried out in batch, semi-batch 
and PMSMPR crystallisers as part of a proof of concept study using laboratory scale (500 mL) 
crystallisers. The solid ⇋ liquid equilibrium for 1:1 and 3:2 p-TSA-TPPO, respectively, can be 
written: 
p ̵TSA  ̵TPPOsolid  ⇋  p ̵TSAsolution   +  TPPOsolution 8.1  
(3 x p  ̵TSA) − (2 x TPPO)solid  ⇋  (3 x p  ̵TSA)solution  +   (2 x TPPO)solution 8.2  
The equilibrium concentrations of p-TSA and TPPO on dissolution of 1:1 p-TSA-TPPO and 
3:2 p-TSA-TPPO are given by: 
[p ̵TSA] =
𝐾𝑠𝑝 1:1
[TPPO]
        (1:1 p-TSA-TPPO) 8.3  
[p ̵TSA] = √
𝐾𝑠𝑝 3:2
[TPPO]2
3
        (3:2 p-TSA-TPPO) 8.4  
where 𝐾𝑠𝑝 is the solubility product, which only depends on the operating temperature, [p-TSA] 
and [TPPO] are respectively, the molar concentrations of p-Toluenesulfonamide and 
triphenylphosphine oxide. Since 3:2 p-TSA-TPPO exhibits incongruent dissolution [323], 
[326], with an intermediate step involving conversion to 1:1 p-TSA-TPPO, the solubility product 
(a) (b) 
(c) (d) 
x300                 300µm x400                  200µm 
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cannot simply be estimated from the molar concentrations of p-TSA and TPPO. For this 
reason, the solubility of 3:2 p-TSA-TPPO was not determined for this system during the study. 
The supersaturation ratio for 1:1 p-TSA-TPPO can be derived from the difference in chemical 
potential between the supersaturated and saturated solutions. The supersaturation ratio, σ, of 
1:1 p-TSA-TPPO, by analogy with the definition of the supersaturation of salts [327], [328] can 
be represent as: 
𝜎 = [
[p ̵TSA] x [TPPO]
𝐾𝑠𝑝 1:1
]
1 2⁄
        (1:1 p-TSA-TPPO) 8.5  
Solubility Studies in MeCN: The solubility of a co-crystal, assuming congruent dissolution 
profile, can be expressed in terms of the mass ratio of solute (dissolved co-crystal) to solvent 
or the mole fraction of dissolved co-crystal in the solvent. The latter can be used to construct 
the solubility correlation similar to single component systems [263], and is evaluated using 
Eqn. 8.6: 
 
𝑥 =
𝑚 𝑀⁄
𝑚 𝑀⁄ + 𝑚𝑠 𝑀𝑠⁄
 8.6  
where 𝑥 is solubility in mole fraction, 𝑚 is mass of dissolved co-crystal, 𝑀 is molar mass of 
dissolved co-crystal, 𝑚𝑠 is mass of solvent and 𝑀𝑠 is molar mass of solvent. In this study, a 
modified version of the commonly used van’t Hoff expression, Eqn. 8.7 [263], was applied. 
Taking into account the change in heat capacity, ∆𝐶𝑝, of solute between its solid and 
supercooled-liquid forms [227], as well as the solubility parameter of solute and solvent [329], 
the following expression is derived: 
 
𝑙𝑛(𝑥𝛾) = −
∆𝐻𝑚,𝑓𝑢𝑠
𝑅
(
1
𝑇𝑚
−
1
𝑇
) 8.7  
where 𝛾 is the activity coefficient, ∆𝐻𝑚,𝑓𝑢𝑠 is the enthalpy of fusion of solute (J/mol), 𝑇𝑚 is the 
melting temperature of solute (K), 𝑇 is the operating temperature (K) and 𝑅 is the universal 
gas constant (8.314 J mol/K). Due to the complexity of determining the heat capacity of solute 
at its supercooled-liquid state, ∆𝐶𝑝 is assumed to be equivalent to the entropy of fusion of 
solute, which is the ratio of ∆𝐻𝑚,𝑓𝑢𝑠 / 𝑇𝑚, that is, Hildebrand’s approximation [329], [330]. 
Taking into account the solubility parameters of the solute and solvent, respectively, Eqn. 8.8 
can be modified as follows: 
 
𝑙𝑛(𝑥) = −
∆𝐻𝑚,𝑓𝑢𝑠
𝑅𝑇𝑚
𝑙𝑛
𝑇𝑚
𝑇
−
𝑣𝜑2∆𝛿2
𝑅𝑇
 8.8  
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where 𝑣 is the molar volume of solute in the liquid phase (cm3/mol), 𝜑 is the volume fraction 
of solvent, ∆𝛿 is the difference in solubility parameters of solvent and solute (J1/2 cm-3/2). Eqn. 
8.8 can be further simplified to give Eqn. 8.9: 
 
𝑙𝑛(𝑥) = −𝐴𝑙𝑛 (
𝐵
𝐴𝑇
) −
𝐶
𝑇
 8.9  
where the constants A (
∆𝐻𝑚,𝑓𝑢𝑠
𝑅𝑇𝑚
) and B (
∆𝐻𝑚,𝑓𝑢𝑠
𝑅
) are estimated using (differential scanning 
colorimetry) DSC, from which the thermochemical properties of the solute (∆𝐻𝑚,𝑓𝑢𝑠 and 𝑇𝑚) 
can be estimated. The constant C (
𝑣𝜑2∆𝛿2
𝑅
) can be obtained by non-linear regression analysis. 
The solubility of solute in terms of mole fraction at any temperature can be determined using 
Eqn. 8.9 when the constants A, B and C are determined. These solubility values can be 
interconverted from mole fraction to mass ratio using Eqn. 8.10:  
 
𝑐 = (
𝑥
1 − 𝑥
) (
𝑀
𝑀𝑠
) 8.10  
the solubility (𝑐) is expressed as the ratio of mass of solute to mass of solvent (g/g). The 
solubilities of p-TSA (MW = 171), TPPO (MW = 278) and 1:1 p-TSA-TPPO co-crystal in MeCN 
were determined gravimetrically in the temperature range 5 – 40 oC. The experimental 
apparatus and procedure used for the gravimetric solubility measurements was described in 
Chapter 3 Section 3.6.3. At each temperature, an excess of solid was added to 80 mL MeCN 
in the 100 mL vessel and equilibrated with constant stirring at 250 rpm for 3 h. The stirrer was 
then switched off, solids allowed to settle, and samples then taken according to the procedure 
described in Chapter 3 Section 3.6.3. Off-line Raman and ATR-FTIR spectroscopy 
measurements were carried out on each solid form to confirm whether any solid-state 
transformation occurred while the crystals were suspended in saturated solution. Three 
representative samples were taken per solubility measurement.  
Thermochemical Studies by DSC: The thermochemical properties of p-TSA, TPPO and 
p-TSA-TPPO co-crystal were estimated based on DSC thermograms. The values of ∆𝐻𝑚,𝑓𝑢𝑠 
and 𝑇𝑚 obtained at 1 °C/min were expressed in Table .The values of ∆𝐻𝑚,𝑓𝑢𝑠 determined for 
p-TSA and TPPO at 298 K were in good agreement with the values reported by Flores et al 
[331] (p-TSA: 23.9 ± 0.3 kJ/mol) and Kirklin and Domalski [332] (TPPO: 17.9 ± 1.0 kJ/mol), as 
shown in Table 8.1. 
Table 8.1: Thermochemical properties of materials estimated from DSC, at heating rate of 
1 C/min. 
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Material 𝑻𝒎 (°C) 
∆𝑯𝒎,𝒇𝒖𝒔 at 𝑻𝒎 
(kJ/mol) 
∆𝑯𝒎,𝒇𝒖𝒔at 298 K 
(kJ/mol) 
p-TSA 139.1 ± 0.5 35.8 ± 2.0 25.9 ± 1.5 
TPPO 158.4 ± 0.6 22.0 ± 1.3 15.2 ± 0.9 
1:1 p-TSA-TPPO 136.8 ± 0.4 47.9 ± 2.1 34.8 ± 2.0 
Solubility Estimation: The values of ∆𝐻𝑚,𝑓𝑢𝑠 and 𝑇𝑚 obtained from DSC, together with Eqn. 
8.9, were used to construct the predicted solubility curves for all three materials in MeCN over 
the temperature range of interest (5 – 40 oC). The comparison between measured (m) and 
predicted (p) solubility of the three materials are illustrated in Figure 8.5 (a) and (b) 
respectively.  
 
Figure 8.5: Solubility of investigated materials in terms of (a) mole fraction and (b) mass ratio 
at different temperature. 
The predicted solubility agrees well with the measured values, resulting in reasonably good 
fits with sum of least square errors of 0.0464, 0.0452 and 0.0124 for the optimised regression 
of the predicted solubility of p-TSA, TPPO and 1:1 p-TSA-TPPO, respectively. The non-linear 
regression fits are expressed in Eqn. 8.11, 8.12, and 8.13 for p-TSA, TPPO and p-TSA-TPPO, 
respectively. The value of the constant 𝐶 for the 1:1 p-TSA-TPPO was the least negative when 
compared to the values derived for p-TSA and TPPO. This implies that the Hildebrand solubility 
parameter, 𝛿, of 1:1 p-TSA-TPPO is small relative to 𝛿 of MeCN; hence, it is more difficult to 
break the intramolecular hydrogen bonds (N-H∙∙∙O=P) of the chemical structure. On the other 
hand, solute-solvent interactions between the single component systems p-TSA and TPPO 
can be more readily broken. In other words, the 1:1 p-TSA-TPPO co-crystal was much less 
soluble in MeCN compared to pure p-TSA and TPPO. The solubilities of pure p-TSA, TPPO 
and 1:1 p-TSA-TPPO in MeCN at 20 °C were: 0.307 ± 0.010, 0.141 ± 0.048 and 0.140 ± 0.004 
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g/g MeCN, respectively (derived from Figure 8.5 (b)), which are similar to results reported by 
Croker et al [323]. 
Evidently, the solubility of 1:1 p-TSA-TPPO is slightly lower than that of TPPO, and much 
lower than that of p-TSA. Other possible factors contributing to the lower solubility of the 
co-crystal compared to its constituent single molecules include possible differences in the 
dipole moment, dielectric constant and polarizability of the multi-component molecular system, 
which would influence nucleophilic and aromatic substitution between the solute and solvent 
molecules that affect solute-solvent interactions [321], [333]. The dissolution of 1:1 p-TSA-
TPPO co-crystal resulted in an equivalent release of its constituent molecules in 1:1 molar 
ratio as shown in Figure 8.5 (b) viz congruent dissolution. 
 
𝑙𝑛(𝑥) = −10.5 𝑙𝑛 (
412
𝑇
) −
(−256)
𝑇
 8.11  
 
𝑙𝑛(𝑥) = −7.53 𝑙𝑛 (
431
𝑇
) −
273
𝑇
 8.12  
 
𝑙𝑛(𝑥) = −10.8 𝑙𝑛 (
410
𝑇
) −
215
𝑇
 8.13  
8.2.2 In Situ Solute Concentration Measurement of p-TSA and TPPO 
Multivariate calibration models were developed using ATR-FTIR spectroscopy and 
ATR-UV/vis spectroscopy for real-time measurement of p-TSA and TPPO concentration. 
Details of the experimental and multivariate statistical data analysis were discussed in Chapter 
3 Section 3.6.1. The ATR-UV/vis multivariate models gave superior prediction of p-TSA and 
TPPO concentrations compared to ATR-FTIR, and were therefore selected to monitor the co-
crystallisation experiments. The application of multivariate calibration models to measure 
concomitantly the concentration of multiple species in the solution phase during crystallisation 
has previous been demonstrated with ATR-FTIR spectroscopy [138], [172], [292], [334]. The 
limitation of ATR-FTIR is that light absorbed by molecules in solution is harder to quantify due 
to scattering that occurs with each reflection of IR radiation in the internal element of the ATR 
crystal [335], as well as particle scattering effects from the solid-phase during crystallisation 
[172], [336]. Furthermore, it is well known that the ATR-FTIR signal can be affected by CO2 
absorption in its optical path length [337]. 
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8.2.3 Batch Operating Conditions 
Small scale batch co-crystallisation studies (1 – 50 mL) on the p-TSA-TPPO co-crystal system 
have previous been reported [6], [13], [30]. Batch co-crystallisation studies at a larger scale 
(500 mL) are presented here to examine aspects of process scalability of p-TSA-TPPO. A 
further aim of the study was to monitor and control the co-crystallisation of either 1:1 or 3:2 
p-TSA-TPPO co-crystal. The experimental apparatus used was described in Chapter 3 
Section 3.6.1 (Figure 3.18). The co-crystallisation runs were monitored using Raman, ATR-
UV/vis, FBRM and PVM probes. Experiments were carried out in either of two ways, Method 
1: simple linear cooling approach or Method 2: combined linear cooling and temperature 
cycling approach. For Method 1, the required amounts of p-TSA, TPPO and MeCN were 
added to the crystalliser and heated to 30, 60, 50 or 70 oC (depending on the amount of each 
starting materials used) at a rate of 1 oC/min. The vessel was the held for 15 min. to allow 
complete dissolution of the materials. For Method 2 the heating/cooling rate was set to either 
-0.02, -0.05, or 1.0 oC/min. For both Method 1 and 2, the heating/cooling rates were changed 
to influence the co-crystallisation outcome, which is similar to the effect of temperature cycling 
on polymorphic transformations [49]. Table 8.2 provides a summary of the experimental 
conditions used for the all the batch experiments.  
For Method 1, the vessel was cooled to a final temperature of either 20 or 5 oC and held for 1 
hour (Table 8.2; Exp. No. 1 – 11). At 20 oC the phase compositions of the co-crystals and 
other solid forms of p-TSA and TPPO are expected to follow the ternary phase diagram. 
However, when the temperature is varied, the phase compositions will also vary, since they 
are highly temperature dependent. Studies carried out using Method 2 (Table 8.2; Exp. No. 
12 – 18) followed the same procedures as Method 1, except that temperature cycles were 
implemented soon after nucleation was detected. Regardless of the experimental conditions, 
a fixed impeller speed of 400 rpm was implemented (power per unit volume of 0.075 kW/m3), 
which was sufficient to maintain crystals in suspension.  
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Table 8.2: Summary of experimental conditions employed during the batch crystallisation of 
p-TSA-TPPO co-crystals. 
Exp. 
No. 
p-TSA 
(g/g 
MeCN) 
TPPO 
(g/g 
MeCN) 
Temperature 
(oC) 
Heating / 
Cooling 
Rate 
(oC/min) 
Component Mass 
Fractions (M) 
Region of 
Phase 
Diagram Initial Final p-TSA TPPO MeCN 
1 0.2987 0.1492 60 20 1.0 / -1.0 0.21 0.10 0.69 1 (3:2 form) 
2 0.2997 0.1497 60 20 1.0 / -0.5 0.21 0.10 0.69 1 (3:2 form) 
3* 0.2634 0.1247 60 
20  
5 
1.0 / -1.0 0.19 0.09 0.72 1 (3:2 form) 
4 0.5776 0.4202 70 5 1.0 / -1.0 0.29 0.21 0.5 1 (3:2 form) 
5* 0.1147 0.1532 60 
20 
5 
1.0 / -1.0 0.09 0.12 0.79 2 (1:1 form) 
6 0.1154 0.1489 60 20 1.0 / -0.5 0.09 0.12 0.79 2 (1:1 form) 
7 0.3793 0.6193 70 5 1.0 / -1.0 0.19 0.31 0.5 2 (1:1 form) 
8 0.0706 0.1059 30 5 0.2 / -0.2 0.06 0.09 0.85 2 (1:1 form) 
9 0.1156 0.1676 60 20 1.0 / -0.5 0.09 0.13 0.78 2 (1:1 form) 
10 0.1115 0.1244 60 20 1.0 / -0.5 0.09 0.10 0.81 2 (1:1 form) 
11 0.1084 0.0964 30 20 0.2 / -0.2 0.09 0.08 0.83 3 (mixture) 
12 0.0833 0.1071 30 5 0.2 / -0.2 0.07 0.09 0.84 2 (1:1 form) 
(13) 0.1728 0.0617 30 5 0.2 / -0.2 0.14 0.05 0.81 1 (3:2 form) 
(14) 0.1484 0.1148 50 
10 
30 
0.5 / -0.5 0.12 0.09 0.79 1 (3:2 form) 
(15) 0.1492 0.1140 50 
20 
35 
5 
0.5 / -0.5 0.12 0.09 0.79 1 (3:2 form) 
(16) 0.1054 0.0971 50 
10 
35 
0.5 / -0.5 0.09 0.08 0.83 3 (mixture) 
(17) 0.1282 0.1282 50 10 1.0 / -1.0 0.10 0.10 0.80 3 (mixture) 
(18) 0.1049 0.0968 30 20 0.2 / -0.2 0.09 0.08 0.83 3 (mixture) 
No brackets = Method 1 experiments; Brackets () = Method 2 experiments; *step heating from 20 to 5 oC 
implemented. 
8.2.4 Semi-Batch Operating Conditions 
A series of semi-batch development experiments were also performed to determine the most 
suitable conditions for the selective crystallisation of the 1:1 and 3:2 stoichiometric co-crystal 
forms of p-TSA-TPPO. The combination of p-TSA/TPPO/MeCN was varied on a mass fraction 
basis by changing the flow rates at which p-TSA and TPPO were charged to the crystalliser. 
Experiments were carried out using the experimental set-up described in Chapter 3 Section 
3.6.1 (Figure 3.18) with slight modification to incorporate two solution feed vessels in the 
design as shown in Figure 8.6.  
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Figure 8.6: Flow diagram of the semi-batch experimental set-up used during the co-
crystallisation studies (process conditions presented are indicative, since they were varied 
for each experimental run). 
Experiments were monitored using the same PAT sensor array applied in the batch study. 
The required amount of p-TSA and TPPO were dissolved in separate vessels to generate 
undersaturated solutions according to Table 8.3. Solutions were prepared by heating 
suspensions of p-TSA and TPPO in MeCN to 30 oC (or 10 oC above saturation according to 
their respective solubility curves, Section 8.2) and holding for 15 min to allow complete 
dissolution of the materials. The resulting solutions were then cooled until just saturated (that 
is, 25 oC or 60 oC for experiment 26) and pumped separately to the 500 mL crystalliser, which 
was kept at a lower temperature (20 oC) to create supersaturation for nucleation of the 
co-crystal. At 20 oC, the suspension composition is expected to follow the ternary phase 
diagram with little to no variation. Any variation in the composition or co-crystal form obtain 
could therefore be linked to changes in the mass flow rate. The semi-batch experiments would 
later inform the development of a periodic flow crystallisation process. Calibrated Masterflex® 
pumps fitted with 3.1 mm ID tubing, and operated in time dispense mode were used to pump 
p-TSA/MeCN and TPPO/MeCN solutions to the crystalliser. The flow rates of p-TSA and 
TPPO solutions were varied from 15 to 32.7 g/min and 20 to 37.7 g/min, respectively. The 
targeted combined flow rate of the two streams was 52.7 g/min for each experimental run. 
Pumps were programmed to operate for 6.71 min, leading to the delivery of ~500 mL of 
combined p-TSA/TPPO/MeCN solution to the crystalliser, which was initially empty. For all 
experiments, the impeller speed of the crystalliser was set to 400 rpm. Table 8.3 gives a 
summary of the experimental conditions for each run.  
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Table 8.3: Summary of experimental conditions employed during the semi-batch 
co-crystallisation of p-TSA-TPPO co-crystals. 
Exp. 
No. 
p-TSA 
(g/g MeCN) 
TPPO 
(g/g MeCN) 
Solution Flow 
Rates (g/min) 
Component Mass Fractions 
(M) Region of 
Phase Diagram p-TSA 
soln. 
TPPO 
soln. 
p-TSA TPPO MeCN 
19 0.2987 0.1482 28 24.7 0.12 0.09 0.79 1 (3:2 form) 
20 0.2987 0.1482 32.7 20.0 0.14 0.05 0.81 1 (3:2 form) 
21 0.2987 0.1482 20.0 32.7 0.09 0.08 0.83 3 (mixture) 
22 0.2987 0.1482 15.0 37.7 0.06 0.09 0.85 2 (1:1 form) 
23 0.2987 0.1482 23.4 29.3 0.10 0.08 0.82 3 (mixture) 
24 0.2987 0.1482 17.7 35 0.08 0.08 0.84 3 (mixture) 
25 0.2987 0.1482 27.5 25.2 0.11 0.07 0.82 1 (3:2 form) 
26 0.4625 0.2016 20.0 32.7 0.12 0.12 0.76 2 (1:1 form) 
8.2.5 Periodic Flow Operating Conditions 
Periodic flow co-crystallisation experiments were carried out using either a single-stage 
PMSMPR (without recycle stream) or a three-stage cascaded PMSMPR unit similar to the 
ones described in Chapter 3 Section 3.6.1 (Figure 3.19 (a) and (b)), with slight modification to 
incorporate two solution feed vessels in the design (similar to the semi-batch set-up). Other 
experimental conditions employed were the same as in the semi-batch study. Figure 8.7 
shows the flow diagrams of the experimental set-up used for the single-stage PMSMPR and 
three-stage cascaded PMSMPR studies. The PMSMPR stages were operated either by 
coupled or decoupled slurry addition/withdrawal method described in previous chapters of this 
thesis. The flow rate for the slurry addition/withdrawal periods was 94.8 g/min. This was the 
maximum flow rate at which particles could be suspended based on visual observation. The 
hold cycle of the periodic flow operation was set to 5, 10 or 15 min to investigate the effect of 
holding time on the CSD. The slurry addition/withdrawal cycle was kept constant at 4.09 min 
for all experiments. The impeller speed of the crystalliser was set to either 450 or 500 rpm in 
each PMSMPR stage. The higher selected stirring speeds were required because of 
difficulties in achieving effective particle suspension, due to the very rapid growth of crystals 
into large size domains that eventually start to settle. The experimental conditions employed 
for the periodic flow crystallisation experiments are presented in Table 8.4. 
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Figure 8.7: Flow diagrams of single-stage PMSMPR (top) and three-stage PMSMPR 
(bottom) configurations used during the co-crystallisation studies (process conditions are 
indicative as they and were varied for each experimental run). 
Table 8.4: Summary of experimental conditions employed during the periodic flow 
crystallisation of p-TSA-TPPO co-crystals. 
Exp. 
No. 
Solution Flow 
Rates (g/min) 
Component Mass 
Fractions (M) 
Temperature  
(°C) Region of 
Phase 
Diagram p-TSA 
soln. 
TPPO 
soln. 
p-TSA TPPO MeCN MSMPR 1 MSMPR 2 MSMPR 3 
(27)^ 32.7 20 0.14 0.05 0.81 5 n/a n/a 1 (3:2 form) 
(28)^ 32.7 20 0.14 0.05 0.81 15 n/a n/a 1 (3:2 form) 
(29) 32.7 20 0.14 0.05 0.81 12.5 n/a n/a 1 (3:2 form) 
30 15.0 37.7 0.06 0.09 0.85 12.5 n/a n/a 2 (1:1 form) 
31 27.0 67.8 0.06 0.09 0.85 20 n/a n/a 2 (1:1 form) 
32 27.0 67.8 0.06 0.09 0.85 25 n/a n/a 2 (1:1 form) 
33 58.8 36.0 0.14 0.05 0.81 20 17 14 1 (3:2 form) 
34 58.8 36.0 0.14 0.05 0.81 25 20 20 1 (3:2 form) 
35 27.0 67.8 0.06 0.09 0.85 25 20 20 2 (1:1 form) 
36 27.0 67.8 0.06 0.09 0.85 20 17 14 2 (1:1 form) 
No brackets = coupled addition/withdrawal; Brackets () = decoupled addition/withdrawal; ^stirring set to 450 rpm, 
for all another experiments the stirring rate was set to 500 rpm.  
8.2.6 Solid State Characterisation 
Solid state characterization of raw materials (p-TSA and TPPO) their 1:1 and 3:2 p-TSA-TPPO 
co-crystal products were carried out using powder X-ray diffraction (PXRD), Raman 
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microscopy, ATR-FTIR spectroscopy, hot stage microscopy (HSM), DSC, scanning electron 
microscopy (SEM) and energy dispersive X-ray spectroscopy (EDS) and high performance 
liquid chromatography (HPLC). The operating principles and experimental procedures for 
each solid state technique were described in Chapter 3 Section 3.2. Patterns of co-crystal 
samples from each experimental run were compared to in-house developed reference 
samples of 1:1 and 3:2 p-TSA-TPPO that were prepared according to the procedures of 
Croker et al. [323], [324].  
PXRD, Raman Microscopy, ATR-FTIR and DSC Analyses: Figure 8.8 (a) – (d) shows the 
patterns obtained from PXRD (a), Raman microscope (b), ATR-FTIR (c), and DSC (d) solid 
state characterizations of p-TSA, TPPO and 1:1 and 3:2 p-TSA-TPPO co-crystal reference 
materials, respectively. For each material analysed, the patterns show distinctive features that 
were exploited to identify subsequent samples collected from different experimental runs 
during the study.  
 
Figure 8.8: Solid state characterization results for p-TSA and TPPO raw materials, and d 
simulated and reference patterns for 1:1 and 3:2 p-TSA-TPPO. (a) PXRD patterns (b) 
Raman spectra; (c) ATR-FTIR spectra; and (d) DSC patterns. 
Clear differences are observed between the co-crystal forms and their respective starting 
materials and physical mixture. For example, The PXRD patterns show distinctive broad (1:1 
p-TSA-TPPO) and sharp (3:2 p-TSA-TPPO) peaks in the 2-Theta (o) positions 7 – 10 and 17 
– 22. The Raman spectra show differences in peak width and position in the regions 3180 – 
(a) (b) 
(c) (d) 
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2855, 1150 – 890, and 780 – 480 cm-1. In terms of the ATR-FTIR signal, 1:1 and 3:2 p-TSA-
TPPO both show distinctive broad peaks in the region 3400 – 3100 cm-1. Distinctive 
differences between the two forms are also observed in the fingerprint region from 1500 to 
400 cm-1. The DSC patterns also show the clear difference between the melt of the two 
co-crystals, their parent compounds and physical mixture. The melts for the different 
crystalline phases are observed at approximately 140 oC (1:1 p-TSA-TPPO), 144 oC (3:2 
p-TSA-TPPO), 139 oC (p-TSA) and 159 oC (TPPO). Interestingly, the physical mixture of 
p-TSA and TPPO shows a very broad endotherm from approximately 121 – 140 oC. It is 
unclear why there is such a significant shift in the endotherm for the physical mixture of the 
two compounds. DSC scans from replicate runs showed a similar profile, which suggests that 
heating the two substances together leads either to the lowering of both of their melting points 
or the formation of different crystalline phase, which has a lower melting point. However, these 
hypotheses require further investigation that is beyond the scope of the current study.  
HSM Analyses: Hot stage microscopy (HMS) studies were carried out on samples of 1:1 and 
3:2 p-TSA-TPPO from selected experimental runs. Figure 8.9 (a) and (b) show the images 
captured from 100 oC until 148 oC (left) and DSC scans (right) for the melting of 3:2 and 1:1 p-
TSA-TPPO. The HMS patterns show melting in the temperature ranges 141 – 148 oC, and 
139 – 143 oC for 3:2 p-TSA-TPPO, and 1:1 p-TSA-TPPO, respectively, which is in good 
agreement with DSC where melting points of 143.7 oC and 139.9 oC were recorded for the 
respective co-crystal forms. The additional endothermic event at 128.2 oC observed in the 3:2 
co-crystal DSC profile is mostly likely residual starting material since this peak seems to 
correspond to the melt of physical mixture of p-TSA and TPPO as shown in Figure 8.8 (d). 
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Figure 8.9: Hot stage microscopy images (left), (a) 1:1 p-TSA-TPPO and (b) 3:2 p-TSA-
TPPO; and respective DSC scans (right) for each sample. 
SEM/EDS Analyses: The crystalline products from selected experiments were analysed by 
SEM/EDS. Figure 8.10 (a)-(d) show the SEM micrographs (x60) of 1:1 p-TSA-TPPO, 3:2 p-
TSA-TPPO and mixture of the two co-crystal forms. The distinct morphology of the 1:1 and 
3:2 p-TSA-TPPO is evident from the SEM micrographs. In particular, Figure 8.10 (e) (x300) 
and (f) (x400) show clearly the rhombic and rod shapes of 1:1 and 3:2 p-TSA-TPPO, 
respectively. The 3:2 p-TSA-TPPO samples Figure 8.10 (c) and (d) obtained from two different 
experimental runs show a clear distinction in crystal size and is attributed to a difference in the 
mass fraction composition of materials in the batch crystalliser (or the supersaturations). This 
leads to different crystal sizes, which suggests that the mass fraction composition of materials 
in the crystalliser can be adjusted to control the mean size and CSD of the final product. Using 
equations 8.5, and taking the equilibrium solubility at the operating temperature (based on 
solubility data) into account, the supersaturation with respect to 1:1 p-TSA-TPPO for these 
two experiments works out to 2.94 (c) and 1.77 (d), respectively. It appears that the growth of 
the crystals is extremely fast and is favoured at low supersaturation (d) compared to high 
supersaturation (c), which is expected. However, the supersaturation of the former is still quite 
(a) 100 oC 139 oC 
141 oC 143 oC 
139.9 oC 
(b) 100 
o
C 141 
o
C 
146 
o
C 148 
o
C 
143.7 
o
C 
128.2 
o
C 
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high, which suggest that the 3:2 co-crystal phase is extremely fast growing as crystals greater 
than 1 mm size were obtained. 
 
Figure 8.10: SEM micrographs of (a) 1:1 p-TSA-TPPO (x60); (b) mixture of 1:1 and 
3:2 p-TSA-TPPO (x60); (c) and (d) 3:2 p-TSA-TPPO (x60); and (e) 1:1 p-TSA-TPPO (x300) 
and (f) 3:2 p-TSA-TPPO (x400) crystals. 
EDS analyses were carried out on single crystals of 1:1 and 3:2 p-TSA-TPPO to determine 
the elemental composition of the crystal surface, and therefore can be used to confirm the co-
crystal form present. Unlike HPLC, EDS is not able to determine the ratio of p-TSA:TPPO in 
the bulk sample, since the technique can only probe small regions on individual crystal faces. 
Figure 8.11 shows the ESD spectra obtained from single crystals of 1:1 and 3:2 p-TSA-TPPO, 
respectively. The spectra show that five elements were detected, oxygen (O), carbon (C), 
nitrogen (N), phosphorous (P) and sulphur (S). Table 8.5 provides a summary of the EDS 
results showing the elemental composition of the 1:1 and 3:2 p-TSA-TPPO co-crystal forms, 
respectively. The data confirms the stoichiometric purity of co-crystal forms, and proves that 
EDS is a useful tool for phase identification. It was not possible to quantify the amount of 
hydrogen in the respective 1:1 and 3:2 p-TSA-TPPO co-crystal samples, since EDS is not 
very sensitive to lighter elements. With the exception of nitrogen and phosphorous, the EDS 
measurements matched well with the theoretical values. EDS is a useful analytical tool that 
can be applied to distinguish between the 1:1 and 3:2 stoichiometric co-crystal forms of p-TSA-
TPPO and complements other solid-state techniques such as PXRD, Raman and ATR-FTIR 
spectroscopy. 
(c) 
(d) 
(b) (a) 
(e) (f) 
x60                       1mm 
x60                        1mm x300                     300µm x400                     200µm 
x60                        1mm x60                        1mm 
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Figure 8.11: EDS spectra of (a) 1:1 and (b) 3:2 p-TSA-TPPO single crystals. 
Table 8.5: EDS measurements on single crystals of 1:1 and 3:2 p-TSA-TPPO. 
Elements 
1:1 p-TSA-TPPO 
Theoretical 
(wt%) 
1:1 p-TSA-TPPO 
EDS Meas. 
(wt%) 
3:2 p-TSA-TPPO 
Theoretical 
(wt%) 
3:2 p-TSA-TPPO 
EDS Meas. 
(wt%) 
Carbon 70.6 70.4 67.6 67.5 
Nitrogen 3.3 3.8 4.1 2.2 
Oxygen 11.3 9.4 12.6 10.6 
Phosphorous 7.3 8.2 6.1 8.3 
Sulphur 7.5 8.0 9.5 8.2 
HPLC Analyses: The purity and stoichiometric composition of the 1:1 and 3:2 p-TSA-TPPO 
co-crystal forms was confirmed by HPLC, applying a univariate calibration model developed 
by preparing different mass fractions of the starting materials (p-TSA and TPPO) in MeCN and 
finding the ratio between the areas of the resolved peaks of both components. Figure 8.12 
shows the calibration curve used to determine the relative amount of p-TSA and TPPO in 
samples obtained from each experimental run. 
(a) 
(b) 
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Figure 8.12: Univariate HPLC calibration model used to determining the purity and 
stoichiometry of 1:1 and 3:2 p-TSA-TPPO co-crystal forms. 
8.2.7 In situ Process Monitoring and Characterisation 
Real-time in process characterizations were carried out applying in situ Raman and ATR-FTIR 
spectroscopy to clear solutions and suspensions of 1:1 and 3:2 p-TSA-TPPO, respectively. 
Figure 8.13 shows the regions selected from in situ Raman spectroscopy for identification of 
the different phases. Results from each of the co-crystallisation runs were routinely correlated 
with HPLC measurements on samples taken at different intervals in order to confirm the 
identity of the solid forms present. Where necessary, other off-line measurement techniques, 
as described earlier in Section 8.2.6, were also employed to validate the results from the in 
situ process measurements and HPLC, for example, in cases where a mixture of different 
crystalline forms were suspected. This study highlights the complementarity of off-line and in 
situ process measurements. Furthermore, the application of both methods provides a robust 
analysis of the co-crystallisation process as well as valuable information for process scale-up. 
The Raman bands in the regions 200 – 350, 600 – 700, 1050 – 1250 and 1550 – 1610 cm-1 
corresponding respectively to vibration modes of aromatic ring wagging (233 – 262 cm-1), C-N 
bending (289 – 304 cm-1), ring deformation (629 – 640 cm-1), C-C ring stretching and C-S 
stretching (1083 – 1110 cm-1), P=O symmetric and asymmetric stretching (1130 – 1200 cm-1) 
and aromatic ring vibrations (1560 – 1620 cm-1). 
It has been shown so far that off-line solid-state and in situ characterisation techniques can 
be applied effectively to distinguish between the different crystalline forms of p-TSA and 
TPPO, including their stoichiometric co-crystal forms. This information can be applied not only 
to distinguish between crystalline forms, but also to inform the development of effective 
crystallisation control strategies in batch, semi-match and periodic flow crystallisers.  
1:1 
3:2 
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Figure 8.13: Regions of in situ Raman spectra used to differentiate between solution and 
solid phases of the p-TSA/TPPO/MeCN system. 
8.2.8 Quantitative Raman Spectroscopy: Complementary Off-line and On-line 
Analyses 
The aim of this study was to develop a multivariate calibration model to quantify the amount 
of 1:1 and 3:2 p-TSA-TPPO in samples collected from experimental runs where temperature 
cycles were implemented. In order to construct the multivariate calibration model dry mixtures 
with different proportions (i.e. 0, 20, 40, 60, 80 and 100 %) of pure 1:1 and 3:2 p-TSA-TPPO 
obtained from previous experimental runs were prepared and analysed using the Raman 
PHAT probe as described in Chapter 3, Section 3.2.3. The experimental procedure involved 
mixing (i.e. without grinding to avoid co-crystal transformation) and spreading evenly each 
calibration standard onto a paper sample holder in a circular shape (~ 5.5 mm diameter) and 
then mounting it on to the PHAT probe stage. The PHAT probe used had a spot size of 6mm 
and working distance of 250 mm a total of five measurements were taken for each calibration 
standard. Between each measurement the sample was remixed and spread as described 
earlier. The collected spectra were pre-processed using SNV normalisation routine to 
minimise the signal noise caused by the different scattering patterns of small and large 
particles. Figure 8.14 below shows the SNV pre-processed spectra at different concentrations 
of 1:1 and 3:2 p-TSA-TTPO. The concentrations ranged from 100 % (sample 1) to 0 % (sample 
6) 1:1 p-TSA-TPPO. As the composition of 1:1 and 3:2 p-TSA-TPPO changes from samples 
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1 to 6, changes in spectral shifts are observed in the regions 1200 – 1177, 950 – 890, 440 – 
370 and 350 – 150 cm-1.  
 
Figure 8.14: Spectra of calibration standards collected using Raman PHAT probe. 
PLSR and PCR multivariate calibration techniques were applied to the pre-processed spectra; 
the resulting models were then validate using spectra of samples collected from subsequent 
experimental runs. The PHAT probe measurements were then correlated with in situ Raman 
MR immersion probe (described in Chapter 3, Section 3.3.1) measurements to further extend 
the capability of the multivariate model to real-time quantification of the crystalline co-crystal 
form. Further details on this aspect of the study are provided in the discussion section 
following. 
The best methods for assessing the co-crystals on a quantitative basis are HPLC (with 
univariate model) and Raman PHAT probe (with multivariate model). The limitation of the 
HPLC method is the inability to determine accurately the composition of the co-crystals when 
a mixture is present due to the requirement to dissolve the crystals before analysis. The 
Raman PHAT probe method on the other hand can be applied to determine the composition 
of mixtures as the samples are analysed in solid form. The other techniques described earlier 
in Section 8.2.6 were used qualitatively (off-line Raman (microscopy), off-line ATR-FTIR, 
PXRD, DSC and HSM) or semi-quantitatively (EDS) to identify the crystalline forms of p-TSA 
and TPPO and provided useful information about the crystalline forms on initial assessment 
of samples prior to their quantitative analysis. 
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8.3 Results and Discussions 
8.3.1 Batch Co-Crystallisation Monitoring and Control  
The batch cooling co-crystallisations of p-TSA with TPPO to give stoichiometric 1:1 and 
3:2 p-TSA-TPPO co-crystal forms, as per the ternary phase diagram, were monitored by 
applying integrated PAT and CryPRINS informatics system tools within the IDS framework to 
extract information pertaining to the stability of each co-crystal form under different operating 
conditions. A further aim was to optimise the batch process for the selective crystallisation of 
each co-crystal form, achieved by tuning either the starting composition of 
p-TSA/TPPO/MeCN or the crystallisation temperature profile. Figure 8.15 (a) and (b) shows 
the process time diagrams obtained from monitoring the crystallisation of 1:1 and 3:2 p-TSA-
TPPO during experiment 5 and 3 (Table 8.2), respectively using FBRM, ATR-UV/vis and ATR-
FTIR spectroscopy. Also shown are the microscope images of the crystalline products.  
 
Figure 8.15: Schematic showing the process time diagrams with temperature, ATR-UV/vis, 
ATR-FTIR and FBRM signals for the crystallisation of: (a) 1:1 p-TSA-TPPO – experiment 5; 
(b) 3:2 p-TSA-TPPO – experiment 3; along with microscope images (top right) and off-line 
ATR-FTIR spectra (bottom right) of samples collected at the end of both processes. 
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As expected, 1:1 p-TSA-TPPO show a distinct rhombic morphology, while the 3:2 form exhibits 
the characteristic elongated prismatic morphology, Figures 8.4 and Figure 8.15 (top left). The 
infrared spectra of the two co-crystal forms, Figure 8.15 (bottom right), also show distinct 
differences in the regions associated with the C-H stretching (2900 – 3000 cm - 1) and N-H 
stretching (3000 – 3400 cm-1) vibration frequencies, respectively. Off-line Raman, XRD, DSC 
and HPLC also confirmed the purity of each co-crystal form. The time diagrams, Figure 8.15 
(a) and (b), are annotated to indicate where important events occurred during each co-
crystallisation run. Signals from the PAT tools show good agreement with respect to the 
detection of nucleation, although the in situ ATR-UV/vis and ATR-FTIR signals are affected 
by temperature. Nucleation of 1:1 p-TSA-TPPO, Figure 8.15 (a), is not observed until cooling 
toward 5 oC (final temperature was ~6.5 oC). On the other hand, nucleation of 3:2 p-TSA-
TPPO, Figure 8.15 (b), occurs at ~21 oC. The contrasting results were due to the difference in 
mass fraction composition of p-TSA/TPPO/MeCN in each experimental run, that is, and 
0.19/0.09/0.72 (experiment 3) and 0.09/0.12/0.79 (experiment 5). The corresponding 𝜎 values 
for the experiments 3 and 5 were 2.69 and 2.29, respectively. Note that the cooling rate was 
held constant for both experiments and the overall temperature profile was the same. These 
experiments were found to be reproducible, in terms of the co-crystal outcome. In addition to 
detecting signal from the solution phase, the ATR-FTIR probe was also able to detect the solid 
phase signal, albeit at the lower limit of the instrument (650 cm-1) when 1:1 p-TSA-TPPO 
nucleated. This is not entirely surprising since it is well known that in situ ATR-FTIR can be 
affected by particle scattering [29], [143], and to a much greater extent than in situ ATR-UV/vis, 
which shows much less sensitivity [303]. However, the ATR-FTIR signal cannot be properly 
interpreted for experiment 3 in which 3:2 p-TSA-TPPO was the product obtained. The signal 
was found to change in almost exactly the same way as the temperature profile, with the 
exception of a sudden spike at the 650 cm-1 peak position at ~110 min. This sudden spike was 
consistent with a sudden increase in FBRM counts/s and a simultaneous drop in ATR-UV/vis 
absorbance, with confirmation of the presence of crystals obtained via real-time PVM imaging. 
The change in behaviour of the 650 cm-1 peak signal may be attributed to material sticking on 
the probe window leading to the observed dramatic change in signal. Furthermore, peaks that 
are close to the limits of the ATR-FTIR range (for the study the instrument had a range 650 – 
2800 cm-1) are often not consistent due to small signal to noise ratio, and therefore their 
reliability for interpretation of process behaviour is strongly cautioned. In fact, the signal 
changes for the ATR-FTIR probe as observed in experiment 3 were not repeatable.  
The mass fraction of MeCN was fixed to 0.50 for experiments 4 and 7 (Table 8.2) and the 
amount of p-TSA and TPPO varied according to the recipe by Croker et al. [323] for obtaining 
pure 3:2 and 1:1 p-TSA-TPPO respectively by cooling crystallisations at 50 mL scale. For 
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experimental runs 4 and 7, pure 3:2 and 1:1 p-TSA-TPPO, respectively, were obtained as 
confirmed by off-line analysis (HPLC, Raman microscopy, off-line ATR-FTIR, EDS and DSC). 
However, due to the high solubility of p-TSA and TPPO in MeCN, it seems impractical to 
consider scale-up of the co-crystallisation process applying the conditions used for 
experimental runs 4 and 7, since the high viscosity of the slurry at these high concentrations 
leads to poor mixing and suspension of the crystals. Furthermore, speciality agro chemicals 
are often highly toxic and expensive, plus the bulk storage of materials could pose health and 
environmental risks [309]. Therefore, the co-crystallisation was investigated at much lower 
concentrations of p-TSA and TPPO in MeCN (see Table 8.2), exploiting the upper most 
regions (toward MeCN) of the ternary phase diagram. Table 8.6 provides a summary of the 
outcomes in terms of co-crystal form obtained, based on-line (in situ Raman) and off-line 
(Raman microscopy, off-line ATR-FTIR, EDS and DSC) analyses. 
Consistent results in terms of co-crystal form were obtained for all investigated compositions 
of p-TSA/TPPO/MeCN, that is, with the exception of experiments 11 and (18). These two 
experiments were identical linear runs (note that temperature cycling was applied to (18) later) 
that were expected to yield a mixture of 1:1 and 3:2 p-TSA-TPPO. Instead, 1:1 p-TSA-TPPO 
and 3:2 p-TSA-TPPO were obtained from experiment 11 and (18), respectively. This is likely 
due to operation of the process in the region of the ternary diagram (Figure 8.1) in the narrow 
region where the boundaries between stable 1:1 p-TSA-TPPO (Region 2), a mixture (Region 
3) and stable 3:2 p-TSA-TPPO are really close. Although one would expect to obtain a mixture 
of co-crystals under the prevailing operating conditions, the outcome perhaps highlights the 
potential variability issues that can arise in the batch process. However, it must be noted that 
the experimental conditions reflect the dynamics of the crystallisation kinetics of the co-crystal 
system. The ternary phase diagram on the other hand reflects the thermodynamic stability at 
a fixed temperature of 20 oC. If the crystalliser was held for a long period (e.g. 24 hrs.) at 20 
oC, then perhaps a mixture of the two co-crystals would have prevailed in experiments 11 and 
(18). However, other control strategies can be explored to achieve the desired crystallisation 
outcome over a shorter time period, namely temperature cycling as demonstrated for 
experiment (18) later. Temperature cycling using active polymorphic feedback control based 
on in situ Raman spectroscopy is a promising method recently explored by Simone et al. [49] 
to eliminate the undesired polymorphic form of orthoaminobenzoic acid (OABA) and then grow 
the desired form. In this study, a simple temperature cycling method was employed to 
eliminate one co-crystal form and grow the desired form. Temperature cycling was 
implemented for experiments (13) and (18). The 1:1 co-crystal form is desired since the 3:2 
form exhibits incongruent dissolution behaviour in MeCN [323], [326]. These experiments also 
shed light on the stability and by extension the thermodynamics of the crystallisation of 1:1 
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and 3:2 p-TSA-TPPO, respectively. The temperature cycles in experiments (13) and (18) were 
implemented based on the in situ Raman signal of peaks associated with the 1:1 and 3:2 co-
crystal form, respectively. 
Figure 8.16 shows the process time diagram for the crystallisation of 3:2 p-TSA TPPO during 
experiment (18) and the subsequent transformation to 1:1 p-TSA-TPPO. The mixture was 
heated up and subjected to a complex temperature profile with ramped heating and cooling 
cycles (Figure 8.16), the same temperature profile was used for experiment (13). The final 
product obtained from experiments (13) and (18) was pure 1:1 p-TSA-TPPO, as confirmed by 
on-line Raman spectroscopy and off-line solid state characterization methods (HPLC, PXRD, 
Raman microscopy and ATR-FTIR) described earlier. 
Table 8.6: Summary of co-crystallisation outcomes for selected experiments, co-crystal form 
was determined by on-line and off-line measurements. 
Exp. 
No. 
p-TSA 
(g/g 
MeCN) 
TPPO 
(g/g 
MeCN) 
Component Mass 
Fractions (M) HPLC Ratio 
p-TSA/TPPO 
p-TSA-TPPO 
Co-crystal 
Form 
Region in 
Ternary 
Phase 
Diagram p-TSA TPPO MeCN 
3 0.2634 0.1247 0.19 0.09 0.72 1.005 3:2 1 (3:2 form) 
4 0.5776 0.4202 0.29 0.21 0.50 1.470 3:2 1 (3:2 form) 
5 0.1147 0.1532 0.09 0.12 0.79 1.034 1:1 2 (1:1 form) 
7 0.3793 0.6193 0.19 0.31 0.50 1.002 1:1 2 (1:1 form) 
8 0.0706 0.1059 0.06 0.09 0.85 1.000 1:1 2 (1:1 form) 
11 0.1084 0.0964 0.09 0.08 0.83 1.006 1:1 3 (mixture) 
12 0.0833 0.1071 0.07 0.09 0.84 1.002 1:1  2 (1:1 form) 
(13) 0.1728 0.0617 0.14 0.05 0.81 1.477 => 1.002 3:2 => 1:1 1 (3:2 form) 
(18) 0.1049 0.0968 0.09 0.08 0.83 1.463 => 0.998 3:2 => 1:1 3 (mixture) 
() Temperature cycles implemented; => Conversion from 3:2 to 1:1 p-TSA-TPPO. 
Figure 8.16 also shows the point where the first sample was taken from the process (arrow 1; 
image S1). The sample taken was confirmed to be pure 3:2 p-TSA-TPPO by both on-line and 
off-line measurements. Following on from that point is the dissolution of 3:2 p-TSA-TPPO 
(arrow 2, image S2), which is marked by a decrease in the FBRM counts/s and the 2nd 
derivative of Raman peak signal at 304 cm-1 (indicative of the presence of 3:2 p-TSA-TPPO). 
Subsequent to this event, nucleation of 1:1 p-TSA-TPPO occurs (arrow 3), marked by a 
sudden increase in FBRM counts/s and the 2nd derivative of Raman peak signal 1145 cm-1 
(indicative of the presence of 1:1 p-TSA-TPPO). This is followed by slight dissolution as the 
temperature continues to increase in the heating cycle (arrow 4). At ~270 min. there is a rapid 
increase in the FBRM counts/s and simultaneous increase in the 2nd derivative 1145 cm-1 peak 
signal (arrow 5; image S3) due to implementation of a temperature cooling cycle. This is 
attributed to secondary nucleation of 1:1 p-TSA-TPPO as the amount of 3:2 p-TSA-TPPO 
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diminishes. The relative solubility of each co-crystal phases plays an important role in the 
conversion between forms. The 3:2 co-crystal is known to undergo incongruent dissolution, 
whereby there is a transformation step involving the formation and subsequent dissolution of 
1:1 p-TSA-TPO [308]. The temperature cooling step implemented from ~334 to 490 min. 
(cooling rate of -0.2 oC/min) led to further secondary nucleation of 1-1 p-TSA-TPPO (arrow 7). 
The microscope image of sample 3, Figure 8.16 (S3), shows there is a mixture of 3:2 and 
1:1 p-TSA-TPPO. The presence of a mixture was also confirmed by off-line solid-state 
characterizations and HPLC analysis. Following this, a temperature heating step was 
implemented (heating rate of 0.2 oC/min) to dissolve 3:2 p-TSA-TPPO (arrow 8; image S3). 
This was then followed by another cooling step to nucleate and grow 1:1 p-TSA-TPPO (arrow 
10; image S4). 
 
1 = Sample 1 at 57 min. 5 = Sample 3 at 272 min. 9 = Nucleation event. 
2 = Sample 2 at 109 min. 6 = Signal loss/fluorescence 10 = Sample 5 at 1137 min.** 
3 = Nucleation event 7 = Nucleation event **growth/agglomeration/ 
   settling observed. 4 = Dissolution event 8 = Sample 4 at 177 min. 
Figure 8.16: Process time diagram for experiment (18) showing the changes in FBRM 
count/s and in situ Raman 2nd derivative signals (top), temperature profile implemented 
(bottom left) and microscope images of samples (bottom right). 
The final sample collected at the end of the batch (image S5) was found to be pure 1:1 p-TSA-
TPPO. As demonstrated earlier, increasing the process temperature soon after nucleation of 
3:2 p-TSA-TPPO leads to its dissolution and subsequent transformation to 1:1 p-TSA-TPPO. 
Temperature  
Profile 
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The 1:1 co-crystal then starts to increase in amount viz secondary nucleation. The switching 
from heating to a cooling cycle soon after the detection of 1:1 p-TSA-TPPO leads to an 
increase in the amount of this co-crystal form and further reduction in the amount of 3:2 p-TSA-
TPPO. The work presented here is a proof of concept study whereby the mass faction 
composition and temperature cycling are applied to control the co-crystallisation process in 
order to obtain the desired stoichiometric form of the p-TSA-TPPO co-crystal system. It has 
been demonstrated that the co-crystal form can be controlled by manipulating the composition 
of p-TSA, TPPO and MeCN, as previously demonstrated by Croker et al. [323], [326] in small 
scale studies. The stoichiometric purity of the final co-crystal was assured by implementation 
of a complex array of on-line and off-line monitoring and characterization techniques. 
8.3.2 In situ Quantitative Analysis of Co-Crystallisation Process Using 
Raman Spectroscopy 
In the previous section the implementation of temperature cycles based on signals from in situ 
Raman spectroscopy was investigated. In this study the Raman control approach was 
investigated in greater detail by applying multivariate statistical methods. The Raman spectra 
obtained in the presence of solids (i.e. after the crystallisation of the respective 1:1 and 3:2 
co-crystal forms or mixtures thereof) using the MR immersion probe  for a series of 
experimental runs reported earlier in Section 8.3.1, (i.e. experiments 8, 11 and (13)), were pre-
processed viz. the application of 2nd derivative with Savitzky-Golay smoothing filter using the 
iC Raman (version 4.1) software interface which was connected to the Kaiser RamanRXN2 
Hybrid spectrometer used in this study (see Chapter 3). In experiments 8, 11 and (13), 1:1 
p-TSA-TPPO, 3:2 p-TSA-TPPO and a mixture of 1:1 and 3:2 p-TSA-TPPO, respectively, were 
obtained on crystallisation. The 2nd derivative spectra of each experimental data set was 
further analysed to identify any trends related to the different co-crystal compositions obtained. 
Figure 8.17 show the specific regions of the overlaid 2nd derivative spectra for the three 
experimental runs that were tracked. The spectra collected soon after nucleation was detected 
are the ones displayed. 
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Figure 8.17: Selected regions of 2nd derivative pre-processed spectra for experiments 8 (top; 
1:1 p-TSA-TPPO), 11 (middle; mixture), and (13) (3:2 p-TSA-TPPO). 
The region from 308 – 300 cm-1, which occurs as a small negative peak was found to be useful 
for tracking 3:2 p-TSA-TPPO. The peak appears when 3:2 p-TSA-TPPO nucleates as pure 
form or as a mixture with 1:1 p-TSA-TPPO and increases in intensity as the amount of 3:2 p-
TSA-TPPO increases. On the other hand, when 1:1 p-TSA-TPPO nucleates as pure form the 
peak at 308 – 300 cm-1 is absent. The region from 1149 – 1137 cm-1, which encompasses a 
large negative peak, was another region of interest that was tracked during this study. The 
centre position of this peak was found to shift position toward higher wavenumbers (i.e. toward 
1149 cm-1) whenever 1:1 p-TSA-TPPO nucleated. Conversely, the centre position shifted 
towards lower wavenumbers (i.e. toward 1137 cm-1) whenever 3:2 p-TSA-TPPO nucleated. 
Tracking of the peak centre position in the region from 1149 – 1137 cm-1 was found to be more 
reliable for the purposes of detecting transformation events involving the two co-crystal forms. 
Based on the centre position of this peak, a decision can be made to trigger heating or cooling 
cycles to convert from between the two co-crystal forms, akin to dynamic feedback control of 
the process. A number of experimental runs were conducted with temperature cycling to 
investigate the solution mediated transformation events from 3:2 p-TSA-TPPO to 1:1 p-TSA-
TPPO and vice versa. Samples were taken during each temperature cycle and analysed by 
using off-line techniques, including HPLC, ATR-FTIR, Raman Microscopy and Raman 
spectroscopy using a PHAT probe accessory fitted to the Kaiser RamanRXN2 Hybrid 
spectrometer (Chapter 3, Section 3.2.3). The results of these experimental runs in terms of 
co-crystallisation outcome are presented in Table 8.7 below. 
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Table 8.7: Summary of experimental results obtained with temperature cycling. 
Exp. 
No. 
p-TSA 
(g/g 
MeCN) 
TPPO 
(g/g 
MeCN) 
Component Mass 
Fractions (M) HPLC Ratio 
p-TSA/TPPO 
p-TSA-TPPO 
Co-crystal 
Form 
Region in 
Ternary 
Phase 
Diagram p-TSA TPPO MeCN 
(14) 0.1484 0.1148 0.12 0.09 0.79 1.486 3:2 => 1:1 1 (3:2 form) 
(15) 0.1492 0.1140 0.12 0.09 0.79 1.151 mix >> 3:2 1 (3:2 form) 
(16) 0.1054 0.0971 0.09 0.08 0.79 1.294 mix >>> 1:1 3 (mixture) 
(17) 0.1384 0.1136 0.11 0.09 0.8 1.182 mix >>> 1:1 3 (mixture) 
() Temperature cycles implemented; => Conversion from 3:2 to 1:1 p-TSA-TPPO; >> Conversion from mixture to 
3:2 p-TSA-TPPO; >>> Conversion from mixture to 1:1 p-TSA-TPPO. 
Figure 8.18 (a) and (b) show the time diagrams with PAT sensor signals from ATR-UV/vis, 
FBRM, PVM and Raman for experiment 14. Several events were detected by the PAT sensors 
during the cooling crystallisation with temperature cycling. The first event labelled (1) involves 
the simultaneous dissolution of the raw materials p-TSA and TPPO. The second event (2) 
marks the nucleation of a p-TSA-TPPO co-crystal which is detected as an increase in FBRM 
and PVM count/s, in Figure 8.18 (a). This event was also detected by Raman spectroscopy, 
Figure 8.18 (b), whereby there is an increase in the second derivative signal of the peak height 
and centre position between 308 – 300 cm-1 and 1149 – 1137 cm-1, respectively. The sudden 
increase in peak height signal between 308 – 300 cm-1 is an indication that 3:2 p-TSA-TPPO 
was the co-crystal form that nucleated. Simultaneously, the centre position of the peak signal 
between 1149 – 1137 cm-1 experiences a shift towards ~1142 cm-1, which also confirms the 
presence of 3:2 p-TSA-TPPO. A simultaneous decrease in intensity of the peak height at 1186 
cm-1 (the solution peak) indicates that the concentrations of the starting materials (p-TSA and 
TPPO) are decreasing. This is expected since the materials are co-crystallising with each 
other. A fluorescence (or interference) event can be seen in the Raman signal of the peak 
positions 308 – 300 cm-1 and 1186 cm-1. However, it appears that this event did not have an 
effect on the 1149 – 1137 cm-1 peak centre position Raman signal. This was therefore seen 
as the more reliable Raman signal to track compared to the two others mentioned previously.  
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Figure 8.18: Process time diagrams showing the changes in temperature and (a) ATR-
UV/vis, FBRM counts/s and PVM counts/s; and (b) Second derivative Raman signals for 
peak centre shift between 1149 – 1137 cm-1 and peak height shifts at 308 – 300 cm-1 and 
1186 cm-1 during experiment (14). 1 = raw materials dissolution; 2 = nucleation of 3:2 p-TSA-
TPPO; 3 and 4 = dissolution of 3:2 p-TSA-TPPO and nucleation of 1:1 p-TSA-TPPO; and 
5 = transformation of 3:2 to 1:1 p-TSA-TPPO 
The third (3) and fourth (4) events that were detected mark the dissolution of 3:2 p-TSA-TPPO 
and subsequent nucleation of 1:1 p-TSA-TPPO during the first and second temperature 
cycles, respectively. This solution-mediated transformation event was detected as subtle 
changes in the FBRM and PVM signals (i.e. shape decrease and subsequent increase in 
counts/s). The Raman peak position at 1149 – 1137 cm-1 confirmed that 3:2 p-TSA-TPPO was 
the co-crystal form that crystallised during the first two temperature cycles and that it started 
to transform on heating to 1:1 p-TSA-TPPO. The transformation was detected as a sharp rise 
in the signal towards 1145 cm-1 (i.e. shift of the peak centre position towards higher 
wavenumbers). Subsequent to this, the fifth (5) event indicates a more gradual increase in the 
Raman signal of the peak centre position between 1149 – 1137 cm-1 as a third temperature 
cycle is implemented. The cooling and heating rates for this third cycle were slower (-0.2 / 0.2 
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oC/min) compared to the first two cycles (-0.5 / 0.5 oC/min). The cooling and heating rates 
were made slower in order to better detect the solution mediated transformation event during 
the heating cycle. With slower heating it was much easier to detect the transformation from 
3:2 p-TSA-TPPO to 1:1 p-TSA-TPPO, although the relative compositions of the two co-crystal 
forms could not be quantified. It is interesting to note that the change in FBRM signal between 
290 and 410 min. Indicates that secondary nucleation of 1:1 p-TSA-TPPO is taking place, 
marked by a sudden increase in counts/s during the heating phase. This was quickly followed 
by a sudden decrease in counts/s nearing the end of the heating cycle, which suggests slight 
dissolution (or perhaps agglomeration) of 1:1 p-TSA-TPPO. These events are attributed to the 
solution mediated transformation from 3:2 to 1:1 p-TSA-TPPO. Figure 8.19 below shows 
microscope images of samples collected at different time intervals during experiment (14), which 
confirms the events reported earlier.  
 
Figure 8.19: Microscope images of samples collected from experiment (14). Circled particle 
show the early stages of transformation from 3:2 to 1:1 p-TSA-TPPO. 
Image (1) shows the distinctive elongated prismatic morphology typically exhibited by 3:2 
p-TSA-TPPO. Image (2) show crystals with poor crystal habit, an indication of the onset of 
transformation from 3:2 to 1:1 p-TSA-TPPO. Subsequent images, (3), (4) and (5) indicate the 
presence of 1:1 p-TSA-TPPO crystals, which show the distinctive rhombic morphology. Figure 
8.20 (a) and (b) show the off-line ATR-FTIR and Raman microscope spectra of the samples 
collected during experiment (14) along with the reference spectra. These spectra further 
confirm the findings discussed earlier for experiment (14). The ATR-FTIR spectra, Figure 8.20 
(a), in the region 3350 to 2900 cm-1 show the distinctive features of pure 1:1 and 3:2 p-TSA-
TPPO (i.e. based on the reference materials). The peaks observed in this region for both co-
crystal forms are a result of the vibration frequencies associated the amine (-NH2) group of p-
TSA. It appears the different hydrogen bonding interactions of the -NH2 with TPPO leads to 
the distinctive peak positions and peak broadening/distortions observed this region. For 
example, there is a shift in peak positions toward lower wavenumbers for 1:1 p-TSA-TPPO 
relative to 3:2 p-TSA-TPPO. Furthermore, 3:2 p-TSA-TPPO shows peak boarding/distortion 
in the region 3350 – 3200 cm-1, while the same can be said for 1:1 p-TSA-TPPO in the region 
3130 – 2930 cm-1. The reference materials of 1:1 and 3:2 p-TSA-TPPO show prominent peaks 
with centre positions at 3224 cm-1, 3106 and 3050 cm-1. Analysis of the sample spectra relative 
to the reference spectra indicate that sample (1) is pure 3:2 p-TPP-TPPO, sample (2) is a 
(1) 90 min 
(1) 58 min  
(2)  172 min  (3) 398 min  (4) 622 min  (5) End  
241 
 
mixture of 1:1 and 3:2 p-TSA-TPPO and samples (3), (4) and (5) are pure 1:1 p-TSA-TPPO. 
The Raman results, Figure 8.20 (b), complement well the ATR-FTIR results explained earlier. 
The peak shifts (i.e. boarding/distortion) between 3090 – 3030 results confirm that sample (1) 
is 3:2 p-TSA-TPPO, sample (2) is a mixture of 1:1 and 3:2 p-TSA-TPPO, and samples (4) and 
(5) are both 1:1 p-TSA-TPPO. The spectrum of sample (3) has similar features to 1:1 p-TSA-
TPPO, but there is some distortion in the region between 3070 – 3060 cm-1. This is an 
indication that this sample may have trace amounts of 3:2 p-TSA-TPPO, which were not 
detected with off-line ATR-FTIR. HPLC analysis on this sample gave a ratio of 1.288, which 
confirms the Raman microscope results. This compares to a value of 1.352 observed for 
sample (2), which was confirmed as a mixture by all the solid-state techniques employed. Note 
that the HPLC method gives a semi-quantitatively determination of the co-crystal composition 
and cannot be used to determine the amount of each co-crystals present in mixtures. It is 
interesting to note that the microscope images did not show any evidence of the presence of 
3:2 p-TSA-TPPO in sample (3), as confirmed by visual inspection. Therefore, a quantitative 
method is required to give a more accurate representation of the co-crystal composition of 
samples. The quantitative method was developed using off-line and on-line Raman 
spectroscopy to determine the relative amounts of the two co-crystals as described in Section 
8.2.8 and below.  
            
Figure 8.20: Off-line ATR-FTIR (left) and Raman (right) spectra showing the peak 
shifts/distortions for the transformation of 3:2 to 1:1 p-TSA-TPPO. 
Quantitative Method Using Raman PHAT and MR Immersion Probe: It was useful to 
correlate the off-line multivariate calibration method developed with the Raman PHAT probe 
to in situ Raman measurements to be able to quantify the amount of each co-crystal in real-
time, in particular, when transformation events are taking place. This provides a useful means 
of determining the end-point of these transformation events and is a useful guide to determine 
when to stop the crystallisation process. Table 8.8 below shows the performance indices of 
1:1 increasing 3:2 increasing
3106 cm -1 3224 cm -13050 cm
-1
1:1 increasing 3:2 increasing
(a) 
(b) 
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the PLSR and PCR multivariate models that were developed using the Raman PHAT probe 
as described in Section 8.2.8. The models were trained on spectra obtained from mixtures of 
know composition of 1:1 and 3:2 p-TSA-TPPO and were able to interpret the data from 
measurements of samples taken from each experiment well. Both models showed similar 
accuracy, hence both were used to test the co-crystal composition of unknown samples. 
Table 8.8: Summary of performance indices for the best PLSR and PCR models 
Model Type 
Pre-Processing 
Applied 
No. C* RMSEP R2 % Error Remarks 
PLSR SNV 2 0.0389 0.9893 ± 3.8 optimum 
PCR SNV 2 0.0375 0.9889 ± 3.8 optimum 
        C* = number of components 
The performance of the multivariate calibration model developed using the Raman PHAT 
probe was checked against samples collected from experimental runs (15), (16) and (17), 
listed in Table 8.7. In these experiments, several temperature cycles were implemented 
intentionally to create the conditions for solution-mediated transformation from 3:2 to 1:1 
p-TSA-TPPO and vice versa. The decision to implement cooling or heating steps was based 
on the signal observed from the in situ Raman MR immersion probe. As explained earlier the 
second derivative of the peak centre positon in the region 1149 – 1137 cm-1 was found to be 
the most reliable for detecting the respective 1:1 and 3:2 co-crystal forms of p-TSA-TPPO. 
Therefore, this signal was tracked and used as the decision variable to switch between heating 
and cooling cycles in order to trigger solution mediated transformation of the two co-crystals. 
Figure 8.21 below shows the time diagram for experiment (15), arrows and numbers indicate 
where samples were taken. The sampling frequency was necessary to capture the 
transformation events and correlate the process signal to the presence of a specific co-crystal 
form or mixture of forms. Nucleation of a mixture of 1:1 and 3:2 p-TSA-TPPO was observed 
in this experiment, although 3:2 p-TSA-TPPO was expected. This was attributed to batch-to-
batch variability often encountered in batch operations. A co-crystal mixture was confirmed by 
the in situ Raman measurement at the peak centre position 1149 – 1137 cm-1 and by off-line 
solid-state analyses (discussed below).  
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1 = Sample 1 at 103 min. 8 = Sample 8 at 495 min. 15 = Sample 15 at 2821 min. 
2 = Sample 2 at 193 min. 9 = Sample 9 at 1300 min. 16 = Sample 16 at 2905 min. 
3 = Sample 3 at 214 min. 10 = Sample 10 at 1393 min. 17 = Sample 17 at 2919 min. 
4 = Sample 4 at 295 min. 11 = Sample 11 at 1410 min. 18 = Sample 18 at 3050 min. 
5 = Sample 5 at 313 min. 12 = Sample 12 at 1495 min. 19 = Sample 19 at 3354 min. 
6 = Sample 6 at 390 min. 13 = Sample 13 at 1513 min. 20 = Sample 20 at 4219 min. 
7 = Sample 7 at 415 min. 14 = Sample 14 at 2919 min.  
Figure 8.21: Time diagram of experiment (15) showing the change in Raman signal (peak 
centre position between 1149 – 1137 cm-1), FBRM and PVM particle counts/s. 
Figure 8.21 shows that stepwise heating of the process vessel to 35 oC led to the gradual 
transformation of the mixture to 1:1 p-TSA-TPPO. Subsequent stepwise cooling from 35 to 20 
oC led to the opposite result, whereby gradual transformation from 1:1 to 3:2 p-TSA-TPPO is 
observed. Further cooling to 5 oC led to further conversion to 3:2 p-TSA-TPPO as the 
equilibrium composition of the mixture keeps shifting with cooling. These results indicate that 
1:1 p-TSA-TPPO is the thermodynamic co-crystal form and 3:2 p-TSA-TPPO is the kinetic 
form. The PLSR and PCR multivariate models were also applied to samples collected from 
experimental run (16); the process time diagram for this shown in Figure 8.22. Points where 
samples were collected are indicated with arrows. Points where important transformation 
events from 3:2 to 1:1 p-TSA-TPPO and vice versa were detected by the PAT probes are also 
indicated. The transformation events were detected by FBRM, PVM and Raman probes. 
However, the Raman MR immersion probe was the most sensitive to the process changes. 
This experiment provided evidence of a correlation between the off-line Raman PHAT probe 
and the in situ Raman MR immersion probe process measurements.  
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1 = Sample1 at 91 min 4 = sample 4 at 576 min 7 = Sample 2779 at  
2 = Sample 2 at 151min 5 = Sample 5 at 1165 min. 8 = Sample 2856 at 
3 = Sample 3 at 420 min 6 = Sample 6 at 1977min.  
Figure 8.22: Time diagram of experiment (16) showing the change in Raman signal (peak 
centre position between 1149 – 1137 cm-1), ATR-UV/vis, FBRM and PVM particle counts/s. 
Figure 8.23 (a) and (b) shows the change in composition of the various samples of the 
co-crystal mixture with time for experiments (15) and (16), respectively, as determined by 
apply the PLSR and PCR multivariate models developed with the Raman PHAT probe. Both 
calibration models gave similar predictions of the composition of co-crystal mixtures at the 
different sampling periods for both experimental runs. The models confirm that a mixture of 
1:1 and 3:2 p-TSA-TPPO nucleated in experiment (15) and that the co-crystal mixture is 
transformed to 1:1 p-TSA-TPPO after ~500 min., which concurs with the discussions earlier 
relating the second derivative signal of the in situ MR immersion probe (i.e. the peak centre 
shift between 1149 – 1137 cm-1) to the co-crystal composition.  
 
Figure 8.23: Change in co-crystal composition for experiment (15) as determined by off-line 
Raman PHAT probe viz multivariate PLSR and PCR calibration models. 
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For experiment (16), the calibration models predicted that pure 3:2 p-TSA-TPPO was formed 
initially, which was then converted to a mixture of 1:1 and 3:2 p-TSA-TPPO and finally to pure 
1:1 p-TSA-TPPO. Figure 8.24 shows the correlation diagram of the in situ Raman MR 
immersion probe measurement for peak centre position shifts between 1149 – 1137 cm-1 and 
the co-crystal composition as determined by off-line measurement using the PHAT probe with 
the multivariate calibration models for experiments (14), (15) and (16). 
 
Figure 8.24: Correlation diagram showing the relationship between Raman in situ MR probe 
and PHAT probe measurements. 
The correlation coefficient indicates that there is good agreement between the two Raman 
measurements. With this information, it is therefore possible to quantitatively determine the 
amount of each co-crystal form present at any given time in the process using the in situ probe. 
An illustration of this point is presented in Figure 8.25, which shows experimental run (17) with 
several temperature cycles. Notice that despite the implementation of identical temperature 
cycles that different co-crystal outcomes were observed, that is, based on the Raman MR 
immersion probe measurements. This experiment was carried out in the region of the ternary 
phase where a mixture was expected to nucleate. It highlights, the variability that can 
sometimes occur in a batch process. Off-line analysis using the PHAT probe can be applied 
to validate the experimental observations from the in situ measurements. These two 
approaches, that is, on-line and offline measurement serve as a robust means of tracking and 
quantifying the changes which occur when phase transformation events take place. This has 
been clearly demonstrated from the results presented earlier. Further validation of the results 
present came from the analysis of samples by Raman microscopy, off-line ATR-FTIR and 
HPLC. 
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1 = 1:1 form nucleates 4 = 1:1 form nucleates 7 = 1:1 form nucleates  
2 = 1:1 and 3:2 mixture  5 = 1:1 and 3:2 mixture 8 = 1:1 form nucleates 
3 = Mixture => 1:1 form 6 = Mixture => 1:1 form  
Figure 8.25: Time diagram showing changes in co-crystal composition for experiment (17) as 
determined by in situ Raman MR immersion probe. 
8.3.3 Semi-Batch Co-Crystallisation Monitoring and Control 
The semi-batch co-crystallisation of p-TSA with TPPO was explored under flow conditions 
whereby a fixed concentration of the two starting materials dissolved in MeCN are pumped 
separately and then combined and mixed in a batch crystalliser (see Figure 8.6). In this study 
the flow rates of the two components were adjusted to crystallise the desired stoichiometric 
form of the p-TSA-TPPO co-crystal system. This operating strategy offers a promising 
alternative to batch, and could potential lend itself to further development into a continuous or 
periodic flow co-crystallisation operation. Table 8.9 provides a summary of the co-
crystallisation outcomes for each of the semi-batch experimental runs. 
0
5000
10000
15000
F
B
R
M
 T
o
ta
l 
C
o
u
n
ts
/s
1138
1140
1142
1144
1146
R
a
m
a
n
 P
e
a
k
 1
1
4
9
-1
1
3
7
 c
m
-1
0
10
20
30
40
50
60
70
P
V
M
 T
o
ta
l 
C
o
u
n
ts
/s
0 500 1000
10
20
30
40
50
Time (min)
T
e
m
p
e
ra
tu
re
 (
C
)
0
2000
4000
6000
8000
10000
12000
F
B
R
M
 T
o
ta
l 
C
o
u
n
ts
/s
-0.5
0
0.5
1
1.5
2
2.5
3
x 10
-3
1
s
t  
D
e
ri
v
a
ti
v
e
 U
V
 2
5
7
 n
m
1138
1140
1142
1144
1146
R
a
m
a
n
 P
e
a
k
 1
1
4
9
-1
1
3
7
 c
m
-1
0
10
20
30
40
50
60
P
V
M
 T
o
ta
l 
C
o
u
n
ts
/s
0 1000 2000 3000
0
10
20
30
40
50
60
70
Time (min)
T
e
m
p
e
ra
tu
re
 (
C
)
 
 
Temperature (C)
FBRM Total Counts/s
1
st
 Devivative 257 nm
Raman Peak 1149-1137 cm
-1
PVM Total Counts/s
0
2000
4000
6000
8000
10000
12000
F
B
R
M
 T
o
ta
l 
C
o
u
n
ts
/s
-0.5
0
0.5
1
1.5
2
2.5
3
x 10
-3
1
s
t  
D
e
ri
v
a
ti
v
e
 U
V
 2
5
7
 n
m
1138
1140
1142
1144
1146
R
a
m
a
n
 P
e
a
k
 1
1
4
9
-1
1
3
7
 c
m
-1
0
10
20
30
40
50
60
P
V
M
 T
o
ta
l 
C
o
u
n
ts
/s
0 1000 2000 3000
0
10
20
30
40
50
60
70
Time (min)
T
e
m
p
e
ra
tu
re
 (
C
)
 
 
Temperature (C)
FBRM Total Counts/s
1
st
 Devivative 257 nm
Raman Peak 1149-1137 cm
-1
PVM Total Counts/s1
2
3
4
5
6
7 8
247 
 
Table 8.9: Summary of co-crystallisation outcomes for the experiments 19 – 26, co-crystal 
form determined by on-line and off-line measurements. 
Exp 
No. 
Mass Fractions (M) 
in Crystalliser HPLC Ratio 
p-TSA/TPPO 
p-TSA-TPPO 
Co-Crystal 
Form 
Region of 
Phase 
Diagram p-TSA TPPO MeCN 
19 0.12 0.09 0.79 1.479 3:2 1 (3:2 form) 
20 0.14 0.05 0.81 1.522 3:2 1 (3:2 form) 
21 0.09 0.08 0.83 1.313 1:1 + 3:2 3 (mixture) 
22 0.06 0.09 0.85 1.002 1:1 2 (1:1 form) 
23 0.10 0.08 0.82 1.475 3:2 3 (mixture) 
24 0.08 0.08 0.84 1.333 1:1 + 3:2 3 (mixture) 
25 0.11 0.07 0.82 1.475 3:2 1 (3:2 form) 
26 0.12 0.12 0.76 1.021 1:1 2 (1:1 form) 
Figure 8.26 (a) and (b) shows the process time diagrams with temperature profile and on-line 
PAT signals from FBRM (solid phase), ATR-UV/vis (solution phase), ATR-FTIR (solution 
phase) and Raman (co-crystal form and solution phase monitoring) for experiment 19. The 
co-crystal form obtained from this experiment was pure 3:2 p-TSA-TPPO as confirmed by both 
on-line (Raman MR immersion probe) and off-line (HPLC, PXRD, Raman microscope and 
ATR-FTIR) measurements. Experiments 20 – 25 (Table 8.9) were carried out under similar 
process conditions to experiment 19, meaning the process temperature (varying from 25 oC 
to 20 oC) and concentrations of p-TSA (0.2987 g/g MeCN) and TPPO (0.1492 g/g MeCN) in 
the feed vessels were exactly the same. The main difference between these runs is the mass 
flow rate of p-TSA and TPPO from the feed vessels (Figure 8.9) to the crystalliser. The results 
show that by changing the mass flow rate of either p-TSA or TPPO, one can change the mass 
fraction composition of materials in the crystalliser and thereby control the co-crystallisation 
outcome. When the flow rate is adjusted so that the mass fractions of p-TSA and TPPO are 
similar, the resulting mixture falls into Region 3 of the ternary diagram and hence two co-crystal 
forms were obtained, for example, as observed from experiments 21 and 24 (Table 8.9). 
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Figure 8.26: Process time diagrams of experiment 19 showing the temperature profile, (a) 
FBRM total particle counts/s (solid phase monitoring) and the change in absorbance and 
peak intensity readings from ATR-UV/vis and ATR-FTIR probes used to monitor the liquid 
phase; and (b) changes in the 2nd derivative Raman peak intensities associated with 1:1 and 
3:2 p-TSA-TPPO, and the liquid phase. Arrows show respectively, nucleation (FBRM 
counts/s) (1), decreasing solute in solution phase (2), crystal growth (3), increasing 3:2 
p-TSA-TPPO peak (4), 1:1 p-TSA-TPPO peak (5), and change in solution phase (6). 
Indeed, the semi-batch co-crystallisation experiments were more consistent in terms of co-
crystallisation outcomes when compared to the batch runs described earlier (Section 8.3.1). 
Moreover, slight changes in the mass flow rate of either p-TSA or TPPO can alter the 
co-crystallisation outcome favouring either 1:1 or 3:2 p-TSA-TPPO or a mixture. However, 
these changes can be avoided if the flow rates are controlled appropriately. 
Principal component analysis (PCA) is often used in chemometrics to extract the dominant 
patterns from chemical data. The result is a complementary set of scores and loadings that 
can be used to visualise trends in the data [188]. PCA analysis was performed on the Raman 
spectra obtained when pure 1:1 and 3:2 p-TSA-TPPO and mixture of the two co-crystals forms 
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nucleated; a total of 390 spectra obtained from batch experiments 8, 11, 12 (13) and (18), and 
semi-batch experiments 19, 21 and 22 were analysed. Figure 8.27 shows the scores plot of 
principal components 1 and 2 obtained from the analysis. It shows there are three clusters of 
data corresponding to each of the three co-crystallisation outcomes observed in the studies 
presented here.  
 
Figure 8.27: PCA scores plot of Raman spectra from different experiments, cluster 1 (3:2 p-
TSA-TPPO), cluster 2 (mixtures of 1:1 and 3:2 p-TSA-TPPO) and cluster 3 (1:1 p-TSA-TPPO). 
Arrows show the direction of increasing amounts of solids as the crystallisations progress. 
Analysis of the PCA scores plot allows for the further identification and confirmation of the co-
crystal form obtained from each experiment and shows the diversity of applications possible 
using the in situ Raman MR immersion probe. PC1 and PC2 combined represent 93.2 % of 
the spectral variance. Clusters 1, 2 and 3 represent co-crystal forms were 3:2 p-TSA-TPPO, 
mixture of 1:1 and 3:2 p-TSA-TPPO and 1:1 p-TSA-TPPO, respectively. Arrows show the 
direction of increasing amount of solids as the crystallisation progresses. PCA can be used as 
an additional tool to monitor and characterise the co-crystallisation process, providing valuable 
information pertaining to the crystalline form that nucleates and grows. It could be used 
qualitatively as an initial screening method to support the development of the co-crystallisation 
with in situ Raman MR immersion probe. 
8.3.4 Periodic Flow Co-Crystallisation Monitoring and Control 
The semi-batch experiments reported earlier were used as a guide to inform the development 
periodic flow crystallisation approaches for producing pure 1:1 and 3:2 p-TSA-TPPO, 
respectively. Table 8.10 below provides a summary of the co-crystallisation outcomes for 
experiments carried out in single-stage and three-stage PMSMPR configurations (Section 
8.2.5; Figure 8.7). In all experimental runs the co-crystal form obtained was the form expected 
based on the operating region in the ternary phase diagram (Figure 8.1). 
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Table 8.10: Summary of experimental conditions employed during the periodic flow 
crystallisation of p-TSA-TPPO co-crystals. 
Exp. 
No. 
Component Mass 
Fractions (M) 
Temperature  
(°C) 
p-TSA-TPPO 
Co-Crystal 
Form 
Region of 
Phase 
Diagram p-TSA TPPO MeCN MSMPR 1 MSMPR 2 MSMPR 3 
(27)^ 0.14 0.05 0.81 5 n/a n/a 3:2 1 (3:2 form) 
(28)^ 0.14 0.05 0.81 15 n/a n/a 3:2 1 (3:2 form) 
(29) 0.14 0.05 0.81 12.5 n/a n/a 3:2 1 (3:2 form) 
30 0.06 0.09 0.85 12.5 n/a n/a 1:1 2 (1:1 form) 
31 0.06 0.09 0.85 20 n/a n/a 1:1 2 (1:1 form) 
32 0.06 0.09 0.85 25 n/a n/a 1:1 2 (1:1 form) 
33 0.14 0.05 0.81 20 17 14 3:2 1 (3:2 form) 
34 0.14 0.05 0.81 25 20 20 3:2 1 (3:2 form) 
35 0.06 0.09 0.85 25 20 20 3:2 2 (1:1 form) 
36 0.06 0.09 0.85 20 17 14 3:2 2 (1:1 form) 
No brackets = coupled addition/withdrawal; Brackets () = decoupled addition/withdrawal; ^stirring set to 450 rpm, 
for all other experiments the stirring rate was set to 500 rpm.  
Figure 8.28 below shows the process time diagrams and FBRM statistical trends of the single-
stage PMSMPR experiments (27)^, (28)^ and (29). For each of these experiments the process 
was operated in Region 3 of the ternary phase diagram where 3:2 p-TSA-TPPO shows 
stability. In each case the decoupled periodic flow method was applied. A state of controlled 
operation (SCO) was not achieved in any of these experiments due to issues with particle 
settling during the crystallisations (confirmed by visual observation). This was due to the fast 
growth rate of the system leading to the formation of millimetre size particles elongated 
prismatic particles (Figure 8.4). The operating temperatures were selected to control 
supersaturation and investigate the best operating condition that led a balance between 
growth and secondary nucleation. For example, the operating temperatures for experiments 
(27)^, (28)^, (29) as indicated in Table 8.10 led to supersaturation levels of 3.28, 2.50 and 2.74 
(i.e. with respect to 1:1 p-TSA-TPPO), respectively. Due to the fast crystal growth rate of 3:2 
p-TSA-TPPO, predominantly large crystals were observed for each experiment, which had a 
tendency of settling to the bottom of the crystalliser. 
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Figure 8.28: Time diagrams (left) and FBRM statistics (right) for experiments (27), (28) and 
(29). 
The time diagrams of the FBRM trends show the no weighted statistics for the median and 
mean square weighted chord length (MSWCL) and the no weighted counts/s for different 
particle size ranges corresponding to small (1 – 50 µm) and medium (50 – 158 µm) and large 
(316 – 1000 µm) particles. The FBRM data are complex, indicating on the one hand persistent 
secondary nucleation for experiments (27)^ and (28)^, seen as an increase in the 1 – 50 µm 
counts/s and marginal decrease in the median and MSWCL, respectively. On the other hand, 
this could be an indication of particles settling, such that smaller particles are detected 
preferentially due to their low settling velocities compared to larger ones. Hence, the stirring rate 
(which was already high) was adjusted stirring rate adjusted from 450 rpm (experiments (27)^ 
and (28)^) to 500 rpm (experiment (29)), but significant effect on particle suspension was 
observed.  Stirring rates above 500 rpm led to bubbles and vortex formation which were not 
desirable when transfer of material out of the crystalliser by pumping, due to inconsistencies 
flow rates. Another interpretation of the results could be the measurement of short chords by the 
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FBRM due to an increase in the length of the 3:2 p-TSA-TPPO crystals as they grow to become 
elongated prisms. Interestingly, for experiment (29), there is a decrease in the 1 – 50 µm with a 
simultaneous, but slight decrease in the median, but increase in the MSWCL. This result differs 
from experiment (27)^ and (28)^, due to blockage problems encountered in this experiment, 
which lead to the disturbances observed in the signals. The microscope images of the product 
crystals obtained from experiments (27)^, (28)^ and (29) are shown in Figure 8.29 below. The 
images show that for all three experimental runs, millimetre size crystals are present. 
Evidently, larger crystals were observed for experiments (28)^ which operated at a lower 
supersaturation level compared to (27)^ and (29). 
 
Figure 8.29: Microscope images of crystals from experiment (27)^, (28)^ and (29). 
Figure 8.30 below shows the process time diagram and FBRM statistics for experiment 30. 
The coupled period flow method was employed for this experiment, due to the issues observed 
during the decoupled PMSMPR runs reported in earlier chapters of this thesis, for example, 
the longer time taken to achieve SCO compared to coupled PMSMPR operation. For 
experiment 30, the multivariate models built for concentration measurement of the two AAIs 
(p-TSA and TPPO) concomitantly (Chapter 3, Section 3.6.1) were employed. The process 
time diagram shows that for this experiment, SCO was attained at ~100 min. However, there 
is significant oscillation of the FBRM total counts/s for the attainment of SCO onwards. The 
FBRM counts/s oscillates between 8500 and 11900 counts/s. The high amplitudes are a result 
of the competing secondary nucleation and growth. Figure 8.31 shows the images of product 
crystals collected at 100, 180 and 250 min, respectively. The microscope images support the 
suggestion that the two crystallisation mechanisms are in competition as there is a mixture of 
large and fine crystals for all samples collected during SCO operation. Experiments 31 and 32 
reported in Table 8.10 were not completed due to significant blockage issues arising due to 
the very large crystals obtained in these from these runs. This can be attributed to the lower 
operating supersaturation whereby crystal growth is promoted over secondary nucleation. The 
supersaturation level for experiment 30 was 2.51, compared to 1.86 and 1.49 for experiments 
31 and 32, respectively. 
(27) End (28) End (29) End 
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Figure 8.30: Time diagram (left) and (FBRM statistics (left) for experiment 30. 
 
Figure 8.31: Microscope images of crystals from experiment 30. 
Several PMSMPR three-stage experiments were carried out in coupled periodic flow mode to 
investigate control over the supersaturation generation and thus try to manipulate the crystal 
size for both the 1:1 and 3:2 co-crystal forms, as highlighted in Table 8.10, for all of these 
experiments the expected co-crystal form was obtained. This is an indication of the consistent 
results that can be obtained with the PMSMPR operation in comparison to the batch runs 
reported on earlier. However, the significant issue of particle size control for each of the co-
crystal forms could not be achieved in three-stage PMSMPR. It may be that further 
investigation is required and process modelling and optimisation implemented in order to 
identify the conditions for producing smaller crystals consistently. 
8.4 Conclusions 
In this chapter, the cooling co-crystallisation of p-TSA with TPPO AAI ingredients to form pure 
1:1 and 3:2 p-TSA-TPPO stoichiometric co-crystals or their mixtures from MeCN was 
demonstrated in laboratory scale batch, semi-batch and single- and three-stage cascaded 
PMSMPR crystallisers. Monitoring and control of the selective co-crystallisations was achieved 
with the aid integrated PAT array within the IDS. Three regions of the ternary phase diagram of 
p-TSA/TPPO/MeCN corresponding to the formation of the pure co-crystals as well as mixtures 
were explored by changing the mass fraction compositions of p-TSA/TPPO/MeCN in the 
crystallisers investigated. In the batch study, there were some consistent results. However, 
batch-to-batch variability issues were occasionally encountered. It was demonstrated that if 
appropriate strategies are implemented using PAT tools that the crystallisation can be controlled 
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and directed towards the desired outcome. This was demonstrated viz the implementation of 
temperature cycles to convert from the 3:2 to 1:1 co-crystal form and vice versa. The 
temperature was changed based on in situ Raman spectroscopy, validated with off-line Raman 
measurements. Using the in situ Raman method, transformation of the co-crystal forms could 
be tracked. Furthermore, quantitative information on the proportions of 3:2 to 1:1 p-TSA-TPPO 
was also obtained by application of multivariate methods to the in situ (MR immersion probe) 
and off-line (PHAT probe) Raman data. The temperature cycling approach is presented as a 
proof of concept approach for the control of crystalline form during co-crystallisation, which prior 
to now was only been demonstrated for polymorphic single component molecular systems. The 
study demonstrates the use of PAT to monitor the transformation events for a co-crystallisation 
process in which solution mediated transformation from one stoichiometric crystalline form to 
another occurs. The information obtained was used to aid the control of the batch co-
crystallisation process in order to obtain the desired crystalline form when operating at different 
temperatures outside the range of the ternary phase diagram. Semi-batch co-crystallisation 
studies were also carried out for comparison with the batch method. In these experimental runs 
solutions of fixed concentrations of the two AAIs (p-TSA and TPPO) were prepared in separate 
vessels. In this proof of concept study, the co-crystallisation was controlled by changing the flow 
rate of the dissolved materials to the crystalliser. It was demonstrated that by changing the flow 
rates, the mass fraction of components sent to the crystalliser could be controlled, thereby 
controlling the outcome of the co-crystallisation. This operation is a promising alternative to 
batch, providing better control over the co-crystallisation outcome and could potentially be 
developed into a continuous or periodic flow co-crystallisation process. Periodic flow 
experiments were performed in single- and three-stage cascaded crystallisers, respectively. 
While consistent results were observed and the desired co-crystal form produced in consecutive 
experimental runs, there were significant issues with control over the product particle size. This 
led to settling and transfer line blockage issues in the single and three-stage PMSMPR 
operations. These issues could not be resolved over the timeline of the study, therefore further 
work is recommended along the lines of process modelling and optimisation aimed at identifying 
better supersaturation conditions which would avoid the formation of very large crystals. The 
studies presented in this chapter show that on-line PAT tools complemented by off-line solid 
state characterization techniques can be applied together to gain a better understanding of the 
crystallisation behaviour of p-TSA-TPPO co-crystal system. This led to the development of 
robust control strategies using either temperature or flow rate control to influence the co-
crystallisation outcome. 
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Main Conclusions  
In this thesis, the dynamics of batch crystallisation, a novel continuous MSMPR configuration 
and a novel operating strategy in MSMPR, known as periodic flow crystallisation (PMSMPR) 
were investigated and compared. The dynamics of these processes are vastly different and 
hence there are differences in the way supersaturation is generated as a result of the different 
trajectories through the phase diagram. The PMSMPR method of operation involves periodic 
transfer of slurry (addition and withdrawal) at high flow rates. The PMSPPR is therefore 
characterised by periodic withdrawal of product slurry. Different concepts in crystallisation 
control using batch, semi-batch, MSMPR and PMSMPR platforms were demonstrated for the 
crystallisation of different molecular systems that exhibit different crystallisation kinetics and 
crystalline forms. The various crystallisation platforms were applied to crystallise: (1) slow 
growing PCM-IPA system, (2) fast growing GLY-H2O system, (3) UBA polymorphic co-crystal 
system and, (4) p-TSA-TPPO stoichiometric co-crystals. Optimised batch and continuous 
MSMPR experiments indicated that different crystal CQA were attainable for the slow-growing 
PCM-IPA system in each platform. However, the continuous MSMPR which was operated at 
steady-state shows more consistency in the product crystal CQA. Inevitably, the yield of 
crystallisation in a single-stage MSMPR was much lower compared to batch, but the 
productivity of crystallisation is significantly higher. The yield was improved by using a multi-
stage MSMPR cascade. Issues were encountered with fouling, transfer line blockages and 
encrustation in the continuous MSMPR. The use of an additive, HPMC, was investigated to 
control the continuous crystallisation process. While the additive effectively controlled the 
crystallisation and led to faster establishment of a steady-state operation, suppression of the 
growth and nucleation kinetics of PCM was evident, which reduces the yield of the MSMPR. 
In an industrial context, it is foreseeable that additives from the list of substances generally 
regarded as safe (GRASS) could be used to control the crystallisation outcome thereby 
leading to in spec product of desired CQA. However, the amount of additive to be applied 
requires careful consideration, due to the potential effects on the crystallisation kinetics as 
demonstrated in this thesis 
In order to alleviate the issues encountered in the continuous MSMPR, an alternative 
crystallisation strategy was investigated viz. periodic flow operation. This novel operating 
strategy involves combining the best aspects of batch and continuous MSMPR operation to 
improve the crystallisation outcomes for PCM-IPA system, and opens up the possibility of 
using flow crystallisation for other slow-growing systems. Due to the slow growth kinetics of 
PCM, the tuneable batch (or holding) period in the periodic mixed suspension mixed product 
removal (PMSMPR) operation is important, since mean the residence time of material can be 
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extended significantly relative to continuous MSMPR operation, whilst narrowing the RTD 
slightly. A novel concept referred to as “periodic steady-state” was introduced to describe 
when the PMSMPR operation reached a state of controlled operation. Periodic steady-state 
is defined as a state of a system that maintains itself despite the transitory effects caused by 
periodic, but controlled disruptions applied to the system (i.e. “state of controlled operation”). 
The work also illustrated the concept of “state of controlled operation” instead of “steady-state 
operation” as a state that can characterize periodic (or continuous) operation. The PMSMPR 
was configured as either a single-, two-, or three-stage unit and operated for up to 11 mean 
residence times without blockage or encrustation problems. The number of PMSMPR stages, 
seed properties (size, shape and distribution), mode of operation (i.e. coupled or decoupled) 
and use of recycle stream were the main variables that influenced the periodic operation, 
significantly affecting the extent of secondary nucleation and growth. Seed material selection 
was shown to affect the product distribution with “fine” high surface area seed leading to 
broader CSD compared to “coarse” low surface area seed. This has implications for the 
filtration, formulation and ultimately the therapeutic properties of a drug product, and it 
demonstrates the importance of selecting the appropriate seed recipe for a crystallisation 
process.  
Adjustment of the PMSMPR holding period could also affect the product distribution, however 
this parameter was not investigated in this study. It is expected that this could have a 
significant effect on the particle attributes and CSD in the PMSMPR operation. For example, 
longer holding times could lead to greater yield, larger crystals, narrow CSD and allow for 
polymorphic transformations to achieve completion. Based on the results from the PMSMPR 
studies presented in this thesis, the best operating strategies for a slow growing system are: 
seeding with well-defined crystalline material, long residence times (i.e. depending on the 
observed growth kinetics) and coupled multi-stage PMSMPR (consisting of at least three-
stages). For fast growing systems that same strategies apply, except that a short residence 
time is should be targeted and a maximum of two PMSMPR stages used in coupled periodic 
flow mode. The stage temperatures of the PMSMPR for fast or slow growing systems should 
be carefully selected to find a balance between growth and secondary nucleation. The choice 
of conditions will depend on the target product CQA, which should be clearly defined at the 
outset. The choice of recycle depends on the whether material conservation is important for a 
given process (which will be driven by the economics factors) and the impurity profile of the 
starting material. In the case of polymorphic systems or where different crystalline forms exist 
for a given material, a systematic approach is recommended, first using batch crystallisation 
to assess the system dynamics and then deciding on a suitable approach for periodic flow 
crystallisation in PMSMPR. 
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The periodic flow crystallisation operation was further demonstrated as a proof-of-concept for 
the crystallisation of GLY-H2O system. GLY is a fast growing API which shows markedly 
different crystallisation kinetics (nucleation and growth) from PCM. In this study, the effect of 
seed properties, product withdrawal strategy, rate of supersaturate generation and decoupled 
or coupled periodic flow operation on the product crystal CQA were investigated and found to 
influence the crystallisation outcome to varying extents. The properties of the seed crystals 
appear to the most significant variable affecting the product size, shape and CSD. In this study, 
dynamic models of the residence time distribution in continuous MSMPR and periodic flow 
PMSMPR crystallisers were developed. The model demonstrated the periodic flow operation 
in terms of extended mean residence time and slightly narrower residence time distribution. In 
addition, process models of periodic flow process were developed with an aim to provide a 
better understanding and improve the performance of the operation. The modelling framework 
was based on the Process System Enterprise’s gCRYSTAL software, wherein the 
crystallisation mechanisms and kinetics of the GLY-H2O system were estimated from batch 
cooling crystallisation experiments. Experiments of periodic flow crystallisations were also 
conducted in single- / three-stage MSMPR crystallisers to validate the process models. Good 
agreements were obtained between the model predictions and the experimental 
measurements. Importantly, significant larger crystals were obtained experimentally and in 
simulation compared to the batch or continuous MSMPR systems, demonstrating the 
advantages of using periodic flow operation. 
Control over polymorphism is critical in industrial crystallisation of fine chemicals since the 
polymorphic form has a significant influence on the physical attributes of the material. This can 
prove even more challenging for multi-component co-crystal systems. Polymorph control of 
the UBA co-crystal system, which has three know polymorphic forms was investigated in 
three-stage cascaded periodic flow PMSMPR crystallisers. Different start-up strategies were 
explored and their ability to produce selectively a particular polymorph of UBA was 
investigated. The experimental conditions for producing pure UBA form I was optimised in the 
PMSMPR cascade. However, pure UBA form III remained elusive (i.e. it was difficult to obtain 
consistently), while UBA form II was never observed due to stability issues with this metastable 
polymorph. It may be that here are too many input variables to consider and perhaps only 
process modelling and simulation can give the best conditions for optimisation in order to 
improve the crystallisation outcomes for the UBA co-crystal system. Furthermore, UBA forms 
I and III showed strikingly similar physicochemical properties (e.g. solubility and melting points) 
and it was unclear which of the co-crystal form was more stable. However, despite these 
challenges UBA form I was isolated using either seeding (with pure form I) or by fast mixing 
of urea and barbituric acid solutions at low temperatures (below 30 oC) in PMSMPR. A 
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cascade of PMSMPR was required to give a longer residence time for complete transformation 
to UBA form I. Relative to batch and continuous crystallisations, the periodic flow process was 
more consistent in producing UBA form I. Furthermore, the study demonstrated that periodic 
flow operation can provide an alternative trajectory in the phase diagram which can lead to 
desired crystallisation outcomes if tuned appropriately by selecting the batch and continuous 
operating periods.  
Finally, the selective co-crystallisation of two model active agro-chemical ingredients, p-TSA and 
TPPO was demonstrated in batch, semi-batch and periodic flow crystallisers. Regions of the p-
TSA/TPPO/MeCN ternary phase diagram that corresponded to the stability of the respective 
stoichiometric co-crystal forms of p-TSA-TPPO, that is, 1:1 and 3:2 (mole ratio) were explored. 
Batch-to-batch variability issues were encounter for the batch studies, however, the 
implementation of temperature cycles triggered by quantitative Raman spectroscopy which 
detected the stoichiometric form being produced and led to better control over the co-
crystallisation form obtained and allowed for investigation of the solution mediated 
transformation from 3:2 to 1:1 p-TSA-TPPO and vice-versa. On the other-hand, the semi-
batch and PMSMPR studies gave much more consistent control over the co-crystal form 
relative to batch, with a feed mixture in the appropriate region of the phase diagram and 
without the need for temperature cycling. The desired co-crystal form was produced 
consistently by manipulating the flow rates of the co-formers (i.e. p-TSA and TPPO) to the 
semi-batch or PMSMPR crystallisers. Due to the very fast growth kinetics of the co-crystals, 
large crystals (millimetre size) were obtained that had a tendency to settle. This phenomenon 
led to classified withdrawal in the PMSMPR and stochastic behaviour, which eventually 
resulted in blockage of transfer lines. 
The crystallisations mentioned earlier were monitored using the integrated process analytical 
technologies (PAT) and CryPRINS informatics systems software within an IDS framework to 
determine when equilibrium (batch operation), steady-state (continuous MSMPR operation) 
or “state of controlled operation” (SCO) (periodic flow PMSMPR operation) is achieved. The 
online methods were supported by off-line solid-state (e.g. PXRD, DSC, Raman and ATR-
FTIR spectroscopy) and wet chemistry methods (e.g. HPLC). The results presented in this 
thesis illustrate the use of PAT and information system tools together to determine when batch, 
continuous and periodic operations reach a controlled state of operation. These tools provided 
a better understanding of the variables and operating procedures influencing these operations. 
The need for an integrated array of PAT sensors was driven by the need to grasp a holistic 
understanding of the process, since the results from a single PAT sensor cannot be interpreted 
unambiguously. PAT sensors must also be selected carefully in order to capture the most 
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useful information about a given system. In this thesis in situ Raman spectroscopy was used 
extensively and can be considered one of the most powerful tools for information gathering 
since it has the capability to sense multiple solution components, plus solid phase properties 
(i.e. polymorphs and other crystalline forms). FBRM and PVM were used extensively as they 
both give useful information on how the particles evolve during a crystallisation process. In 
situ ATR-UV/vis was useful for monitoring solution phase (conjugated systems only) without 
interference from the solid phase. The use of in situ ATR-FTIR was also investigate, however, 
this was the least useful technique for solution phase monitoring due primarily to the 
requirement for high solute concentrations, but also to the slight but noticeable effect of particle 
scattering on the process signal and the sensitivity of the fibre optic cable to the slight 
movements or disturbance.  
Another significant aspect of this thesis was the use of PAT tools (i.e. spectroscopy techniques 
only) for the development of multivariate calibration models. Most notable was the use of 
Raman spectroscopy to monitor and quantify solute concentration and composition of solid 
phase. Raman is the most promising technique for multivariate data analysis, due to the ability 
to quantify solution and solid phase composition. 
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Recommendations 
The modified continuous MSMPR operation and novel periodic flow operating strategy 
presented in this thesis could be explored further for the crystallisation of a wider range of 
compounds.  
The design of the modified continuous MSMPR crystalliser could be optimised by developing 
the simulation and process models for the system. In particular, investigation of the 
hydrodynamic and population balance models together could shed light on ways to improve 
their performance. Due to the complexity of the system, it is difficult to explore process 
optimisation experimentally, hence initial modelling and simulation in silico, with later 
experimental validation is necessary. In addition, a cascade of MSMPR could be investigated 
for controlled supersaturation generation and more stable operation. MSMPR cascade can 
give (a) better yields, and (b) allows more degrees of freedom (i.e. the various stage 
temperatures and possible stage residence times) to tailor product properties. 
There were some problems with the product CSD for GLY-H2O system, either due to the 
kinetic parameters used in the simulations or the limited range of the crystallisation 
experiments performed, which led to undesirable mismatch for the cascaded three-stage 
PMSMPR operation. Further investigation is therefore required to improve either the model 
predictions or expand the range of experimental conditions. Besides the analysis of the 
possible reasons for the mismatch in the CSD, future work could consider benchmark 
experiments of conventional continuous MSMPR crystallisation upon which the benefits of 
periodic flow crystallisation processes could be demonstrated more clearly in terms of crystal 
attributes, yield and productivity. Model identification is an important consideration, for 
example in the case of GLY crystallisation further work is required to (a) expand the range of 
data collected experimentally and (b) investigate different model assumptions with respect to 
phenomena such as agglomeration, secondary nucleation, breakage, and so on.  
The periodic flow crystallisation process also requires further investigation and 
characterisation at laboratory scale to determine the effect of batch holding and continuous 
withdrawal cycles on the system stability and product CQA, as well as to investigate the most 
effective start-up procedures and the time to achieve a “state of controlled operation”. While 
the crystallisation kinetics were estimated for GLY based on batch experimental data and the 
population balance models for the system developed, process optimisation was not 
investigated. This is an essential step to perform in order to identify the best operating 
conditions for the crystallisation of product with desired CQA. Process simulation 
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(demonstrate for GLY system in this thesis) is required as a route to optimisation since it gives 
useful information about the crystallisation mechanism and kinetics. 
Aspects of parameter estimation, process modelling and simulation could also be investigated 
for the co-crystal systems presented in this thesis. This will inform process optimisation steps 
that can lead to further demonstration of the periodic flow crystallisation concept. 
Further investigations of the polymorphism control in the PMSMPR are required, in particular 
for single component molecular systems (which were not covered in this thesis).  
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Appendix 1 
1.1. A1. Generic Multivariate Model Development Code (GLY-H2O) 
clc; 
clear; 
load StepwiseVariables7 % variable selection using forward multiple linear 
regression (MLR) 
tic 
  
% Calibration model training data set 
data=xlsread('Calibration_Model_Data.xlsx','Training_Set'); % Reads data 
from Excel 
X=data(2:120,in); % Selected variables from MLR   
y=data(2:120,3328); % Concentration values for model training data 
[n,p]= size(X); % Gives size of the temperature and spectral data matrix 
 
% Preprocessing 
meanX=mean(X); % Calculates the mean spectrum 
[X] = msc(X,mean(X)); % Multiplicative scatter correction pre-processing  
[X] = savgol(X,7,3,1); % Derivative pre-processing 
[X_Scaled,mx,stdx]=autoscale(X,[],[]); % Auto-scaling of spectra + 
temperature  
[y_Scaled,my,stdy]=autoscale(y,[],[]); % Auto-scaling of assigned 
concentration values 
 
% PLS model 
 [Xloadings,Yloadings,Xscores,Yscores,betaPLS3,PLSPctVar,PLSmsep,stats] = 
plsregress(X_Scaled,y_Scaled,7,'CV',10); % Performs PLS regression with 
components 
  
figure (1), plot(1:7,cumsum(100*PLSPctVar(2,:)),'-bo'); 
xlabel('Number of PLS components'); 
ylabel('Percent Variance Explained in Y'); % The plot shows how much 
variance is explained by each PLS factor 
yfitPLS = [ones(n,1) X_Scaled]*betaPLS3 *stdy + my; % Calculates 
concentration of the test data with the developed model 
yval=[ones(n,1) X_Scaled]*betaPLS3; 
 
% PCR Model 
[PCALoadings,PCAScores,PCAVar] = princomp(X_Scaled); % Builds PCR model 
betaPCR = regress(y_Scaled-mean(y_Scaled), PCAScores(:,1:10)); % Change no. 
"10" here to change no. of components  
betaPCR = PCALoadings(:,1:10)*betaPCR *stdy + my; % This should be same as 
in previous line 
betaPCR = [mean(y_Scaled) - mean(X_Scaled)*betaPCR; betaPCR]; 
yfitPCR = [ones(n,1) X_Scaled]*betaPCR; 
  
figure (2), plot(100*cumsum(PCAVar(1:10))/sum(PCAVar(1:10)),'r-^'); % 
Variance plot 
xlabel('Number of PCR components'); 
ylabel('Percent Variance Explained in Y'); 
  
PCRmsep=sum(crossval(@pcrsse,X,y,'KFold',10),1)/n; % Calculates PCR RMSEP 
and Cross Validation 
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save MainModel betaPLS3 meanX mx stdx my stdy % Saves model parameters  
  
% PRESS Plot 
figure (3), plot(0:10,PLSmsep(2,:),'b-o',0:10,PCRmsep,'r-^'); % Predicted 
Residual Error Sum of Squares (PRESS) plot was used to evaluate the quality 
of the method 
xlabel('Number of components'); 
ylabel('Estimated Mean Squared Prediction Error'); 
legend({'PLSR' 'PCR'},'location','NE'); 
  
% Principal Component Analysis 
figure (4) % PCA plot 
pcclusters = clusterdata(PCAScores(:,1:10),7); 
gscatter(PCAScores(:,1),PCAScores(:,2),pcclusters); % For generating Scores 
scatter plot. 
xlabel('PC1'); 
ylabel('PC2'); 
  
figure (5), plot(y,yfitPLS,'bo'); % Plots actual vs predicted 
concentrations (PLS model) 
xlabel('Observed Response'); 
ylabel('Fitted Response'); 
legend({'PLSR with 7 Components'},  ... 
    'location','NW'); 
 
figure (6), plot(y,yfitPCR,'r^'); % Plots actual vs predicted 
concentrations (PCR model) 
xlabel('Observed Response'); 
ylabel('Fitted Response'); 
legend({'PCR with 10 Components'},  ... 
    'location','NW'); 
  
% Error calculation PCR/PLS 
TSS = sum((y-mean(y)).^2); 
RSS_PLS = sum((y-yfitPLS).^2); 
rsquaredPLS = 1 - RSS_PLS/TSS 
RSS_PCR = sum((y-yfitPCR).^2); 
rsquaredPCR = 1 - RSS_PCR/TSS 
  
% Model validation 
data=xlsread('Validation Data.xlsx','Validation_Set'); 
X2=data(2:179,in); % Validataion data 
y2=data(2:179,3328); % Concentration values for validation data 
 
% Pre-processing of validation data 
[X2] = msc(X2,meanX); 
[X2] = savgol(X2,7,3,1); 
[n,p]=size(X);  
[X2_Scaled]=autoscale(X2,mx,stdx); 
  
yvalPLS = [ones(size(X2_Scaled,1),1) X2_Scaled]*betaPLS3 *stdy+my; % Auto-
scaling relative to training data set 
yvalPCR = [ones(size(X2_Scaled,1),1) X2_Scaled]*betaPCR *stdy+my; % Auto-
scaling relative to training data set 
  
figure (7), plot(y2,yvalPLS,'bo',y,yfitPLS,'r^'); % Plots actual vs 
predicted concentrations for PLS model 
xlabel('Observed Response'); 
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ylabel('Fitted Response'); 
legend({'PLSR with 7 Components'},  ... 
'location','NW'); 
  
figure (8), plot(y2,yvalPCR,'bo',y,yfitPCR,'r^'); % Plots actual vs 
predicted concentrations for PCR mode 
xlabel('Observed Response'); 
ylabel('Fitted Response'); 
legend({'PCR with 3 Components'},  ... 
'location','NW'); 
  
% Error calculation PCR/PLS 
TSS = sum((y2-mean(y)).^2); 
RSS_PLS = sum((y2-yvalPLS).^2); 
rsquaredPLS = (1 - RSS_PLS/TSS); 
RSS_PCR = sum((y2-yvalPCR).^2); 
rsquaredPCR = (1 - RSS_PCR/TSS); 
  
% Root mean squared error of prediction calculation 
 PLSrmsep=sqrt(sum((y2-yvalPLS).^2)/178) %RMSEP for PLS model 
PCRrmsep=sqrt(sum((y2-yvalPCR).^2)/178) %RMSEP for PCR model 
  
% Applying the model for prediction of an unknown data set 
data=xlsread('Prediction_Data.xlsx','Prediction_Set'); 
X3=data(2:179,in); % Prediction data 
 
[X3] = msc(X3,meanX); 
[X3] = savgol(X3,7,3,1); 
[n,p]=size(X);  
[X3_Scaled]=autoscale(X3,mx,stdx); 
 
yvalPLS = [ones(size(X3_Scaled,1),1) X3_Scaled]*betaPLS3 *stdy+my; 
yvalPCR = [ones(size(X3_Scaled,1),1) X3_Scaled]*betaPCR *stdy+my; 
 
toc 
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1.2. A1. Statistical Plots for Multivariate Models (GLY-H2O) 
Figure 1.1. A1 below show the statistical plots derived from the PLSR and PCR multivariate 
calibration models developed using the codes in Section 1.1. A1. 
 
Figure 1.1. A1: Statistical plots derived from the PCR and PLS multivariate calibration 
models. 
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Appendix 2 
2.1. A2. Urea-Barbituric Acid Co-Crystal Studies in PMSMPR: 
Raman Spectra  
Raman spectroscopy and PXRD are complementary solid state characterization techniques; 
hence both were used to monitor the UBA polymorphic form during each experiment reported 
in the paper. Figure 2.1. A2, experiments 1 – 4 and (5) and Figure 2.2. A2, experiments 6 – 9 
shows Raman spectra of samples taken from the third-stage PMSMPR (MSMPR 3) after 50 min 
(a) and 220 min (b), for unseeded and seeded co-crystallization experiments. 
  
Figure 2.1. A2: Raman spectra of samples taken from each PMSMPR stage during 
experiments 1 – 4 and (5), reference patterns for UBA forms I and III; BA forms I and II; 
urea; a) MSMPR 3 at 50 min and b) MSMPR 3 at 220 min. 
Exp 1. Exp 2. 
Exp 3. Exp 4. 
Exp (5). 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
290 
 
 
Figure 2.2. A2: Raman spectra of samples taken from each PMSMPR stage during 
experiments 6 – 9, reference patterns for UBA forms I and III; BA forms I and II; urea; a) 
MSMPR 3 at 50 min and b) MSMPR 3 at 220 min. 
Highlighted regions in Figure 2.1. 2A and Figure 2.2. 2A were used for polymorph identification: 
367 – 681 cm-1 (aliphatic chain vibrations), 1624 – 1775 cm-1 (C=O stretching) and 2885 – 2990 
cm-1 (C-H stretching).  
2.1. A2. Urea-Barbituric Acid Co-Crystal Studies in PMSMPR: 
PXRD Patterns 
Figure 2.3. A2, experiments 1 – 4 and (5) and Figure 2.4. A2, experiments 6 – 9 shows the 
PXRD patterns of samples taken from each PMSMPR stage at different time intervals. The 
PXRD patterns captured well the change in polymorphic composition in each stage of the 
PMSMPR, particularly in the region 23 – 31° 2θ. Two peaks present at 27° and 29° 2θ, which 
are unique peaks in the patterns of UBA form III and UBA form I, respectively, indicate a 
mixture of UBA form I and III is initially produced. As the PMSMPR progresses the peak at 27° 
2θ is no longer present and there is an increase in the intensity of the peak at 29° 2θ, which 
signifies the conversion to UBA form I.  
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Figure 2.3. 2A: PXRD of samples taken from each PMSMPR stage during experiments 1 – 4 
and (5), showing simulated patterns for UBA forms I, II and III calculated from single crystal 
X-ray data collected at room temperature; a) MSMPR 1 at 30 min., b) MSMPR 2 at 40 min, 
c) MSMPR3 at 50 min., d) MSMPR 1 at 150 min., e) MSMPR 2 at 160 min. and f) MSMPR 3 
at 220 min. 
Exp 1. 
  
  
Exp 2. 
  
  
Exp 3. 
  
  
Exp 4. 
  
  
  
  
Exp (5). 
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Figure 2.4. A2: PXRD of samples taken from the PMSMPR cascade during experiments 6 – 
9, showing simulated patterns for UBA forms I, II and III calculated from single crystal X-ray 
data collected at room temperature; a) MSMPR 3 at 50 min. and b) MSMPR 3 at 220 min.  
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